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Abstract
This thesis describes the exploitation of microbially-derived cis-1,2-dihydrocatechols 
as starting materials for the synthesis of chiral (non-racemic) cyclopropanes.
Chapter One provides an overview of the importance of chiral (non-racemic) 
cyclopropanes and the methods currently available for their synthesis. The potential of 
c/s-l,2-dihydrocatechols to act as precursors of cyclopropanes is then discussed and 
accompanied by a commentary on the manner in which the former compounds are 
generated and currently exploited in chemical synthesis.
Chapter Two details a study of various different ways in which the nitrile-containing 
ds-l,2-dihydrocatechol derivative 63 can be cyclopropanated as well as the manner in 
which certain of the resulting cyclopropanes can be manipulated.
Chapter Three describes work which capitalizes on the results outlined in the 
previous one and which has led to the synthesis of the industrially important pyrethroid 
synthon 87 from the brominated cfs-l,2-dihydrocatechol 14 (X=Br).
The work described in Chapter Four is concerned with elaborating the toluene- 
derived d s-1,2-dihydrocatechol 17 to analogues (e.g. I l l)  of presqualene diphosphate 
(PSDP, 112), a biologically significant monochiral cyclopropane.
Chapter Five outlines work directed towards construction of the polycyclopropyl 
arrays associated with the structurally unique and biologically significant natural 
products FR-900848 (180) and U-106305 (181). The starting materials used in these 
studies were the cd-l,2-dihydrocatechols 14 (X=I) and 16 derived by microbial 
oxidation of iodobenzene and /7-iodotoluene respectively.
The final section of this thesis (Chapter Six) details the experimental procedures 
developed in connection with the work described in Chapters Two-Five.
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Glossary
The following abbreviations have been used throughout this thesis:
2D two dimensional
Ac acetyl
ACC 1 -aminocyclopropane-1 -carboxylic acid
AIDS acquired immuno-deficiency syndrome
app. apparent NMR spectra)
APT attached proton test
Ar aryl
AR analytical reagent
aq. aqueous
atm. atmosphere
Bn benzyl
Bu butyl
Bz benzoyl
c concentration (g/100 mL)
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cat. catalyst
CETP cholesteryl ester transfer protein
Cl chemical ionization
cone. concentrated
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DMAP
DME
DMF
DMSO
ee
EFE
El
equiv.
ether
Et
etc.
eV
GC
h
HETCOR
HIV
HMG-CoA
HPLC
HRMS
Hz
IC50
IR
J
L D 5 0
LDA
LDL-C
M+*
Me
MEPY
4-A,V-(dimethylamino)pyridine
1,2-dimethoxyethane
V,V-dimethylformamide
dimethyl sulfoxide
enantiomeric excess
ethylene-forming enzyme
electron impact
equivalents
diethyl ether
ethyl
et cetera (and so on) 
electron volt 
gas chromatography 
hour(s)
heteronuclear correlation spectroscopy
human immuno-deficiency vims
hydroxymethylglutaryl-CoA
high pressure liquid chromatography
high resolution mass spectrum
hertz
concentration required for 50% inhibition of substrate 
infrared
coupling constant (Hz)
lethal dose required to kill 50% of a population
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molecular ion (mass spectra)
methyl
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MS m ass spectrum
m /z m ass-to-charge ratio
N A D PH nicotinam ide adenine d inucleotide phosphate hydride
NM O A -m ethy lm orpho line  A -oxide
N M R nuclear m agnetic resonance
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Chapter One
1.1  Biologically Significant Cyclopropyl Compounds
The highly strained but generally readily accessible cyclopropane ring-system has 
proven to be a useful building block for the stereo-controlled synthesis of a wide range 
of both cyclic and open-chain compounds.1 This ring-system is also often incorporated 
into synthetically derived compounds of biological interest.2 In addition, these three- 
membered carbocycles are frequently encountered as key structural components within 
a diverse range of naturally occurring compounds,3 including those of marine origin.4 
For example, the novel cytotoxic agent curacin A (1), isolated by Gerwick et. al. in 
1994, has generated significant interest within the scientific community5 and it is the 
most prominent member of a small family6 of potent antimitotic lipids isolated from the 
Caribbean marine cyano bacterium Lyngbya majuscula. The compound consists of a 
disubstituted thiazoline ring bearing a chiral cyclopropane ring and an aliphatic side- 
chain with a single stereogenic centre. Curacin A exerts its anti-proliferative effects 
through a high-affinity association with the colchicine-binding site of the cytoskeletal 
protein tubulin.7 This result is intriguing because curacin A has little structural similarity 
to the alkaloid colchicine.
Constanolactones A and B (2 and 3, respectively), which were isolated from the 
marine red alga Constantinea simplex harvested off the west-coast of the United States, 
are cyclopropane-contain ing  e icosano ids.8’9 These com pounds and other 
cyclopropanated oxylipins each contain twenty carbon atoms and are probably 
biosynthesized from arachidonic acid and eicosapetanenoic acid. As such they are 
thought to be representative products associated with a general pathway in marine 
prostanoid biosynthesis.4’10' 12
2
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O
2, constanolactone A: Rj = OH, R2  = H
3, constanolactone B: Rj = H, R2  = OH
Ambruticin (4) is a representative member of a new class of antibiotics isolated from 
a bacterium belonging to the class Myxobactertales.13 This compound is highly active 
against systematic medical pathogens such as Coccidioides imitus, H istoplasma  
capsulatum and Blastomyces dermatitidis as well the dermatophytic filamentous fungi. 
As a consequence, ambruticin has attracted much attention from synthesis chemists and 
a significant challenge associated with the preparation of this compound involves the 
stereo-controlled assembly of the central cyclopropane ring.14
Derivatives of cyclopropanated diterpene phorbol (5) such as phorbol myristate 
acetate (PMA, 6) are recognized as important compounds for controlling all intracellular 
signal transduction that is mediated through protein kinase C (PKC).15 Recently, the 
related compound prostratin (7) has also attracted attention because of its anti-HIV 
activity.16 Photolabile phorbol esters in which there is a diazoacetyl group at positions 
12 or 13 have been synthesized from phorbol and found to bind with significant affinity 
to the peptide residue (the so-called peptide C domain) incorporating the phorbol ester­
binding domain of PKC.17 As a consequence such phorbol ester derivatives could be 
exploited for photoaffinity labelling of peptide C.
OH
4
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5, phorbol: Rj = R2 = OH
6, PM A: R, = OCO(CH2) i2CH3, R2= OCOCH3
7, prostratin : R) = H, R2 = OCOCH3
There is also considerable interest in the biological properties of non-natural 
cyclopropyl-containing compounds. For example, replacement of proteogenic amino 
acids by their 2,3-methano- or cyclopropyl-amino acid equivalents within a peptide 
chain should lead to conformationally restricted analogues that might have rather 
different and possibly biologically significant properties.18-20 Such "peptidomimetics" 
offer possibilities as biosynthetic and mechanistic probes21’22 and, since the 
cyclopropane ring is probably capable of interacting with both nucleophiles and 
electrophiles, such cyclopropyl compounds could act as suicide inhibitors of various 
enzymatic processes.23
A number of naturally occurring 1-aminocyclopropane-l -carboxylic acids (ACC's) 
are known including the "parent" system 8. The chiral ethyl derivative, 9, which is 
known as coronamic acid, is obtained by hydrolysis of the plant toxin coronatine.24 
Both synthetic and naturally occurring 2,3-methanoamino acids are of great biological 
interest and include compounds which inhibit ethylene-forming enzyme (EFE),25 amino 
tra n s fe ra se ,26 tryptophane hydrolase,27 Dopa decarboxylase,28 histadine 
decarboxylase,29 and carboxypeptidase.23 The majority of these fascinating compounds 
contain optically active cyclopropane units.
H H
8 (ACC) 9 (coronamic acid)
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1 .2  Methods for the Synthesis of Enantiopure Cyclopropanes
Dramatic advances in the understanding of biological processes at the molecular level 
have generated a significant demand for enantioselective syntheses of natural products 
and related therapeutic agents. This situation presents exciting challenges in organic 
synthesis.30 As part of this demand there is a real need for enantioselective routes to 
monochiral cyclopropanes and the following paragraphs outline established work in this 
area.
Besides resolution of their racemates, various synthetic methods have been used for 
preparing optically active cyclopropanes, some of which are now conducted on an 
industrial scale.31 Stoichiometric chiral reagents have been developed for the 
enantioselective cyclopropanation of allylic alcohols32»33 with the most efficient system 
discovered to date involving the dioxaboralane 10 (Schem e 1.1), a bifunctional, 
chiral (non-racemic) ligand containing both an acidic and basic site that allow for 
simultaneous chelation of the acidic Simmons-Smith reagent34 and the basic allylic 
alcohol. As a consequence, highly enantioselective Simmons-Smith cyclopropanation 
reactions can be conducted on a wide range of allylic alcohols.
r3
Zn(CH2I)2
Me2NOQ CONMe2w
Bu
r 3
Yields: >80% 
ee = 88-94%
10
Product Yield E nantioselectivity
>98% ee = 93%
H ° ^
Et
90% ee = 93%
H0^ Pf 85% ee = 94%
Scheme 1.1: Asymmetric Simmons-Smith Cyclopropanations o f Various Allylic 
Alcohols using Dioxaboralane 10.
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Recently, carbohydrate-derived auxiliaries have been employed for the Simmons- 
Sm ith cy c lo p ropana tion  re a c tio n .32’35 For exam ple, extrem ely  high 
diastereoselectivities were observed in the cyclopropanation of the glycosylated 
cinnamyl alcohol 11 using an excess of diethylzinc and diiodomethane (Scheme 1.2). 
Studies have shown that the key structural elements of the ß-D-glucose auxiliary that 
dictate the absolute stereochemistry associated with the product cyclopropane 12 are the 
C-l oxygen and the unprotected alcohol at C-2, with the latter forming the 
corresponding ethylzinc alkoxide with one equivalent of ZnEt2- This alkoxide is an 
efficient bidentate ligand for complexing a second equivalent of the active 
cyclopropanating agent, which is probably Z?f?(iodomethyl)zinc.35g
BnO
BnO
BnO
BnO
BnO
BnO
ZnEt2
OH CH2I2
OH
> 97% yield 
>95%  de
BnO
BnO
BnO
EtZn
BnO
BnO
BnO 9 ^ ^ ^  Ph
o~.
EtZn ' Zn— CH2I 
\
c h 2i
Scheme 1.2
The synthesis of enantiomerically-enriched cyclopropanes can also be achieved by 
using transition-metal based carbenoid reagents to effect cyclopropanation of prochiral 
alkenes. Particularly successful methods have been developed by Davies,36 Evans,37 
Masamune,38 Pfaltz,39 and Doyle.40 For example (Scheme 1.3), in the presence of 
the carbenoid precursor ethyl diazoacetate, styrene is converted into the corresponding
6
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rra/i5-carboxyl-substituted cyclopropane 13 in 99% ee using only 1 mol% of the 
appropriate copper catalyst. Despite these impressive results, the transition-metal 
catalyzed addition of carbenoids to alkenes suffer from a serious drawback, namely, the 
requirement that diazo-carbonyl compounds be used as the cyclopropanating agents 
meaning that products are restricted to carbonyl-containing cyclopropanes. To date, and 
not through lack of effort,41 no efficient means for the enantioselective delivery of 
simple methylene has been achieved using precursor diazo compounds.
Et02C ^ N 2 + P h ' ^
CuOTf
cat
1 mol %
cat =
ph" A
C 0 2Et C 0 2Et
13
tram  : cis = 73 : 27
ee tram = 99% 
ee cis = 91%
95% overall yield
Scheme 1.3
1 .3  B iocatalytic P roduction  of c is - l ,2 -D ih y d r o c a te c h o ls
c/s-l,2-Dihydrocatechols of the general type 14 offer interesting possibilities as 
starting materials for the synthesis of enantiopure cyclopropyl compounds. However, 
before such possibilities are enunciated it is necessary to provide a commentary on the 
production and general utility of these compounds.
In 1968, Gibson's group42-45 elucidated the oxidative pathway by which many 
aromatic compounds are degraded by the soil micro-organism Pseudomonas putida 
(Schem e 1.4).46 The ferrodoxin-based enzyme systems responsible for these 
fascinating conversions have been named dioxygenases and are generally found in 
procaryotes. As part of Gibson's research, he identified a chemically mutated form 
(39D) of Pseudomonas putida that lacked the dehydrogenase enzyme responsible for 
carrying the primary product of arene oxidation, viz. the cis-\ ,2-dihydrocatechol 14, 
further downstream. As a consequence when arenes are presented to this mutant
7
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organism significant quantities of diols of the general type 14 can be accumulated. 
Further, Gibson established that the product of oxidation of toluene, viz. compound 14 
(X=Me), is an enantiomerically pure compound which possesses the illustrated absolute 
configuration.46 Since the original work in this area it has been shown that many arenes 
are cA-dihydroxylated, in a completely regio- and enantio-selective manner, by the 
toluene-dioxygenase enzyme system.47
Pseudomonas 
putida 39D 
or
Escherichia coli 
JM109 (pDTG601)
X = Cl, Br, I, CN, Me etc. 14
Scheme 1.4: Biotransformation o f Arenes by Micro-organisms Containing the 
Toluene-Dioxygenase Enzyme System.
Although Pseudomonas putida 39D is the most commonly exploited micro-organism 
for this type of conversion others are available. In fact the process has now been refined 
to such an extent that recombinant gene technology48 allows for the production of E. 
coli cells which over-express the dioxygenase enzyme responsible for this oxidation 
process, thereby allowing for highly efficient production (up to 35 g of product/litre of 
fermentation broth) of various cis-\ ,2-dihydrocatechols. To date, more than two 
hundred and fifty metabolites produced by dioxygenase-mediated oxidation of 
aromatics have been reported.49 Some examples of metabolites generated from mono- 
and poly-nuclear aromatic substrates are shown in Figure 1.1.
8
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Figure 1.1: Examples ofArene Metabolites Formed via P. putida 39/D and/or E. coli 
JM 109 (pDTG601) Toluene Dioxygenase-Catalyzed Degradation of Polynuclear 
Aromatic Compounds.
The outcome of any particular biotransformation is dependant upon both the 
electronic nature and size of the substituents attached to the aromatic ring undergoing 
reaction.50 For example, microbial oxidation of toluene affords cA-l,2-dihydrocatechol 
(+)-17, while reaction of /7-iodotoluene 15 (with Pseudomonas putida UV4) provides 
a ca. 90:10 mixture of the diols (+)-16 and (-)-16. Thus, in the latter transformation, 
the more bulky iodine atom present within substrate 15 provides the main 
stereodirecting effect (Scheme 1.5).51 Interestingly, monochiral diol (-)-17, viz. the 
enantiomer of the compound obtained by direct microbial oxidation of toluene, is 
generated by hydrogenolytic cleavage of the C-I bond in diols (+)-16 and (-)-16. The 
resulting 90:10 mixture of toluene diols (+)-17 and (-)-17 is then treated with 
Pseudomonas putida NCIMB 8859 which selectively dehydrogenates the minor 
enantiomer and further degrades the resulting catechol to carbon dioxide. As a 
consequence, pure diol (-)-17 is left behind.52
9
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H2, Pd/C
P. putida 
NCIMB 8859 
C 0 2 - --------------------
Scheme 1.5
The biotransformations described above are considered to be "environmentally 
friendly" or "green" since the conversion consumes potentially hazardous aromatic 
compounds. Furthermore, these transformations underscore the potential of biocatalysis 
and the use of enzymes to achieve selective organic transformations and, thereby, 
reducing the waste stream.49 The enzymatic preparation of chiral compounds can, in a 
single reaction step, produce a relatively complex species with defined absolute 
stereochemistry and all this in an aqueous medium.
1.4  Synthetic Applications of c/s-l,2-Dihydrocatecho!s
The ds-l,2-dihydrocatechols derived from aromatic compounds show considerable 
promise as starting materials for the development of both efficient and enantiospecific 
routes to a structurally diverse range of compounds. Given the multiple functionalities 
contained within c/s-l,2-dihydrocatechols of the type 14, there are a number of
10
Chapter One
stereocontrolled transformations possible. The vicinal-c/s-diol moiety offers the 
potential to control the facial selectivity of reactions involving additions to the carbon- 
carbon double-bonds within compounds 14 and thereby dictating the stereochemistries 
of the newly formed stereogenic centres. Thus, through chelation control the 
unprotected cfs-diol unit can direct attack to the syn-face of the diene unit, while the 
steric demands of diol protecting groups such as acetonides normally directs attack to 
the anti-face of the diene unit. Furthermore, the substituent X on the diene unit 
generally strongly differentiates the two double bonds such that one of these is 
generally attacked preferentially in electrophilic addition reactions. This same 
substituent also strongly influences the regioselectivity of Diels-Alder and other 
cycloaddition reactions. The steric demands of the substituent X can also permit 
selective mono-protection/derivatization of the hydroxyl group remote from it. In an 
overall sense, then, these various structural elements generally allow for highly 
controlled reactions of the cA-l,2-dihydrocatechols.
To date, the only commercially manufactured products which are known to exploit an 
arene ds-diol derivative as a synthetic intermediate are those illustrated in Figures 1.2 
and 1.3. In 1995 Genencor reported the "green" manufacture of indigo 19 via the 
indole-derived cA-2,3-dihydrodiol 18 which was obtained using a recombinant strain 
of E. coli containing naphthalene dioxygenase cloned from a Pseudomonas putida
Figure 1.2: Commercial Applications of cis-7,2-Dihydrocatechols.
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species.53 More recently, Merck have produced the HIV protease inhibitor indinavir 
(Crixivan™, 21) using, as a key intermediate, the diol 20 obtained by microbial 
oxidation of indene.54
Within the realm of polymer chemistry, formation of high purity polyphenylene 23 
from benzene cA-l^-dihydrocatechol 22 was first reported in 1983 (Figure 1.3).55 
More recently, a related synthesis of poly(l,4-phenylenevinylene) (PPV56, 26), based 
on the l iving ring-opening metathesis polymerization (ROMP)57 o f 
bicyclo[2.2.2]octadiene derivative 24, has been developed by Grubbs et a/.58 Thus, 
Diels-Alder elaboration of 3,5-cyclohexadiene-cA-l,2-diol 22 afforded &A(carboxylate) 
derivative 24, which was subjected to ring-opening polymerization to provide polymer 
25. This latter material was converted into the commercially significant copolymer PPV 
(26) by thermolytic extrusion of carbon dioxide and methanol.
O
22 24
H3CO(0)CO 0C (0)0C H 3
25
-2n CO2 
-2n MeOH
26 (PPV)
Figure 1.3: The Application of cis-1,2-Dihydrocatechol 22 to Polymer Chemistry
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The ready capacity of cis-\ ,2-dihydrocatechols such as 14 to engage, as the 4n 
component, in diastereofacially selective Diels-Alder cycloaddition reactions with the 
consequent formation of bicyclo[2.2.2]octenes59 has prompted efforts to investigate the 
elaboration of these adducts to decal in, steroid and taxoid skeleta.60'63 For example, the 
simple cis-\ ,2-dihydrocatechol derivative 27 was converted, via reaction sequences 
involving Diels-Alder cycloaddition and anionic oxy-Cope rearrangement steps, into the 
enantiopure decalin 30 (Scheme 1.6).60 By using simple modifications of this 
chemistry the psewdo-enantiomer, 32, of decalin 30 was also able to be prepared from 
acetonide 27.
Scheme 1.6
A Diels-Alder cycloaddition reaction between bromoacetal 33 (Scheme 1.7) and p- 
benzoquinone afforded a single adduct which, after five simple chemical steps, was 
converted into compound 34. The diol moiety within this bicyclo[2.2.2]octanyl- 
containing system was then manipulated so as to give ketone 35. Addition of the chiral
13
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organocerium reagent 36 to this last compound proceeded with high diastereofacial 
selectivity to provide the l,5-dien-3-ol 37 which upon anionic oxy-Cope rearrangement 
and subsequent loss of methoxide ion afforded the highly functionalized steroidal 
nucleus 38. The enantiomer of compound 38 could also be prepared by the addition of 
the optical antipode of the organocerium reagent 36 to ent-35 (itself available through 
straightforward manipulation of diol 34) thus providing an enantiodivergent approach 
to novel steroidal systems.61
OMe OMe
OMe
38 37
Scheme 1.7
A concise synthesis of the AB-ring substructure associated with the enantiomer of 
paclitaxel (Taxol™, 44), which was inspired by the challenge of securing a short route 
to this powerful antimitotic agent,62 is outlined in Scheme 1.8. Thus, a Diels-Alder 
cycloaddition reaction between p-methoxybenzylidene acetal 39 (which is readily 
obtained from c/s-l,2-dihydrocatechol 17) and a-chloroacrylonitrile afforded a 4:1 
epimeric mixture of or/Tzo-adducts 40 which were manipulated, over four steps, to give
14
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the methylenated compound 41. Further chemical transformations of this latter 
compound then afforded the l,5-dien-3-ol 42 which underwent anionic oxy-Cope 
rearrangement upon treatment with sodium hydride to provide the gera-dimethylated 
bicyclo[5.3.1]undecene system 43.63 The protocol just described provides, in a 
concise fashion, access to the AB-ring framework associated with e/r?-paclitaxel. Since 
the compound ent-39 is also available (in ca. 98% ee), via a two-step sequence 
involving microbial oxidation of p-iodotoluene and reductive iodination of the resulting 
cA-l,2-dihydrocatechol (see pages 9-10), then the enantiomer of compound 43 is also 
accessible by this same chemical pathway.
Scheme 1.8
Perhaps the most dramatic illustration of the hidden symmetry elements associated 
with the cA-l,2-dihydrocatechols is Hudlicky's enantiodivergent synthesis of the 
optical antipodes of pinitol, a cyclitol isolated from several plant sources (Scheme 
1.9). 64,65 The pathways leading to these enantiomers are exactly the same in that they 
both start with compound 33 and use identical sets of reagents and conditions.
15
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However, by simply changing the order in which the requisite steps of the reaction 
sequence were carried out, access to either enantiomer was possible. Thus, on the 
pathway to (+)-pinitol, the acetonide derivative, 33, of cis-\ ,2-dihydrocatechol 14 
(X=Br) was dihydroxylated and the resultant diol 45 reductively debrominated with 
lithium aluminium hydride. The ensuing disubstituted olefin was then subjected to 
hydroxy-directed epoxidation and subsequent alumina-promoted methanolysis of the
OSO4
OH
*'/ 
Br
33
1. LiAlH4
2. w-CPBA
3. CH3OH, A120 3
48
1. UAIH4
2. CH3OH, AI9O3
3. 0 s 0 4
H30 + h 3o +
OH OH
H\ A. .^OH H3CO, A.,nOH
h 3co'' sY ^ " oh H O ^ T "OH
OH OH
(+)-47 (-)-47
Scheme 1.9: Enantiodivergent Syntheses of (+)- and (-)-Pinitol, [(+)- and f-j-47, 
respectively].
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epoxide ring gave triol (+)-46. Hydrolytic cleavage of the acetonide moiety then 
provided (+)-pinitol [(+)-47]. By simply reordering the steps in the sequence 
enantiomer (-)-47 could be obtained.
Recently, iterative methods for the synthesis of oligocyclitols, hydrolytically stable 
analogues of oligosaccharides which continue to gain attention because of their 
therapeutic potential, have been developed.66-68 For example, alkenyl epoxide 48 
(Scheme 1.10) and alcohol 50, both of which are readily prepared from cis-1,2- 
dihydrocatechol derivative 33, have been condensed with one another to give the 
conjugate 51. This last compound could then be reacted with epoxide 48 to provide the 
novel carbocyclic nor-trisaccharide 52 (Scheme 1.10).
OH
Br Br Br
52 51
Scheme 1.10
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In the alkaloid domain, the pharmaceutically important natural products lycoridine 
and pancratistatin (57) have recently been synthesized by an extraordinarily concise 
route that further demonstrates the utility of cis-\ ,2-dihydrocatechols in chemical 
synthesis.69' 72 The preparation of compound 57 (Scheme 1.11) began with 
subjection of the diene/acetonide 33 to the Jacobson-Evans aziridination71 protocol. 
The tosyl aziridine 53 so-formed underwent coupling with the cuprate obtained by 
or/7?o-metallation of amide 54. Further chemical manipulations of the resulting 
conjugate, 55, then furnished the diol 56, which, upon reaction with aqueous sodium 
benzoate, provided the naturally occurring and biologically active (-i-)-pancratistatin 
(57).
2 steps
TsN
CONMe2
OH
(hi)
6 steps
57 56
Scheme 1.11: Reagents and Conditions: (i) .s-BuLi, TMEDA, THF, -78 °C. (ii) CuCN, -78 °C. 
(iii) sodium benzoate, H2O.
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1.5 Possibilities for the Synthesis of Enantiopure Cyclopropanes 
from cis-1,2-Dihydrocatechols
c/s-l,2-Dihydrocatechols of the general type 14 offer interesting possibilities as 
starting materials for the synthesis of enantiopure cyclopropyl compounds. In principle, 
monocyclopropanation of diene 14 could lead to any one of four possible 
bicyclo[4.1.0]heptenes, viz. compounds 58-61 (Figure 1.4). If the X group 
associated with such compounds could be removed then the product derived from 
compound 60 would be the enantiomer of that derived from isomer 58. Similarly, 
removal of the X group from within compound 61 would give the enantiomer of that 
compound obtained when the X-group was removed from isomer 59. Alternatively 
(Figure 1.5), oxidative cleavage of the diol 58 would give open-chain dialdehyde
Figure 1.4: Relationships between Four Possible Products Arising from Mono- 
Cycloprop anation of cis-1,2-Dihydrocatechol 14.
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62 while similar treatment of compound 60 would give the enantiomeric dialdehyde 
ent-62. Related manipulation of isomers 59 and 61 would give the enantiomeric pair 
ent-62/62.
Remarkably, for all the substantial activity that has centred on exploiting microbially- 
derived cis-1,2-dihydrocatechols in chemical synthesis there has been almost no effort 
directed towards their use in the synthesis of chiral (non-racemic) cyclopropanes.73-75
ent-62 (X=H) 60 (X=H) 61 (X=H) 62 (X=H)
Figure 1.5: Relationships Between Products Arising from  Oxidative-Cleavage o f 
Mono-Cyclopropanated cis-1,2-Dihydrocatechol Derivatives 58-61.
1 .6  Aims of the Research Work Described in this Thesis
On the basis of the foregoing it would seem that the monochiral c ij- 1,2- 
dihydrocatechols 14 offer unique possibilities as far as the preparation of enantiopure 
cyclopropyl compounds are concerned. Consequently, the primary aim of the current 
study was to explore such possibilities, viz., the synthesis of enantiopure cyclopropyl 
compounds from c/s-l,2-dihydrocatechols. The following chapters describe the 
outcomes of such efforts.
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2 .1  Introduction
The pursuit of the aims enunciated in the previous chapter required an initial 
investigation of methods for effecting cyclopropanation of cfs-l,2-dihydrocatechols of 
the general type 14. Consequently, this chapter describes the outcomes of an 
examination of such reactions which have provided hitherto unreported mono-chiral 
cyclopropanes. Chemical modifications of certain of these compounds, in an attempt to 
provide enantiomeric pairs of non-ring-fused cyclopropanes, have also been examined.
X = Cl, Br, I, CN, Me etc.
2 .2  Mono-cyclopropanation of cj's-1,2-DihydrocatechoIs: an Overview
In principle, there are three obvious and distinct ways in which mono- 
cyclopropanation of cii-l,2-dihydrocatechols of the general type 14 could be effected. 
Firstly, phase-transfer generated dihalogenocarbenes could react with these dienes and 
it might be anticipated that there would be some preference for these electrophilic 
species to add to the more-nucleophilic double-bond within diene 14. In practice,^0 it 
has been shown that dichloro- and dibromo-carbenes do not react very effectively with 
the unprotected diols 14 - such reactions give a complicated mixture of adducts and it 
may be that under these circumstances carbene insertion into the OH bonds is 
complicating matters. In contrast, the readily prepared acetonide derivatives of 14 
engage in a smooth reaction with such carbenes and cyclopropanation almost invariably 
takes place, as expected, at the less-substituted double-bond. The diastereo-facial 
selectivity associated with such reactions is also very high with addition taking place at 
that face of the double-bond opposite to the sterically demanding acetonide unit 75
% Unpublished observations within these laboratories, 1994-1995.
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A regio-complementary outcome to the one just described might be expected if a 
good Michael acceptor was present in the molecule, as could be the case for the diene 
14 (X=CN). Thus, nucleophilic cyclopropanation of such a compound, or perhaps the 
acetonide derivative there-of, might allow for introduction of a methylene bridge across 
the more substituted double-bond. Again, steric factors should ensure good diastereo- 
facial selectivity with the newly introduced cyclopropyl carbon and its associated 
substituents being delivered to that face of the double-bond opposite to the acetonide 
residue.
In principle, Simmons-Smith cyclopropanation of compounds of the general type 14 
should allow cyclopropanation of the a-face of the double-bonds within these 
molecules through an hydroxy-directed processes. In practice, however, the Lewis- 
acidic conditions associated with this type of cyclopropanation reaction result in 
dehydration of the substrate and the formation of phenolic products which are of no 
relevance to the present objectives. Nevertheless, the nucleophilic and electrophilic 
cyclopropanation reactions described in the preceeding paragraphs appeared worthy of 
investigation and studies of such chemistry form the basis of the discussion in the 
following sections.
2.3  Nucleophilic Cyclopropanation of the Benzonitrile-derived cis- 
1,2-Dihydrocatechol
In an effort to examine the potential regio-chemical complementarity between the 
nucleophilic and electrophilic cyclopropanation reactions mentioned above the 
previously described76 acetonide derivative, 63 (Scheme 2.1), of benzonitrile diol 14 
(X=CN) was chosen as a substrate because it is unique amongst the readily available 
cA-l,2-dihydrocatechols in having a built-in Michael-acceptor. Interestingly, when 
benzonitrile diol derivative 63 was subjected to flash column chromatography 
dimerization occurred to give the Diels-Alder product 64 [54% from 14 (X=CN)]. The 
spectral data obtained for this compound were in full accord with those reported by 
Tran et al.,76 and it is pertinent to note that analogous dimers have been obtained from
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related cis-\ ,2-dihydrocatechol derivatives.77 Nevertheless, dimerization could be 
avoided if compound 63 was used immediately after preparation.
Scheme 2.1: Reagents and Conditions: (i) 2,2-dimethoxypropane, p-toluenesulfonic acid (0.05 
mole equiv.), 0 °C, 1 h. (ii) flash column chromatography, silica gel, 54% from 14 (X=CN).
The nucleophilic cyclopropanation of compound 63 was studied first. When this 
compound was reacted with diphenylsulfonium isopropylidene78 (Me2 C=SPh2 ), 
formed in situ by reaction of diphenylethylsulfonium tetrafluoroborate, methyl iodide 
and lithium  diisopropylam ine, then an inseparable  m ixture of two 
monocyclopropanation products, 65 (48%) and 66 (24%), was isolated after column 
chromatography (Scheme 2.2).# The structures of these compounds were established 
through spectroscopic and chemical correlation studies (see below). There are a number
Scheme 2.2: Reagents and Conditions: (i) diphenylethylsulfonium tetrafluoroborate (1.0 mole 
equiv.), LDA (1.1 mole equiv.), THF, DME, CH2 CI2 (5:5:1), -78 °C, 0.75 h then Mel (1.0 mole 
equiv.), 2 h then LDA (1.1 mole equiv.), -78 °C, 1.25 h, 72%.
of features of the reaction portrayed in Scheme 2.2 that deserve comment. In keeping 
with expectation, cyclopropanation of the more-substituted double-bond within
# Reaction first performed by Pallich, S. in these laboratories.
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compound 63 had taken place but, rather surprisingly, there was a significant 
preference for reaction at the seemingly more congested a-face of this substrate. On the 
basis of these results, it would seem possible that there is a high-affinity association 
between the positively charged terminus of the isopropylidene substituted ylide and the 
oxygens contained within substrate 63. A survey of the literature reveals that a similar 
diastereofacial selectivity by Krief et al. in the reaction of y-alkoxy-a,ß-unsaturated 
ester 67 with diphenylsulfonium isopropylidene which produced cyclopropane 68 
(Scheme 2.3) as the exclusive product of reaction.79 Thus, this reaction proceeds by a 
pathway in which the acetonide oxygen(s) of substrate 67 co-ordinate(s) to the ylide 
such that the sterically more-hindered cyclopropanation product, 68, is obtained.
Scheme 2.3: Reagents and Conditions: (i) diphenylsulfonium isopropylidene (3.0 mole equiv.), 
DME, -78 °C, 0.4 h then -60 °C to -50 °C, 0.6 h then -50 °C to 20 °C.
The foregoing observations suggested that installation of a methylene-cyclopropyl 
moiety into nitrile 63, so as to provide compound 69, should be possible via reaction 
with dimethylsulfoxonium methylide.80 To these ends, the acetonide 63 was treated 
with one equivalent of dimethylsulfoxonium methylide at room temperature (Scheme 
2.4). However, after work-up, phenol 70 (76%) was the only isolable product of
Scheme 2.4: Reagents and Conditions: (i) dimethylsulfoxonium iodide (1.5 mole equiv.), NaH, 
DMSO, -78 °C to 0 °C, 2 h, 76%.
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reaction. It seems that under the reaction conditions, compound 63 engages in an 
addition/elimination reaction sequence (Figure 2.1) involving loss of one molar 
equivalent of acetone to provide intermediate 71 which, after aromatization via 
elimination of dimethylsulfoxide and protonation, gives rise to the observed product, 
viz. phenol 70. The spectral data obtained for compound 70 were in full accord with 
the proposed structure.* Thus, in the downfield region of the 300 MHz ]H NMR 
spectrum of this product a doublet ( / = 8.4 Hz) was observed at Ö 7.16 and this is 
assigned to the proton at C5. The remaining downfield resonances, at 8 7.10 (d, J = 
1.8 Hz) and 5 7.00 (dd, J = 8.4 and 1.8 Hz) are attributed to H2 and H4, respectively. 
The three-proton singlet at 5 2.46 is assigned to the methyl-group protons. The 70 eV 
electron impact mass spectrum of compound 70 showed a base peak at m/z 133, which 
corresponds to the expected molecular ion.
Figure 2.1: Proposed Mechanism for the Conversion of Compound 63 into Phenol
70.
Methylation reactions of the type just described and involving dimethylsulfoxonium 
methylide have been observed previously.81 For example, phenalenone 73 reacts with 
this ylide to give 9-methylphenalenone 74, rather than the expected product 72 
(Scheme 2.5).81a In this instance, compound 74 is obtained partly because of co­
ordination of the positive-end of the ylide dipole to the carbonyl oxygen of compound 
73 such that the nucleophilic end of the ylide is closer to the ß'-carbon. Clearly, the 
formation of phenol 70 from compound 63 was of no relevance to main objectives of 
the work described in this thesis. The successful cyclopropanation of diene 63 with
The synthesis of this compound has been reported previously (Chem. Abstr., 1957, 51, 14632b), 
but no spectral data has been provided.
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diphenylsulfonium isopropylylide but not dimethylsulfoxonium methylide might be 
attributed to the operation of the gem-dimethyl (Thorpe-Ingold) effect in the former 
case.82
^ (2r
72 73 74
Scheme 2.5: Reagents and Conditions: (i) dimethylsulfoxonium iodide (1.5 mole equiv.), NaH, 
DMSO, -78 °C to 0 °C, 2 h.
2.4 Attempted Electrophilic Cyclopropanation of the Benzonitrile- 
derived cts-l,2-Dihydrocatechol
Attempts to effect electrophilic cyclopropanation of compound 63 with 
dibromocarbene also yielded some surprises. Thus, treatment of substrate 63 with 
bromoform and aqueous sodium hydroxide in the presence of the phase-transfer 
catalyst benzyltriethylammonium chloride (TEBAC),83 conditions frequently used to 
generate dibromocarbene, afforded a mixture of four adducts which could be separated 
from one another through a combination of fractional crystallization and 
chromatographic techniques (Scheme 2.6). In addition to obtaining significant 
quantities of the expected mono-adduct 76 (27%), compounds 77 (31%) and 78 (7%) 
together with small amounts of a single bis-adduct, 75 (5%), were also obtained.
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Scheme 2.6: Reagents and Conditions', (i) CHBr3 (5.0 mole equiv.), 50% w/v aq. NaOH, 
TEBAC, C6H6, 5 °C to 20 °C, 16 h, 70% overall yield.
Resubjection of purified mono-adduct 76 to reaction with CHBr3/NaOH/TEBAC 
afforded, in quantitative yield, the same his-adduct, 75, as observed originally 
(Scheme 2.7), thus suggesting that the former compound is the precursor to the latter 
in the original reaction involving diene 63.# Confirmation of these structures followed 
from a single crystal X-ray analyses as well as chemical correlation and spectroscopic 
studies (see below). In the 300 MHz iH NMR spectrum of the bis-adduct 75 (Figure 
2.2), the doublets observed at 5 4.90 (J = 8.4 Hz) and 4.48 (7 = 8.4 Hz) are assigned 
to the oxymethine hydrogens, H3a and H5b, respectively. In the more upfield region of 
the spectrum three cyclopropyl hydrogens are apparent, one of which is significantly 
deshielded (5 2.75) relative to the other two (5 2.35). This lower field resonance is 
assigned to the hydrogen (H4a) that is sy/r-related to the nitrile group. The remaining 
signals within the spectrum (two three-proton singlets at 5 1.58 and 1.39) correspond 
to the acetonide methyl group protons of structure 75.
# Interestingly, when compounds 77 and 78 were resubjected to reaction with CHBr3/NaOH/TEBAC 
only the starting materials were recovered.
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Scheme 2.7: Reagents and Conditions: (i) CHBr3 (10.0 mole equiv.), 50% w/v aq. NaOH, 
TEBAC, C6H6, 5 °C to 20 °C, 16 h, 98%.
Inspection of molecular models suggested that both faces of the double-bond within 
compound 76 are hindered [one by the endo-bromine at C(6) and the other by the 
endo-methy\ at C(2)] and, therefore, it was not clear as to the stereochemical outcome 
of the dibromocarbene addition reaction leading from this compound to adduct 75. 
NMR spectroscopic analysis of bis-adduct 75 (Figure 2.2) was not informative in 
this regard so the compound was subjected to single-crystal X-ray analysis.84 These 
data (Figure 2.3) establish that the two cyclopropyl moieties are in an ««^-relationship 
to one another. Furthermore, since it was clear (from NMR spectroscopic studies) that 
alkcne 76 contains a trisubstituted double-bond and is the proven precursor to 75, then 
this crystallographic study also provides definitive proof as to the structure of the 
former compound.
Figure 2.3: CS Chem3D Pro™ Drawing of Compound 75 Generated Using Data 
Derived From an X-ray Crystallographic Study.
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The formation of compounds 77 and 78 in the reaction of diene 63 with 
NaOH/CHBr3 was unexpected in that cyclopropanation of the less nucleophilic of the 
two double-bonds within this substrate has taken place under conditions that might 
normally have been expected to involve generation of electrophilic carbenes which are 
very selective for more nucleophilic alkenes. Consequently, it is proposed that 
tribromomethyl anion (which is the initially generated species in the reaction between 
CHBr3 and NaOH) is adding in a 1,4-fashion to the Michael-acceptor 63 and the 
resulting conjugates, 79 or 80, undergo a 3-exo-tet cyclization reaction to give the 
observed products (Figure 2.4). In other words, the unexpected products 77 and 78 
do not seem so surprising if it is considered they are really likely to be products of a 
nucleophilic cyclopropanation reaction (albeit a rather unusual one). There is literature 
precedence for the 1,4-addition of the trihalomethyl anion to Michael-acceptors as a 
competitive process in dihalocarbene addition reactions.85 Indeed, in some cases, it 
may be that the products of formal cyclopropanation derive from cyclization of the 
Michael addition product and not from direct carbene addition.86
Na+ o h " 
+
HCBr3
-H2Q
Na+ 'CBr3 Na+Br' + :CBr2
Figure 2.4: Proposed Mechanism for the Conversion of Diene 63 into Products 77 
and 78.
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The acquisition of compounds 77 and 78 allowed for the conduct of a chemical 
correlation study (Scheme 2.8) which enabled proof of the structures of compounds 
66 and 65. Thus, reaction of each of compounds 77 and 78 with methyl iodide and 
the higher order cuprate Me2 C u (C N )L i2 ,87 readily obtained by reaction of 
methyllithium with cuprous cyanide, resulted in their smooth conversion into the 
corresponding gem -dimethylated cyclopropanes 66 and 65, compounds which had 
been obtained earlier while investigating the reaction of diene 63 with 
diphenylsulfonium isopropylidene.
Scheme 2.8: Reagents and Conditions: (i) CuCN (10.0 mole equiv.), MeLi (20.0 mole equiv.), 
Mel (36.0 mole equiv.), THF/Et20, -78 °C to 0 °C, 0.5 h, 85% for 66 and 78% for 65 .
Sufficient quantities of compounds 66 and 65 were available by this second route 
such that straightforward recrystallization of each could be carried out. This provided 
samples of sufficient quality for single crystal X-ray analyses of each compound 
(Figure 2.5) to be undertaken and, thereby, allowing for definitive proof of structure. 
These studies not only proved the stereochemical outcomes associated with the reaction 
between nitrile 63 and diphenylsulfonium isopropylidene, but also of compounds 77 
and 78, derived from "electrophilic" cyclopropanation of substrate 63.
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Figure 2.5: CS Chem3D Pro™ Drawing o f Compounds 66 (left) and 65 (right) 
Generated Using Data Derived From an X-ray Crystallographic Study.
2.5 Synthesis of non-Ring-Fused Cyclopropanes in Enantiopure Form
A further objective of the present work was to assess the capacity of cyclopropanes 
such as 66 to participate in reaction sequences involving oxidative cleavage of cis- 
vicinal-diol moieties. This type of reaction should lead to open-chain cyclopropanes 
containing malono-half-nitrile substructures which might be expected to undergo 
thermally-induced decarboxylation and, thereby, allow for construction of trans-1,2- 
disubstituted cyclopropanes, structures which are ubiquitous in nature (see, for 
example, compounds 2-4 shown on page 3). In order to explore such possibilities, 
compound 66 was hydrogenated (Scheme 2.9) under standard conditions to furnish 
the saturated analogue 81 in 99% yield. Hydrolysis of the acetonide moiety within 
compound 81 using 60% aqueous acetic acid at 80 °C then afforded the cis-diol 82 
(94%) as a white powder. Lead tetraacetate-mediated oxidative cleavage of glycol 82 
provided the dialdehyde 83 (88%) as a stable oil. The spectral data obtained for the 
latter compound were in full accord with the proposed structure. Thus, in the downfield 
region of the 300 MHz *H NMR spectrum of compound 83 two singlets were 
observed at 8 9.76 and 8 9.58 and these are assigned to the aldehyde hydrogens present 
within the structure. In the aliphatic region of the spectrum the two-proton triplet at 5 
2.55 and the two-proton multiplet at 8 2.05 are assigned to the methylene hydrogens
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within compound 83. The remaining signals correspond to the protons of the gem- 
dimethyl moiety (5 1.50 and 1.38). In an effort to access structures which embody a
rrGms-l,2-disubstituted cyclopropane ring, compound 83 was oxidized with silver 
oxide (Ag2Ü) to give diacid 84, which was characterized as the corresponding diester 
85 (65% from 83). However, efforts to effect thermally-induced decarboxylation of 
acid 84 in refluxing carbon tetrachloride,88 so as to give a /röms-l^-disubstituted 
cyclopropane, were unsuccessful because of a competing lactonization to give 
compound 86 (56%). The spectral data obtained for this product were in full accord 
with the proposed structure. Thus, a 13C NMR study revealed that this product contains 
three quaternary (C), one methine (CH), three methylene (CH2) and two methyl (CH3) 
carbons. The 70 eV electron impact mass spectrum of compound 86 showed a base
peak at m/z 167, which corresponds to the expected molecular ion. The conversion
Scheme 2.9: Reagents and Conditions: (i) 10 % Pd/C, H2, EtOH, 20 °C, 40 h, 99%. (ii) AcOH 
(60% aq.), 80 °C, 20 °C, 16 h, 94%. (iii) Pb(OAc)4 (2.15 mole equiv.), CaC03 (12.2 mole equiv.), 
CH2C12, 0 °C, 0.75 h, 88%. (iv) AgN03 (5.0 mole equiv.), KOH (42.0 mole equiv.), EtOH/H20, 20 
°C, 6 h. (v) CH2N2 (excess), CH2C12, 0 °C, 2 h, 65% from 83. (vi) CC14) reflux, 6 h, 56%.
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(84 —> 86) most likely involves homo-Michael addition of the less-hindered carboxylic 
acid moiety to the gem-dimethylated carbon of the cyclopropane ring which cleaves to 
give a carbanion stabilized by both the nitrile and remaining carboxylic acid groups. 
After a prototropic shift within the initial cyclization product, decarboxylation ensues to 
give the observed lactone 86.
In principle, by using essentially the same reaction sequence developed for the 
synthesis of compound 83, its enantiomer (ent-83), should be accessible from nitrile 
65. Such chemistry would establish an enantiodivergent route to monochiral and non­
ring-fused cyclopropanes from the single benzonitrile diol 63 precursor. However, 
because of the limitations of time, such reactions were not performed.
2.6 Summary
The reactions described in this chapter reveal something of the scope and limitations 
associated with nucleophilic and electrophilic cyclopropanation of c is -1,2- 
dihydrocatechols. They also form the basis of chemistry that has been used for the 
synthesis of an important pyrethroid synthon, details of which are provided in the 
following chapter.
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3 .1  Introduction
The work described in the previous chapter suggests that enantiopure c is-1,2- 
dihydrocatechols could be elaborated, via  regio- and/or diastereo-selective 
cyclopropanation reactions, to various cyclopropane-containing compounds. The aim of 
the work described in this chapter was to examine the use of compound 17 as the 
starting material for the synthesis of the chiral (non-racemic) cyclopropane 87, a key 
synthon associated with the production of the commercially significant (1/?, cis)- 
pyrethroid class of insecticides such as Deltamethrine™ (88).
3 .2  Biological and Commercial Significance of (17?, cis)-Pyrethroid 
Insecticides
Pyrethroids are used worldwide as insecticides in both domestic and agricultural 
contexts.89’90 Pyrethrins, which are the original and natural insecticides found in 
certain Chrysanthemum species, have provided the lead compounds from which more 
active synthetic analogues have been developed. The commercial pyrethroids are 
superior to the natural ones in that only low application rates are required because the 
former, but not the latter, compounds exhibit high photostability. Furthermore, the 
commercially produced compounds have low mammalian toxicities and are 
biodegradable. One of the most generally successful commercial products within this 
group is Deltamethrine™ (88) which is marketed by Rhone-Poulenc Rohrer.91
Pyrethroids are nerve-ending poisons and the precise electrophysical effects they 
exert are dependant upon their exact structure. Such effects can include uncoupling of
37
Chapter Three
the motorneuron in the ganglion and/or repetitive back-firing of the motoraxon to the 
central nervous system and neuromuscular junction. Besides a whole set of structural 
demands, a definite range of lipophilicity is essential for the insecticidal action of 
pyrethroids.89 The more polar compounds, like the naturally occurring pyrethrin II 
(89), tend to act more rapidly, at least in terms of their transient knock-down effect. 
Structural variations, studied over the last thirty years, have culminated in many active 
compounds, some of which bear, at first glance, little or no resemblance to the natural 
materials. However, it has recently been proposed that all active pyrethroid insecticides 
must be able to adopt a "horseshoe" or "clamp" conformation in the target and 
membrane-bound protein within the sodium-channel of the nerve ending of the insect.89
Many pyrethroids are sold as mixtures of all possible stereoisomers, although the one 
possessing the (1/^-stereochemistry at the cyclopropane ring usually embodies almost 
all of the biological activity. Only in rare instances, such as in the case of 
Deltamethrine™ (88), has the active enantiomer been marketed exclusively.
89 (pyrethrin II) 90 (pyrethrin I)
3.3  Current Methods for the Synthesis of (1R, c/s)-Pyrethroid 
Insecticides
Worldwide, many hundreds of tonnes of pyrethroid insecticides are produced 
annually. The quest for higher activity and the highest possible cost/efficacy ratios has 
prompted great efforts by industrial and academic groups to develop ever more practical 
and stereoselective routes to the most active compounds. A large number of synthetic 
routes to chrysanthemic acid (the parent core of the pyrethroids) and its analogues have
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been disclosed,89' 92 although often only in the patent literature. Most of these routes 
lead to a mixture of cis- and trans-diastereoisomers and only very few enantioselective 
syntheses of the biologically active enantiomers have been described. The latter involve 
the use of chirons,93 asymmetric induction employing chiral auxiliaries,94 chiral 
catalysts95 and enzymes 96
The crucial gem-dimethyl cyclopropyl unit contained within pyrethroid insecticides 
can be incorporated by nucleophilic cyclopropanation techniques using a phosphonium- 
or a sulfonium-isopropylylide. Much of the work of this type has been carried out in 
Krief s laboratory over the past twenty years.79 For example, his group has shown that 
by starting with cheap materials such as L-tartaric acid, the £>/s-y-alkoxy-oc,ß- 
unsaturated ester 91 (Scheme 3.1) can be produced and then subjected to reaction 
with diphenylsulfonium isopropylidene. In this manner the bA-cyclopropanated 
compound 92 was obtained in an almost completely diastereoselective79 fashion. This 
last compound was transformed into the desired methyl (\R ,3S  ,cis)-\\Qmicaromc 
aldehyde (87), precursor of Deltamethrine™  (88),97 by hydrolysis of the 1,3- 
dioxolane moiety and oxidative cleavage of the resulting vicinal-diol moiety.
v
Scheme 3.1: Reagents and Conditions: (i) diphenylsulfonium isopropylidene (3.0 mole equiv.), 
DME, -78 °C, 0.4 h then -60 °C to -50 °C, 0.6 h then -50 °C to 20 °C. (ii) 2 M HCIO4 (6.0 mole 
equiv.), THF, 20 °C, 6 h. (iii) NaI04 (1.5 mole equiv.), MeOH, pH 7.2, 20 °C, 1 h.
In an alternate approach to pyrethroids developed by A. I. Meyers at Colorado State 
University, cyclopropanation of chiral oc,ß-unsaturated bicyclic y-lactam 93 with 
diphenylsulfonium isopropylidene afforded the gem-dimethyl cyclopropyl adduct 94 in 
94% and as a single diastereom er ( S c h e m e  3.2).  The high levels of
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diastereoselectivity obtained in this reaction are attributed to the stereo-directing effect of 
the rm -butyl moiety present within the starting material. The chiral cyclopropane 94 
was elaborated over six steps, to (-)-deltamethrinic acid (95), the optical antipode of the 
commercial material.98
Scheme 3.2: Reagents and Conditions: (i) diphenylsulfonium isopropylidene (3.0 mole equiv.), 
DME, -78 °C, 0.25 h then -60 °C to -50 °C, 0.45 h then -50 °C to 20 °C. (ii) Red-Al (0.7 mole 
equiv.), THF, 20 °C, 12 h. (iii) Bu4NH2P 04, CH2C12/H20  (1:1), 20 °C, 96 h. (iv) CBr4, PPh3. (vii) 
Br2, NaOH, -10 °C, 1 h then reflux, 1 h.
Currently, manufacture of chrysanthemate 87, the key intermediate for the synthesis 
of (1R ,  cfsO-pyrethroids, is based on ozonolytic degradation of optically active trans- 
chrysanthemic acids, which are themselves obtained by resolution of synthetically 
derived racemic acid.99 Thus, treatment of frarcs-chrysanthemic acid 96 with D-(-)- 
threo-amine (97) resulted in the clean separation of the salt of the (1R, trans)-acid. 
Isolated by simple filtration, this salt yielded, after acidification, pure (1R, trans)- 
chrysanthemic acid (Scheme 3.3).
2. Fractional Recrystallization
3. Acidification HO O
96
(racemic)
96
(1R, trans)
Scheme 3.3: Commercial Method Used fo r  the Resolution o f (±)-trans- 
Chrysanthemic Acid 96.
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3 .4  Chemoenzymatic Route to a Key Intermediate for the Synthesis of 
(1/?, c/s)-Pyrethroids
It was envisaged that the microbially-derived c/s-l,2-dihydrocatechol 17 could be 
exploited for the synthesis (in near enantiopure form) of the key pyrethroid synthon 87. 
The relevant retrosynthetic analysis associated with the proposed study is outlined in 
Figure 3.1. Thus, it was anticipated that compound 87 could be derived from 
oxidative cleavage of the acyclic vicinal-diol 98 which could, in turn, be obtained via 
ozonylitic cleavage of the double bond present in the A4-carene 99.* The precursor to 
compound 99, viz. bicycle 100, should be available via diastereo- and regio-selective 
addition of dibromocarbene to the bis-TBS ether of c/s-1,2-dihydrocatechol 17.
Figure 3.1: Retrosynthetic Analysis of Pyrethroid Synthon 87 Based Upon Using 
the Toluene-Derived cis-1,2-Dihydrocatechol 17 as Starting Material.
In the event, when the TBS-protected derivative, 101, of the toluene-derived cis- 
1,2-dihydrocatechol 17 (Scheme 3.4) was reacted with dibromocarbene, an 
inseparable ca. 1:2 mixture of regioisomeric adducts, 100 and 102, was observed. As
* Efforts aimed at effecting a related conversion of the naturally occurring A-^-carene into cyclopropane 
87 have been reported.^®
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a consequence, this mixture of compounds was subjected to reaction, at -78 °C, with 15 
molar equivalents of the higher order cuprate Me2Cu(CN)Li2 and methyl iodide. In this 
way the corresponding mixture of trimethylated compounds, 99 and 103, was 
obtained and these products could be separated from each other by chromatography on 
silica gel.
In the 300 MHz *H NMR spectrum of compound 99, the one-proton singlet at 5 
5.39 is assigned to the olefinic hydrogen. In the more upfield region of the spectrum 
two oxymethine hydrogen resonances are apparent at 8 3.65 (d, J  = 2.6 Hz) and 3.33 
(dd, J  = 5.0 and 2.6 Hz) while the resonance at 8 1.73 is assigned to the methyl group 
at C-4 within compound 99. In the aliphatic region of the spectrum, the resonances at 8 
1.55 and 1.14 are assigned to the two cyclopropyl protons. The hydrogens of the 
geminally related methyl groups attached to the cyclopropane rings resonate at 8 1.12 
and 0.93, while the remaining resonances within the spectrum correspond to the TBS- 
ether hydrogens. The 300 MHz *H NMR spectrum of regioisomer 103 was rather 
similar save for the fact that two resonances, due to the vicinally-related olefinic
Scheme 3.4: Reagents and Conditions: (i) TBSC1 (2.5 mole equiv.), imidazole (4.0 mole equiv.), 
DMF, 20 °C, 3 h, 98 %. (ii) CHBr3 (5.0 mole equiv.), 50% w/v aq. NaOH, TEBAC, C6H6, 5 °C to 
20 °C, 16 h, 68%. (iii) CuCN (10.0 mole equiv.), MeLi (20.0 mole equiv.), Mel (20.0 mole equiv.), 
THF/Et20 , -78 °C to 0 °C, 0.5 h, 80%.
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hydrogens, were observed at 8 5.85 and 5.72. The single cyclopropyl hydrogen (at C6) 
appeared at 8 1.55.
A more satisfactory means of gaining access to the key A4-carene 99 is shown in 
Scheme 3.5 and starts with the /^-(ferf-buty ld im ethylsily l) ether, 104, of the 
bromobenzene-derived ds-l,2-dihydrocatechol 14 (X=Br). The former compound was 
readily obtained by reacting diol 14 (X=Br) with terf-butyldimethylsilyl chloride in the 
presence of imidazole (94%). Treatment of compound 104 with dibromocarbene, 
generated under phase-transfer conditions from bromoform and aqueous sodium 
hydroxide, then afforded the cycloadduct 105 (64%) as the only isolable product of 
reaction. Thus, in keeping with related conversions,73 carbene addition occurred in a 
completely selective manner to the less-hindered face of the more electron-rich double­
bond within diene 14 (X=Br). Compound 105 was subjected to reaction, at -78 °C, 
with twenty-two molar equivalents of the higher order cuprate Me2 Cu(CN)Li2 and 
methyl iodide which resulted in formation of a trimethylated compound, 99 (70%), 
having spectral properties identical with those observed for the product of reaction of 
compound 100 with the higher order cuprate Me2Cu(CN)Li2 (Scheme 3.4).
Ozonolytic cleavage of the double bond within the A4-carene 99, followed by 
reductive work-up with dimethyl sulfide then afforded the keto-aldehyde 106. In the 
300 MHz *H NMR spectrum of this product (Figure 3.2) the most downfield 
resonance appeared as a doublet (7 = 3.7 Hz) at 8 9.69 and is attributed to the aldehyde 
proton. The signals for the oxymethine hydrogens appeared as a one-proton doublet of 
doublets at 8 4.20 (J  = 12.0 and 3.2 Hz) and a doublet at 3.75 (7 = 3.2 Hz). The three- 
proton singlet at 8 2.20 is ascribed to the acetyl group protons while the cyclopropyl 
hydrogens resonate at 8 1.97 and 1.53. In the aliphatic region of the spectrum, the 
resonances at 8 1.26 and 1.25 are assigned to the hydrogens of the geminally-related 
cyclopropyl methyl groups. The remaining resonances correspond to the hydrogens of 
the TBS-ether moieties.
Attempted oxidation of compound 106 to the corresponding acid using either silver 
oxide (Ag20) or pyridinium dichromate (PDC) afforded complex mixtures of products.
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Scheme 3.5: Reagents and Conditions: (i) TBSC\ (2.5 mole equiv.), imidazole (4.0 mole equiv.), 
DMF, 20 °C, 3 h, 94%. (ii) CHBr3 (5.0 mole equiv.), 50% w/v aq. NaOH, TEBAC, C6H6, 5 °C to 20 
°C, 16 h, 64%. (iii) CuCN (23.0 mole equiv.), MeLi (46.0 mole equiv.), Mel (22.0 mole equiv.), 
THF/Et20, -78 °C to 0 °C, 0.5 h, 70%. (iv) O3 (excess), CH2CI2, -78 °C, 0.1 h then Me2S (excess), 
-78 °C to 20 °C, 4 h, 78%. (v) NaC102 (3.0 mole equiv.), NaH2P04 (1.0 mole equiv.), 2-methyl-2- 
butene (2.5 mole equiv.), t-BuOH/THF/H20, 0 °C, 3 h. (vi) CH2N2 (excess), Et20/CH2Cl2, 0 °C, 2 
h, 86% from 106. (vii) TBAF.H20  (3.0 mole equiv.), THF, 20 °C, 3 h, 64%. (viii) Pb(OAc)4 (2.1 
mole equiv.), CaC03 (12.0 mole equiv.), CH2CI2, 0 °C, 0.75 h, 71%.
However, Pinnick's sodium chlorite (NaC102) procedure101 cleanly produced the 
desired acid which was immediately converted (using ethereal diazomethane) into the 
corresponding methyl ester 107 (86% from 106). Completion of the synthesis of 
target 87 simply required two-fold desilylation of compound 107 followed by 
oxidative cleavage of the resulting open-chain diol 98. However, the first of these 
conversions proved to be anything but straightforward. Ceric ammonium nitrate (CAN) 
is known to remove TBS-ethers as well as oxidatively cleave glycols,102-103 so it was 
conceivable that the two steps just mentioned could be achieved by this one reagent.
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Unfortunately, when treated with CAN, substrate 107 gave a complex mixture of 
products which included the target 87, albeit in low yield. Similarly, treatment of the 
substrate with tetra-n-butylammonium fluoride (TBAF) in THF gave many products, 
including a trace (c a . 10%) of compound 87. The formation of this latter compound 
under these conditions probably occurs via a fluoride ion-promoted retro-aldol reaction 
(Figure 3.3). Treatment of bis-ether 107 with HF-pyridine gave the desired diol but, 
even under the most favourable circumstances, in only 30% yield. Finally, it was 
established that treatment of the substrate with TBAF hydrate gave the desired keto-diol 
98 in acceptable yield (64%). The synthesis was then completed by lead tetraacetate- 
promoted cleavage of diol 98 which afforded the target cyclopropane 87 in 71% yield.
Figure 3.3: Proposed Mechanism fo r  the Fluoride-ion Induced Conversion o f 
Compound 107 into Hemicaronic Aldehyde 87.
The spectral data obtained for compound 87 were in full accord with those reported 
previously.104 In the downfield region of the 300 MHz !H NMR spectrum of this 
product (Figure 3.4) a doublet (,J = 6.5 Hz) was observed at 6 9.76, and is assigned 
to the aldehyde proton. The singlet at 8 3.71 is attributed to the methyl protons of the 
ester group. Two one-proton cyclopropyl resonances were observed with the doublet ( J  
= 8.0 Hz) at 5 2.14 being assigned to HI, while the (apparent) triplet (7=  8.0 Hz) at 5 
1.85 is assigned to the neighbouring cyclopropyl-hydrogen, H3. The magnitude of the 
vicinal coupling ( J  = 8.0 Hz) suggests a cA-stereochemistry about the cyclopropane 
ring, as required.104
Two low-field resonances (at 8 200.8 and 170.7) were observed in the 75.4 MHz 
13C NMR spectrum of compound 87 (Figure 3.5) and the former signal is assigned
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to the aldehyde carbon, while the latter is assigned to the carbonyl carbon of the methyl 
ester moiety. The signal at 8 57.5 is assigned to the s/?3-hybridized carbon of the methyl 
ester. In the upfield region, the two signals at 8 41.1 and 36.3 are attributed to the sp3- 
hybridized cyclopropyl carbons bearing hydrogens. The quaternary cyclopropyl carbon 
resonates at 8 30.2, while the remaining signals, at 8 28.5 and 15.2, correspond to the 
two methyl group carbons associated with compound 87.
In the infrared spectrum of pyrethroid 87 two characteristic carbonyl stretching 
bands were observed at 1729 and 1701 cm-1. The 70 eV electron impact mass spectrum 
of compound 87 showed a MH+ ion at m/z 157 and a prominent fragment ion at m/z 
141 which is presumably due to loss of methyl radical. The specific rotation observed 
for the sample of compound 87 {[oc]d20 - 55.0 ° (c 1.3, chloroform)} prepared by the 
route just described was in general agreement with reported values {e.g. [oc]d20 - 76.9 
° (c 17.1, acetone)104}.
3 .5  C onclusions
The microbial oxidation product 14 (X=Br) has been converted into the chiral (non- 
racemic) cyclopropane 87, a key synthon for the commercially significant (1R, cis)- 
pyrethroid class of insecticides. The reaction sequence serves to highlight the potential 
utility of microbially-derived cis-1,2-dihydrocatechols in the preparation of monochiral 
cyclopropanes.105
While there are some attractive features to the sequence just described there is 
definitely room for improvement especially in respect to the matter of atom economy. 
Thus, as the synthesis of compound 87 stands at present only four of the carbon atoms 
present in c/s-l^-dihydrocatechol 14 (X=Br) are carried through to the target. This 
situation could be improved dramatically if it were possible to effect diastereofacially 
selective g^ra-dimethylcyclopropanation of starting material 14 (X=Br) such that this 
reaction occurred from the a-face (Scheme 3.6). The product of the reaction, viz. 
compound 108, could then be subjected to oxidative cleavage of the cis-vicinal-diol 
m oiety so as to produce dialdehyde 109 , which through brom inative
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decarbonylation106 of the allylic aldehyde group might be converted into the 
Deltamethrine™ precursor 110.
Of course, the greatest challenge associated with implementing such ideas involves 
achieving the pivotal cyclopropanation reaction [viz. 14 (X=Br) —» 108] in a diastereo- 
and regio-selective manner. Our present state of knowledge concerning the 
cyclopropanation of c/s-l^-dihydrocatechols does not suggest an obvious way of 
achieving this. Nevertheless, such important objectives are being pursued by other 
members of this laboratory.
14 (X=Br)
Scheme 3.6
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4 .1  Overview
In the preceeding chapter a means for converting ds-l,2-dihydrocatechol 14 (X=Br) 
into a key intermediate, 87, associated with the synthesis of commercially significant 
pyrethroid insecticides was described. The aim of the work described in this chapter 
was to use cis-1,2-dihydrocatechol 17 as the starting material for the synthesis of the 
chiral (non-racemic) cyclopropane 111, which, by virtue of it being a structural 
analogue of presqualene diphosphate 112 (PSDP), was expected to be a potential 
inhibitor of cholesterol biosynthesis. The difference between the target compound 111 
and the natural product 112 is that the positions of the side-chains have been 
interchanged. As such, compound 111 should be recognized by the relevant enzyme 
systems but not be able to be processed by them.
112 (presqualene diphosphate, PSDP)
4 .2  Biological Properties of Presqualene Diphosphate
An important means for reducing the concentration of low-density lipoprotein 
cholesterol (LDL-C) in blood plasma, a key risk factor in coronary heart disease, is to 
inhibit cholesterol biosynthesis.107’108 The biosynthesis of cholesterol comprises some 
twenty-six reaction steps, and these are summarized in Figure 4.1. A number of 
therapeutic agents for the treatment of elevated LDL-C levels are presently available and 
these act to reduce levels of mevalonic acids by inhibiting hydroxymethylglutaryl-CoA 
(HMG-CoA) reductase.109 This desirable effect on plasma LDL-C is a consequence of
52
Chapter Four
Acetyl-CoA
HMG-CoA
HMG-CoA
Reductase < =
Lovastatin
Fluvastatin
Mevalonate
Isopentenyl - Dimethylallyl
Diphosphate Diphosphate
Farnesylate
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tRNA
Geranyl
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Squalene
Synthase
Squalene
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Epoxidase
trans-Prenyl 
Transferase
ds-Prenyl
Transferase(3S)-2,3-Oxidosqualene
Oxidosqualene
Cyclase
Lanosterol
Ubiquinone Cholesterol Dolichol
Figure 4.1: Biosynthetic Pathway Associated with the Production o f Cholesterol and 
Bio genetically Related Compounds.
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inhibition of cholesterol biosynthesis in the liver, leading to the upregulation of the LDL 
receptor. However, mevalonate is an important precursor for non-steroidal isoprenoids 
such as dolichol, ubiquinone and isopentenyl tRNA. It is also required for production 
of farnesyl diphosphate and geranylgeranyl diphosphate, the terpenoid compounds 
necessary in protein prenylation (Figure 4 .1).110' 112 Clearly, then, inhibition of the 
biosynthesis of mevalonic acid will have some undesirable side-effects. The concerns 
raised by such matters have prompted many researchers to focus their efforts on the 
development of inhibitors of cholesterol biosynthesis that act at alternate (especially 
later) points on the pathway. One of these is the first committed step in the biosynthesis 
of cholesterol, which is catalyzed by squalene synthase (SQS) .113-119 Thus, this 
enzyme effects the T-l coupling120 of farnesyl diphosphate 113 so as to produce the 
triterpene squalene 114 via the intermediate cyclopropane presqualene diphosphate 
(PSDP, 112, Figure 4 .2 ).121 It is thought that PSDP (112) rearranges to squalene 
114 by a series of steps that involve loss of inorganic pyrophosphate (PPj), 
rearrangement of the hydrocarbon skeleton and incorporation of hydrogen from 
nicotinamide adenine dinucleotide phosphate hydride (NADPH) .122 A key feature of 
the pathway associated with this transformation is the likely involvement of a tertiary 
cyclopropylcarbinyl cationic intermediate 115 (Figure 4 .3).123 Because of its key 
position in the biosynthetic pathway, squalene synthase is an attractive target for the 
development of pharmacological drugs to reduce serum cholesterol levels. Presumably 
inhibition of this enzyme would not lower levels of important non-steroidal isoprenoids 
in the cell.
Interestingly, very recently PSDP has been shown to act as a potent signalling agent 
that regulates oxygen-radical formation in neutrophils, a key response in microbial 
killing, inflammation and tissue injury.124 On the basis of the foregoing, it would seem 
that PSDP analogues could be very important compounds from a biological standpoint.
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-cr5:cr ''o
H+
112 (presqualene diphosphate, PSDP)
-NADPH
NADP+, PPj
Figure 4.2: Biosynthesis o f Squalene ( 114)  from  Farnesyl Diphosphate (113).
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Figure 4.3: Putative Carbocationic Intermediates 115-117 Involved in the 
Conversion o f Presqualene Diphosphate (112) into Squalene (114).
4 .3  Squalene Synthase (SQS) Inhibitors
Notable progress has been made in the development of PSDP analogues capable of 
inhibiting squalene biosynthesis and metabolism . 125 For example, many stable 
analogues of farnesyl diphosphate have been synthesized, and a good proportion of 
these are inhibitors of SQS. Analogues of PSDP that mimic its reductive rearrangement 
to squalene have also been developed. Thus, compounds 118-120 (Figure 4.4) were
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all designed to mimic the carbocationic species 115-117 and, indeed, in the presence 
of added inorganic diphosphate (PPp, they proved to be good inhibitors of SQS.126’127
HO
\
120
Figure 4.4: Analogues o f PSDP that Inhibit Squalene Synthase (SQS).
The screening of fermentation cultures for natural products that inhibit SQS has also 
proven fruitful. Several novel fungal metabolites that act as potent inhibitors have been 
discovered with, perhaps, the most notable examples being squalestatins 1 [a.k.a. 
zaragozic acid A (121)], 2 and 3.128-130
zaragozic acid A / squalestatin 1 (121)
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4 .4  Methods for the Synthesis of Presqualene Diphosphate
Several syntheses of racemic presqualene alcohol, the necessary precursor to PSDP, 
have been reported,131' 133 including one where the required alcohol was obtained in 
enantiomerically pure form via resolution of the racemate.134 However, only one 
enantioselective synthesis of (+)-presqualene alcohol has been described to date.135 
Thus, the natural, (\R,2R,3R), enantiomer of PSDP (112) was synthesized from 
farnesol in greater than 98% ee by Poulter et al. (Scheme 4.1). The key step was an 
intramolecular and enantioselective cyclopropanation of famesyl diazoacetate ( 122) 
which was catalyzed by treatment of this compound with the chiral rhodium catalyst 
(Rh2[5(/?)-MEPY]4) and provided the lactone 123 in greater than 94% enantiomeric 
excess. Standard manipulation of compound 123 afforded aldehyde 124 which was 
then elaborated, in a straightforward manner, to PSDP (112).135
4 .5  Design of a Potential Squalene Synthase Inhibitor
On the basis of the foregoing, it was envisaged that cyclopropane 111 could act as a 
potent inhibitor of SQS and, hence, the biosynthesis of cholesterol. This proposal was 
based on the idea that a structurally related analogue of PSDP such as compound 111, 
which has the same overall carbon-chain length and stereochemistry (about the central 
cyclopropane unit) as the natural substrate 112, would be recognised by the SQS
112 (presqualene diphosphate, PSDP)
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123
(ii)-(vi)
(vii)-(x)
o 6p 2o h 2c * H
^ \ / \ r
112 (presqualene diphosphate, PSDP)
Rh2[5(R)-MEPY]4
M e02C 9
Rh-----Rh
N C 02Me 
0
O'J ,n 2 i COjMe
M c O j C ,  .  * ■  —  I
H
Scheme 4.1: Reagents and Conditions: (i) Rh2[5(/?)-MEPY]4, CH2CI2, reflux, 96%. (ii) NaOH, 
MeOH, 21 h. (iii) CH2N2 (excess), 0 °C, 0.1 h. (iv) NMO , 4Ä molecular sieves, TPAP (0.05 mole 
equiv.), CH2C12, 20 °C, 0.5 h, 79% from 123. (v) NaOH, MeOH, 25 h, 20 °C, 85%. (vii) [(£)-5,9- 
dimethyl-deca-4,8-dien]triphenylphosphonium iodide, n-BuLi, THF, 0 °C, 0.25 h then Mel, 0.25 h then 
n-BuLi, 0.25 h. 53%. (viii) LiAlH4, Et20 , 0 °C, 3 h, 96%. (ix) (n-Bu4N)H2P04, CCI3CN, CH3CN, 
20 °C, 1 h. (x) (PhO)2POCl, Bu3N, (n-Bu4N)H2P04, C6H5N, 20 °C, 5 h. (19% over 2 steps).
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enzyme. However, by virtue of the position of the cyclopropane moiety within this 
structure, the compound should not be capable of being processed by the enzyme (or, at 
least, not processed in the "normal" way) and would, therefore, act as an inhibitor of it. 
Interestingly, the subtle structural modification associated with analogue 111 swaps the 
longer-farnesyl (left-hand) side-chain in PSDP 112 with the shorter-geranyl aliphatic 
side-chain. Likewise, the shorter-geranyl (right-hand) side-chain present within PSDP 
112 replaces the longer-farnesyl side-chain in compound 111. In other words, the two 
side-chains attached to the central cyclopropane ring have been interchanged. It was 
anticipated that cw-l,2-dihydrocatechol 17, obtained from microbial oxidation of 
toluene, could be utilized in the synthesis of this very interesting target compound 111.
4 .6  Synthesis of Structural Analogues of Presqualene Alcohol
The relevant disconnections associated with the proposed synthesis of target 111 
from czs-l,2-dihydrocatechol 17 are outlined in Figure 4.5. Thus, in the synthetic 
direction, Wittig olefination of compound 125 would provide compound 111. It was 
expected that aldehyde 125 could, in turn, be derived from selective Wittig olefination 
of the sterically more accessible carbonyl moiety present within dialdehyde 126. 
Dialdehyde 126 should be accessible via oxidative cleavage of diol 127, which would 
be obtained via straightforward manipulation of acetonide 128, the 2,3-dihydro- 
analogue of toluene-derived diol 17. Furthermore, manipulation of the readily available 
l-bromo-3-methyl-2-butene (130) and geranyl bromide (132) by known protocols 
should provide the necessary precursors, 129 and 131, respectively, to the ylides 
required for the aforementioned Wittig olefination reactions.136
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Wittig
Olefination
\V /
M e02C H
Wittig
Olefination
126
17 128
\  /v
Oxidative
Cleavage
.,\OH
"OH
Figure 4.5: Retro synthetic Analysis of PSDP Analogue 111 Based Upon Using the 
Toluene-Derived cis-7,2-Dihydrocatechol 17 as Starting Material.
In reality, the synthetic sequence began (Scheme 4.2) with selective reduction of 
the less-substituted double-bond present in cis-\ ,2-dihydrocatechol 17. This 
conversion was effected with diimide137 and afforded the previously reported ene-diol 
133 as a white crystalline solid in 83% yield. The spectral data obtained on this latter
131 132
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compound were in full accord with those previously reported by Hudlicky et a /.138 
Another method for preparing compound 133 involved catalytic hydrogenation of diene 
17 using 5% rhodium supported on alumina. Although both procedures for effecting 
the conversion (17) (133) were high yielding, the latter was more amenable to
large-scale synthesis and, thus, represented the method of choice. Protection of the diol 
unit present within compound 133 as the corresponding acetonide was readily achieved 
by reaction with 2,2-dimethoxypropane and a catalytic amount of p-toluenesulfonic acid 
monohydrate (Scheme 4.2) and in this manner derivative 128 was obtained in 94% 
yield.
17 133 128
Scheme 4.2: Reagents and Conditions: (i) dipotassium azodicarboxylate (7.0 mole equiv.), AcOH 
(14.5 mole equiv.), MeOH, 20 °C, 0.75 h, 83%. (ii) 5% Rh/Al20 3, H2, EtOH, 20 °C, 16 h, 96%. 
(iii) 2,2-dimethoxypropane, p-toluenesulfonic acid (0.05 mole equiv.), 0 °C, 1 h, 94%.
The task of modifying alkene 128 so as to provide access to the key cyclopropyl 
compound 127 was approached in two distinct ways. The first involved reaction of the 
former compound with ethyl diazoacetate in the presence of a metal catalyst 
{[(OAc)2Rh]2 } so as to effect cyclopropanation of the double-bond within compound 
128. This method had the attraction that it should allow for the direct production of a 
cyclopropane carboxylic acid derivative. In the event, however, slow addition of ethyl 
diazoacetate to a dichloromethane solution of olefin 128 containing rhodium(II) acetate 
dimer139 gave at best, a 10% yield of the cyclopropyl-ester 134 which was obtained as 
a ca. 1:1 mixture of epimers (Scheme 4.3). Large quantities of diethyl fumarate (135) 
and diethyl maleate (136) were recovered from the reaction mixture and these products 
presumably arise through dimerization of the intermediate carbenoid.139
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Et02C
128 134 135 136
Scheme 4.3: Reagents and Conditions: (i) ethyl diazoacetate (6.0 mole equiv.), Rh20Ac4 (0.05 
mole equiv.), CH2CI2 , reflux, slow addition, 12 h.
In principle, the difficulties mentioned above could be overcome by cyclopropanation 
of the olefin present within compound 128 using dibromocarbene since the resultant 
adduct would possess functionality that might allow for its elaboration, through the 
agency of metal-for-halogen exchange reactions, to compound 127. To these ends, 
acetonide 128 was reacted with bromoform and aqueous sodium hydroxide in the 
presence of the phase-transfer catalyst triethylbenzylammonium chloride and in this 
manner a single dibromocarbene adduct, 137, was obtained in 72% yield (Scheme 
4.4). In keeping with related conversions,73 it was assumed, at this point, that carbene 
addition had occurred at the less-hindered ß-face of the double bond present within 
compound 128. Subsequent X-ray crystallographic and chemical correlation studies 
(vide infra) proved that this assumption was correct.
Scheme 4.4: Reagents and Conditions: (i) CHBr3 (25.0 mole equiv.), 50% w/v aq. NaOH, 
TEBAC, C6H6, 5 °C to 20 °C, 16 h, 72%. (ii) Bu3SnH (1.0 mole equiv.), C6H6, 5-20 °C, 16 h, 
88% .
Dibromocarbene adduct 137 was subjected to reaction, at 0 °C, with one molar
equivalent of tributyltin hydride and this resulted in formation of a ca. 2:1 mixture of the 
epimeric mono-bromo compounds 138 and 139 (88%). These products of reductive 
debromination, which could be separated from one another by flash column
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chromatography, were easily differentiated by *H NMR spectroscopy. Thus, that 
epimer in which the vicinally related cyclopropyl protons are in a rrarcs-relationship to 
one another (viz. compound 138) displays a smaller coupling constant (7trans = 4.0 Hz) 
than its counterpart in which there is a cA-relationship between the analogous protons 
(7cis = 7.7 Hz).140 Indeed, throughout the series of mono-substituted cyclopropanes 
prepared in connection with the synthesis of PSDP analogues the expectation that 7cjs 
was always greater than 7trans was used to assign the stereochemistry of the non­
hydrogen substituent at the apex of the three-membered ring (see Table 4.1). These 
structural assignments were confirmed by a single crystal X-ray analysis of a derivative 
of compound 139.
Compound 138 was treated, at -96 °C, with a solution of terr-butylithium in hexane 
and the cyclopropyllithium species resulting from the ensuing metal-for-halogen 
exchange reaction was trapped with methyl chloroformate to give the corresponding 
cyclopropyl ester 140 (80%, Schem e 4.5). An analogous reaction involving 
compound 139 provided ester 141 in 83% yield. That these conversions proceeded
(iii)
C 02Me C 02Me
139 141 142 (X-ray)
Scheme 4.5: Reagents and Conditions: (i) t-BuLi (2.0 mole equiv.), 0.2 h then methyl 
chloroformate (1.1 mole equiv.), Et20, -96°C, 2 h, 80%. (ii) t-BuLi (2.0 mole equiv.), 0.2 h then 
methyl chloroformate (1.1 mole equiv.), Et2Ü, -96°C, 2 h, 83%. (iii) NaOMe (2.0 mole equiv.), 
MeOH, reflux, 16 h, 78%. (iv) AcOH (60% aq.), 80 °C, 16 h, 79%. (v) AcOH (60% aq.), 80 °C, 16 h, 
72%.
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Chapter Four
with retention of stereochemistry was confirmed by *H NMR spectroscopic analyses 
(Table 4.1) and single crystal X-ray analyses of a species obtained later in the reaction 
sequences. Inspection of molecular models suggested that because of the exo- 
orientation of the ester moiety within compound 140 it should be less sterically 
congested than epimer 141. On this basis, it seemed reasonable that under suitable 
reaction conditions, compound 141 could be epimerized to give the desired and more 
stable £jto-isomer 140. Indeed, when compound 141 was treated with sodium 
methoxide in refluxing methanol epimer 140 was obtained in 78% yield and as the 
exclusive product of reaction.
Hydrolysis of the isopropylidene unit within compound 141 was achieved using 
60% aqueous acetic acid and gave compound 142 (79%, Scheme 4.5, Table 4.1) 
which was subjected to single-crystal X-ray analysis. This analysis (see Figure 4.6) 
established the ds-relationship between the vicinally-related cyclopropyl protons within 
this compound and, therefore, the e«Jo-orientation of the carbomethoxy group at C7. 
Thus, these data, along with the *H NMR spectroscopic arguments advanced earlier, 
serve to establish the stereochemical relationship of the vicinally-related cyclopropyl 
protons within all of compounds 127 and 138-142.
Figure 4.6: CS Chem3D Pro™ Drawing of Compound 142 Generated Using Data 
Derived From an X-ray Crystallographic Study.
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With significant quantities of compound 140 in hand studies towards the synthesis 
of the target molecule 111 were continued and involved initial removal of the acetonide 
group using 60% aqueous acetic acid. In this manner, diol 127 was obtained in 72% 
yield. Lead-tetraacetate-promoted cleavage of the diol moiety present within compound 
127 afforded the corresponding acyclic dialdehyde 126 in high (91%) yield (Scheme 
4.6). Isomer 143 was prepared in a similar fashion from precursor 142. In the 300 
MHz NMR spectrum of dialdehyde 126 the signal due to the hydrogen of the 
"neopentyl" aldehyde appears as a singlet at 8 9.37 while the one-proton doublet (7 = 
2.4 Hz) at 5 9.74 is assigned to the proton of the remaining aldehyde. The magnitude of 
the coupling (76,7= 6.0 Hz) between the vicinally-related cyclopropyl protons in 
compound 126 was smaller than that (76,7= 8.9 Hz) associated with epimer 143.
>OH
OH
(i)
M e02% H 
H
126
> C 
C 0 2Me
142
H C 0 2Me
ITC'
143
Scheme 4.6: Reagents and Conditions: (i) Pb(OAc)4 (3.0 mole equiv.), CaC03  (12.2 mole 
equiv.), CH2C12, 0 °C, 0.75 h, 91% for 126; 95% for 143.
A pivotal feature of the projected synthesis of compound 111 (Figure 4.5) was the 
expectation that regioselective Wittig olefination of dialdehyde 126 could be effected 
with ylide 147 derived from phosphonium salt 129. Certainly, inspection of molecular 
models revealed that the "neopentyl" aldehyde present within compound 126 is more 
sterically encumbered than it's "normal" counterpart. Thus, under the correct set of 
reaction conditions preferential Wittig reaction of the latter aldehyde group might be 
expected.
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The required phosphonium salt, 129, was synthesized according to known protocols 
(Scheme 4 .7).136 Thus, alkylation of the copper-lithium enolate anion of ethyl 
acetate141 with l-bromo-3-methy 1-2-butene (130) provided the y,8-unsaturated ester 
144 (97%) which was immediately converted to the corresponding alcohol, 145 
(88%), via reduction with lithium aluminium hydride. This latter compound was 
subjected to reaction, at 0 °C, with methanesulfonyl chloride to furnish the 
corresponding mesylate, which was immediately displaced with sodium iodide in 
acetone to give iodide 146 (62% from 145). Finally, iodide 146 and 
triphenylphosphine were stirred together in the dark at room temperature for 7 days. 
Filtration of the resultant powder afforded phosphonium salt 129 (45%) and the 
spectral data for this compound were in full accord with those reported previously.136
130 144 145
(hi), (iv)
147 129 146
Scheme 4.7: Reagents and Conditions: (i) LDA (2.0 mole equiv.), EtOAc (2.0 mole equiv.), Cul 
(4.0 mole equiv.), THF, -110 °C, 1 h, 97%. (ii) LiAlH4 (1.1 mole equiv.), Et20 , 0 °C, 6 h, 88%. (iii) 
methanesulfonyl chloride (1.1 mole equiv.), NEt3 (1.5 mole equiv.), CH2 CI2 , 0 °C, 0.25 h. (iv) Nal 
(1.5 mole equiv.), acetone, 20 °C, 16 h, 62% from 145. (v) PPhß (1.3 mole equiv.), CöHö, 20 °C, 7 
days, 45%. (vi) n-BuLi (1.0 mole equiv.), THF, 0 °C, 0.25 h then Mel (1.0 mole equiv.), 0.25 h then 
n-BuLi (1.0 mole equiv.), 0.25 h.
Phosphonium ylide 147 was generated in situ by treatment of phosphonium salt 129 
with a solution of rc-butyllithium in hexane at 0 °C. Alkylation of this ylide with 
iodomethane and treatment of the resulting salt with a second aliquot of rc-butyllithium 
then afforded the blood-red ylide 147, which was cooled to -78 °C. Addition of this 
ylide, via cannula, to a cooled (-78 °C) solution of dialdehyde 126 in THF afforded,
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after flash column chromatography, a ca. 2:1 mixture of compounds 125 and 148 
(83% combined yield, Scheme 4.8).
M e02C H
PPh3 + O
H
147 126
(i)
Scheme 4.8: Reagents and Conditions: (i) inverse addition (via cannula), -78 °C, 1 h, 83%.
The geometry about the newly created carbon-carbon double-bond within these 
compounds can be assigned with confidence by inspecting the relative chemical shifts 
of the 13C NMR resonances due to the methyl groups attached to this same double­
bond. Thus, on the basis of literature precedence,142-145 the more downfield resonance 
(5 23.6) is attributed to that compound (148) possessing Z-geometry while the one at 5 
16.2 is assigned to the target £-isomer 125. Inspection of the 300 MHz NMR 
spectrum of the mixture of compounds 125 and 148 (Figure 4.7) reveals that all 
resonances due to analogous protons within these compounds are essentially coincident 
with the exception of the "neopentyl" aldehyde hydrogens which appear as singlets at 5 
9.26 and 9.25 and in a ca. 2:1 ratio. The singlet nature of the aldehyde resonances in 
this spectrum indicates that the expected regioselectivity has been achieved in the Wittig 
reaction. The four-proton multiplet at 8 5.08 corresponds to the olefinic hydrogens 
present within compounds 125 and 148. The six-proton singlet at 8 3.70 is ascribed to 
the ester methyl group protons within the two isomers. In the aliphatic region of the
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spectrum the doublet at 6 2.33 (J = 6.5 Hz) is assigned to the hydrogen adjacent to the 
cyclopropyl ester. The complex multiplet at 6 2.04 is assigned to the eight methylene 
hydrogens present within the isoprenoid side-chain. The multiplet at 8 1.97 is attributed 
to the remaining cyclopropyl hydrogen, while three distinct olefinic-methyl resonances 
are apparent in the upfield region at 8 1.67, 1.60 and 1.58. A fourth and higher field 
methyl group resonance, at 8 1.39, is assigned to the cyclopropyl-methyl hydrogens 
within structures 125 and 148.
Compounds 125 and 148 could not be separated from one another by flash 
chromatographic or HPLC techniques.# Furthermore, efforts to effect Z —» E 
isomerization of the newly-formed double-bond within compound 148 by heating 
compounds 125 and 148 in the presence of thiophenol146’147 did not significantly 
alter the ratio of isomers within the mixture. The consequent inability to separate 
compounds 125 and 148 meant that this mixture was carried into the next step of the 
reaction sequence in the hope that subsequent mixtures of products might prove 
separable. To these ends, phosphonium salt 131 was synthesized from geranyl 
bromide 132 in five steps and 30% overall yield (Scheme 4.9) by a procedure 
essentially identical with that previously described for the synthesis of congener 
129.135 Thus, alkylation of the copper-lithium enolate anion of ethyl acetate with 
geranyl bromide 132 provided the ester 149 (100%), which was reduced with lithium 
aluminium hydride to the corresponding alcohol 150 (100%). Reaction of the derived 
mesylate with sodium iodide in acetone then gave iodide 151 (48% from 150). 
Finally, reaction of compound 151 with triphenylphosphine gave the required 
phosphonium salt 131 (63%). The spectral data obtained on the latter compound were 
in full accord with those reported previously.135
 ^The Horner14  ^ and Julia14  ^ olefin syntheses have also been utilized for the synthesis of tri-substituted 
alkenes. These methods have been reported to give favourable /rans-selectivity which can be further tuned by 
judicious choice of base and solvent. However, in the present study, any amount of (Z)-isomer formed at this 
stage in the reaction sequence would be inseparable by HPLC techniques, and efforts to increase (£)/(Z)- 
selectivity in the olefination reaction were not pursued.
71
Chapter Four
(i)
C 02Et
132 149
(ii)
(iii), (iv)
OH
151 150
(v)
PPh3
131 152
Scheme 4.9: Reagents and Conditions: (i) LDA (2.0 mole equiv.), EtOAc (2.0 mole equiv.), Cul 
(4.0 mole equiv.), THF, -110 °C, 1.5 h, 100%. (ii) LiAlH4 (1.1 mole equiv.), Et20 , 0 °C, 6 h, 100%. 
(iii) methanesulfonyl chloride (1.1 mole equiv.), NEt3 (1.5 mole equiv.), CH2CI2 , 0 °C, 0.25 h. (iv) 
Nal (1.5 mole equiv.), acetone, 20 °C, 16 h, 48% from 150. (v) PPh3 (1.3 mole equiv.), CöHß, 20 
°C, 7 days, 63%. (vi) n-BuLi (2.0 mole equiv.), THF, 0 °C, 0.25 h then Mel (2.0 mole equiv.), 0.25 h 
then rc-BuLi (2.0 mole equiv.), 0.25 h.
The ylide 152 was generated by initial reaction of salt 131 with rc-butyllithium and 
treating the ylide so-formed with methyl iodide. The new phosphonium salt produced in 
this manner was then treated with a second aliquot of rc-butyllithium to produce target 
152. This latter species was then reacted, in situ, with 0.5 molar equivalents of the ca. 
2:1 mixture of compounds 125 and 148. In this manner, a ca. 4:3:3:2 mixture (as 
judged by 13C NMR analysis of the crude reaction mixture) of compounds 153-156 
was obtained in 73% combined yield after flash chromatography (Scheme 4.10). 
Subjection of this mixture to semi-preparative HPLC on silica provided separation to 
the extent that two fractions [Fractions X (more mobile) and Y (less mobile)], were 
obtained and each of these contained two of compounds 153-156.+
+ The spectroscopic and structural assignments of compounds 153-156 and related compounds are 
discussed in more detail in a subsequent section (4.9).
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(i)
153 (A = E-B = E)
154 (A = Z; B = E) Fraction Y
155 (A = E\ B = Z)
156 (A = Z; B = Z) Fraction X
Scheme 4.10: Reagents and Conditions: (i) inverse addition (via cannula), 0 °C, 16 h, 73%.
On the basis that derivatives of compounds 153-156 might be capable of further 
separation, fractions X and Y were each subjected to the next step in the reaction 
sequence. Thus, reduction of the ester moieties within the compounds associated with 
each of these fractions using lithium aluminium hydride gave the corresponding 
alcohols 157-160 (Scheme 4.11). However, the product alcohols contained within 
these fractions also proved to be inseparable by flash chromatographic and HPLC 
techniques.
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153 (A = E\ B = E)
154 (A = Z; B = E) Fraction Y
155 (A = E\ B = Z)
156 (A = Z; B = Z) Fraction X
(i)
h o h 2c  h
157 (A = E; B = E)
158 (A = Z; B = E) Fraction Y
159 (A = E\ B = Z)
160 (A = Z; B = Z) Fraction X
Scheme 4.11: Reagents and Conditions: (i) LiAlH4 (3.5 mole equiv.), Et20, 0 °C, 3 h; 93% 
yield for Fraction X, 91% yield for Fraction Y.
4 .7  Attempted Phosphorylation of Structural Analogues of 
Presqualene Alcohol
In an attempt to produce PSDP analogues that might be capable of inhibiting SQS, 
efforts were made to convert the primary alcohols 157-160 (obtained as mixtures in 
the manner described above) into their corresponding diphosphates using a protocol 
recently reported by Poulter et al. (Scheme 4 .12).135 Thus, the pairs of alcohols 
157/158 and 159/160 derived from fractions X and Y, respectively, were each 
treated in with 1.2 equivalents of tetra-rc-butylammonium diphosphate in the presence of 
an excess of trichloroacetonitrile to afford a ca. 2:1 mixture of monophosphorylated and 
diphosphosphorylated products, together with recovered starting material (ca. 10%). 
After purification on a hydrophobic Sephadex LH-20 column, the two monophosphate 
fractions, each containing a pair of compounds, were independently reacted with 
diphenylchlorophosphate and the very modest amounts of tetrabutylammonium
74
Chapter Four
diphosphate thus obtained were subjected to Sephadex LH-20 chromatography. For 
comparative biological studies it was considered necessary to replace the tetra-n- 
butylammonium cation with an ammonium ion. To these ends, the diphosphate 
mixtures were passed through a cation-exchange chromatography column but 
subjection of the eluted fractions to preparative-scale reversed-phase HPLC150 failed to 
provide any of the anticipated PSDP analogues 111 and 161-163.*
157 (A = E\ B = E)
158 (A = Z; B = E) Fraction Y
159 (A = £; B = Z)
160 (A = Z; B = Z) Fraction X
162 (A = E\ B = Z)
163 (A = Z; B = Z) Fraction X
Scheme 4.12: Reagents and Conditions: (i) (n-Bu4N)H2PC>4 (1.2 mole equiv.), CCI3CN, 
CH3CN, 20 °C, 1 h. (ii) (PhO)2POCl (1.0 mole equiv.), BU3N (2.0 mole equiv.), (n-Bu4N)H2P0 4  
(3.4 mole equiv.), C6H5N, 5 h.
4 .8  Synthesis of Ammonium Analogues of Presqualene Diphosphate
The difficulties noted above regarding the acquisition of PSDP analogue 111 and its 
various geometrical isomers prompted consideration of methods for preparing the 
primary amine 164, the ammonium salt of which could be considered as an analogue
Similar problems associated with cation exchange reactions involving other PSDP analogues have 
been noted by R. Coates and his colleagues working at the University of Illinois, Urbana-Champaign 
(personal communication from R. Coates to M. Banwell, 4/11/98).
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of the first formed carbocationic intermediate, 115, associated with the conversion of 
PSDP into squalene (see Figure 4.3, page 56). Acquiring compound 164 seemed a 
worthwhile objective since related amines, e.g. 119, have proven to be good inhibitors 
of SQS. To these ends, the esters 153-156 contained within fractions X and Y were
hydrolyzed to the corresponding pairs of carboxylic acids 165-168 (Scheme 4.13). 
Following protocols developed by Poulter et al.,127 introduction of the required amine 
moiety was achieved using Curtius rearrangement procedures. Thus, the pairs of 
compounds 165/166 and 167/168 were each heated at 100 °C for 30 minutes with 
diphenyl phosphorazidate, and the isocyanates thus formed were intercepted with 2- 
trimethylsilylethanol to provide, after standard aqueous work-up, the pairs of 
carbamates 169/170 and 171/172. These carbamates were then cleaved with tetra-n- 
butylammonium fluoride so as to provide the amine pairs 164/173 and 174/175 
targeted for biological assay. It was found that these amines were very susceptible to 
decomposition, even when stored at -20 °C under a nitrogen atmosphere. As a 
consequence, all efforts to isolate the individual components of these mixtures by 
HPLC techniques proved fruitless.
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155 (A = £; B = Z)
156 (A = Z; B = Z) Fraction X
(i)
165 (A = £; B = E)
166 (A = Z; B = E) Fraction Y
167 (A = E\ B = Z)
168 (A = Z; B = Z) Fraction X
(ii)
O
169 (A = E\ B = E)
170 (A = Z; B = E) Fraction Y
171 (A = E\ B = Z)
172 (A = Z; B = Z)
(iii)
Fraction X
174 (A = E\ B = Z)
175 (A = Z; B = Z) Fraction X
Scheme 4.13: Reagents and Conditions: (i) KOH, MeOH, 20 °C, 16 h. (ii) (PhO)2 PON3 (1.0 
mole equiv.), 100 °C, 0.5 h then TMS(CH2)20H (1.0 mole equiv.), 50 °C, 12 h. 62% yield for 
Fraction X, 73% yield for Fraction Y. (iii) TBAF, 50 °C, 1 h. 35% yield for Fraction X, 60% yield for 
Fraction Y.
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4 .9  Spectroscopic Analysis of Presqualene Diphosphate 
Analogues
Considerable efforts were made to establish the full structures of the esters 153-156 
contained within fractions X and Y as well as compounds derived from each of these 
fractions. Confident assignment of the structures of these compounds followed from 
analysis of the 13C NMR chemical shifts of the signals due to the carbons of the methyl 
groups at the two double-bonds (A and B) established through Wittig chemistry as well 
as analysis of the chemical shifts of the cyclopropyl methyl carbons. The first part of 
the argument associated with these assignments centres on the chemical shift of the 
signals due to the latter carbons. The relevant signals in each fraction were assigned on 
the basis of the initial assumption that the signals due to the protons of this group will 
resonate at higher field in the 1H NMR than those due to their counterparts in any of the 
other methyl groups within these compounds. Using HETCOR techniques the signals 
due to the cyclopropyl methyl carbons could then be identified and in the 13C NMR 
spectrum of fraction X these appeared as overlapping signals at 5 20.5 while in fraction 
Y these were also observed as overlapping signals, but now at Ö 19.7 (Tables 4.2 
and 4.3). Clearly then, there was some reasonable variation in the chemical shift of this 
carbon atom. Given that there is only one such signal in the 13C NMR spectrum of each 
fraction and that the structural feature most likely to affect the chemical shift of this 
carbon is the geometry about the nearby double-bond (B) in the farnesyl side-chain, 
then it is proposed that the two compounds in each fraction have the same geometry (E 
or Z) about this (B) double bond.
The second key assumption is based on the well-substantiated142_145>151’152 
argument that the carbons of methyl groups associated with Z-configured double-bonds 
resonate in the range ca. 5 20.5-24.0 while their counterparts in ^-configured alkenes 
appear at significantly higher field, viz. ca. 5 16.0-17.0. Some relevant comparisons 
are shown in Figure 4.8.143>135
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153 (A = £; B = E)
154 (A = Z; B = E) Fraction Y
155 (A = E\ B = Z)
156 (A = Z; B = Z) Fraction X
RESONANCE CHEMICAL SHIFT ASSIGNMENT
A 23.8 ppm (Z)-CH3
B 22.9 ppm (Z)-c h 3
C 20.5 ppm cyclopropyl-CH3
D 18.0 ppm (E)-C H3
E 17.9 ppm (£)-CH3
F 16.3 ppm (£)-c h 3
Table 4.2: NMR Chemical Shifts of Methyl Groups Within Compounds 153 and
154 in the region 8 25.0-15.0 (Fraction X).
RESONANCE CHEMICAL SHIFT ASSIGNMENT
A 23.7 ppm (Z)-c h 3
B 19.7 ppm cyclopropyl-CH3
C 18.0 ppm (£)-c h 3
D 17.1 ppm (£)-c h 3
E 16.4 ppm GE)-C H3
F 16.3 ppm (£)-c h 3
Table 4.3: 13C NMR Chemical Shifts of Methyl Groups Within Compounds 155 and 
156 in the region 8 25.0-15.0 (Fraction Y).
Inspection of the 13C NMR spectra of Fractions X and Y reveals that in the spectrum 
of the latter there is only one signal, at 8 23.7, due to a methyl group associated with a 
Z-configured double-bond. By comparison, in the spectrum of fraction X two signals,
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16.8 ppm
23.5 ppm
Figure 4.8: Selected 13C NMR Chemical Shifts for (EJ- and (Z)- Terpenes.
at 5 23.8 and 22.9, are observed in this region and given that the intensity of the lower 
field of these is twice the intensity of the other this is taken to imply these are methyl 
groups associated with three Z-configured double-bonds in this sample. Taken 
together, all these data strongly suggest that fraction Y contains compounds 153 and 
154 while fraction X contains compounds 155 and 156.
The spectroscopic "trends" presented above for esters 153-156 continue throughout 
the series of compounds derived there-from and, therefore, support structural 
assignments made throughout this series of PSDP analogues.
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4.10  Biological Evaluation of Presqualene Diphosphate Analogues 164 
and 173-175
Despite the susceptibility of amines 164 and 173-175 to decomposition, 3.6 
milligrams of Fraction X were recovered and have been submitted for biological 
testing.& These compounds are being tested as inhibitors of the enzyme squalene 
synthase (SQS) in a standard assay with farnesyl diphosphate. To date, however, the 
results of such tests are not available.
4.11 Summary
An efficient and enantioselective first-generation synthesis of amine analogues, 164 
and 173-175, of presqualene diphosphate has been achieved using cis-1,2- 
dihydrocatechol 17, derived by microbial oxidation of toluene, as starting material. The 
atom-economical sequences used serve to highlight the potential utility of microbially- 
derived c/s-l,2-dihydrocatechols in the preparation of mono-chiral cyclopropanes.
& These compounds have been submitted to Professor Dale Poulter (Department of Chemistry, 
University, Salt Lake City, Utah 84112) for biological evaluation.
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5.1 Introduction
In the preceding two chapters means for converting c/5-l,2-dihydrocatechols 14 
(X=Br) and 17 into the biologically significant chiral (non-racemic) cyclopropanes 87 
and 164/173-175, respectively, were described.
14 (X=Br) 87
17
164 (A = E\ B = E) 
173 (A = Z; B = E) Fraction Y
174 (A = E\ B = Z)
175 (A = Z; B = Z) Fraction X
The aim of the work described in this chapter was to examine the potential of cis-1,2- 
dihydrocatechols as starting materials for the construction of polycyclopropyl 
compounds related to the natural products FR-900848 (180) and U-106305 (181). 
However, prior to discussing such work, some background commentary on these 
structurally remarkable target molecules (180 and 181) is required.
°=<
■ r f
OH
180 (FR-900848)
181 (U-106305)
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5 .2  Biological Significance of the Polycyclopropane-Containing 
Natural Products FR-900848 and U-106305
There is considerable concern, especially amongst the medical profession, regarding 
fungal disease. Pathogens such as Candida albicans, Cryptococcus neoformans, 
Pneumocystis carnii and Aspergillis fumigatus are the cause of high morbidity and 
mortality in patients who have AIDS, diabetes or immune systems suppressed by 
drugs.153 Although rarely fatal, dermatophtye-type infections such as Tinea pedis and 
Candidiasis are widespread throughout the world. Current therapies for the treatment of 
serious fungal infections are deficient and, as such, several pharmaceutical companies 
world-wide are focussing their efforts to develop superior anti-infective agents.
Fermentation broths are typically rich in novel anti-infective compounds, due to 
evolutionary pressures of microbial antagonism and the isolation and structural 
elucidation of such agents plays a significant role in the discovery of new therapeutic 
agents. In 1990 Yoshida et al. reported the isolation and partial structural elucidation of 
FR-900848 (180), an anti-fungal pentacyclopropane nucleoside natural product 
produced by Streptoverticillum fervens,354 FR-900848 (180) shows useful activity 
against filamentous fungi such as Aspergillus niger, Mucor rouxianus and Fusarium 
oxysporum, with inhibiting concentrations as low as 0.05 micrograms per mL. In 
contrast, the compound is essentially inactive against non-filamentous fungi such as 
Candida albicans as well as Gram-positive and -negative bacteria.153’155 Compound 
180 displays low mammalian toxicity, with an LD50 of 1 g per kg of body weight in 
mice. The polycyclopropyl array associated with FR-900848 is structurally remarkable 
but the role that this conformationally restricted fatty-acid type side-chain plays in the 
bioactivity and mode of action of the compound remains unclear.
Recently, Upjohn scientists reported the isolation of U-106305 (181), a metabolite 
from the fermentation broth of Streptomyces sp. UC-11136.156 U-106305, which 
inhibits the plasma protein cholesteryl ester transfer protein (CETP), shows a striking 
similarity to FR-900848 (180) and is structurally remarkable being graced with six 
cyclopropane rings, five of which are contiguously related.
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5 .3  Established Methods for the Synthesis of FR-900848 
and U-106305
Barrett et al. recently reported157 a total synthesis of FR-900848 (180) and used 
Charette asymmetric cyclopropanation chemistry to control the stereocentres present 
within the side-chain of this compound (Scheme 5.1). Thus, mucandiol 182 was 
exhaustively cyclopropanated in the presence of the chiral auxiliary 1 0 34 to provide 
bicyclopropane 183 in high enantiomeric excess. Pyridinium chlorochromate (PCC)- 
promoted oxidation of the latter compound and immediate subjection of the product 
dialdehyde to Wittig-Horner olefination provided the expected (£,£)-diester. DIBAL-H 
reduction of this diester and bicyclopropanation of the resulting bis-allylic alcohol, 
again using Charette methodology, then provided a quatercyclopropane, which after 
selective mono-protection gave compound 184 which was essentially uncontaminated 
with any other diastereom ers. This intermediate was further elaborated to 
quinquecyclopropane 185 which was, in turn, converted into compound 186. Finally, 
/?A(2-oxo-3-oxazolidinyl)phosphinic chloride mediated coupling of the latter compound 
with the nucleoside amine 187 gave FR-900848 (180).
Falck et al. have also reported a total synthesis of FR-900848 (Scheme 5.2).158 
Thus, Charette cyclopropanation34 of vinylstannane 188 and silylation of the derived 
cyclopropylmethanol provided stannane 189 in 90% ee which was trarcs-metallated 
with sec-butyllithium. The anion thus formed was added to [ICuPBu3 ] 4  and the 
resulting conjugate subjected to an oxygen induced159»160 dimerization at low 
temperature so as to give bicyclopropane 190 in 98% ee. The observed enrichment in 
enantiomeric composition is a result of the statistical distribution of products and 
represents a variation of the Horeau amplification principle.158 Using standard 
methods, compound 190 was converted into the corresponding carboxylic acid which 
was, in turn, subjected to a bromo-decarboxylation (Hiinsdiecker) reaction161 thereby 
giving compound 191. A repetition of the dimerization protocol transformed this latter 
compound into quatercyclopropane 192. Partial deprotection of compound 192 and
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(i)
H O - < i X r OH
183
(ii) -(vi)
Ho-^xjxfXl^ 0™5
184
(vii)-(x)
H o^r ^ < r < ix r< r-OTBS
182 Me2NOQ CONMe2w
% ' °
Bu
10
185
(xi)-(xvi)
c o 2Yi
186
180
Scheme 5.1: Reagents and Conditions: (i) 10, Et2 Zn, CH2 I2 , CH2 CI2 , 0 °C to 20 °C, 89%. (ii) 
PCC, NaOAc, CH2C12, 0 °C to 20 °C. (iii) Ph3P=CHC02Et, CH2C12, 67% from 183. (iv) DIB AL­
II, CH2C12, -78 °C, 94%. (v) 10, Et2Zn, CH2l2, DME, -15 °C to 20 °C, 93%. (vi) NaH, TBSC1, 
THF, 44%. (vii) PCC, NaOAc, CH2C12, 0 °C to 20 °C. (viii) (£)-M e02CCH=CHCH2P(0)(0Me)2, 
NaH, THF, 0 °C to 20 °C, 90%. (ix) DIBAL-H, CH2C12, -78 °C, 91%. (x) 10, Et2Zn, CH2l2, 
CH2CI2 , -40 °C, 90%. (xi) A-(phenylsulfenyl)succinimide, Bu3P, CßHö, 89%. (xii) Raney Ni, EtOH, 
-40 °C. (xiii) NH4F, EtOH, 65 °C. (xiv) PCC, NaOAc, CH2C12, 0 °C to 20 °C. (xv) (£)- 
Me02CCH=CHCH2P(0)(0M e)2, NaH, THF, 20 °C. (xvi) KO(TMS)3, CH2C12, 85%. (xvii) 187, 
6/s(2-oxo-3-oxazolidinyl)phosphinic chloride, Et3N, 69%.
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(iv)-(vi)
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(viii)-(xi)
CH0
193
(xii)-(xvi)
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194
(xvii)
180
191
\ / )  N 0 2
0=<
OH
OH
Schem e 5.2: Reagents and Conditions: (i) 10, Et2 Zn, CH2 I2 » CH2 CI2 , 20 °C, 98%. (ii) TPSC1, 
imidazole, DMF, 20 °C, 88%. (iii) s-BuLi, THF, -40 °C; [ICuPBu]4, -78 °C; 0 2, -78 °C, 73%. (iv) 
TBAF, THF, 20 °C, 72%. (v) RuCl3/N aI04, CC14/CH3CN/H20  (1:1:1.5), 20 °C, 91%. (vi) 2- 
mercaptopyridine-A-oxide, DMAP, BrCCl3, 20 °C, hv, 77%. (vii) f-BuLi, THF, -40 °C; [ICuPBu]4, 
-78 °C; 0 2, -78 °C, 75%. (viii) TBAF, THF, 20 °C, 72%. (ix) TPAP, NMO, 4Ä molecular sieves, 
CH2C12, 20 °C, 91%. (x) 195, rc-BuLi, THF, -78 °C, 65%. (xi) Li, naphthalene, THF, -78 °C, 70%. 
(xii) TBAF, THF, 20 °C, 95%. (xiii) TPAP, NMO, 4Ä molecular sieves, CH2C12, 20 °C, 91%. (xiv) 
(£ )-E t0 2CCH = CH CH 2P(0)(O Et)2, LiN(TMS)2, THF, -78 °C to 20 °C, 89%. (xv) LiOH, 
MeOH/H20. (xvi) DMAP, 4-nitrophenol, CH2C12, 20 °C, 73%. (xvii) 187, DMF, 76%.
Ley-Griffith oxidation of the resulting alcohol then provided the corresponding 
aldehyde which readily reacted with the a-anion of sulfone 195. Further manipulation 
of the product sulfone then gave the new aldehyde 193. Horner-Emmons chain- 
extension of compound 193 followed by frarcs-esterification with 4-nitrophenol then
87
Chapter Five
provided the ester 194. Finally, reaction of 5'-deoxy-5,6-dihydrouridine (187) with 
compound 194 in DMF at room temperature gave FR-900848.
Two total syntheses of U -106305 (181) have also been reported recently, one by 
Barrett162 and the other by Charette.163 Both use a bidirectional strategy that is closely 
related to the syntheses discussed for FR-900848 (180).
FR-900848 and U -106305 also provide intriguing model compounds upon which to 
base a new class of materials - the stereoregular polycyclopropanes. Such compounds 
may well have unique and useful physical properties. Indeed, extensive crystallographic 
studies has shown that all-syrc-rnms-disubstituted cyclopropane oligomers containing 
three to seven cyclopropane rings are helical, at least in the solid state.162’164 Recently, 
and in an effort to further pursue the materials science possibilities associated with 
polycyclopropyl arrays, syn-trans-1,21 -septecyclopropane 196 was macrolactonized to 
give the corresponding coronane 197, a dilactone comprising a 22-membered ring 
(Scheme 5 .3).165
O
OH
o o
/  \
H,
H
197
Scheme 5.3: Reagents and Conditions: (i) 2,4,6-Cl3C6H2COCl, NEtß, DMAP, reflux, THF, 
74% .
88
Chapter Five
The foregoing discussion serves to highlight the potential importance of 
polycyclopropyl arrays. As a consequence, new methods for their synthesis continue to 
be sought.166 It was envisaged that c/5-l,2-dihydrocatechols could be exploited as 
starting materials for the construction of this alluring class of compounds, and the 
methods for achieving this are discussed in the following section.
5 .4  Chemoenzymatic Approaches to the Quatercyclopropyl Sub­
structures Associated with FR-900848 and U-106305
Initial efforts focussed on diester 198 as the synthetic target and the idea that 
stereoselective and exhaustive cyclopropanation of compound 201 would give the 
quatercyclopropane 200 which, after oxidative cleavage of the cfs-diol moieties, would 
deliver the related tetra-aldehyde 199 (Figure 5.1). Two further aspects of the
Et° 2Cx i x r < r < r  c° 2ei
198
II
CHO CHO
r<r<h<r<l
OHC CHO
199
14 (X=I) 201
Figure 5.1: Retro synthetic Analysis of Compound 198 Based Upon Using the 
Iodobenzene-derived cis-l,2-Dihydrocatechol 14 (X-I) as Starting Material.
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approach were (i) that compound 201 might be accessible via Ullmann-type coupling 
of the enantiopure ds-l,2-dihydrocatechol 14 (X=I) derived by microbial oxidation of 
iodobenzene and, (ii), that the terminal aldehyde groups within compound 199 could, 
on steric grounds, be selectively oxidized to the corresponding carboxylic acid groups 
while, if desired, the internal aldehyde moieties could be deleted using Wilkinson's 
catalyst, a system known167 to effect decarbonylation of tertiary cyclopropane 
carboxaldehydes with retention of configuration. In principle, the cd-relationship 
between the two cyclopropane ring substituents at either end of compound 199 could 
be changed into the thermodynamically more favoured fra/is-relationship via base- 
catalyzed epimerization* and thereby delivering compound 198, an obvious precursor 
to the key intermediate 192 associated with Barrett's synthesis of FR-900848 (180). 
Of course, and perhaps more significantly, the chemistry implied by Figure 5.1 
should allow for the synthesis of a range of interesting analogues of FR-900848 (180) 
and U-106305 (181).
In initial attempts (Scheme 5.4) to implement the ideas outlined above, the 
acetonide derivative, 202,168 of diol 14 (X=I) was metallated with terf-butyllithium in 
pentane at -96 °C and the resulting lithio-species frans-metallated using zinc chloride. 
The organozinc species so-formed was then subjected to Negishi cross-coupling169 
with iodide 202 and the tetra-ene 203 (40%) was thereby obtained.# Not surprisingly, 
this hitherto unknown and interesting "dimer", which cannot be accessed via microbial 
oxidation of biphenyl, was found to be highly susceptible to dimerization and 
aromatization, especially when exposed to even mildly acidic reagents such as silica gel. 
To circumvent such difficulties, the silica gel used to purify this "dimer" was 
impregnated with triethylamine and then the compound could then be purified by flash 
chromatography using this adsorbant. After purification compound 203 was found to 
be reasonably stable, and could be stored for extended periods under nitrogen at 0 °C.
An analogous epimerization (viz. 141—>140) was carried out during work directed towards the 
synthesis of PSDP analogues (see Scheme 4.5, page 65).
$ A related coupling has recently been reported by Noheda et a/.176
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Treatment of £/s-acetonide 203 with chloroform and aqueous sodium hydroxide in 
the presence of the phase-transfer catalyst triethylbenzylammonium chloride afforded, 
after flash column chromatography, a single /?/s-dichlorocarbene adduct, viz. 
compound 204 (29%). In the 300 MHz NMR spectrum of this product (Figure 
5.2), the multiplet at 8 6.03 is attributed to the two magnetically equivalent alkene 
protons while doublets at 8 4.75 (7 = 7.6 Hz) and 4.66 (7 = 7.6 Hz) are assigned to the 
two pairs of oxymethine hydrogens within the molecule. In the upfield region of the 
spectrum the two pairs of cyclopropyl hydrogens resonate as a four-proton multiplet at 
8 2.35. The remaining signals correspond to the two pairs of equivalent methyl group 
protons (8 1.33 and 1.25) within structure 204. In keeping with related conversions 
(see, for example, 101^100 on page 42), it was assumed that dichlorocarbene 
addition to compound 203 had occurred in a diastereofacially-selective manner to the 
less-hindered face of the two disubstituted double-bonds within tetra-ene 203. Final 
proof of the structure of compound 204 followed from chemical correlation studies and 
a single-crystal X-ray analysis (see below).
14 (X=I) 202
Scheme 5.4: Reagents and Conditions: (i) 2,2-dimethoxypropane, p-toluenesulfonic acid (0.05 
mole equiv.), 0 °C, 1 h, 82%. (ii) r-BuLi (2.0 mole equiv.), 0.2 h then ZnCl2 (1.0 mole equiv.), -96 
°C, 0.5 h then compound 202 (1.0 mole equiv.), Pd(PPh3 ) 4  (0.05 mole equiv.), 2 h, 40%. (iii) 
CHC13, 50% w/v aq. NaOH (120 mole equiv.), TEBAC, 5 °C to 20 °C, 16 h, 29%.
In an effort to confirm the structure assigned to compound 204, a stepwise strategy
was employed for its independent synthesis (Scheme 5.5). Thus, the acetonide 
derivative, 202, of diol 14 (X=I) was subjected to reaction with dichlorocarbene
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Cl
204
Scheme 5.5: Reagents and Conditions: (i) CHCI3, 50% w/v aq. NaOH (12.0 mole equiv.), 
TEBAC, 5 °C to 20 °C, 16 h, 78%. (ii) AcOH (60% aq.), 80 °C, 16 h, 81%. (iii) (Me3Sn)2 (1.07 
mole equiv.), Pd(PPh3)4 (0.05 mole equiv.), THF, 50 °C, 16 h, 73%. (iv) compound 206 (0.90 mole 
equiv.), Pd(PPh3)4 (0.05 mole equiv.), 1,4-dioxane, 60 °C, 8 h. (v) Ac20, pyridine, 20 °C, 8 h, 74% 
from 206 . (vi) K2C 0 3 (6.0 mole equiv.), MeOH, reflux, 16 h. (vii) 2,2-dimethoxypropane, p- 
toluenesulfonic acid (0.05 mole equiv.), 0 °C, 1 h, 84% from 209 .
(generated under phase-transfer conditions) and in this manner compound 205 was 
obtained in 78% yield and as a single diastereomer. Removal of the acetonide protecting 
group present within adduct 205 was effected using 60% aqueous acetic acid and
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provided diol 206 in 81% yield. The latter compound was converted into the 
corresponding trimethylstannyl-derivative 207 (73%) by palladium-catalyzed coupling 
with hexamethylditin.171 The next step in the reaction sequence required application of 
a homo- or cross-coupling protocol to produce the dimeric compound 208. The 
transition-metal promoted coupling reactions of organic halides with organostannanes 
(Stille cross-coupling), organoboranes (Suzuki cross-coupling) or organic zinc species 
(Negishi cross-coupling) represent some of the most attractive methods for the creation 
of sp2 to sp2 carbon bond linkages because such conversions can normally be achieved 
under mild conditions and in high yield.172 Indeed, when the alkenyl iodide 206 was 
reacted with the stannane 207 under classical Stille cross-coupling conditions the tetra- 
ol species 208 was obtained. Because of its poor solubility in a wide range of solvents, 
this product was extremely difficult to handle so, for the purposes of purification and 
characterization, it was immediately converted into the corresponding terra-acetate 
derivative 209 (74% from 206) under standard conditions. All spectoscopic data 
obtained on this latter material were in full accord with the assigned structure but final 
confirmation of its structure followed from a single crystal X-ray analysis of this 
material (Figure 5.3).
Figure 5.3: CS Chem3D Pro™ Drawing o f Compound 209 Generated Using Data 
Derived From an X-ray Crystallographic Study (Acetyl Groups Omitted fo r Clarity).
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The acquisition of compound 209 allowed for the conduct of the chemical correlation 
study alluded to earlier. Thus, base-catalyzed hydrolysis of the acetate groups present 
within compound 209 was effected with potassium carbonate in methanol and resulted 
in its smooth conversion into the highly insoluble tetra-ol 208. The latter material was 
immediately treated with 2,2-dimethoxypropane and a catalytic amount of p- 
toluenesulfonic acid monohydrate to afford, after flash chromatography, b/s-acetonide 
204 (84% from 209), which was identical, in all respects, with the material obtained 
earlier (see Scheme 5.4, page 91).
Various attempts to effect cyclopropanation of the double-bonds within dienes 204 
and 208 proved unsuccessful. On the basis that the inductive-electron withdrawing 
effects of the chlorine atoms within dienes 204 and 208 might be deactivating the 
double-bonds towards electrophilic cyclopropanation, methods for the reductive 
dechlorination of these compounds were sought. To these ends, the tetra-ol 208 was 
subjected to several different types of dissolving metal reductions but in each case only 
starting material was returned. This outcome is probably the result of formation of 
insoluble polyalkoxide salts under the reduction conditions being employed. While it 
seemed as though reductive dechlorination of the corresponding b/s-acetonide, 204, 
could circumvent such problems, the dechlorinated material so-formed was 
exceptionally acid-sensitive and could not be deprotected under normal conditions used 
to remove acetonide protecting groups.
In a final attempt to set up favourable cyclopropanation conditions, efforts were made 
to convert compound 208 into acyclic congenor 211 on the basis that the double-bonds 
within the latter compound, or the corresponding tetra-ol, might be more susceptible to 
Simmons-Smith type cyclopropanation reactions (Scheme 5.6). To these ends tetra-ol 
208 was treated with sodium metaperiodate, and the resulting product (which proved 
to be a dialdehyde-see below) was then reduced with sodium borohydride to give the 
unsymmetrical mono-ring opened adduct, which was characterized as the corresponding 
tetra-acetate 210. In the 300 MHz NMR spectrum of the latter product, the doublets 
at 5 6.15 (J = 3.1 Hz) and 5.72 (7 = 3.1 Hz) are assigned to the two different alkene
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hydrogens. Six oxymethine signals were observed between 6 4.95 and 4.07, and in the 
more upfield region of the spectrum four distinct resonances due to the cyclopropyl 
hydrogens appear between 8 2.70 and 2.12. The remaining signals (8 2.08 and 2.05) 
correspond to the four acetoxy-methyl groups present within compound 210.
Scheme 5.6: Reagents and Conditions: (i) NaI04 (3.0 mole equiv.), THF/H2O (1:1), 5 °C, 1 h. 
(ii) NaBH4 (22.0 mole equiv.), THF/MeOH (10:1), 5 °C, 8 h. (iii) Ac20 , pyridine, 20 °C, 8 h, 50% 
from 208 . (iv) K2CO3 (18.0 mole equiv.), MeOH, reflux, 16 h. (v) NaI04 (8.0 mole equiv.), 
THF/H20  (1:1), 5 °C, 1 h. (vi) NaBH4 (8.0 mole equiv.), THF/MeOH (10:1), 5 °C, 8 h. (vii) Ac20 , 
pyridine, 20 °C, 8 h, 60% from 210.
Conversion, via hydrolytic removal of the acetate groups, of compound 210 into the 
corresponding tetra-ol and subjection of this latter material to reaction with sodium 
metaperiodate gave the expected dialdehyde/diol. This last compound was then reduced 
with sodium borohydride to give the expected tetra-ol which was characterized as the 
corresponding tetra-acetate 211 (60% from 210). In the downfield region of the 300 
MHz ]H NMR spectrum of product 211 a two-proton doublet (J  = 7.9 Hz) was 
observed at 8 6.00 and this is assigned to the two equivalent alkene hydrogens. The 
two-proton singlet at 8 4.86 is attributed to the allylic oxymethine protons, while the 
doublet (J  = 7.9 Hz) at 8 4.14 is attributed to the oxymethine protons adjacent to the 
cyclopropyl moiety. Two two-proton cyclopropyl resonances were observed at 8 2.75 
(dd, J  = 7.8 and 1.6 Hz) and 2.85 (ddd, J = 7.8, 7.5 and 7.3 Hz) and the remaining 
signals (8 2.09 and 2.06) correspond to the two types of acetoxy-methyl groups present 
within compound 211.
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All attempts to effect cyclopropanation of compound 211 under a variety of 
conditions were unsuccessful. In all cases starting material was recovered. Difficulties 
associated with cyclopropanating the double-bonds in compounds such as 208 and 
211 prompted a consideration of exploiting this behaviour and targeting the synthesis 
of the left-hand ends of FR-900848 (180) and U-106305 (181), both of which contain 
the same combination of terminal methyl group and tri-cyclopropyl array interrupted by 
a carbon-carbon double-bond (Figure 5.4). Efforts directed towards these ends, 
which are detailed in the following section, seemed worthwhile because both Barrett157 
and Charette163 had experienced considerable difficulties in establishing the terminal 
methyl group associated with these polycyclopropane arrays.
OH
OH
180 (FR-900848)
181 (U-106305)
Figure 5.4
5 .5  Chemoenzymatic Syntheses of Derivatives of the Cyclopropane- 
Containing Terminus Associated with FR-900848 and U-106305
It was envisaged that the microbially-derived ds-l,2-dihydrocatechol 16 could be 
exploited for the synthesis, in enantiopure form, of the rn-cyclopropyl array 212. The 
relevant retrosynthetic analysis associated with the proposed study is outlined in 
Figure 5.5. Thus, it was expected that the tricyclopropane 213 could be constructed 
via oxidative cleavage of the cis-v icinal diol present within compound 214. In 
principle, the aldehyde moieties within compound 213 could be deleted using
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Wilkinson's catalyst167 so as to provide target 212. It was anticipated that two-fold 
cyclopropanation of compound 215 would provide target 214 and, in keeping with 
previous results (see above), it was anticipated that the cyclohexyl double-bond present 
within compound 215 would not engage in any cyclopropanation reaction. Compound 
215 could, in turn, be derived from a Heck reaction between iodide 216 and (£)-2,4- 
pentadienoic acid or the corresponding methyl ester. Tricycle 216 should be readily 
obtained from compound 16, which is the product from microbial oxidation of p- 
iodotoluene.*
C 02Me
212
M e02C
212
Figure 5.5: Retro synthetic Analysis of Tricyclopropane 212 Based Upon Using the 
p-Iodotoluene-Derived cis-1,2-Dihydrocatechol 16 as Starting Material.
It should be noted that compound 212 is in the opposite enantiomeric series to that required for the 
synthesis of the naturally occurring enantiomers of FR-900848 (180) and U-106305 (181). However, 
development of a synthesis of ent-216 (or the corresponding diol) would make possible access to the 
correct enantiomeric series and thereby lead to the appropriate compound, viz. ent-212. This has been 
achieved (see pages 104-107).
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In an effort to test the feasibility of the ideas enunciated in Figure 5.5, the acetonide 
derivative, 217, of diol 16 was treated with dichlorocarbene to afford compound 216
(77%, Scheme 5.7). It should be noted that compound 216 is necessarily obtained in 
only ca. 80% ee because this is the enantiomeric excess associated with precursor 16 
derived via microbial oxidation of p-iodotoluene. However, since compound 216 is a 
solid it could be recrystallised to constant melting point and [a]o- On the basis of doing 
this, it is assumed, that compound 216 and all of its derivatives are of >95% ee.& In an 
initial effort to examine the utility of Heck-type reactions173 for replacing the iodine
atom within compound 216 by an unsaturated side-chain that could be
cyclopropanated, this material was subjected to reaction with methyl acrylate under
HO pH 0/5
o o
219 (syn)
220 (anti)
Cl H
216
Scheme 5.7 Reagents and Conditions: (i) 2,2-dimethoxypropane, p-toluenesulfonic acid (0.05 
mole equiv.), 0 °C, 1 h, 97%. (ii) CHC13, 50% w/v aq. NaOH (14.0 mole equiv.), TEBAC, 5 °C to 20 
°C, 16 h, 77%. (iii) methyl acrylate (1.2 mole equiv.), PPh3 (0.2 mole equiv.), K2CO3 (2.0 mole 
equiv.), Et4NH4Cl (1.0 mole equiv.), Pd(OAc)2 (0.05 mole equiv.), DMF, 75 °C, 16 h, 78%. (iv) 
CH2N2 (excess), Pd(OAc)2 (0.05 mole equiv.), 0 °C, 1 h, 86%.
& This assumption remains because no effort has been made to establish the enantiomeric purity of 
compound 216.
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standard Heck conditions. The diene-ester 218 (78%) thus obtained was 
cyclopropanated with diazomethane and palladium acetate174 and an inseparable ca. 
2.3:1 mixture of two diastereomers, 219 and 220 (86% combined yield), was thereby 
produced.$ In keeping with expectation, no products arising from cyclopropanation of 
the internal olefin present within diene-ester 218 was observed.
The results just described prompted efforts to explore methods for the synthesis of 
derivatives of the left-hand terminus associated with polycyclopropanes FR-900848 and 
U -106305 (see Figure 5.4). To these ends, iodide 216 was subjected to a Heck 
reaction with (£)-2,4-pentadienoic acid173 and the resulting triene acid treated with 
diazomethane so as to give the corresponding ester 215 (45% from 216, Scheme 
5.8). The former reaction was found, at times, to be low yielding, perhaps because of 
the propensity of (£)-2,4-pentadienoic acid to polymerize upon heating.173 To
Scheme 5.8 Reagents and Conditions: (i) (Zs)-2,4-pentadienoic acid (1.25 mole equiv.), Pd(OAc)2 
(0.05 mole equiv.), PPh3 (0.2 mole equiv.), K2CO3 (2.0 mole equiv.), Et4NCl (1.0 mole equiv.), 
DMF, 75 °C, 16 h then CH2N2 (excess), Et2 0 , 5 °C, 2 h, 45% from 216.
circumvent such difficulties an alternative route to compound 215 was pursued, based 
upon the stepwise construction of the target molecule (Scheme 5.9). Thus, iodide 
216 was subjected to a Stille-type cross-coupling reaction with the known (E)-tn-n- 
butyl-l-propen-3-ol stannane (prepared in three steps from propargyl alcohol)176 to 
afford com pound 221 (74%). Oxidation of this latter compound using 
tetrapropylammonium perruthenate with 7/-methylmorpholine-./V-oxide as co-oxidant177
$ The limited diastereoselectivities observed in this cyclopropanation reaction match those obtained 
when a chiral phenyloxazolidinone containing an oc,ß-unsaturated ester was cyclopropanated with 
diazomethane and palladium acetate.173
216 215
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223 (A=syn, B=syn)
224 (A=syn, B=anti)
225 (A=anti, B-syn)
226 (A=anti, B =anti)
214 (A=syn, B=syn)
227 (A=syn, B =anti)
228 (A=anti, B=syn)
229 (A=anti, B=anti)
215
230 tA=syn, B=syn)
231 (A=syn, B =anti)
232 (A-anti, B=syn)
233 (A=anti, B=anti)
(vii), (viii)
213 (A=syn, B =syn)
234 (A=syn, B=anti)
235 (A-anti, B=syn)
236 (A-anti, B=anti)
Scheme 5.9 Reagents and Conditions: (i) (£)-tri-n-butyl-l-propen-3-ol stannane (6.0 mole equiv.), 
THF, 50 °C, 16 h, 74%. (ii) NMO (2.0 mole equiv.), 4Ä molecular sieves, TPAP (0.05 mole equiv.), 
CH2 CI2 , 20 °C, 2 h, 74%. (iii) trimethylphosphonoacetate (1.5 mole equiv.), NaH (1.5 mole equiv.), 
THF, 50 °C, 2 h, 83%. (iv) CH2N2 (excess), Et20, 5 °C, 2 h, 86%. (v) AcOH (60% aq.), 80 °C, 16 h. 
(vi) NaI04 (8.0 mole equiv.), THF/H20  (1:1), 5 °C, 1 h. (vii) NaBH4 (8.0 mole equiv.), THF/MeOH 
(10:1), 5 °C, 8 h. (viii) AC2 O, pyridine, 20 °C, 8 h, 67% from 223-226. [See Scheme 5.7 for 
structures that define the manner in which the syn- and anh-descriptors are employed here].
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provided aldehyde 222, which was subjected to a Horner-Wadsworth-Emmons 
olefination reaction.178 In this manner, compound 215 was obtained in 83% yield.
Compound 215 was cyclopropanated with diazomethane in the presence of 
palladium acetate and in this manner a ca. 4:3:1:1 mixture% of the four possible 
products 223-226, (86% combined yield) was obtained. The chromatographically least 
mobile of these diastereoisomers could be separated from the other three via semi­
preparative normal-phase HPLC on silica. In the downfield region of the 300 MHz lH 
NMR spectrum of this single product (Figure 5.6) a one-proton doublet (7 = 6.3 Hz) 
was observed at 5 5.42, and assigned to the alkenyl hydrogen. Two mutually coupled 
oxymethine protons were observed at 6 4.41 (d, 7 = 6.6 Hz) and 8 4.39 (d, 7 = 6.6 
Hz), while the singlet at 8 3.66 is attributed to the methyl protons of the carbomethoxy 
group. The doublet (7 = 6.3 Hz) at 8 1.82 is assigned to the cyclopropyl-hydrogen 
adjacent to the gem-dichloro cyclopropyl moiety. A three-proton singlet at 8 1.56 and a 
six-proton singlet at 8 1.39 account for the protons of the remaining three methyl 
groups. In the low-field region of the spectrum four signals, at 8 1.40, 1.10, 0.73 and 
0.53, are observed and are assigned to the remaining eight cyclopropyl-hydrogens 
within this compound.
The acetonide groups within the ca. 4:3:1:1 mixture of diastereoisomers 223-226 
were removed using aqueous acetic acid so as to afford the corresponding mixture of 
diols 214 and 227-229. Treatment of these latter compounds with sodium 
metaperiodate then gave a mixture of unstable dialdehydes 230-233, which were 
immediately reduced to the corresponding mixture of open-chain diols using sodium 
borohydride. The mixture of these latter compounds was acetylated under standard 
conditions to give the compounds 213 and 234-236 (67% from 223-226), again as a 
ca. 4:3:1:1 mixture of diastereoisomers which were inseparable by various 
chromatographic techniques including semi-preparative HPLC. However, one of the 
four compounds must necessarily have the structure which corresponds to the left-hand 
end of both enr-FR-900848 (180) and e/if-U-106305 (181).
This ratio was determined by analytical gas chromatography. Injection temperature = 150 °C; final 
temperature = 300 °C; temperature gradient = 10 °C/min.
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As noted earlier, the synthesis of ent-216 would allow access, via the chemistry 
outlined above, to the natural enantiomeric series associated with these polycyclopropyl 
arrays. Consequently, some efforts were focussed on preparation of iodide ent-216 
from diol 17. To these ends (Schem e 5.10), the readily available acetonide 
derivative,75 27, of c/s-l,2-dihydrocatechol 17 was treated with chloroform and 
aqueous sodium hydroxide in the presence of the phase-transfer catalyst 
triethylbenzylammonium chloride. As a result, a 1.2:1 mixture of cycloadducts 237 and 
238 was obtained in 82% overall yield. These regioisomers could not be separated 
from one another by flash chromatography so the mixture was subjected to acid-
239 240
(iii)
1- I
241 242 243
Scheme 5.10 Reagents and Conditions: (i) CHCI3, 50% w/v aq. NaOH (12.0 mole equiv.), 
TEBAC, 5 °C to 20 °C, 16 h, 82%. (ii) AcOH (60% aq.), 80 °C, 16 h, 63%. (iii) DMSO (3.2 mole 
equiv.), oxalyl chloride (1.5 mole equiv.), NEt3 (3.2 mole equiv.), CH2CI2, -78 °C, 2.5 h, 65%. (iv) 
CDCI3 (NMR tube), 20 °C, 12 h, 100%. (v) I2 (4.2 mole equiv.), CC^/pyridine (1:1), 20 °C, 64%.
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catalyzed hydrolysis of the acetonide protecting group. The resulting diols 239 and 
240 were then readily separated by flash column chromatography75 and the former 
product mono-oxidized under Swern179 conditions to afford enone 242. While this 
product was somewhat unstable, and often underwent a ring-expansion reaction with 
loss of HC1 so as to give the troponoid 241, careful iodination180 of compound 242 
under conditions defined by Johnson et al. provided iodide 243 in 64% yield after 
flash chromatography.
Diastereoselective 1,2-reduction of the enone moiety present within compound 243 
so as to give the target syn-diol 244 proved to be anything but straightforward. Thus, 
reaction of enone 243 with a variety of reducing agents (Table 5.1) afforded mixtures 
of syn- and anti-dio\s 244 and 245, with the anti-diol being the major product of 
reaction in most instances (Scheme 5.11, Table 5.1). For example, reduction of 
ketone 243 with zinc borohydride at -78 °C (Entry 3, Table 5.1) afforded a 4:96
243 244 245
Scheme 5.11 Reagents and Conditions: (i) See Table 5.1 (below).
Entry Reducing
Agent
Temp. Time Combined
Yield
Ratio of 
products 
244:245
1 NaBH4 0°C 8 hours 98 % 36:64
2 NaBH4 -78 °C 8 hours 94% 14:86
3 ZnBH4 -78 °C 1 hour 93 % 4:96
4 UAIH4 o°c 6 hours 8 6 % 3:97
5 DIBAL-H o°c 2.5 hours 92 % 37:63
6 DffiAL-H -78 °C 2.5 hours 84% 44:56
Table 5.1: Results of Subjecting Acyloin 243 to 1,2-Reduction With a Variety of 
Hydride Donors.
105
Chapter Five
mixture of syn- and anti-diols 244 and 245, which were only separable by preparative 
HPLC techniques. The observed preference for production of the anti-diol in these 
reduction processes probably derives from chelation of the reducing agent to the C-2 
hydroxyl group with the result that the ensuing conjugate delivers hydride from the a- 
face of the molecule. Despite these unexpected results, a formal connection was made 
between diol 244 and its enantiomer ent-244.
In order to confirm the structure of diol 244, its enantiomer was also prepared. 
Thus, hydrolysis of the acetonide group present within compound 216 afforded diol 
ent-244 (Scheme 5.12), and the spectral data obtained for this latter compound were 
identical to those obtained for compound 244. The specific rotation observed for the 
sample of compound ent-244 { [ a ] o 20 - 57.2 ° (<c 3.2, chloroform)} prepared by the 
route just described was of essentially the same magnitude but opposite sign to 
compound 244 {[oc]d20 + 54.0 ° (c 1.0, chloroform)}.
216 ent- 244
Scheme 5.12 Reagents and Conditions: (i) AcOH (60% aq.), 80 °C, 16 h, 76%.
5.6  Conclusion
The reactions described in this chapter reveal the scope and limitations associated 
with preparing polycyclopropyl substructures associated with the natural products FR- 
900848 (180) and U-106305 (181) using c is -\,2-dihydrocatechols as starting 
materials. A series of hitherto unknown polycyclopropanes have been prepared from 
cfs-l,2-dihydrocatechols 14 (X=I) and 16. Further work in this area would seem to be 
warranted.
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6.1 General Experimental Procedures
Instrumentation and Equipment.
Proton (iH), carbon (13C) and phosphorous (31P) NMR spectra were recorded on a 
Varian Gemini 300 spectrometer, operating at 300 MHz for proton, 75.4 MHz for 
carbon and 121.4 MHz for phosphorous, respectively. Deuterochloroform (CDCI3) 
was used as solvent unless otherwise indicated. Chemical shifts are recorded as 8 
values in parts per million (ppm), the nominal standard being tetramethylsilane (TMS) 
(0.00 ppm). Proton spectra recorded in deuterochloroform were referenced against 
residual CDCI3 (7.26 ppm), while the central peak (77.0 ppm) of the CDCI3 triplet was 
used as the internal reference for carbon spectra. In those cases where dö-acetone 
[(CÜ3)2CO] was used as solvent, carbon spectra were referenced to the central peak 
(29.2 ppm) of the (CD3)2CO heptet. Data are recorded as follows: chemical shift (8), 
relative integral, multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet, 
dd=doublet of doublets etc., br=broad), coupling constant(s) (7 Hz). Distortionless 
enhancement by polarization transfer (DEPT), attached proton test (APT) and 
heteronuclear correlation (HETCOR) techniques were employed for the assignment of 
NMR spectra.
Infrared spectra (vmax) were recorded on either a Perkin-Elmer 1800 Fourier 
Transform Infrared Spectrophotometer or a Perkin-Elmer 683 Infrared 
Spectrophotometer. Samples were analyzed as either KBr discs (for solids) or as thin 
liquid films (for oils) on potassium bromide (KBr) plates.
Low and high resolution mass spectra were recorded on a VG Micromass 7070F 
double-focussing mass spectrometer using (unless otherwise stated) positive ion 
electron impact (El, 70 eV electron beam) techniques at the voltages indicated. Mass 
spectral data are listed as mass-to-charge ratio (m/z), assignment (where possible) and 
relative intensity (% of base peak).
108
Chapter Six
Optical rotations {[oc]d } were recorded on a Perkin-Elmer 241 polarimeter using 
(unless otherwise stated) spectroscopic grade chloroform or acetone as solvent at the 
temperature and concentration (c) (g/100 mL) indicated.
Melting points were recorded on a Reichert Hot-Stage microscope and are 
uncorrected.
Elemental analyses were performed by the Australian National University 
Microanalytical Services Unit on a Carbo Erba EA 1106 CHN-O Elemental Analyzer. A 
titrometric method, using mercury nitrate, was employed for halogen analysis.
Ozonolyses were performed using a Wallace and Tieman Ozonator with the oxygen 
fiow rate and power adjusted to approximately 25 L/h and 200 V, respectively.
Analytical thin layer chromatography (TLC) was conducted on aluminium-backed 
0.2 mm thick silica gel 60 GF254 plates (supplied by Merck) and the chromatograms 
were visualized under a 254 nm UV lamp and/or by treatment with a reagent solution 
[either anisaldehyde/sulfuric acid/ethanol (2:5:93) dip, phosphomolybdic acid/ethanol (8 
g/200 mL) dip or phosphomolbdic acid/ceric (IV) sulfate/sulfuric acid/water (37.5 g:7.5 
g:37.5 mL:720 mL) dip] followed by heating. Flash chromatography was conducted 
according to the method of S till181 using the analytical reagent (AR) grade solvents 
indicated.
High performance liquid chromatography (HPLC) was conducted on a Waters p.- 
Porasil™ semi-preparative silica column (7.8 x 300 mm) connected to an ISCO Model 
2350 pump. The peaks were detected using an ERMA ERC-7512 refractive index 
detector connected to a Spectra-Physics SP4270 reporting integrator.
Gas chromatography (GC) was performed on either a Varian 3400 Gas 
Chromatograph fitted with a SGE Cydex-B chiral capillary column (25 m x 0.22 mm 
internal diameter, film thickness = 25 micron) or a Varian Vista Series Gas 
Chromatograph fitted with a SGE BPX5 silica capillary column (25 m x 0.22 mm 
internal diameter, film thickness = 25 micron). The peaks were detected using a flame- 
ionization detector and helium was the carrier gas in all cases (flow rate ca. 35 cm/sec). 
Specific temperature programs are detailed for each individual case.
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Materials and Methods:
All cis-1,2-dihydrocatechols were generously provided by Genencor International 
Inc. (Palo Alto, CA) and used as obtained with the exception of compounds 16 and 
17. (For general procedures for the extraction of (15,2/?)-cij-3-methyl-3,5- 
cyclohexadiene-l,2-diol (17) and (lS,2S)-cA-3-iodo-5-methyl-3,5-cyclohexadiene- 
1,2-diol (16) from their corresponding fermentation broths see pages 136 and 182, 
respectively).
Many reagents and starting materials are available from the Sigma-Aldrich-Fluka 
Chemical Company and were used as supplied. Ethereal diazomethane was prepared 
according to the method of de Boer and co-workers.182 Drying agents and other 
inorganic salts were purchased from AJAX or BDH Chemicals. Reaction solvents and 
reagents were purified according to established procedures.183 The concentrations of 
alkyl lithium solutions obtained from Aldrich were determined by titration with sec- 
butanol (1.0 M solution in toluene) using 1,10-phenanthroline as indicator.184 
Tetrahydrofuran (THF) and diethyl ether (Et2Ü) were distilled, under nitrogen, from 
sodium benzophenone ketyl, while methanol and ethanol were distilled from their 
respective magnesium alkoxide salts. Benzene (CßHö), toluene, dichloromethane 
(CH2CI2) and A,A-dimethylformamide (DMF) were distilled from calcium hydride. 
Pyridine and triethylamine (NEt3) were distilled from potassium hydroxide pellets. 
Dimethyl sulfoxide (DMSO) was distilled at reduced pressure (ca. 15 mmHg) and the 
initial 20% of the distillate was discarded before collection began. Sodium iodide was 
dried overnight under high vacuum (0.5 mmHg) at 70 °C then cooled and stored in a 
desiccator. 4 Ä Molecular sieves were dried by heating in a 1000 Watt microwave oven 
(running at full power for 0.1 h). The cooled sieves were then transferred to an oven 
dried container and sealed.
Reactions employing air- and/or moisture-sensitive reagents were carried out under 
an atmosphere of dry, oxygen-free nitrogen in oven- or flame-dried apparatus. 
Solutions were concentrated under reduced pressure on a Büchi R-114 rotary
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evaporator. When reactions were conducted at, or below, 0 °C the internal temperature 
was monitored using an alcohol thermometer.
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6.2 Experimental Details Associated with Work Described in Chapter 
Two
(lS ,2 /? ,5 /? ,6S ,7S ,8S ,9S ,10/O -M -D icyano-5 ,6:9 ,10-6is-  
(isopropylidenedioxy)tricyclo[6.2.2.0]dodeca-3,11 -diene (64).
p-Toluenesulfonic acid monohydrate (318 mg, 1.60 mmol) was added, in one 
portion, to a magnetically stirred solution of (15',2/?)-c/5'-3-cyano-3,5-cyclohexadiene- 
1,2-diol (14, X=CN) (1.21 g, 8.75 mmol) in dry acetone (20 mL) and 2,2- 
dimethoxypropane (10 mL, 16.2 mmol) maintained at ca. -10 °C (salt-ice bath) under a 
nitrogen atmosphere. After 0.5 h the reaction mixture was treated with triethylamine 
(1.0 mL) then concentrated under reduced pressure. The residue thus obtained was 
partitioned between Et20 (50 mL) and water (30 mL). The separated aqueous phase 
was extracted with Et2Ü (2 x 50 mL) then the combined organic phases were dried 
(MgSC>4), filtered and concentrated under reduced pressure. The material obtained in 
this way was subjected to flash chromatography (2:1 hexane/EtOAc elution) which 
afforded, after concentration of the appropriate fractions (R/0.3), a white solid. 
Recrystallization (hexane/EtOAc) of this material then gave compound 64 [834 mg, 
54% from 14 (X=CN)] as colourless needles, m.p. 252-253 °C (lit.76 m.p. 211 °C).
*H NMR (300 MHz) 5: 6.72 (1H, d, J = 5.7 Hz), 6.14 (1H, apparent t, J = 8.4 Hz), 
6.00 (1H, d, J = 8.4 Hz), 4.46 (2H, s), 4.24 (1H, d, J = 3.3 Hz), 4.18 (1H, d, J =
4.5 Hz), 3.04 (1H, d, J = 6.3 Hz), 2.86-2.81 (1H, m), 2.42 (1H, d, J = 8.4 Hz), 1.40 
(3H, s), 1.36 (3H, s), 1.33 (3H, s), 1.30 (3H, s).
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13C NMR (75.4 MHz) 5: 141.2 (CH), 130.9 (CH), 129.2 (CH), 120.0 (C), 117.6 
(C), 116.8 (C), 111.2 (C), 109.9 (C), 79.8 (CH), 77.9 (CH), 76.7 (CH), 69.3 (CH), 
44.1 (C), 39.6 (CH or CH3), 37.9 (CH or CH3), 33.2 (CH or CH3), 28.2 (CH or 
CH3), 26.7 (CH or CH3), 25.6 (CH or CH3), 25.4 (CH or CH3).
IR vmax 2998, 2982, 2936, 2924, 2882, 2246, 2216, 1650, 1557, 1255 cm-1 
EIMS (70eV) m/z 354 (M+\ 7), 339 [(M-H3C-)+, 84], 281 (100), 238 (52), 221 
(73), 209 (48), 193 (52), 120 (66), 100 (89).
Elemental Analysis Found: C, 67.67; H, 6.62; N, 7.76; C20H22N2O4 requires: C, 
67.78; H, 6.26; N, 7.90%.
Optical Rotation [a]D20 + 105.4 0 (c 3.8, CHCI3); {lit.76 [a]D20 + 110.9 0 (c 0.4, 
CHCI3)}.
(3aS,5a5,6aS',6b/?)-2,2,6,6-Tetramethyl-3a,6,6a,6b-tetrahydrocyclo- 
propa[e]-l,3-benzodioxolo-6a(5a//)-carbonitrile (65) and 
(3aS,5a/?,6a/?,6b/?)-2,2,6,6-Tetramethyl-3a,6,6a,6b-tetrahydrocyclo- 
propa[e]-l,3-benzodioxolo-6a(5a//)-carbonitrile (66).
diphenylethylsulfonium
tetrafluoroborate
LDA, Mel
Lithium diisopropylamine (1.6 mL of a 0.69 M solution in THF, 1.09 mmol) was 
added, dropwise, to a magnetically stirred suspension of diphenylethylsulfonium 
tetrafluoroborate78 (299 mg, 0.99 mol) in dry CH2CI2 (65 pL, 1.00 mmol), dry THF 
(5 mL) and dry DME (5 mL) maintained at -78 °C (acetone/dry-ice slush bath) under a 
nitrogen atmosphere. After stirring for 0.75 h at -80 °C to -70 °C methyl iodide (66 pL, 
1.05 mmol) was added, dropwise, to the reaction mixture and the resulting solution 
stirred at -70 °C for 2 h. A further aliquot of lithium diisopropylamine (1.6 mL of a 
0.69 M solution in THF, 1.09 mmol) was then added and after 1.25 h a solution of
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compound 63 (172 mg, 0.97 mmol) in dry THF (0.5 mL) was added to the by now 
orange-coloured reaction mixture. The solution thus obtained was warmed to 18 °C 
over 2 h then diluted with water (10 mL) and Et20 (50 mL). The separated aqueous 
phase was extracted with Et2Ü (3 x 50 mL) and the combined organic phases were then 
dried (MgSC>4), filtered and concentrated under reduced pressure to provide a pale- 
yellow oil which was subjected to flash chromatography (2:1 hexane/EtOAc elution). 
Concentration of the appropriate fractions (R/0.7) then gave a ca. 2:1 mixture (as 
judged by *H NMR analysis) of compounds 65 and 66 (140 mg, 66%) as a clear, 
colourless oil. All attempts to separate the components of this mixture failed but 
comparison of the *H NMR spectrum of this material with the analogous spectra of 
authentic samples of compounds 65 and 66 (see pages 119 and 120), prepared as 
described below, left little doubt as to the nature of the materials produced by the 
process described here.
3-Hydroxy-6-methylbenzenenitrile (70).
Trimethyloxosulfonium iodide80 (285 mg, 1.30 mmol) was added, in portions, to a 
magnetically stirred suspension of sodium hydride (50 mg of a 60% dispersion in 
mineral oil, 1.24 mmol) (which was freed of oil by washing several times in anhydrous 
hexane) in dry DMSO (4 mL) maintained at 5 °C (ice-bath) under a nitrogen 
atmosphere. After 0.5 h a solution of diene 63 (200 mg, 1.13 mmol) in dry THF (2 
mL) was added dropwise. The by now purple-coloured reaction mixture was stirred at 
18 °C for 2 h then diluted with water (20 mL) and Et2Ü (100 mL). The separated 
aqueous phase was extracted with Et2Ü (1 x 100 mL) and the combined organic phases 
were then dried (MgSOq), filtered and concentrated under reduced pressure. The
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material obtained in this way was subjected to flash chromatography (2:1 hexane/EtOAc 
elution) which afforded, after concentration of the appropriate fractions (Ry0.5), 
compound 70 (114 mg, 76%) as a clear, colourless oil.
*H NMR (300 MHz) 5: 7.18 (1H, d, J  = 8.4 Hz), 7.10 (1H, d, J  = 1.8 Hz), 7.01 
(1H, dd, J  = 8.4 and 1.8 Hz), 6.10 (1H, bs), 2.46 (3H, s).
13C NMR (75.4 MHz) 8: 154.2 (C), 134.3 (C), 131.9 (CH), 121.2 (CH), 118.9 
(CH), 118.2 (C), 112.9 (C), 19.7 (CH3).
IR vmax 3327, 2922, 2239, 1622, 1579, 1507, 1298 cm '1
EIM S (70eV) m/z 133 (M +\ 100), 119 (93), 106 (27), 91 (24), 77 (32).
HRMS Found M +\ 133.0527 C8H7NO requires M +\ 133.0527.
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(3a/? ,3bS ,4a /? ,4b /? ,5a /? ,5bS)-4 ,4 ,5 ,5 -T etrabrom ohexahydro-2 ,2-  
dim ethyldicyclopropa[> ,g]-l ,3 -benzodioxolo-3b(3a//)-carbonitrile  (75), 
(3a /? ,5a /? ,6a /? ,6bS)-6 ,6 -D ibrom o-2 ,2-d im ethyl-3a ,5a ,6a ,6b -  
tetrahydrocyclopropa[e]-l,3 -benzodioxolo-4(5a//)-carbon itr ile  (76), 
(3a1S ,5a5 ,6a /? ,6b /? )-6 ,6 -D ib rom o-2 ,2 -d im eth y l-3a ,5a ,6a ,6b -  
tetrahydrocyclopropa[e]-l,3 -benzo-dioxolo-6a(5a//)-carbonitrile  (77) 
and (3a5 ,5a /? ,6aS ,6b /?)-6 ,6 -D ibrom o-2 ,2-d im eth yl-3a ,5a ,6a ,6b -  
tetrahydrocyclopropa[e]-l,3 -benzodioxolo-6a(5a//)-carbonitr ile  (78).
Sodium hydroxide (30.25 mL of a 50% w/w aqueous solution, 380 mmol) was 
added, dropwise, to a magnetically stirred solution of compound 63 (11.0 g, 62.1 
mmol), bromoform (27.5 mL, 313.5 mmol) and benzyltriethylammonium chloride (205 
mg, 0.88 mmol) in dry benzene (220 mL) maintained at 5 °C (ice-bath). The resulting 
brown-coloured reaction mixture was stirred vigorously at 18 °C for 16 h then diluted 
with CHCI3 (300 mL) and water (270 mL). The separated aqueous phase was extracted 
with CH2CI2 (3 x 200 mL) and the combined organic phases were then dried (MgSOzO, 
filtered and concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (2:1 hexane/EtOAc elution) which afforded three 
fractions, A-C.
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Concentration of fraction A (Ry0.8) yielded a white solid. Recrystallization 
(hexane/CHCl3) of this material gave compound 75 (1.50 g, 5%) as colourless prisms, 
m.p. 219-220 °C.
*H NMR (300 MHz) 5: 4.90 (1H, d, J = 8.4 Hz), 4.48 (1H, d, J = 8.4 Hz), 2.75 
(1H, s), 2.35 (2H, m), 1.58 (3H, s), 1.39 (3H, s).
13C NMR (75.4 MHz) 8: 119.6 (C), 110.4 (C), 72.7 (CH), 68.8 (CH), 38.3 (CH or 
CH3), 32.2 (CH or CH3), 27.8 (CH or CH3), 25.2 (C), 25.1 (C), 24.9 (CH or CH3), 
22.6 (CH or CH3), (one signal due to a quaternary carbon not observed).
IR vmax 3043, 3015, 2992, 2916, 2224, 1382 cm '1.
EIMS (70eV) m/z 507, 505, 503, 501 [(M-H3C-)+, 10, 20, 28, 19], 446 (8), 381 
(11), 364 (19), 274 (57), 100 (100).
Elemental Analysis Found: C, 27.41; H, 1.89; Br, 61.37; N, 2.35; Ci2HiiBr4NC>2 
requires: C, 27.67; H, 2.13; Br, 61.21; N, 2.69%.
Optical Rotation [a]D20 - 39.5 0 (c 1.0, CHCI3).
Concentration of fraction B (Ry0.7) yielded a white solid comprised of a ca. 4.4:1 
mixture (as determined by *H NMR analysis) of compounds 76 and 77. 
Recrystallization (hexane/EtOAc) of this material yielded compound 76 (5.90 g, 27%) 
as colourless prisms, m.p. 205-206 °C.
!H NMR (300 MHz) 5: 6.83 (1H, d, J = 5.7 Hz), 4.74 (1H, d, J = 6.6 Hz), 4.49 
(1H, d, J = 5.7 Hz), 2.58 (2H, m), 1.43 (3H, s), 1.40 (3H, s).
13C NMR (75.4 MHz) 5: 139.0 (CH), 116.9 (C), 114.8 (C), 110.9 (C), 70.1 (CH), 
69.3 (CH), 31.5 (CH or CH3), 29.7 (C), 28.5 (CH or CH3), 27.5 (CH or CH3), 25.8 
(CH or CH3).
IR v max 2991,2241, 1456, 1381, 1059 cm*1.
EIMS (70eV) m/z 352, 350, 348 (M+\ 0.5, 0.7, 0.5), 337, 335, 333 [(M-H3C-)+ 6, 
8, 6], 290 (34), 274 (55), 210 (100), 182 (48), 103 (77).
Elemental Analysis Found: C, 38.14; H, 2.96; Br, 45.81; N, 4.06; C n H n B r 2N02 
requires: C, 37.85; H, 3.18; Br, 45.79; N, 4.01%.
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Optical Rotation [a]D20 -96.7 0 (c 2.9, CHC13).
Recrystallization (hexane/Et20) of the solid obtained from concentration of the 
mother liquors associated with the recrystallization described above yielded compound 
77 (6.80 g, 31%) as colourless prisms, m.p. 100-101 °C.
*H NMR (300 MHz) 6: 6.03-5.97 (2H, m), 4.60 (1H, d, J = 7.2 Hz), 4.51 (1H, m), 
2.78 (1H, d, J = 5.4 Hz), 1.45 (3H, s), 1.41 (3H, s).
13C NMR (75.4 MHz) 6: 129.4 (CH), 121.1 (CH), 117.5 (C), 111.4 (C), 71.0 
(CH), 69.4 (CH), 35.3 (CH), 32.0 (C), 27.7 (CH3), 27.1 (C), 26.1 (CH3).
IR vmax 2991, 2936, 2241, 1381, 1220, 1059 cm'1.
EIMS (70eV) m /z 352, 350, 348 (M+\ 0.3, 0.5, 0.3), 337, 335, 333 [(M-H3C-)+, 6, 
8, 6], 292 {[M-(CH3)2CO]+\ 76}, 274 (73), 210 (99), 182 (47), 103 (100). 
Elemental Analysis Found: C, 37.82; H, 2.95; Br, 45.78; N, 3.81; CnHnBr2N02 
requires: C, 37.85; H, 3.18; Br, 45.79; N, 4.01%.
Optical Rotation [a]D20 -1.07 0 (c 3.1, CHC13).
Concentration of fraction C (R/0.6) yielded a white solid. Recrystallization 
(hexane/EtOAc) of this material then gave compound 78 (1.52 g, 7%) as colourless 
prisms, m.p. 180-181 °C.
*H NMR (300 MHz) 6: 6.14-6.09 (2H, m), 4.82 (1H, d, J  = 6.4 Hz), 4.66-4.65 
(1H, m), 2.85 (1H, d, J  = 4.6 Hz), 1.50 (3H, s), 1.37 (3H, s).
13C NMR (75.4 MHz) 6: 127.8 (CH), 123.1 (CH), 119.8 (C), 108.0 (C), 71.9 
(CH), 68.5 (CH), 38.5 (CH), 31.2 (C), 29.7 (C), 24.7 (CH3), 23.2 (CH3).
IR vmax 2990, 2936, 2242, 1383, 1374, 1217, 1061 cm’1.
EIMS (70eV) m /z 337, 335, 333 [(M-H3C)+, 20, 25, 20], 292 {[M-(CH3)2CO]+\ 
36}, 210 (39), 182 (38), 103 (62).
Elemental Analysis Found: C, 37.67; H, 2.89; Br, 45.52; N, 3.92; CnHnBr2N02 
requires: C, 37.85; H, 3.18; Br, 45.79; N, 4.01%.
Optical Rotation [a]o20 -36.3 0 (c 3.6, CHC13).
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(3a /? ,3bS,4a/? ,4b/? ,5af l ,5bS)-4 ,4 ,5 ,5 -Tetrabromohexahydro-2 ,2-
d im ethyld icyc lopropa[e,g ]-l ,3 -b en zod ioxolo-3b(3a//)-carbon itrile  (75).
Sodium hydroxide (370 pL of a 50% w/w aqueous solution, 0.47 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 76 (102 mg, 0.30 mmol), 
bromoform (333 pL, 3.82 mmol) and benzyltriethylammonium chloride (5 mg, 0.02 
mmol) in dry benzene (3 mL) maintained at 5 °C (ice-bath). The dark-coloured reaction 
mixture was stirred vigorously at 18 °C for 16 h then diluted with CHCI3 (10 mL) and 
water (5 mL). The separated aqueous phase was extracted with CH2CI2 (3 x 20 mL) 
and the combined organic phases were then dried (MgSCL), filtered and concentrated 
under reduced pressure. The material obtained in this way was subjected to flash 
chromatography (2:1 hexane/EtOAc elution) which afforded, after concentration of the 
appropriate fractions (R/0.8), compound 75 (145 mg, 98%) as a white solid, m.p. 
219-220 °C. The spectral data obtained on this material were identical, in all respects, 
with those derived from an authentic sample of compound 75 produced under the 
conditions defined earlier (see page 115).
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(3aS,5aS,6aS,6bR)-2 ,2 ,6 ,6 -Tetramethyl-3a ,6 ,6a ,6b-tetrahydrocyclo-  
propa[e] -l ,3-benzodioxolo-6a(5a/7)-carbonitr ile  (65).
Copper cyanide (436 mg, 4.89 mmol) was washed with dry toluene ( 2 x 2  mL), with 
the solvent being removed under high vacuum (IO 3 Torr) after each wash. The tan 
powder thus obtained was suspended in dry THF (3 mL) under an atmosphere of 
nitrogen and the resulting suspension was cooled to -78 °C (acetone/dry-ice slush bath) 
then methyllithium (7.0 mL of a 1.4 M solution in Et20, 9.80 mmol) was added 
dropwise. The heterogeneous mixture produced in this manner was removed from the 
cold-bath and left to stir at 18 °C for 0.8 h and then recooled to -78 °C. Dibromide 78 
(168 mg, 0.489 mmol) was added at -78 °C then the reaction mixture was warmed to 0 
°C and allowed to stir at this temperature for 0.1 h. After this time, methyl iodide (1.10 
mL, 17.7 mmol) was added slowly over 0.2 h and after an additional 0.2 h the reaction 
mixture was quenched with ammonium chloride (60 mL of a 10% w/v aqueous solution 
in 10% ammonia water) then extracted with Et20 (2 x 50 mL). The combined organic 
phases were dried (MgSC>4) then filtered and concentrated under reduced pressure to an 
orange oil. The material obtained in this way was subjected to flash chromatography 
(2:1 hexane/EtOAc elution) which afforded, after concentration of the appropriate 
fractions (Rf 0.8), a white solid. Recrystallization (hexane) of this material then gave 
compound 65 (83 mg, 78%) as colourless needles, m.p. 93-94 °C. 
l U  NMR (300 MHz) 6: 5.92 (1H, dd, J  =  10.4 and 4.2 Hz), 5.83 (1H, dd, J  =  10.4 
and 3.0 Hz), 4.79 (1H, d, J  =  8.2 Hz), 4.62 (1H, dd, J  =  10.4 and 3.0 Hz), 1.90 (1H, 
d, J  = 4.2 Hz), 1.47 (3H, s), 1.41 (3H, s), 1.32 (3H, s), 1.10 (3H, s).
13C NMR (75.4 MHz) 6: 124.8 (CH), 123.9 (CH), 122.7 (C), 107.3 (C), 72.7 
(CH), 69.9 (CH), 34.5 (CH), 34.4 (C), 26.8 (CH3), 25.0 (CH3), 24.5 (C), 22.9 
(CH3), 16.9 (CH3).
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IR vmax 2981, 2940, 2225, 1659, 1458, 1385 cm '1.
EIMS (70eV) m/z 219 (M +\ 0.4), 204 [(M-H3C-)+, 27], 161 {[M-(CH3)2CO ]+\ 
78}, 146 (90), 132 (80), 120 (92), 103 (100).
HRMS Found (M-H3C-)+ 204.1029. C i3H i7N 0 2 requires (M-H3C-)+, 204.1024. 
Optical Rotation [ a ] o 20 - 12.3 ° (c 2.1, CHC13).
(3aS,5a/?,6aR,6bR)-2,2,6,6-Tetramethyl-3a,6,6a,6b-tetrahydrocyclo-  
propa[e]-l,3-benzodioxolo-6a(5a//)-carbonitrile (66).
Copper cyanide (444 mg, 4.96 mmol) was washed with dry toluene ( 2 x 2  mL) with 
the solvent being removed under high vacuum (10'3 Torr) after each wash. The tan 
powder thus obtained was suspended in dry THF (3 mL) under an atmosphere of 
nitrogen and the resulting suspension was cooled to -78 °C (acetone/dry-ice slush bath) 
then methyllithium (7.1 mL of a 1.4 M solution in Et20 , 9.91 mmol) was added 
dropwise. The heterogeneous mixture produced in this manner was removed from the 
cold-bath and left to stir at 18 °C for 0.8 h and then recooled to -78 °C. Dibromide 77 
(172 mg, 0.49 mmol) was added at -78 °C then the reaction mixture was warmed to 0 
°C and allowed to stir at this temperature for 0.1 h. After this time, methyl iodide (1.1 
mL, 17.7 mmol) was added slowly over 0.2 h and after an additional 0.2 h the reaction 
mixture was quenched with ammonium chloride (60 mL of a 10% w/v aqueous solution 
in 10% ammonia water) then extracted with Et20  (2 x 50 mL). The combined organic 
phases were dried (MgS04) then filtered and concentrated under reduced pressure to an 
orange oil. The material obtained in this way was subjected to flash chromatography 
(2:1 hexane/EtOAc elution) which afforded, after concentration of the appropriate
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fractions (Ry0.7), a white solid. Recrystallization (hexane) of this material then gave 
compound 66 (92 mg, 85%) as colourless needles, m.p. 77-78 °C.
*H NMR (300 MHz) 6: 5.91 (1H, dd, J = 10.4 and 5.4 Hz), 5.70 (1H, dd, J  = 10.4 
and 2.8 Hz), 4.48 (1H, d, J = 6.9 Hz), 4.30 (1H, m), 1.84 (1H, d, J  = 5.4), 1.47 
(6H, s), 1.39 (3H, s), 0.92 (3H, s).
13C NMR (75.4 MHz) 5: 125.6 (CH), 123.7 (CH), 120.6 (C), 110.4 (C), 71.0 
(CH), 68.8 (CH), 30.4 (CH), 29.0 (C), 27.8 (CH3), 26.2 (CH3), 25.8 (CH3), 21.0 
(C), 15.3 (CH3).
IR vmax 3025, 2984, 2975, 2938, 2230, 1651, 1454, 1243 cm '1.
EIMS (70eV) m/z 219 (M +\ 1.2), 204 [(M-H3C ) +, 25], 161 {[M-(CH3)2CO ]+\ 
100}, 146 (57), 132 (45), 120 (92).
• HRMS Found (M-H3C-)+ , 204.1025. C i3H i7N 0 2 requires (M-H3C-)+ , 204.1024. 
Optical Rotation [oc]d 20 + 10.1 ° (c 1.6, CHC13).
(3aS ,5a/? ,6a /? ,6b /?)-2 ,2 ,6 ,6 -T etram ethylhexahydrocyclopropa[e]-l ,3 -  
benzodioxolo-6a(5a//)-carbonitrile  (81).
66 81
10% Palladium on carbon (570 mg) was added to a solution of compound 66 (717 
mg, 3.27 mmol) in absolute EtOH (40 mL) and the resulting mixture was stirred under 
an atmosphere of dihydrogen at 18 °C for 40 h. The mixture thus obtained was filtered 
through a short pad of TLC-grade silica gel and the filtrate concentrated under reduced 
pressure. The material obtained in this way was subjected to flash chromatography (2:1 
hexane/EtOAc elution) which afforded, after concentration of the appropriate fractions 
(R/-0.8), compound 81 (719 mg, 99%) as a clear, colourless oil.
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!H NMR (300 MHz) 5: 4.14 (1H, d, J = 5.7 Hz), 3.89-3.87 (1H, m), 2.12-2.09 
(1H, m), 1.68-1.66 (1H, m), 1.30-1.19 (3H, m), 1.55 (3H, s), 1.39 (3H, s), 1.37 
(3H, s), 1.03 (3H, s).
13C NMR (75.4 MHz) 5: 121.2 (C), 109.0 (C), 75.2 (CH), 69.2 (CH), 31.3 (CH or 
CH3), 28.2 (CH or CH3), 26.3 (CH or CH3), 26.2 (CH or CH3), 26.1 (CH2), 25.7 
(C), 21.1 (C), 16.9 (CH2), 16.3 (CH or CH3).
IR vmax 2986, 2938, 2230, 1454, 1381, 1248 c n r1.
EIMS (70eV) m/z 206 [(M-H3C-)+, 27], 163{[M-(CH3)2CO ]+\ 21}, 146 (63), 104
( 100).
HRMS Found (M-H3C )+, 206.1186. C i 3H i9N 0 2 requires (M-H3C-)+, 206.1181. 
Optical Rotation [oc]d20 - 1.9 ° (c 1.9, CHC13).
( \ R ,  2 R y 35 ,4 /?)-2 ,3-D ihydroxy-7,7-d im ethylb icyclo  [4.1.0] heptane-1- 
carbonitrile (82).
A magnetically stirred solution of compound 81 (703 mg, 3.18 mmol) in acetic acid 
(80 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled reaction 
mixture was then diluted with water (10 mL) and EtOAc (200 mL). The separated 
aqueous phase was extracted with EtOAc (3 x 50 mL) and the combined organic phases 
were then dried (M gS04), filtered and concentrated under reduced pressure. The 
material obtained in this way was subjected to flash chromatography (2:1 hexane/EtOAc 
elution) which afforded, after concentration of the appropriate fractions (R/-0.1), 
compound 82 (547 mg, 94%) as a clear, colourless oil.
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*H NMR (300 MHz) 8: 3.89 (1H, m), 3.67 (1H, bs), 3.54-3.52 (1H, m), 2.99 (1H, 
bs), 2.08-2.03 (1H, m), 1.88-1.77 (1H, m), 1.46-1.44 (1H, m), 1.43 (1H, d, J  = 7.1 
Hz), 1.38 (3H, s), 1.30-1.24 (1H, m), 1.07 (3H, s).
13C NMR (75.4 MHz) 8: 122.2 (C), 67.6 (CH), 65.4 (CH), 30.4 (CH), 27.0 (CH2), 
26.7 (CH3), 26.0 (C), 21.2 (C), 15.8 (CH3), 13.9 (CH2).
IR vmax 3325 (br), 2919, 2225, 1456, 1119, 1072 cm '1.
EIMS (70eV) m/z 182 [(MH+), 1], 163 [(M-H20)+ \ 30], 137 (87), 122 (76), 108 
(100), 94 (70).
HRMS Found (M-H20)+ \ 163.0996. C i0H i3NO requires (M-H20 )+ \ 163.0997. 
Optical Rotation [oc]d 20 + 1.0 ° (c 1.6, H20).
(l/?,3/?)-l-Formyl-2,2-dimethyl-3-(3-oxopropyl)cyc!opropane- 
carbonitrile (83).
A solution of lead tetraacetate (169 mg, 0.38 mmol) in dry CH2C12 (3 mL) was 
added, dropwise, to a magnetically stirred suspension of compound 82 (33 mg, 0.18 
mmol) and calcium carbonate (216 mg, 2.16 mmol) in dry CH2C12 (6 mL) maintained 
at 0 °C (ice-bath) under a nitrogen atmosphere. After 0.75 h the reaction mixture was 
quenched with Et20  (20 mL) and the resulting mixture filtered through a short pad of 
TLC-grade silica gel. The filtrate was then concentrated under reduced pressure to 
afford compound 83 (28 mg, 88%) as a clear, colourless oil.
*H NMR (300 MHz) 8: 9.76 (1H, s), 9.58 (1H, s), 2.55 (2H, apparent t, J  = 6.9 
Hz), 2.11-2.06 (3H, m), 1.50 (3H, s), 1.38 (3H, s).
13C NMR (75.4 MHz) 8: 200.7 (CH), 192.9 (CH), 119.1 (C), 46.7 (CH), 44.8 (C), 
42.9 (CH2), 40.5 (C), 26.9 (CH3), 16.1 (CH2), 14.7 (CH3).
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IR Vmax 2975, 2919, 2243, 2209, 1731, 1654, 1623, 1387 cm’1.
EIMS (70eV) m/z 180 [(MH+), 20], 179 (M+\ 10), 150 (21), 135 (100). 
HRMS Found M+\ 179.0948 C i0H i3NO2 requires M+\ 179.0946. 
Optical Rotation [ a ]D20 - 20.7 ° (c 2.8, CHC13).
Methyl (l/?,2/?)-2,-Cyano-2,-methoxycarbonyl-3',3,-dimethyl-3- 
cyclopropylpropanoate (85).
1- Ag20
2. CH2N2
MeQ2C^ ^ / /<yA„^xC02Me 
H CN
Potassium hydroxide (6.5 mL of a 1.05 M solution in H2O, 6.95 mmol) was added, 
dropwise, to a magnetically stirred solution of silver nitrate (143 mg, 0.85 mmol) and 
compound 83 (39 mg, 0.22 mmol) in water/EtOH (0.8 mL/2 mL). After 6 h at 18 °C 
the reaction mixture was filtered through a pad of Celite™ and the filtrate acidified to ca. 
pH 2 with 3% HC1 then extracted with EtOAc (3 x 50 mL). The combined organic 
phases were dried (MgSCXO, filtered and concentrated under reduced pressure and the 
pale-yellow oil thus obtained was dissolved in CH2CI2 (75 mL) and the resulting 
solution cooled to ca. -10 °C (salt-ice bath) and treated with an ethereal solution of 
diazomethane (excess) until a green colour persisted. After 2 h the reaction mixture was 
concentrated under reduced pressure and the yellow oil obtained in this way was 
subjected to flash chromatography (EtOAc elution) which afforded, after concentration 
of the appropriate fractions (Ry0.8), compound 85 (34 mg, 65% from 83) as a clear, 
colourless oil.
*H NMR (300 MHz) 6: 3.77 (3H, s), 3.69 (3H, s), 2.35 (2H, apparent dt, J = 5.3 
and 2.8 Hz), 2.20-2.08 (2H, m), 1.76 (1H, t, J = 5.3 Hz), 1.49 (3H, s), 1.31 (3H, s). 
13C NMR (75.4 MHz) 5: 177.3 (C), M l .2 (C), 119.1 (C), 53.2 (CH3), 52.1 (CH3), 
43.2 (CH or CH3), 35.9 (C), 33.2 (CH2), 26.7 (CH or CH3), 22.0 (C), 18.9 (CH2), 
14.7 (CH or CH3).
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IR Vmax 2956, 2931,2237, 1739, 1438, 1294, 1267 cn r1.
E1MS (70eV) m/z240 [(MH+), 6], 224 [(M-H3C-)+, 20], 207 (65), 175 (80), 148
( 100).
HRMS Found (M-H3C)+, 224.0923. C12H17NO4 requires (M-H3C-)+, 224.0922. 
Optical Rotation [<x]d20 - 15.0 0 (c 1.4, CHC13).
(55')-5-Cyanomethyl-6,6-dimethyl-2H-pyran-2-one (86).
o
A solution of compound 84 (41 mg, 0.19 mmol) in CCI4 was heated at reflux for 6 
h. The cooled reaction mixture was then concentrated under reduced pressure and the 
residue subjected to flash chromatography (EtOAc elution). Concentration of the 
appropriate fractions (R/-0.7) then gave compound 86 (18 mg, 56%) as a clear, 
colourless oil.
*H NMR (300 MHz) 5: 2.61-2.56 (3H, m), 2.32-2.14 (3H, m), 1.98-1.90 (1H, m), 
1.48 (3H, s), 1.34 (3H, s).
13C NMR (75.4 MHz) 6: 170.2 (C), 118.2 (C), 83.7 (C), 39.7 (CH), 29.3 (CH3), 
28.8 (CH2), 23.4 (CH3), 22.7 (CH2), 19.7 (CH2).
IR vmax 2983, 2930, 2940, 2248, 1731, 1277 cm-1.
EIMS (70eV) m/z 167 (M+\ 16), 152 [(M-H3C-)+, 33], 124 (48), 109 (44), 81 (95). 
HRMS Found M+\ 167.0945. C9Hi3N 02 requires M+\ 167.0946.
Optical Rotation [a ]D20 - 12.3 0 (c 1.3, CHC13).
CN
84 86
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6.3 Experimental Details Associated with Work Described in Chapter 
Three
(lS ,2/?)-[(3-M ethyl-3 ,5-cyclohexadiene-l,2-d iyl)£is(oxy)]£is(l,l-  
dimethylethyl)dimethylsilane (101).
TBSC1
imidazole
17 101
A solution of ter?-butyldimethylsilyl chloride (2.63 g, 17.5 mmol) in dry DMF (5 
mL) was added, dropwise, to a magnetically stirred solution of (\S,2R)-cis-3-me\hy\- 
3,5-cyclohexadiene-l,2-diol (17) (880 mg, 7.0 mmol) and imidazole (1.90 g, 28.0 
mmol) in dry DMF (10 mL) maintained at 18 °C under a nitrogen atmosphere. After 
stirring for 3 h the reaction mixture was diluted with water (70 mL) and Et2 Ü (100 mL). 
The separated aqueous phase was extracted with Et20 (2 x 100 mL) and the combined 
organic phases then dried (MgSO^, filtered and concentrated under reduced pressure. 
The material obtained in this way was subjected to flash chromatography (7:3 
Et2 0 /CH2 Cl2 elution) which afforded, after concentration of the appropriate fractions 
(Ry0.9), compound 101 (2.44 g, 98%) as a clear, colourless oil.
*H NMR (300 MHz) 5: 5.84 (1H, dd, J = 5.2 and 2.2 Hz), 5.75-5.66 (2H, m), 4.17- 
4.15 (1H, m), 3.95 (1H, d, J = 5.2 Hz), 1.87 (3H, s), 0.91-0.89 (18H, m), 0.10-0.01 
(12H, m).
13C NMR (75.4 MHz) 6: 140.1 (C), 128.0 (CH), 124.7 (CH), 119.8 (CH), 73.8 
(CH), 71.4 (CH), 26.4 (CH3), 26.3 (CH3), 20.8 (CH3), 18.7 (C), -2.6 (CH3), -3.7 
(CH3), -3.8 (CH3), -4.5 (CH3).
IR vmax 2955, 2930, 1472, 1254, 1098, 837 cm'1.
EIMS (70eV) m/z 354 (M+\ 28), 339 [(M-H3C-)+ 4], 239 (17), 165 (27), 147 (64). 
HRMS Found M+\ 354.2405. Ci9H380 2Si2 requires M+\ 354.2410.
Optical Rotation [oc]d 20 + 43.3 ° (c 3.2, CHC13).
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( l /? ,2 /? ,3S ,4 /? ) - { (4 ,7 ,7 -T r im eth y lb icyc lo [4 .1 .0 ]h ep t -4 -en e-2 ,3 -  
diyl)ftis(oxy)}&is(l , l-dimethylethyl)dimethylsilane (99) and 
( l / ? ,2 /? ,3 S ,6 /? ) - { ( l ,7 ,7 -T r im eth yIb icyc lo [4 .1 .0 ]h ep t -4 -en e -2 ,3 -  
diyI)£ /s (oxy)}£fs( l , l -d im ethyle thyl)dimethyls i lane  (103).
101
1. CHBr3, NaOH, TEBAC
2. MeLi, CuCN, Mel
OTB S 
OTB S
99 103
* ' /
OTBS
OTBS
Sodium hydroxide (3.39 mL of a 50% w/w aqueous solution, 42.4 mmol) was 
added, dropwise, to a magnetically stirred solution of compound 101 (2.4 g, 6.9 
mmol), bromoform (3.0 mL, 35.1 mmol) and benzyltriethylammonium chloride (25 
mg, 0.10 mmol) in dry benzene (40 mL) maintained at 5 CC (ice-bath). The dark-brown 
reaction mixture thus obtained was stirred vigorously at 18 °C for 16 h then diluted with 
CHCI3 (150 mL) and water (100 mL). The separated aqueous phase was extracted with 
CH2CI2 (3 x 100 mL) and the combined organic phases were then dried (MgSCLO, 
filtered and concentrated under reduced pressure. The material obtained in this way was 
subjected to flash chromatography (hexane elution) which afforded, after concentration 
of the appropriate fractions (R/0.6), a ca. 2:1 mixture (as judged by ’H NMR analysis) 
of compounds 100 and 102 (2.44 g, 68%) as a clear, colourless oil. All attempts to 
separate the components of this mixture failed, and as such, this material was used, 
without purification, in the next step of the reaction sequence.
Copper cyanide (4.2 g, 47 mmol) was washed with dry toluene ( 2 x 5  mL) with the 
solvent being removed under high vacuum (10-3 Torr) after each wash. The tan powder 
thus obtained was suspended in dry THF (50 mL) under an atmosphere of nitrogen and 
the resulting suspension was cooled to -78 °C (acetone/dry-ice slush bath) then 
methyllithium (67.0 mL of a 1.4 M solution in Et20, 93.0 mmol) was added dropwise. 
The heterogeneous mixture produced in this manner was removed from the cold-bath 
and left to stir at 18 °C for 0.8 h and then recooled to -78 °C. A ca. 2:1 mixture of
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compounds 100 and 102 (2.44 g, 4.64 mmol) in dry THF (5 mL) was added then the 
reaction mixture was warmed to 0 °C and allowed to stir at this temperature for 0.1 h. 
After this time, methyl iodide (5.5 mL, 94 mmol) was added slowly over 0.2 h and 
after an additional 0.2 h the reaction mixture was quenched with ammonium chloride 
(200 mL of a 10% w/v aqueous solution in 10% ammonia water) then extracted with 
Et2 Ü (2 x 100 mL). The separated aqueous phase was extracted with Et20 (3 x 150 
mL) and the combined organic phases were then dried (MgS04), filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (hexane elution) which afforded two fractions, A and B.
Concentration of fraction A (Ry0.8) yielded compound 103 (1.0 g, 53%) as a clear, 
colourless oil.
NMR (300 MHz) 5: 5.87-5.82 (1H, m), 5.72 (1H, dd, J = 8.3 and 2.6 Hz), 3.82 
(1H, dd, J = 6.1 and 2.6 Hz), 3.52 (1H, d, J = 2.6 Hz), 1.55 (1H, s), 1.23 (3H, s), 
1.16 (3H, s), 0.96 (3H, s), 0.91 (9H, s), 0.88 (9H, s), 0.06-0.02 (12H, m).
13C NMR (75.4 MHz) 5: 131.9 (CH), 130.4 (CH), 70.5 (CH), 69.0 (CH), 32.9 
(CH or CH3), 27.5 (C), 26.3 (CH or CH3), 26.2 (CH3), 23.1 (CH), 18.7 (C), 17.8 
(CH3), 17.5 (CH3), -3.8 (CH3), -4.5 (CH3), -4.6 (CH3).
IR vmax 2956, 2929, 2858, 1473, 1253, 1119, 836 cn r1.
EIMS (70eV) m /z 396 (M+\ 13), 381 [(M-H3C-)+, 30], 339 [(M-H9C4-)+, 33], 265 
(34), 147 (53).
HRMS Found M+*, 396.2886. C2 2H44Ü2Si2 requires M+‘, 396.2879.
Optical Rotation [oc]d20 + 103.7 ° (c 3.0, CHC13).
Concentration of fraction B (Ry0.7) yielded compound 99 (500 mg, 27%) as a 
clear, colourless oil.
*H NMR (300 MHz) 6: 5.39 (1H, bs), 3.66 (1H, d, J = 2.6 Hz), 3.33 (1H, dd, J = 
5.0 and 2.6 Hz), 1.73 (3H, s), 1.55 (1H, s), 1.15-1.13 (1H, m), 1.12 (3H, s), 0.93 
(3H, s), 0.91 (9H, s), 0.87 (9H, s), 0.14-0.05 (12H, m).
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13C NMR (75.4 MHz) 8 : 140.1 (C), 123.1 (CH), 73.3 (CH), 70.3 (CH), 27.8 (CH 
or CH3), 27.5 (CH or CH3), 26.5 (CH3), 26.3 (CH or CH3), 25.6 (CH or CH3), 24.2 
(C), 22.0 (CH or CH3), 18.4 (C), 15.4 (CH or CH3), -3.8 (CH3), -4.2 (CH3).
IR vmax 2956, 2929, 2886, 2857, 1472, 835 cm-1.
EIMS (70eV) m/z 396 (M+\ 100), 381 [(M-H3C-)+, 80], 339 [(M-H9C4*)+, 46], 265 
(48), 147 (60).
HRMS Found M+\ 396.2878. C22H440 2 Si2 requires M+\ 396.2879.
Optical Rotation [oc]d20 - 103.3 ° (c  2.1, CHCI3).
(IS, 2S)-[(3-B romo-3,5-cy clohexadiene-l, 2-diy \)bis (oxy)]bis(  1,1- 
dimethylethyl)dimethylsilane (104).
,v0H TBSC1
•''OH imidazole
X
14 (X=Br) 104
A solution of terr-butyldimethylsilyl chloride (23.0 g, 150 mmol) in dry DMF (50 
mL) was added, dropwise, to a magnetically stirred solution of (l,S,2.S)-ci,s-3-bromo- 
3,5-cyclohexadiene-l,2-diol (14, X=Br) (7.5 g, 39.5 mmol) and imidazole (16.3 g, 
240 mmol) in dry DMF (120 mL) maintained at 18 °C under a nitrogen atmosphere. 
After stirring for 3 h the reaction mixture was diluted with water (200 mL) and Et20  
(150 mL). The separated aqueous phase was extracted with Et20  (2 x 200 mL) and the 
combined organic phases were then dried (MgS04), filtered and concentrated under 
reduced pressure. The material obtained in this way was subjected to flash 
chromatography (7:3 Et20 /CH2Cl2 elution) which afforded, after concentration of the 
appropriate fractions (R^0.9) compound 104 (15.6 g, 94%) as a clear, colourless oil. 
!H NMR (300 MHz) 6 : 6.31 (1H, d, J = 5.6 Hz), 5.86-5.82 (1H, m), 5.77-5.72 
(1H, m), 4.50-4.47 (1H, m), 4.01 (1H, d, J = 5.6 Hz), 0.93 (9H, s), 0.89 (9H, s), 
0.14-0.01 (12H, m).
^ \. .» O T B S
OTB S 
Br
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13C NMR (75.4 MHz) 8: 133.3 (CH), 127.4 (CH), 123.7 (C), 122.6 (CH), 72.9 
(CH), 70.9 (CH), 23.7 (CH3), 23.6 (CH3), 16.1 (C), -6.8 (CH3), -7.0 (CH3).
IR vmax 2995, 2930, 2858, 1472, 1390 cm-1.
EIMS (70eV) m/z 420, 418 (M +\ 100, 94), 339 [(M-Br-)+, 37], 147 (100), 73 (64). 
HRMS Found M +\ 420.1361. C i8H3581B r0 2 requires M + \ 420.1338. Found M +\ 
418.1376. C i8H3579Br02 requires M +\ 418.1358.
Optical Rotation [oc]d20 + 30.5 ° (c 4.2, CHC13).
(l/?,2/?,35,4 /?)-{(4 ,7 ,7-Tribromobicyclo[4 .1 .0]hept-4-ene-2 ,3-  
diyl)/>£s(oxy)}feis(l,l"dimethylethyI)dimethylsilane (105).
Br
OTB S CHBr3, NaOH
B r ^
H"..
H
> s ..»OTBS
OTBS TEBAC V OTBS
Br Br
104 105
Sodium hydroxide (6.70 mL of a 50% w/w aqueous solution, 83.8 mmol) was 
added, dropwise, to a magnetically stirred solution of compound 104 (5.8 g, 13.8 
mmol), bromoform (6.1 mL, 69.6 mmol) and benzyltriethylammonium chloride (45 
mg, 0.20 mmol) in dry benzene (50 mL) maintained at 5 °C (ice-bath). The dark-brown 
reaction mixture thus obtained was stirred vigorously at 18 °C for 16 h then diluted with 
CHC13 (600 mL) and water (300 mL). The separated aqueous phase was extracted with 
CH2C12 (3 x 400 mL) and the combined organic phases were then dried (MgSOzO, 
filtered and concentrated under reduced pressure. The material obtained in this way was 
subjected to flash chromatography (hexane elution) which yielded, after concentration 
of the appropriate fractions (Ry0.6), compound 105 (5.20 g, 64%) as a clear, 
colourless oil.
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lH NMR (300 MHz) 8: 6.09 (1H, d, J = 3.6 Hz), 4.09 (1H, d, = 3.6 Hz), 3.69 
(1H, dd, J = 6.1 and 2.8 Hz), 2.35 (1H, dd, J  = 10.4 and 2.8 Hz), 1.99 (1H, dd, J  =  
10.4 and 6.1 Hz), 0.95 (9H, s), 0.90 (9H, s), 0.21-0.13 (12H, m).
13C NMR (75.4 MHz) 8: 129.2 (C), 127.1 (CH), 76.4 (CH), 73.4 (CH), 38.3 (C), 
34.0 (CH), 33.1 (CH), 26.3 (CH3), 26.2 (CH3), 18.5 (C), -4.2 (CH3).
IR vmax 2955, 2929, 2895, 2857, 1625, 1388 cm'1.
EIMS (70eV) m/z 593, 591, 589, 587 (M+\ 0.2, 0.18, 0.16, 0.04), 536, 534, 532, 
530 [(M-H9C4-)+, 10, 8, 7, 4], 511 (21), 452 (20), 172 (29), 147 (100).
HRMS Found (M-H9C4-)+ 536.8982. Ci9H3581Br302Si2 requires (M-H9C4-)+, 
536.8960. Found (M-H9C4-)+, 534.8992. Ci9H3579Br81Br202Si2 requires (M- 
H9C4-)+ 534.8980. Found (M-H9C4 )+, 532.9011. Ci9H3579Br281Br02Si2 requires 
(M-H9C4-)+ 532.9000. Found (M-H9C4-)+, 530.9038. Ci9H3579Br30 2Si2 requires 
(M-H9C4-)+, 530.9021.
Optical Rotation [a]D20 - 64.2 ° (c 3.8, CHC13).
,3S,4/?)-{(4,7,7-Trimethylbicyclot4.1.0]hept-4-ene-2,3- 
diyl)£js(oxy)}£is(l,l-dimethylethyl)dimethylsilane (99).
105 99
Copper cyanide (17.1 g, 190 mmol) was washed with dry toluene ( 2x5  mL) with 
the solvent being removed under high vacuum (10-3 Torr) after each wash. The tan 
powder thus obtained was suspended in dry THF (150 mL) under an atmosphere of 
nitrogen and the resulting suspension was cooled to -78 °C (acetone/dry-ice slush bath) 
then methyllithium (273 mL of a 1.4 M solution in Et20, 380 mmol ) was added 
dropwise. The heterogeneous mixture produced in this manner was removed from the
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cold-bath and left to stir at ambient temperature for 0.8 h and then recooled to -78 °C. 
Compound 105 (4.88 g, 8.30 mmol) in dry THF (10 mL) was added then the reaction 
mixture was warmed to 0 °C and allowed to stir at this temperature for 0.1 h. After this 
time, methyl iodide (134 mL, 186 mmol) was added slowly over 0.2 h and after an 
additional 0.2 h the reaction mixture was quenched with ammonium chloride (400 mL 
of a 10% w/v aqueous solution in 10% ammonia water) then extracted with Et2 0  (2 x 
100 mL). The separated aqueous phase was extracted with Et2Ü (3 x 400 mL) and the 
combined organic phases were then dried (MgSC>4), filtered and concentrated under 
reduced pressure. The material obtained in this way was subjected to flash 
chromatography (hexane elution) which afforded, after concentration of the appropriate 
fractions (R /0.7) compound 99 (2.30 g, 70%) as a clear, colourless oil. The spectral 
data obtained on this material were identical, in all respects, with those derived from an 
authentic sample of compound 99 produced under the conditions defined earlier (see 
page 127).
( l / ? ,3 5 ,4 ,S ,5 /? ) - 3 - { l ,2 -ß i s [ ( l , l -d im et h y le th y l ) d im e th y l s i ly l ]o x y -3 -  
oxobutyl}-2,2-dimethy!cyclopropanecarboxaldehyde (106).
A stream of ozone (ca . 40% ozone in oxygen) was passed through a magnetically 
stirred solution of compound 99 (681 mg, 1.72 mmol) in dry CH2 CI2 (40 mL) 
maintained at -78 °C (acetone/dry-ice slush bath) until the solution turned blue (ca. 0.2 
h). The excess ozone was displaced by a stream of oxygen and dimethyl sulfide (2.0 
mL, 27.2 mmol) was added, dropwise, to the reaction mixture which was then warmed 
to 18 °C over 4 h, and diluted with water (20 mL). The separated aqueous phase was 
extracted with CH2CI2 (2 x 100 mL) and the combined organic phases were then dried
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(MgSÜ4), filtered and concentrated under reduced pressure. The material obtained in 
this way was subjected to flash chromatography (1:1 hexane/Et20 elution) which 
afforded, after concentration of the appropriate fractions (R/0.8) compound 106 (574 
mg, 78%) as a clear, colourless oil.
*H NMR (300 MHz) 5: 9.67 (1H, d, J = 3.7 Hz), 4.20 (1H, dd, J = 12.0 and 3.2 
Hz), 3.75 (1H, d, J = 3.2 Hz), 2.20 (3H, s), 1.97 (1H, dd, J = 12.0 and 2.3 Hz),
1.53 (1H, t, J = 9.2 Hz), 1.26 (3H, s), 1.25 (3H, s), 0.93 (9H, s), 0.88 (9H, s), 0.20 
(3H, s), 0.12 (6H, s), 0.04 (3H, s).
13C NMR (75.4 MHz) 8: 212.7 (C), 201.0 (CH), 82.5 (CH), 72.9 (CH), 40.3 (CH 
or CH3), 39.4 (CH or CH3), 31.1 (C), 29.1 (CH or CH3), 28.5 (CH or CH3), 26.2 
(CH3), 26.1 (CH3), 18.6 (C), 15.3 (CH or CH3), -3.0 (CH3), -4.3 (CH3), -4.9 
(CH3).
IR v max 2930, 2958,2858, 1703, 1472, 1254, 1118 cm-1.
EIMS (70eV) m/z 428 (M+\ 0.7), 413 [(M-H3C-)+, 0.3], 385 (4), 302 (30), 241
( 66).
HRMS Found M+\  428.2788. C22H44Ü4Si2 requires M+', 428.2778.
Optical Rotation [a ]o 20 - 25.4 ° (c 3.8, CHC13).
Methyl (l/?,3S,41S,5/?)-3-{l,2-ß is[(l,l-d im ethyIethyl)dim ethyl- 
silyl]oxy-3-oxobutyl}-2,2-dimethylcyclopropanecarboxylate (107).
\ u  OTBSNx ” * o l.NaC102, NaH2P 04 H20
H»- 2-methyl-2-buteneJ OTBS1 2. CH2N2
106
OTB S
OTBS 
O OMe
107
A magnetically stirred solution of compound 106 (722 mg, 1.69 mmol) in tert- 
butanol (9.6 mL) and water (2.4 mL) was treated with 2-methyl-2-butene (2.1 mL of a 
2M solution in THF, 4.2 mmol) followed by sodium dihydrogen orthophosphate 
monohydrate (245 mg, 1.77 mmol) at 18 °C. After 0.2 h sodium chlorite (457 mg, 5.1
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mmol) was added in one portion and stirring then continued at 0 °C (ice-bath) for 3 h. 
The reaction mixture was then quenched with HC1 (30 mL of a 1M aqueous solution) 
and extracted with CH2CI2 (4 x 100 mL). The combined organic phases were dried 
(MgS04), filtered and concentrated under reduced pressure to give a colourless oil. 
This material (crude carboxylic acid) was dissolved in CH2CI2 (75 mL), cooled to ca. 
-10 °C (salt-ice bath) then treated with an ethereal solution of diazomethane (excess) 
until a green colour persisted. After 2 h the reaction mixture was concentrated under 
reduced pressure and the residue subjected to flash chromatography (1:1 hexane/Et20 
elution) which afforded, after concentration of the appropriate fractions (R/0.8), 
compound 107 (664 mg, 86% from 106) as a clear, colourless oil.
*H NMR (300 MHz) 6: 4.22 (1H, d, J = 9.8 Hz), 3.78 (1H, s), 3.62 (3H, s), 2.21 
(3H, s), 1.61 (1H, d, J = 8.0 Hz), 1.25-1.22 (1H, m), 1.25 (3H, s), 1.17 (3H, s), 
0.93 (9H, s), 0.88 (9H, s), 0.20 (3H, s), 0.12 (3H, s), 0.10 (3H, s), 0.03 (3H, s). 
13C NMR (75.4 MHz) 6: 213.2 (C), 172.8 (C), 82.8 (CH), 78.0 (CH), 51.9 (CH3), 
36.2 (CH or CH3), 29.9 (CH or CH3), 29.2 (CH or CH3), 28.9 (CH or CH3), 26.3 
(CH3), 18.6 (C), 15.0 (CH or CH3), -2.7 (CH3), -4.0 (CH3), -4.6 (CH3).
IR vmax 2955, 2930, 2858, 1726, 1472, 1254, 1083 cm'1.
EIMS (70eV) m/z 458 (M+\ 2), 302 (30), 271 (100), 245 (72), 211 (25).
HRMS Found M+\ 458.2875. C23H460 5 Si2 requires M+\ 458.2883.
Optical Rotation [oc]d20 - 20.7 0 (c 2.3, CHC13).
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Methyl (l/?,3S,4S,5/?)-3-(l,2-D ihydroxy-3-oxobutyl)-2,2-dim ethyl- 
cyclopropanecarboxylate (98).
Hydrogen fluoride-pyridine (0.5 mL) was added, dropwise, to a magnetically stirred 
solution of compound 107 (103 mg, 0.23 mmol) in dry acetonitrile (1.5 mL) 
maintained at 18 °C under a nitrogen atmosphere. After 3 h the reaction mixture was 
quenched with NaHC03 (5 mL of a saturated aqueous solution) and extracted with 
EtOAc (2x10 mL). The combined organic phases were then dried (MgSC>4), filtered 
and concentrated under reduced pressure. The material obtained in this way was 
subjected to flash chromatography (EtOAc elution) which afforded, after concentration 
of the appropriate fractions (R/0.7), compound 98 (32 mg, 62%) as a clear, colourless 
oil.
*H NMR (300 MHz) 5: 4.48 (1H, dd, J = 9.9 and 4.0 Hz), 4.29 (1H, d, J = 4.0 Hz), 
3.64 (3H, s), 2.46 (1H, bs), 2.26 (3H, s), 1.66 (1H, bs), 1.57 (1H, d, J = 8.7 Hz), 
1.36 (1H, d, J = 9.9 Hz), 1.33 (3H, s), 1.22 (3H, s).
13C NMR (75.4 MHz) 5: 209.2 (C), 172.8 (C), 80.6 (CH), 68.9 (CH), 52.0 (CH3), 
33.3 (CH or CH3), 30.3 (CH or CH3), 29.2 (CH or CH3), 27.6 (CH or CH3), 25.5 
(C), 15.1 (CH or CH3).
IR vmax 3386 (b), 2954, 2928, 1724, 1440, 1378, 1197, 1179 cn r1.
EIMS (70eV) m/z 231 [(MH+), 2)], 230 (M+\ 0.6), 215 [(M-H3C-)+, 2], 198 (3), 
187 [(M-C2H30)+ , 35], 155 (47), 125 (100).
HRMS Found M +\ 230.1154. C n H i80 5 requires M+\ 230.1154.
Optical Rotation [a]D20 + 29.7 ° (c 1.9, CHC13).
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Methyl (l/?,3S)-3-Formyl-2,2-dimethylcyclopropanecarboxylate (87).
98 87
A solution of lead tetraacetate (104 mg, 0.235 mmol) in dry CH2CI2 (2 mL) was 
added, dropwise, to a magnetically stirred suspension of compound 98 (25 mg, 0.11 
mmol) and calcium carbonate (133 mg, 1.33 mmol) in dry CH2CI2 (2 mL) maintained 
at 0 °C (ice-bath) under a nitrogen atmosphere. After 0.75 h the reaction mixture was 
quenched with Et20 (20 mL) then filtered through a short pad of TLC-grade silica gel. 
The filtrate was concentrated under reduced pressure and the residue subjected to flash 
chromatography (1:1 hexane/Et20 elution) which afforded, after concentration of the 
appropriate fractions (R/0.6), compound 87 (12 mg, 71%) as a clear, colourless oil.
NMR (300 MHz) 5: 9.76 (1H, d, J = 6.5 Hz), 3.71 (3H, s), 2.14 (1H, d, J = 8.0 
Hz), 1.85-1.84 (1H, t, J = 8.0 Hz), 1.55 (3H, s), 1.27 (3H, s).
13C NMR (75.4 MHz) 5: 200.8 (CH), 170.7 (C), 57.5 (CH3), 41.1 (CH), 36.3 
(CH), 30.2 (C), 28.5 (CH3), 15.2 (CH3).
IRVmax 2957,2890, 1729, 1701, 1440, 1202, 1136 cm'1.
EIMS (70eV) m/z 157 [(MH+), 20)], 141 [(M-H3C-)+, 35)], 128 [(M-CO)+\ 60)],
114 (32), 97 [(M-CH3C 02-)+ 100)].
HRMS Found (M-H3C )+, 141.0553. C8Hi20 3 requires (M-H3C )+, 141.0551. 
Optical Rotation [a]D20 - 55.0 0 (c 1.3, CHC13).
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7.4 Experimental Details Associated with Work Described in Chapter 
Four
General Procedure for the Extraction of (15,2/?)-cis-3-m ethyl-3,5- 
cyclohexadiene-l,2-diol (17) from the Fermentation Broth Supplied by 
Genencor International Inc.
The fermentation broth containing compound 17 was stored in 250 mL plastic bottles 
at -30 °C. Prior to extraction the broth (247 g) was thawed out away from direct light. 
The resulting material was poured into a separating funnel and diluted with EtOAc (500 
mL) and brine (200 mL). The separated aqueous layer was extracted with EtOAc (4 x 
500 mL) and the combined organic phases were then washed with water (1 x 200 mL) 
before being dried (MgS0 4 ), filtered and concentrated under reduced pressure to afford 
a tan solid (34 g) which was comprised, for the most part, of the title compound 17. 
This material was used, without purification, in the next step of the reaction sequence.
(15,2/? )-3-M ethylcyclohex-3-ene-l,2-diol (133).
dipotassium
azodicarboxylate,
Method One:
Acetic acid (4.2 mL, 73.3 mmol) was added, dropwise, to a magnetically stirred 
solution of dipotassium azodicarboxylate (6.9 g, 36 mmol) and (15,2/?)-ds-3-methyl- 
3,5-cyclohexadiene-l,2-diol (17) (567 mg, 4.49 mmol) in MeOH (20 mL) maintained 
at 0 °C (ice-bath). After nitrogen evolution had ceased (ca . 0.75 h), the solvent was 
removed under reduced pressure and the residue treated with EtOAc (200 mL) and
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water (100 mL). The separated organic phase was washed with NaHCC>3 (100 mL of a 
saturated aqueous solution) then dried (MgSC>4), filtered and concentrated under 
reduced pressure. The residue was subjected to flash chromatography (Et2Ü elution) 
which afforded, after concentration of the appropriate fractions (Ry0.4), a white solid. 
Recrystallization (Et2Ü) of this material then gave compound 133 (475 mg, 83%) as 
colourless needles, m.p. 73-74 °C (lit.138 m.p. 82-83 °C).
l H  NMR (300 MHz) 5: 5.54 (1H, m), 3.91 (1H, d, J = 3.8 Hz), 3.76-3.70 (1H, m), 
2.76 (2H, bs), 2.11-2.02 (2H, m), 1.79 (3H, bs), 1.79-1.63 (2H, m).
13C NMR (75.4 MHz) 6: 133.8 (C), 125.8 (CH), 70.4 (CH), 70.0 (CH), 25.6 
(CH2), 24.2 (CH2), 21.2 (CH3).
IRVmax 3285 (b), 2940, 2872, 1451, 1128, 1051 cm’1.
EIMS (70eV) m/z 128 (M +\ 11), 110 [(M-H20 )+ \ 15], 84 [(M -C02)+ \ 100], 55 
(35).
Elemental Analysis Found: C, 65.35; H, 9.52; C7H12O2 requires: C, 65.60; H, 
9.44%.
Optical Rotation [a ]D20 - 149.5 0 (c 1.9, CHCI3); (lit.76 [a ]D20 - 151.7 0 (c 0.6, 
CHCI3)}.
Method Two:
5% Rhodium on alumina (75 mg) was added to a solution of ( lS,2/?)-cA-3-methyl- 
3,5-cyclohexadiene-l,2-diol (17) (500 mg, 3.96 mmol) in absolute EtOH (15 mL) and 
the resulting mixture was stirred under an atmosphere of dihydrogen at 18 °C for 16 h. 
After this time the reaction mixture was filtered through a short pad of TLC-grade silica 
gel and the filtrate concentrated under reduced pressure. The material obtained in this 
way was subjected to flash chromatography (Et2Ü elution) which afforded, after 
concentration of the appropriate fractions (R.^0.4), compound 133 (485 mg, 96%) as a 
white solid, m.p. 73-74 °C. The spectral data obtained on this material were identical, in 
all respects, with those derived from an authentic sample of compound 133 prepared 
by Method One (above).
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(3a/?,7aS)-2,2,4-Trim ethyl-3a,6,7,7a-tetrahydro-l,3-benzodioxole
(128).
OH,,\w n  2,2-dimethoxypropane
•», p-toluenesulfonic acid
OH
128
p-Toluenesulfonic acid monohydrate (300 mg, 2.3 mmol) was added, in one portion, 
to a magnetically stirred solution of compound 133 (1.36 g, 10.6 mmol) in 2,2- 
dimethoxypropane (40 mL, 324 mmol) maintained at ca. -10 °C (salt-ice bath) under a 
nitrogen atmosphere. After 0.5 h the reaction mixture was treated with triethylamine 
(0.5 mL) then concentrated carefully at atmospheric pressure. The residue thus obtained 
was partitioned between Et20 (100 mL) and water (30 mL). The separated aqueous 
phase was extracted with Et20 (2 x 50 mL) then the combined organic phases were 
dried (MgSOzO, filtered and concentrated carefully at atmospheric pressure. The 
material obtained in this way was subjected to flash chromatography (5:1 hexane/Et20 
elution) which afforded, after concentration of the appropriate fractions (Ry0.5), 
compound 128 (1.67 g, 96%) as a volatile, clear, colourless oil.
*H NMR (300 MHz) 6: 5.59 (1H, bs), 4.27 (2H, s), 2.23-2.08 (2H, m), 1.84-1.68 
(2H, m), 1.77 (3H, bs), 1.39 (6H, s).
13C NMR (75.4 MHz) 6: 132.8 (C), 125.9 (CH), 108.8 (C), 75.8 (CH), 74.1 (CH), 
28.5 (CH3), 27.1 (CH3), 26.1 (CH2), 21.3 (CH2), 20.9 (CH3).
IR V m a x  2936, 1368, 1244, 1077 cm'1.
EIMS (70eV) m/z 168 (M+-, 11), 110 {[M-(CH3)2CO]+\ 15}, 84 (100), 55 (35). 
HRMS Found M+\ 168.1150. C i0H i6O2 requires M+\ 168.1150.
Optical Rotation [a]D20 + 24.3 ° (c 3.0, CHC13).
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(3alS,5aS',6al?,6b/?)-6,6-Dibromohexahydro-2,2,6a-trimethyl-5a//- 
cyclopropa[e]-l,3-benzodioxole (137).
Br
123 137
Sodium hydroxide (6.55 mL of a 50% w/w aqueous solution, 75.5 mmol) was 
added, dropwise, to a magnetically stirred solution of compound 123 (500 mg, 3.0 
mmol), bromoform (6.5 mL, 75.5 mmol) and benzyltriethylammonium chloride (20 
mg, 0.086 mmol) in dry benzene (10 mL) maintained at 5 °C (ice-bath). The dark- 
brown reaction mixture was stirred vigorously at 18 °C for 16 h then diluted with 
CHCI3 (200 mL) and water (100 mL). The separated aqueous phase was extracted with 
CH2CI2 (3 x 100 mL) and the combined organic phases were then dried (MgSC>4), 
filtered, concentrated under reduced pressure with the excess bromoform needing to be 
removed under high vacuum (10*3 Torr). The residue was subjected to flash 
chromatography (5:1 hexane/Et20 elution) which afforded, after concentration of the 
appropriate fractions (Ry0.5), compound 137 (784 mg, 77%) as a clear, colourless 
oil.
*H NMR (300 MHz) 5: 4.17 (1H, d, J = 5.4 Hz), 4.03-4.00 (1H, m), 2.29 (2H, m), 
1.68-1.60 (2H, m), 1.51 (3H, s), 1.44 (3H, s), 1.35 (3H, s), 1.34-1.21 (1H, m).
13C NMR (75.4 MHz) 6: 107.7 (C), 75.4 (CH), 73.7 (CH), 46.9 (C), 35.0 (CH3), 
30.4 (C), 28.7 (CH3), 26.6 (CH2), 26.3 (CH3), 23.3 (CH3), 21.6 (CH2).
IR vmax 2986, 2935, 1380, 1371 cm'1.
EIMS (70eV) m/z 342, 340, 338 (M+\ 44, 64, 43), 327, 325, 323 [(M-H3C-)+, 46, 
66, 45], 284 (100), 283 (54), 259 (64), 201 (100).
HRMS Found M+*, 341.9459. Ci iHi681Br2C>2 requires M+', 341.9476. Found 
M+\ 339.9485. C nH i679Br81Br02 requires M+\ 339.9496. Found M+\ 337.9504. 
CnHi679Br202 requires M+', 337.9517.
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Optical Rotation [a ]D20 + 7.1 ° (c 1.4, CHC13).
(3a5 ,5aS ,61S,6a/? ,6b /?)-6-Brom ohexahydro-2 ,2 ,6a-trim ethyI-5a^-  
cyclopropa[e]-l,3 -benzodioxole  (138) and (3a5,5aS',6R,6aR,6b/?)-6- 
B rom o-2 ,2 ,6a-tr im ethyl-5a /7-cyclopropa[e]-l ,3 -benzodioxole  (139).
Freshly prepared tri-rc-butyltin hydride (1.2 mL, 4.12 mmol) was added, dropwise, 
to a magnetically stirred solution of compound 137 (1.17 g, 3.44 mmol) in dry 
benzene (2 mL) maintained at 0 °C (ice-bath) under a nitrogen atmosphere. The reaction 
mixture was stirred at 18 °C for 16 h then concentrated under reduced pressure to 
provide a ca. 2:1 mixture (as determined by *H NMR analysis) of compounds 138 and 
139. This material was subjected to flash chromatography (2:1 hexane/Et20 elution) 
which afforded two fractions, A and B.
Concentration of fraction A (Ry0.5) yielded compound 138 (524 mg, 58%) as a 
clear, colourless oil.
*H NMR (300 MHz) 5: 4.24 (1H, d, J = 7.2 Hz), 4.14-4.11 (1H, m), 2.84 (1H, d, J 
= 4.0 Hz), 2.01-1.99 (2H, m), 1.76-1.66 (2H, m), 1.47 (3H, s), 1.47-1.36 (1H, m), 
1.35 (3H, s), 1.34 (3H, s).
13C NMR (75.4 MHz) 5: 107.4 (C), 75.5 (CH), 74.4 (CH), 36.9 (CH), 28.7 (CH), 
26.8 (CH2), 26.5 (CH3), 23.3 (CH3), 22.3 (C), 21.9 (CH3), 19.5 (CH2).
IRVmax 2985,2957,2933, 1247, 1216 cm '1.
EIM S (70eV) m/z 262, 260 (M +\ 23, 23), 247, 245 [(M-H3C-)+, 92, 91], 181 [(M- 
Br-)+, 100], 123 (84), 95 (66).
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HRMS Found M+\ 262.0395. C nH i781Br02 requires M+\ 262.0391. Found M+\ 
260.0412. CnH i779Br02 requires M+\ 260.0411.
Optical Rotation [a]D20 + 140.5 ° (c 2.1, CHC13).
Concentration of fraction B (Ry0.3) yielded compound 139 (173 mg, 29%) as a 
clear, colourless oil.
!H NMR (300 MHz) 6: 4.09 (1H, d, J = 5.5 Hz), 4.03-4.00 (1H, m), 3.04 (1H, d, J 
= 7.7 Hz), 2.17-2.13 (2H, m), 1.66-1.57 (2H, m), 1.46 (3H, s), 1.37-1.29 (1H, m), 
1.36 (3H, s), 1.25 (3H, s).
13C NMR (75.4 MHz) 6: 108.3 (C), 74.0 (CH), 72.0 (CH), 29.7 (CH), 28.1 (CH), 
27.6 (CH3), 25.7 (CH3), 22.9 (C), 21.8 (CH2), 20.0 (CH3), 16.5 (CH3).
IR vmax 2985, 2957, 2933, 1247, 1216 cm*1.
EIMS (70eV) m/z 262, 260 (M+\ 17, 16), 247, 245 [(M-H3C-)+, 50, 34], 183, 181 
[(M-Br-)+, 45], 123 (77), 95 (100).
HRMS Found M+\ 262.0392. C nH i781Br02 requires M +\ 262.0391. Found M+\ 
260.0411. C nH i779Br02 requires M+\ 260.0411.
Optical Rotation [a]D20 + 16.6 0 (c 1.2, CHC13).
Methyl (3aS,5aS,6S',6a/?,6b/?)-2,2,6a-Trimethylhexahydrocyclo- 
propa[e]-l,3-benzodioxolo-6(5a//)-carboxylate (140).
terr-Butyllithium (27.8 mL of a 1.7 M solution in pentane, 48.6 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 138 (6.41 g, 24.3 mmol) in 
dry Et20  (90 mL) maintained at -85 °C (acetone/liquid-nitrogen slush bath) under a 
nitrogen atmosphere. After 0.1 h methyl chloroformate (2.96 mL, 37 mmol) was
H H
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added, dropwise, and the reaction mixture was then warmed to 18 °C. The reaction 
mixture was diluted with water (100 mL) and Et2 Ü (200 mL) then the separated 
aqueous phase was extracted with Et2 Ü (3 x 100 mL). The combined organic phases 
were dried (MgS04), filtered and concentrated under reduced pressure and the residue 
subjected to flash chromatography (3:1 hexane/Et20 elution). Concentration of the 
appropriate fractions, (Ry0.4), then gave compound 140 (4.67 g, 80%) as a clear, 
colourless oil.
*H NMR (300 MHz) 5: 4.26 (1H, d, J = 6.3 Hz), 4.17 (1H, m), 3.66 (3H, s), 2.13- 
2.01 (2H, m), 1.73-1.68 (2H, m), 1.50 (1H, d, J = 5.2 Hz), 1.46 (3H, s), 1.44-1.39 
(1H, m), 1.33 (3H, s), 1.26 (3H, s).
13C NMR (75.4 MHz) 5: 172.8 (C), 108.2 (C), 74.9 (CH), 72.1 (CH), 51.9 (CH3), 
28.6 (C), 28.5 (CH or CH3), 27.5 (CH or CH3), 25.7 (CH or CH3), 24.3 (CH or 
CH3), 21.7 (CH2), 16.3 (CH2), 15.3 (CH3).
IR vmax 2990, 2875, 1729, 1442, 1380 cm '1.
EIMS (70eV) m/z 240 (M+\ 55), 225 [(M-H3C-)+, 76], 182 {[M-(CH3)2CO]+\ 
52}, 151 (72), 95 (100).
HRMS Found M+\ 240.1357. C i3H2o04 requires M+\ 240.1361.
Optical Rotation [oc]d 20 + 2.1 ° (c 1.4, CHC13).
Methyl (3aS,5aS,6/?,6a/?,6b/?)-2,2,6a-Trimethylhexahydrocyclo- 
propa[e]-l,3-benzodioxolo-6(5a//)-carboxylate (141).
terr-Butyllithium (1.20 mL of a 1.7 M solution in pentane, 2.10 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 139 (277 mg, 1.05 mmol) in 
dry Et20 (3 mL) maintained at -85 °C (acetone/liquid-nitrogen slush bath) under a
C02MeBr
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nitrogen atmosphere. After 0.1 h methyl chloroformate (128 jllL ,  1.6 mmol) was added, 
dropwise, and the reaction mixture was then warmed to 18 °C. The reaction mixture 
was diluted with water (10 mL) and Et2 Ü (30 mL) then the separated aqueous phase 
was extracted with Et2 Ü (3 x 50 mL). The combined organic phases were dried 
(M gS04), filtered and concentrated under reduced pressure and the residue subjected to 
flash chromatography (2:1 hexane/Et20 elution). Concentration of the appropriate 
fractions, (Ry0.5), then gave compound 141 (210 mg, 83%) as a clear, colourless oil. 
!H NMR (300 MHz) 5: 4.35-4.31 (2H, m), 3.63 (3H, s), 1.96-1.91 (2H, m), 1.62- 
1.59 (2H, m), 1.51-1.42 (2H, m), 1.43 (3H, s), 1.31 (3H, s), 1.24 (3H, s).
13C NMR (75.4 MHz) 8: 171.7 (C), 107.0 (C), 75.2 (CH), 72.9 (CH), 51.7 (CH3), 
31.9 (C), 29.9 (CH or CH3), 28.5 (CH or CH3), 27.6 (CH or CH3), 27.4 (CH2),
26.0 (CH or CH3), 24.4 (CH or CH3), 17.0 (CH2).
IR vmax 2987, 2866, 1730, 1441, 1371 c n r1.
EIMS (70eV) m/z 240 (M +\ 77), 225 [(M-H3C-)+, 81], 182 {[M-(CH3)2CO ]+\
45}, 151 (80), 95 (100).
HRMS Found M +\ 240.1360. C i3H2o 0 4 requires M + \ 240.1361.
Optical Rotation [oc]d20 + 43.4 ° (c 5.6, CHC13).
Methyl (S a S jS a S jö S ^ a R jö b R j-l^ ö a -T rim eth y lh ex a h y d ro cy clo -  
p ro p a [e]-l,3 -b en zo d io x o lo -6 (5 a //)-ca rb o x y la te  (140).
..>'0,
' d
Small peices of sodium metal (1.2 g, 53 mmol) were added over 0.5 h to a round- 
bottomed flask containing anhydrous MeOH (20 mL) maintained at 0 °C (ice-bath) 
under a nitrogen atmosphere. After 1 h a solution of compound 141 (1.28 g, 5.3 
mmol) in anhydrous MeOH (5 mL) was added, dropwise, and the reaction mixture was
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then heated at reflux for 16 h. The cooled reaction mixture was treated with NH4CI (20 
mL of a saturated aqueous solution) and EtOAc (100 mL) and the separated aqueous 
phase was extracted with EtOAc (2 x 100 mL). The combined organic phases were then 
dried (M gS04), filtered and concentrated under reduced pressure and the residue 
subjected to flash chromatography (3:1 hexane/Et20 elution) which afforded, after 
concentration of the appropriate fractions (Ry0.4), compound 140 (1.0 g, 78%) as a 
clear, colourless oil. The spectral data obtained on this material were identical, in all 
respects, with those derived from an authentic sample of compound 140 produced 
under the conditions defined earlier (see page 142).
Methyl (1/?,2R,3 S ,6R,7R)-2 ,3-D ihydroxy-1-m ethylb icyclo[4.1.0]- 
heptane-7-carboxylate (127).
A magnetically stirred solution of compound 140 (3.0 g, 12.5 mmol) in acetic acid 
(60 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled reaction 
mixture was diluted with water (100 mL) and EtOAc (200 mL) then the separated 
aqueous phase was extracted with EtOAc (2 x 100 mL). The combined organic phases 
were dried (MgS04), filtered and concentrated under reduced pressure and the residue 
subjected to flash chromatography (1:1 E tO A c/Et20 elution) to afford, after 
concentration of the appropriate fractions (Ry0.6), compound 127 (1.79 g, 72%) as a 
clear, colourless oil.
*H NMR (300 MHz) 5: 3.95 (1H, d, J = 3.0 Hz), 3.64 (3H, s), 3.56-3.52 (1H, m), 
2.18-2.05 (2H, m), 1.62-1.55 (3H, m), 1.31 (1H, d, J = 4.6 Hz), 1.28 (3H, s), 
(signals due to two -OH protons not observed).
H H
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13C NMR (75.4 MHz) 5: 172.8 (C), 70.9 (CH), 68.3 (CH), 51.9 (CH3), 33.2 (C), 
29.8 (CH or CH3), 26.6 (CH or CH3), 23.9 (CH2), 20.8 (CH2), 15.5 (CH or CH3). 
IR vmax 3427 (b), 2952, 1728, 1206, 1046 cm-1.
EIMS (70eV) m/z 182 [(M-H20)+ \ 14], 150 (45), 122 (57), 97 (100), 87 (94). 
HRMS Found (M-H20 )+ \ 182.0945. C i0H i6O4 requires (M-H20 )+ \ 182.0942. 
Optical Rotation [oc]d 20 - 55.6 ° (c 1.6, CHC13).
Methyl (1R,2R,35,6/?,7S)-2,3-D ihydroxy-l-m ethylbicyclo[4.1.0]- 
heptane-7-carboxylate (142).
A magnetically stirred solution of compound 141 (4.0 g, 16.6 mmol) in acetic acid 
(80 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled reaction 
mixture was diluted with water (100 mL) and EtOAc (200 mL) then the separated 
aqueous phase was extracted with EtOAc (3 x 100 mL). The combined organic phases 
were dried (MgS04), filtered and concentrated under reduced pressure and the residue 
subjected to flash chromatography (1:1 EtOAc/Et20  elution) to afford, after 
concentration of the appropriate fractions (R^O.5), a white solid. Recrystallization 
(Et20) of this material then gave compound 142 (2.6 g, 78%) as colourless needles, 
m.p. 66-67 °C.
*H NMR (300 MHz) 8: 3.93 (1H, d, 7 = 3.0 Hz), 3.92-3.89 (1H, m), 3.64 (3H, s), 
2.30 (2H, bs), 2.03-1.98 (1H, m), 1.75-1.65 (3H, m), 1.46 (1H, d, 7 = 9.0 Hz), 1.36 
(1H, t, 7 = 9.0 Hz), 1.25 (3H, s).
13C NMR (75.4 MHz) 8: 172.1 (C), 69.9 (CH), 67.6 (CH), 51.7 (CH3), 29.3 (CH 
or CH3), 27.0 (C), 26.5 (CH2), 25.5 (CH or CH3), 24.5 (CH or CH3), 15.5 (CH2). 
IR vmax 3409 (b), 2951, 1725, 1442, 1171 cm'1.
141 142
147
Chapter Six
EIMS (70eV) m/z 182 [(M-H20)+', 19], 150 (44), 122 (56), 97 (94), 87 (100). 
HRMS Found (M-H20 )+ \ 182.0938. C i0H i6O4 requires (M-H20 )+ \ 182.0942. 
Optical Rotation [ a ] o 20 + 69.3 ° (c 12.0, CHCI3).
Methyl (l/?,2R,3R)-2-FormyI-2-methyl-3-(3-oxopropyl)cyclopropane- 
carboxylate (126).
OH
OH
lead tetraacetate 
CaC03
A solution of lead tetraacetate (265 mg, 0.902 mmol) in dry CH2C12 (3 mL) was 
added, dropwise, to a magnetically stirred mixture of compound 127 (56 mg, 0.28 
mmol) and calcium carbonate (338 mg, 3.4 mmol) in dry CH2C12 (3 mL) maintained at 
0 °C (ice-bath) under a nitrogen atmosphere. After 0.75 h the reaction mixture was 
quenched with Et20  (20 mL) then filtered through a short pad of TLC-grade silica gel. 
The filtrate was concentrated under reduced pressure to yield compound 126 (51 mg, 
91%) as a clear, colourless oil.
l H  NMR (300 MHz) 5: 9.75 (1H, d, J  = 2.4 Hz), 9.37 (1H, s), 3.70 (3H, s), 2.55- 
2.51 (2H, m), 2.13 (1H, d, J  = 6.0 Hz), 2.07-1.81 (3H, m), 1.41 (3H, s).
13C NMR (75.4 MHz) 8: 201.0 (CH), 200.0 (CH), 170.2 (C), 52.4 (CH3), 43.5 
(CH2), 39.5 (C), 35.7 (CH), 33.0 (CH), 19.5 (CH3), 13.1 (CH2).
IR v max 2956, 1725, 1699, 1202, 1175 cm'1.
EIMS (70eV) m/z 197 [(M-H-)+, 3], 183 [(M-H3C-)+, 16], 155 (66), 139 (25), 127 
(70), 109 (82), 95 (100).
HRMS Found (M-H)+, 197.0818. C10H14O4 requires (M-H-)+, 197.0813. 
Optical Rotation [a]D20 - 116.1 0 (c 4.1, CHC13).
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Methyl (lS,2/?,3/?)-2-Formyl-2-methyl-3-(3-oxopropyl)cyclopropane- 
carboxylate ( 143).
C 0 2Me
142
lead tetraacetate 
CaCC>3
A solution of lead tetraacetate (396 mg, 0.902 mmol) in dry CH2CI0 (4 mL) was 
added, dropwise, to a magnetically stirred suspension of compound 142 (84 mg, 0.42 
mmol) and calcium carbonate (504 mg, 5.0 mmol) in dry CH2CI2 (7 mL) maintained at 
0 °C (ice-bath) under a nitrogen atmosphere. After 0.75 h the reaction mixture was 
quenched with Et20 (20 mL) then filtered through a short pad of TLC-grade silica gel. 
The filtrate was concentrated under reduced pressure to yield compound 143 (80 mg, 
95%) as a clear, colourless oil.
!H NMR (300 MHz) 8: 9.82 (1H, s), 9.77 (1H, d, J =  1.0 Hz), 3.70 (3H, s), 2.57 
(2H, apparent t, J = 6.6 Hz), 2.39-2.30 (2H, m), 2.13 (1H, d, J  = 8.9 Hz), 1.72-1.70 
(1H, m), 1.22 (3H, s).
13c NMR (75.4 MHz) 8: 201.3 (CH), 201.2 (CH), 170.5 (C), 52.6 (CH3), 43.8 
(CH2), 37.1 (C), 35.8 (CH), 34.9 (CH), 19.8 (CH3), 15.8 (CH2).
IRVmax 2955, 1726, 1441, 1200, 1172 cm'1.
EIMS (70eV) m /z 197 [(M-H-)+, 1], 155 (16), 139 (25), 127 (26), 95 (100).
HRMS Found (M-H-)+, 197.0819. C10H14O4 requires (M-H )+, 197.0813.
Optical Rotation [a]o20 + 15.0 0 (c 2.4, CHC13).
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Ethyl 5-Methylhex-4-enoate (144).
LDA C 0 2Et
EtOAc, Cul
130 144
n-Butyllithium (30.0 mL of a 2.5 M solution in hexane, 74.6 mmol) was added, 
dropwise, to a magnetically stirred solution of diisopropylamine (10.5 mL, 74.6 mmol) 
in dry THF (30 mL) maintained at -78 °C (acetone/dry-ice slush bath) under a nitrogen 
atmosphere. The resulting mixture was warmed to 18 °C then kept at 0 °C for 0.2 h 
before being re-cooled to -78 °C.
The solution of lithium diisopropylamine thus formed was transferred, via cannula, 
to a magnetically stirred suspension of dry EtOAc (7.3 mL, 74.6 mmol) and cuprous 
iodide (28.3 g, 149.2 mmol) in dry THF (135 mL) maintained at -110 °C (EtOH/liquid- 
nitrogen slush bath) under a nitrogen atmosphere. The resulting tan-coloured 
suspension was stirred at -30 °C for 0.5 h then a solution of 4-bromo-2-methylbut-2- 
ene (130) (4.3 mL, 37.3 mmol) in dry THF (30 mL) was added dropwise. The 
reaction mixture was warmed to 18 °C then poured into water (800 mL). After NH4CI 
(200 g, 3.8 mol) had been added to the resulting mixture the separated aqueous phase 
was extracted with Et2Ü (2 x 500 mL) and the combined organic phases then dried 
(MgSC>4), filtered and concentrated under reduced pressure to yield compound 144 
(6.0 g, 97%) as a clear, colourless oil. The spectral data obtained on this material were 
identical, in all respects, with those previously reported. 136 This material was used, 
without purification, in the next step of the reaction sequence.
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5-M ethylhex-4-en-l-o l (145).
LiAlH4
OH
144 145
A solution of compound 144 (16.7 g, 100 mmol) in dry Et20 (50 mL) was added, 
dropwise, to a magnetically stirred suspension of lithium aluminium hydride (4.2 g, 
110 mmol) in dry Et20 (70 mL) maintained at 0 °C (ice-bath) under a nitrogen 
atmosphere. The reaction mixture was stirred at 18 °C for 6 h then treated, sequentially, 
with water (13 mL) and sodium hydroxide (13 mL of a 15% aqueous solution). The 
resulting suspension was filtered and the solids thus retained were washed successively 
with Et20 (400 mL) and hot CHCI3 (400 mL). The combined filtrates were then dried 
(MgSC>4), filtered and concentrated under reduced pressure to yield compound 145 
(10.0 g, 88%) as a clear, colourless oil. The spectral data obtained on this material were 
identical, in all respects, with those previously reported.136 This material was used, 
without purification, in the next step of the reaction sequence.
6-Iodo-2-m ethylhex-2-ene (146).
M ethanesulfonyl chloride (7.4 mL, 96 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 145 (10.0 g, 88 mmol) and triethylamine 
(18.6 mL, 134 mmol) in dry CH2CI2 (110 mL) maintained at 0 °C (ice-bath) under a 
nitrogen atmosphere. After 0.25 h the reaction mixture was diluted with ice-cold water 
(50 mL) and the aqueous phase was extracted with CH2CI2 (2 x 200 mL). The 
combined organic phases were washed with cold HCl (1 x 200 mL of a 10% aqueous 
solution), NaHCÜ3 (1 x 300 mL of a saturated aqueous solution) and NaCl (1 x 100
2. Nal, acetone
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mL of a saturated aqueous solution). The separated organic phase was then dried 
(MgSC>4), filtered and concentrated under reduced pressure to afford a clear, colourless 
oil. This material was added to a magnetically stirred solution of sodium iodide (22.0 g, 
146 mmol) in dry acetone (200 mL) maintained at 18 °C under a nitrogen atmosphere. 
After stirring for 16 h the reaction mixture was diluted with pentane (200 mL) and the 
resulting mixture filtered through a short pad of TLC-grade silica gel. The filtrate was 
concentrated under reduced pressure and the residue subjected to flash chromatography 
(pentane elution). Concentration of the appropriate fractions (Ry0.7) afforded 
compound 146 (12.3 g, 62% from 145) as a clear, colourless oil. The spectral data 
obtained on this material were identical, in all respects, with those previously 
reported .136 This material was used, without purification, in the next step of the 
reaction sequence.
(2-M ethylhex-2-ene)triphenylphosphonium iodide (129).
A magnetically stirred solution of compound 146 (5.3 g, 23.6 mmol) and 
triphenylphosphine (7.71 g, 29.2 mmol) in dry benzene (4 mL) that was protected from 
light with aluminium foil was stirred at 18 °C under a nitrogen atmosphere for 7 days. 
The resulting cloudy reaction mixture was poured into Et2Ü (150 mL) and the 
precipitated solids removed by vacuum filtration. This material was dried under vacuum 
(IO-3 Torr) to yield compound 129 (5.2 g, 45%) as a white powder, m.p. 142-143 °C 
(lit.136 m.p. 142-143 °C).
NMR (300 MHz) 5: 7.81-7.26 (18H, m), 4.97 (1H, m), 3.59-3.53 (2H, m), 
2.33-2.26 (2H, m), 1.69-1.59 (2H, m), 1.62 (3H, s), 1.54 (3H, s).
benzene
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13C NMR (75.4 MHz) 5: 135.4 (CH), 134.7 (C), 133.9-133.7 (d, J = 10.0 Hz, 
CH), 130.9-130.7 (d, J = 12.5 Hz, CH), 122.1 (CH), 118.8 (C), 117.7 (C), 28.9- 
28.6 (d, J = 16.0 Hz, CH2), 26.0 (CH3), 22.9 (CH2), 22.3 (CH2), 18.4 (CH3). 
31p NMR (121.4 MHz) 5: 25.1 (1H, s).
Methyl 3-[(3,E)-4',8 ,-Dimethylnona-3',7’-dienyl]-(l/?,2/?,3/?)-2- 
formyl-2-methylcyclopropanecarboxylate (125) and Methyl 3-[(3’Z)- 
4',8,-Dimethylnona-3,,7 ,-dienyl]-(lR,2/?,3/?)-2-formyl-2-methylcyclo- 
propane-carboxylate (148).
1. n-BuLi
2. Mel
3. n-BuLi
rc-Butyllithium (573 pL of a 1.6 M solution in hexane, 0.92 mmol) was added, 
dropwise, to a magnetically stirred suspension of (2-methyl-2-hexene)- 
triphenylphosphonium iodide (129) (443 mg, 0.92 mmol) in dry THF (10 mL) 
maintained at 0 °C (ice-bath) under a nitrogen atmosphere. After 0.25 h, methyl iodide
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(59 pL, 0.92 mmol) was added, dropwise, to the orange-coloured reaction mixture. 
Stirring was continued for an additional 0.25 h before a second aliquot of n- 
butyllithium (573 jiL of a 1.6 M solution in hexane, 0.92 mmol) was added. After an 
additional 0.25 h, the red-coloured reaction mixture was cooled to -78 °C (acetone/dry- 
ice slush bath) and after 0.25 h it was transferred, via cannula, to a magnetically stirred 
solution of compound 126 (180 mg, 0.92 mmol) in dry THF (3 mL) maintained at -78 
°C (acetone/dry-ice slush bath) under a nitrogen atmosphere. The reaction mixture was 
warmed to 18 °C then quenched with solid NH4CI (ca. 500 mg). The resulting mixture 
was diluted with Et20 (100 mL) then filtered through a short pad of TLC-grade silica 
gel. The filtrate was concentrated under reduced pressure to give a pale-yellow oil 
which was subjected to flash chromatography (3:1 hexane/Et20 elution). Concentration 
of the appropriate fractions (Ry0.5) then gave a ca. 2:1 mixture (as determined by 
NMR and 13C NMR analysis) of compounds 125 and 148 (222 mg, 83%) as a clear, 
colourless oil.
*H NMR (300 MHz) 5: 9.26 (1H, s), 9.25 (1H, s), 5.17-5.00 (4H, m), 3.70 (6H, 
s), 2.33 (2H, d, J = 6.5 Hz), 2.06-2.02 (8H, m), 1.98-1.96 (2H, m), 1.67 (6H, s), 
1.60 (6H, s), 1.58 (6H, s), 1.39 (6H, s).
13C NMR (75.4 MHz) 5: 199.9 (CH), 199.8 (CH), 170.6 (C), 136.8 (C), 136.7 (C),
131.9 (C), 131.6 (C), 124.4 (CH2), 124.3 (CH2), 123.7 (CH2), 122.7 (CH2), 52.2 
(CH3), 39.9 (CH2), 39.6 (CH2), 39.5 (CH), 36.3 (CH), 32.8 (CH), 32.7 (CH), 32.1 
(CH2), 31.1 (CH), 27.8 (CH2), 27.7 (CH2), 27.4 (CH2), 27.1 (CH2), 26.8 (CH2),
25.9 (CH3), 23.6 (Z-CH3), 17.9 (CH3), 17.8 (CH3), 16.2 (CH3), 12.9 (CH3).
IR vmax 2954, 2930, 1735, 1713 cm-1.
EIMS (70eV) m/z 292 (M+\ 3), 249 (22), 217 (21), 163 (31), 95 (49), 69 (100). 
HRMS Found M+\ 292.2040 C i8H280 3 requires M+\ 292.2038.
Optical Rotation [ a ]D20 - 107.7 0 (c 1.3, CHC13).
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Ethyl (4E)-5,9-Dimethyldeca-4,8-dienoate (149).
LDA
EtOAc, Cul
C 0 2Et
132 149
rc-Butyllithium (74.0 mL of a 2.5 M solution in hexane, 180 mmol) was added, 
dropwise, to a magnetically stirred solution of diisopropylamine (26.0 mL, 184 mmol) 
in dry THF (75 mL) maintained at -78 °C (acetone/dry-ice slush bath) under a nitrogen 
atmosphere. The resulting mixture was warmed to 18 °C then kept at 0 °C for 0.2 h 
before being re-cooled to -78 °C.
The solution of lithium diisopropylamine thus-formed was transferred, via cannula, 
to a magnetically stirred suspension of dry EtOAc (18.0 mL, 184 mmol) and cuprous 
iodide (70 g, 368 mmol) in dry THF (270 mL) maintained at -110 °C (EtOH/liquid- 
nitrogen slush bath) under a nitrogen atmosphere. The resulting tan-coloured 
suspension was stirred at -30 °C for 0.5 h then a solution of geranyl bromide (132) 
(20.0 g, 92 mmol) in dry THF (30 mL) was added, dropwise, and the reaction mixture 
was warmed to 18 °C and the reaction mixture was poured into water (1.5 litres). After 
NH4CI (400 g, 7.6 mol) had been added to the resulting mixture the separated aqueous 
phase was extracted with Et2 0  (2 x 800 mL) and the combined organic phases then 
dried (MgSOzO, filtered and concentrated under reduced pressure to yield compound 
149 (20.5 g, 100%) as a clear, colourless oil. The spectral data obtained on this 
material were identical, in all respects, with those previously reported.136 This material 
was used, without purification, in the next step of the reaction sequence.
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(4£)-5,9-Dimethyldeca-4,8-dien-l-ol (150).
A solution of compound 149 (20.5 g, 92 mmol) in dry Et2Ü (50 mL) was added, 
dropwise, to a magnetically stirred suspension of lithium aluminium hydride (3.9 g, 
101 mmol) in dry Et2 0  (70 mL) maintained at 0 °C (ice-bath) under a nitrogen 
atmosphere. The reaction mixture was stirred at 18 °C for 6 h then treated, sequentially, 
with water (12 mL) and sodium hydroxide (12 mL of a 15% aqueous solution). The 
resulting suspension was filtered and the solids thus retained were washed successively 
with Et2Ü (350 mL) and hot CHCI3 (350 mL). The combined filtrates were dried 
(MgSOzO, filtered and concentrated under reduced pressure to yield compound 150 
(16.7 g, 100%) as a clear, colourless oil. The spectral data obtained on this material 
were identical, in all respects, with those previously reported. 136 This material was 
used, without purification, in the next step of the reaction sequence.
(6Zs)-10-Iodo-2,6-dimethyldeca-2,6-diene (151).
I I l.M eS 0 2Cl,NEt3
----------=--------—
2. Nal, acetone
150 151
Methanesulfonyl chloride (7.1 mL, 92 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 150 (16.8 g, 92 mmol) and triethylamine 
(17.8 mL, 128 mmol) in dry CH2CI2 (110 mL) maintained at 0 °C (ice-bath) under a 
nitrogen atmosphere. After 0.25 h the reaction mixture was diluted with ice-cold water 
(50 mL) and the aqueous phase was extracted with CH2CI2 (2 x 200 mL). The 
combined organic phases were washed with cold HCl (1 x 200 mL of a 10% aqueous 
solution), NaHCC>3 (1 x 300 mL of a saturated aqueous solution) and NaCl (1 x 100
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mL of a saturated aqueous solution). The separated organic phase was then dried 
(MgSOzO, filtered and concentrated under reduced pressure to afford a clear, colourless 
oil. This material was added to a magnetically stirred solution of sodium iodide (22.0 g, 
146 mmol) in dry acetone (200 mL) maintained at 18 °C under a nitrogen atmosphere. 
After stirring for 16 h the reaction mixture was diluted with pentane (200 mL) and the 
resulting mixture filtered through a short pad of TLC-grade silica gel. The filtrate was 
concentrated under reduced pressure and the residue subjected to flash chromatography 
(pentane elution). Concentration of the appropriate fractions (R^0.6) afforded 
compound 151 (13.0 g, 48% from 150) as a clear, colourless oil. The spectral data 
obtained on this material were identical, in all respects, with those previously 
reported .136 This material was used, without purification, in the next step of the 
reaction sequence.
[(4Zs)-5,9-D im ethyl-deca-4,8-dien]triphenylphosphonium  iodide (129).
A magnetically stirred solution of compound 151 (11.0 g, 37.7 mmol) and 
triphenylphosphine (13.0 g, 49.0 mmol) in dry benzene (7 mL) that was protected from 
light with aluminium foil was stirred at 18 °C under a nitrogen atmosphere for 7 days. 
The resulting cloudy reaction mixture was poured into Et2Ü (150 mL) and the 
precipitated solids removed by vacuum filtration. This material was dried under vacuum 
(10'3 Torr) to yield compound 131 (13.0 g, 63%) as a white powder, m.p. 97-98 °C 
(lit.135 m.p. 96-97 °C).
*H NMR (300 MHz) 5: 7.77-7.66 (15H, m), 7.40-7.38 (3H, m), 5.01-4.99 (2H, m), 
3.70-3.68 (2H), 3.59-3.53 (2H, m), 2.36-2.33 (2H, m), 2.02-1.96 (4H, m), 1.70- 
1.66 (2H, m), 1.57 (6H, s), 1.54 (3H, s).
benzene
151 131
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13C NMR (75.4 MHz) 8: 137.9 (C), 135.2-1.35.1 (d, J = 2.1 Hz, CH), 133.6-133.4 
(d, J = 10.2 Hz, CH), 131.2 (CH), 130.5-130.4 (d, J = 12.6 Hz, CH), 123.9 (CH), 
121.5 (CH), 118.3 (C), 117.2 (C), 39.4 (CH2), 28.2-28.1 (d, J = 16.4 Hz, CH2), 
26.3 (CH2), 25.6 (CH3), 22.4 (CH2), 17.5 (CH3), 16.4 (CH3).
31P NMR (121.4 MHz) 8: 22.3 (1H, s).
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Methyl 2 - [ ( l ,JE ,5 ,£:)-2 , ,6 , ,1 0 , - T r im e t h y l - l , , 5 , , 9 , -undecatr ienyl]-2 -
m e th y l -3 - [ ( 3 , ,£ ) - 4 " , 8 ” -d im eth y ln o n a -3 M, 7 M- d i e n y l ] - ( l f l , 2 S , 3 / 0 -  
cyclopropanecarboxylate (153), Methyl 2-[ (rZs,5 ,JE )-2 ' ,6 , ,10'-  
Tr imethy 1-r , 5 ’,9 ' -u ndecatr ien y l ] -2 -m ethy l-3-[ (3 ' ’Z ) -4 " , 8 M-dimethyl  
n o n a -3 " ,7 M-dienyl] -( l /? ,2S,3 /?)-cyclopropanecarboxylate  (154), 
Methyl 2 - [ ( r Z , 5 ,Zs)"2\6, ,1 0 ,- T r i m e t h y l - l , , 5 ' ,9 , -undecatr ienyl] -2 -
m e th y l -3 - [ ( 3 ” Zs ) - 4 , \ 8 , , -d im e th y ln o n a -3 M,7" -d ien y l ] - ( l /? ,2 S ,3 /? ) -
cyclopropanecarboxylate (155) and Methyl 2 - [ ( l ,Z ,5 '^ ) -2 ' ,6 , ,10'- 
Tr imethy 1-1',5’,9*-u ndecatr ien y l ] -2 -m ethy l-3 - [ (3MZ ) -4 " ,8 ” -dimethyl  
n on a-3M,7 ” -dienyl] -( l /? ,2S,3 /?)-cyclopropanecarboxylate  (156).
153 (A = £; B = E)
154 (A = Z; B = E) Fraction Y
155 (A = E\ B = Z)
156 (A = Z; B = Z) Fraction X
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rc-Butyllithium (979 pL of a 1.6 M solution in hexane, 1.6 mmol) was added, 
dropwise, to a magnetically stirred suspension of [(£ ')-5 ,9 -d im e th y l-4 ,8 - 
decadienyl]triphenylphosphonium iodide (131) (863 mg, 1.6 mmol) in dry THF (18 
mL) maintained at 0 °C (ice-bath) under a nitrogen atmosphere. After 0.25 h methyl 
iodide (101 pL, 0.92 mmol) was added, dropwise, to the orange-coloured reaction 
mixture. Stirring was continued for an additional 0.25 h before a second aliquot of n- 
butyllithium (979 pL of a 1.6 M solution in hexane, 1.6 mmol) was added. After an 
additional 0.25 h, the red-coloured reaction mixture was transferred via cannula to a 
magnetically stirred solution of a ca. 2:1 mixture of compounds 125 and 148 (228 mg, 
0.78 mmol) in dry THF (4 mL) maintained at 0 °C (ice-bath) under a nitrogen 
atmosphere. The mixture was warmed to 18 °C then quenched with solid NH4CI (ca. 
500 mg). The resulting mixture was diluted with Et2Ü (100 mL) then filtered through a 
short pad of TLC-grade silica gel. The filtrate was concentrated under reduced pressure 
to provide a pale-yellow oil which was subjected to flash chromatography (3:1 
hexane/Et20 elution). Concentration of the appropriate fractions (Ry0.5) then gave a ca. 
4:3:3:2 mixture (as determined by ^ C - 'H  2D HETCOR NMR spectroscopic 
techniques) of compounds 153-156 (258 mg, 73%) as a clear, colourless oil. 
Subjection of this material to preparative HPLC (p-Porasil™ column, 100:1 hexane:te/t- 
butyl methyl ether elution, flow rate = 8 mL/min) afforded two fractions (X and Y).
Concentration of the fraction X (R? 18.6 min) gave a ca. 2:1 mixture of compounds 
155 and 156 (156 mg, 44%).
*H NMR (300 MHz) 8: 5.29 (1H, s), 5.15-5.07 (4H, m), 3.67 (3H, s), 2.49-1.95 
(16H, m), 1.68, 1.62 , 1.60, 1.59 (21H, singlets, corresponding to 7 methyl group 
protons), 1.56-1.24 (2H, m), 1.22 (3H, s).
13C NMR (75.4 MHz) 8: 173.6 (C), 140.9 (C), 135.8 (C), 135.5 (C), 131.9 (C), 
131.7 (C), 126.4 (CH), 126.3 (CH), 124.9 (CH), 124.7 (CH), 124.7 (CH), 124.6 
(CH), 124.4 (CH), 124.1 (CH), 51.7 (CH3), 40.1 (CH2), 40.0 (CH2), 34.0 (CH or 
CH3), 32.9 (CH or CH3), 32.8 (CH or CH3), 32.7 (CH2), 32.2 (CH2), 31.9 (CH2),
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30.7 (CH2), 30.6 (CH2), 29.9 (CH2), 29.6 (CH2), 27.9 (CH2), 27.8 (CH2), 27.0 
(CH2), 26.9 (CH2), 26.8 (CH2), 26.0 (CH3), 23.8 (Z-CH3), 23.0 (C), 22.9 (Z-CH3), 
20.5 (CH3), 18.0 (CH3), 17.9 (CH3), 16.3 (CH3).
IRVmax 2965,2924, 2856, 1731, 1440, 1158 cm-1.
EIMS (70eV) m/z 454 (M+\ 14), 385 [(M-H9C5-)+, 9], 317 (7), 285 (5), 257 (10), 
247 (8).
HRMS Found M+', 454.3806. C3iÜ5o0 2 requires M+', 454.3810.
Optical Rotation [(x]d20 - 13.9 ° (c 7.5, CHC13).
Concentration of the fraction Y (Rt 21.2 min) gave a ca. 2:1 mixture compounds 153 
and 154 (138 mg, 39%).
*H NMR (300 MHz) 6: 5.29 (1H, s), 5.10-5.06 (4H, m), 3.69 (3H, s), 2.07-1.97 
(16H, m), 1.70, 1.68, 1.59, 1.59 (21H, singlets, corresponding to 7 methyl group 
protons), 1.56-1.24 (2H, m), 1.22 (3H, s).
13C NMR (75.4 MHz) 6: 173.7 (C), 140.8 (C), 135.9 (C), 135.7 (C), 135.5 (C), 
131.9 (C), 131.6 (C), 125.7 (CH), 125.7 (CH), 124.9 (CH), 124.6 (CH), 124.1 
(CH), 124.1 (CH), 51.7 (CH3), 40.0 (CH2), 39.6 (CH2), 34.0 (CH or CH3), 33.3 
(CH or CH3), 33.2 (CH or CH3), 32.2 (CH2), 30.9 (CH2), 30.9 (CH2), 29.9 (CH2), 
29.6 (CH2), 27.9 (CH2), 27.8 (CH2), 27.1 (CH2), 27.0 (CH2), 26.7 (CH2), 26.0 
(CH3), 23.7 (Z-CH3), 23.0 (C), 19.7 (CH3), 18.0 (CH3), 17.1 (CH3), 16.4 (CH3), 
16.3 (CH3).
IRVmax 2965, 2924, 2856, 1731, 1440, 1158 cm'1.
EIMS (70eV) m/z 454 (M+\ 22), 385 [(M-H9C5O+ 14], 317 (10), 285 (9), 257 
(13), 247 (7).
HRMS Found M+‘, 454.3810. C3iH5o0 2 requires M+', 454.3810.
Optical Rotation [a]D20 - 23.3 0 (c 1.4, CHC13).
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2 - [ ( l ,E , 5 ' £ ) - 2 , ,6 , , 1 0 ' - T r i m e t h y l - l , , 5 ' ,9 ,-u ndecatr ieny l ] -2 -m ethy l-3 -  
[ ( 3 " / i  ) -4 , ' ,8M-d im e th y ln o n a -3 M,7 M-d ien y l ] - ( l /? ,2 S ,3 /? )cy c lo p ro p a n e-  
methanol (157), 2 - [ ( l ,i s ,5 ’Zs)-2, ,6 , , 1 0 , - T r i m e t h y l - l , , 5 , ,9 ' -undeca-  
t r ien y l ] -2 -m eth y l -3 - [ (3MZ ) - 4 M,8 , , -d im e th y ln o n a -3 ” ,7 M-dienyl]-  
(l /?,2.S,3/?)cyclopropanemethanol (158), 2 - [ ( r Z , 5 ,Zs)-2',6, ,10'-  
T r i m e t h y l - l , ,5 , , 9 ,-u n d e c a tr ien y l ] -2 - m et h y l -3 - [ (3 " £ ) -4 " ,8 , , -dimethyl-  
non a-3" ,7M-dienyI]-(l /?,25',3/?)cyclopropanemethanol (159) and 2- 
[ ( l ,Z ,5 ,^ ) - 2 ’,6 , , 1 0 ' - T r im e t h y l - l ' , 5 , , 9 ’-u ndecatr ien y l ] -2 -m ethy l-3 -  
[(3 , ,Z ) - 4 M,8 ' , -d im e th y ln o n a -3 ” ,7 , , -d ien y l ] - ( l /? ,2 lS ,3 /? )cyc lop rop ane-  
methanol (160).
155 (A = E\ B
156 (A = Z; B
Z)
Z)
Fraction X
LiAlH4
157 (A = £; B = E)
158 (A = Z; B = E) Fraction Y
159 (A = E\ B = Z)
160 (A = Z; B = Z) Fraction X
A solution of compounds 155 and 156 (43 mg, 0.093 mmol) in dry Et20 (1.0 mL) 
was added, dropwise, to a magnetically stirred suspension of lithium aluminium 
hydride (13 mg, 0.32 mmol) in Et2Ü (1.5 mL) maintained at 0 °C (ice-bath) under a 
nitrogen atmosphere. The reaction mixture was stirred at 18 °C for 3 h then treated with 
NaCl (2 mL of a saturated aqueous solution) and citric acid (2 mL of a saturated 
aqueous solution). The resulting mixture was extracted with Et20 ( 2 x 1 0  mL) then the 
combined organic phases were dried (MgSOzO, filtered and concentrated under reduced
162
Chapter Six
pressure to give a colourless oil which was subjected to flash chromatography (2:1 
hexane/Et20 elution). Concentration of the appropriate fractions (Rf 0.4) then gave a ca. 
2:1 mixture (as judged by 13C NMR analysis) of compounds 159 and 160 (36 mg, 
93%) as a clear, colourless oil.
*H NMR (300 MHz) 5: 5.29 (1H, s), 5.16-5.08 (4H, m), 3.69 (2H, d, J = 7.4 Hz), 
2.26-1.96 (16H, m), 1.68, 1.67, 1.63, 1.61, 1.59 (21H, singlets, corresponding to 7 
methyl group protons), 1.12 (3H, s), 0.86-0.77 (1H, m), 0.43-0.41 (1H, m).
13C NMR (75.4 MHz) Ö: 139.9 (C), 135.7 (C), 135.4 (C), 135.3 (C), 131.6 (C), 
128.1 (CH), 128.0 (CH), 125.6 (CH), 124.8 (CH), 124.7 (CH), 124.6 (CH), 64.1 
(CH2), 40.1 (CH2), 34.1 (CH or CH3), 33.9 (CH or CH3), 32.6 (CH2), 32.3 (CH2), 
31.9 (CH2), 30.4 (CH2), 30.4 (CH2), 30.1 (CH2), 29.9 (CH or CH3), 29.8 (CH3),
28.5 (CH2), 28.4 (CH2), 27.0 (CH2), 26.9 (CH2), 26.5 (CH2), 23.9 (C), 23.8 (C),
23.6 (Z-CH3), 22.9 (Z-CH3), 21.2 (CH3), 17.9 (CH3), 17.8 (CH3), 16.3 (CH3).
IR vmax 2965, 2925, 2855, 1448 cm'1.
EIMS (70eV) m/z 426 (M+\ 5), 339 (4), 289 (4), 271 (5), 217 (16).
HRMS Found M+‘, 426.3868. C3oH5oO requires M+', 426.3861.
Optical Rotation [oc]d 20 + 2.5 ° (c 5.8, CHC13).
Lithium aluminium hydride-promoted reduction of compounds 153 and 154 (58 
mg, 0.13 mmol) in the same manner described above for compounds 155 and 156 
gave a pale-yellow oil upon work-up. Subjection of this material to flash 
chromatography (2:1 hexane/Et20  elution) afforded, after concentration of the 
appropriate fractions (Ry0.4) a ca. 2:1 mixture (as judged by 13C NMR analysis) of 
compounds 157 and 158 (50 mg, 91%) as a clear, colourless oil.
*H NMR (300 MHz) 6: 5.26 (1H, s), 5.16-5.06 (4H, m), 3.68 (2H, m), 2.08-1.93 
(16H, m), 1.71, 1.68, 1.67 (21H, singlets, corresponding to 7 methyl group protons), 
1.12 (3H, s), 0.74-0.70 (1H, m), 0.46-0.42 (1H, m).
13C NMR (75.4 MHz) 5: 139.5 (C), 135.6 (C), 135.4 (C), 131.9 (C), 131.6 (C), 
131.5 (C), 127.6 (CH), 125.7 (CH), 124.8 (CH), 124.7 (CH), 124.6 (CH), 124.5
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(CH), 64.2 (CH2), 40.1 (CH2), 40.0 (CH2), 33.8 (CH), 33.7 (CH), 32.3 (CH2), 
31.9 (CH2), 31.3 (CH2), 31.2 (CH2), 31.1 (CH2), 30.0 (CH2), 29.9 (CH3), 28.5 
(CH2), 28.4 (CH2), 27.0 (CH2), 26.8 (CH2), 26.0 (CH2), 24.0 (C), 23.7 (Z-CH3), 
20.3 (CH3), 18.0 (CH3), 17.1 (CH3), 16.4 (CH3), 16.3 (CH3).
IR vmax 2965, 2925, 2855, 1448 cn r1.
EIMS (70eV) m/z 426 (M+\ 7), 339 (6), 289 (6), 271 (10), 217 (39).
HRMS Found M+\ 426.3858. C30H50O requires M+\ 426.3861.
Optical Rotation [a]D20 - 2.2 ° (c 1.1, CHC13).
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{ 2 - [ ( l ' E ,5 ' E ) - 2 , , 6 ' , 1 0 ' - T r im e t h y l - l , ,5 , ,9 ' -u ndeca tr ien y l ] -2 -m ethy l-3 -  
[ ( 3 " E ) - 4 " , 8 M-d im e th y ln o n a -3 M,7 " -d ie n y l ] - ( l /? ,2 /? ,3 S ) -c y c lo p ro p y l} -  
2-[(trimethyls ily l)ethyl]carboxamide (169), { 2 - [ ( l ’£ , 5 ' JE ) - 2 , , 6 , ,10'-  
T r i m e t h y l - l , , 5 , , 9 ,-u n decatr ien y l ] -2 -m ethy l-3 - [ (3"Z )-4" ,8"-d im ethy l-  
n o n a -3 M,7 M-d ien y l] - ( l /? ,2 /? ,3S) -cyc lop rop yl} -2 - [ ( tr im ethy ls i ly l ) -  
ethyl]-carboxamide (170), {2 - [ ( l 'Z ,5 ,£ ) - 2 , , 6 , ,1 0 , - T r i m e t h y l - l , ,5 , , 9 ’- 
u n d eca tr ien y l ] -2 -m eth y l-3 - [ (3ME ) - 4 M,8 " -d im eth y ln o n a -3 M,7 M-dienyl]-  
(l /?,2 /?,3S)-cyclopropyl}-2-[(trimethyIsily l) -ethyl]carboxamide (171) 
and { 2 - [ ( l ,Z , 5 ' £ ) - 2 ' , 6 , ,1 0 , - T r i m e t h y l - l , , 5 , , 9 , -u ndecatr ien y l ] -2 -  
m e th y l - 3 - [ ( 3 , ,Z ) - 4 M, 8 M- d im e th y ln o n a -3 " ,7 M-d ien y l ] - ( l /? ,2 /? ,3 5 ) -  
cyclopropyl}-2-[(trimethylsilyl)ethyl]-carboxamide (172).
153 (A = £; B = E)
154 (A = Z; B = E) Fraction Y
155 (A = E\ B = Z)
156 (A = Z; B = Z) Fraction X
1. KOH, MeOH
2. (PhO)2PON3 
TMS(CH2)2ÖH
O
N H
169 (A = E\ B = E)
170 (A = Z; B = E) Fraction Y
171 (A = E; B = Z)
172 (A = Z; B = Z) Fraction X
Potassium hydroxide (3.75 mL of a 1.2 M solution in MeOH, 4.5 mmol) was added 
to compounds 155 and 156 (58 mg, 0.125 mmol) and the resulting mixture was 
stirred at 18 °C for 16 h then treated, sequentially, with H2 O (4 mL) and HC1 (3 mL of 
a 1M aqueous solution). The mixture thus obtained was extracted with CH2 CI2 (4 x 
100 mL) and the combined organic phases were then dried (MgSOq), filtered and
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concentrated under reduced pressure to give a pale-yellow oil (48 mg, 98%). This crude 
acid was dissolved in anhydrous toluene (100 (XL) and the solution thus formed treated, 
dropwise, with triethylamine (15 |iL, 0.12 mmol) and diphenyl phosphorazidate (23 
|xL, 0.12 mmol). The resulting solution was heated at 100 °C for 0.2 h then cooled to 
50 °C and treated with 2-(trimethylsilyl)ethanol (30 |iL, 0.12 mmol). After a further 16 
h at 50 °C the reaction mixture was cooled then diluted with water (1 mL) and Et20 (5 
mL). The separated aqueous phase was extracted with Et2Ü (5 mL) and the combined 
organic phases were then dried (MgSC>4), filtered and concentrated under reduced 
pressure to give a pale-yellow oil which was subjected to flash chromatography (6:1 
hexane/Et20 elution). Concentration of the appropriate fractions (Rf 0.4) then gave a ca. 
2:1 mixture (as judged by 13C NMR analysis) of compounds 171 and 172 (41 mg, 
62%) as a clear, colourless oil.
*H NMR (300 MHz) 6: 5.30-5.09 (5H, m), 4.70 (1H, bs), 4.28 (2H, m), 2.42-2.12 
(17H, m), 1.71, 1.67, 1.60 (21H, singlets, corresponding to 7 methyl group protons), 
1.42 (1H, m), 1.10 (3H, s), 1.00 (2H, bs), 0.03 (9H, s).
13C NMR (75.4 MHz) 5: 157.9 (C), 141.2 (C), 140.8 (C), 140.7 (C), 135.7 (C), 
135.6 (C), 130.2 (CH), 130.0 (CH), 126.3 (CH), 125.5 (CH), 124.7 (CH), 124.6 
(CH), 124.4 (CH), 124.0 (CH), 63.2 (CH2), 41.6 (CH), 41.5 (CH), 40.0 (CH2),
32.9 (CH2), 32.5 (CH), 29.7 (CH2), 29.4 (CH2), 29.2 (CH2), 28.0 (CH2), 27.9 
(CH2), 27.0 (CH2), 26.5 (CH2), 26.4 (CH2), 26.0 (CH3), 23.7 (Z-CH3), 23.1 (C), 
22.8 (Z-CH3), 20.7 (CH3), 20.6 (CH3), 18.0 (CH3), 16.3 (CH3), -1.2 (CH3).
IR vmax 3450, 2950, 2920, 2840, 1700, 1500, 1370, 1245 c n r 1.
EIMS (70eV) m/z 555 (M +\ 4), 527 [(M-CO)+\ 14], 512 (20), 458 (35), 410 (27), 
390 (51).
HRMS Found M + \ 555.4466. C35H6iN 0 2Si requires M + \ 555.4471.
Optical Rotation [a ]D20 - 1.5 ° (c 4.6, CHC13).
Treatment of the mixture of esters 153 and 154 (73 mg, 0.156 mmol) in the same 
manner as described immediately above for isomers 155 and 156 gave a pale-yellow
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oil upon work-up. This material was subjected to flash chromatography (6:1 
hexane/Et20 elution). After concentration of the appropriate fractions (Ry0.3), a ca. 2:1 
mixture (as judged by 13C NMR analysis) of compounds 155 and 156 (46 mg, 73%) 
was obtained as a clear, colourless oil.
*H NMR (300 MHz) 5: 5.30-5.09 (5H, m), 4.70 (1H, bs), 4.28 (2H, m), 2.42-2.12 
(17H, m), 1.71, 1.67, 1.60 (21H, singlets, corresponding to 7 methyl group protons), 
1.42 (1H, m), 1.10 (3H, s), 1.00 (2H, bs), 0.03 (9H, s).
13C NMR (75.4 MHz) 5: 157.9 (C), 141.2 (C), 140.8 (C), 140.7 (C), 135.7 (C), 
135.6 (C), 130.2 (CH), 130.0 (CH), 126.3 (CH), 125.5 (CH), 124.7 (CH), 124.6 
(CH), 124.4 (CH), 124.0 (CH), 63.2 (CH2), 41.6 (CH), 41.5 (CH), 40.0 (CH2),
32.9 (CH2), 32.5 (CH), 29.7 (CH2), 29.4 (CH2), 29.2 (CH2), 28.0 (CH2), 27.9 
(CH2), 27.0 (CH2), 26.5 (CH2), 26.4 (CH2), 26.0 (CH3), 23.7 (Z-CH3), 22.8 (Z- 
CH3), 20.0 (CH3), 19.9 (CH3), 18.1 (C), 18.0 (CH3), 16.3 (CH3), -1.2 (CH3).
IR vmax 3450, 2950, 2920, 2840, 1700, 1500, 1370, 1245 cm '1.
EIMS (70eV) m/z 555 (M+\ 12), 527 [(M-CO)+\ 17], 512 (22), 458 (33), 410 (32), 
390 (56).
HRMS Found M+', 555.4466. C35H6iN02Si requires M+‘, 555.4471.
Optical Rotation [oc]d 20 - 6.9 ° (c 2.9, CHC13).
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[( l ' .E,5,£ ) - 2 , ,6 , ,10 , - T r im e t h y l - l , ,5 , ,9'-undecatrienyl]-A^-methyI-2-  
[(3"Zs ) - 4 M, 8 M-d im eth y ln o n a -3 , , , 7 M-d ien y l ] - ( l /? ,2 /? ,3 S ) -cy c lo p ro p -  
anamine (164), [ ( l ’E , 5 ,E ) - 2 , ,6 , ,1 0 ,- T r i m e t h y l - l , ,5 ' ,9 , -undecatr ienyl] -  
iV -m ethyl-2- [ (3MZ ) - 4 M,8 " -d im e th y ln o n a -3 M,7 " -d ie n y l ] - ( l /? ,2 /? ,3 5 ) -  
cyclopropanamine (173), [ ( l ,Z ,5 ,Z^)-2',6',10, -T r^m eth y l- l , , 5 , , 9 , - 
undecatr ienyl ]-N-methyl-2-[ (3"Zi)-4M,8 M-d im eth y ln o n a -3 , , ,7"-d ienyl] -  
(l /?,2/?,35)-cyclopropanamine (174) and [ ( l 'Z ,5 'E ) -2 \6 '910'- 
T r i m e t h y l - l , , 5 , , 9 , -u n d eca tr ien y l ] -N -m eth y l -2 - [ (3 " Z )-4 , , ,8 M- 
dim ethy lnon a-3M,7M-dienyl]-( l /? ,2 /? ,3S)-cyclopropanamine (175).
N H
169 (A = E; B = E)
170 (A = Z; B = E) Fraction Y
171 (A = E\ B = Z)
172 (A = Z; B = Z) Fraction X
TBAF
164 (A = E\ B = E) 
173 (A = Z; B = E) Fraction Y
174 (A = E\ B = Z)
175 (A = Z; B = Z) Fraction X
A solution of tetra-rc-butylammonium fluoride hydrate (45 mg, 0.14 mmol) in THF 
(80 jliL) was added, dropwise, to a magnetically stirred solution of compounds 171 
and 172 (20 mg, 0.04 mmol) and the resulting mixture stirred at 50 °C for 1 h. The 
cooled reaction mixture was then diluted with water (1 mL) and Et2Ü (5 mL). The 
separated aqueous phase was extracted with Et20 ( 2 x 5  mL) and the combined organic 
phases were then dried (MgSO/O, filtered and concentrated under reduced pressure. The 
material obtained in this way was subjected to flash chromatography (5:5:1 
hexane/EtOAc/MeOH elution) which afforded, after concentration of the appropriate
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fractions (R/0.6), a ca. 2:1 mixture (as judged by 13C NMR analysis) of compounds 
174 and 175 (9 mg, 60%) as a clear, colourless oil.
NMR (300 MHz) 5: 5.20-5.08 (5H, m), 2.17-1.99 (16H, m), 1.88 (1H, d, J  =
3.8 Hz), 1.68, 1.67, 1.63, 1.60, (21H, singlets, corresponding to 7 methyl group 
protons), 1.36-1.07 (2H, m), 1.14 (3H).
13C NMR (75.4 MHz) 6: 139.6 (C), 135.4 (C), 135.1 (C), 131.8 (C), 131.7 (C), 
130.2 (CH), 128.1 (CH), 125.6 (CH), 124.8 (CH), 124.7 (CH), 124.6 (CH), 43.4 
(CH), 40.0 (CH), 40.0 (CH2), 33.3 (CH), 33.2 (CH2), 32.3 (CH2), 29.8 (CH2),
29.5 (CH2), 28.4 (CH2), 28.3 (CH2), 27.0 (CH2), 26.9 (CH2), 26.5 (CH2), 26.0 
(CH3), 25.1 (C), 23.8 (Z-CH3), 22.8 (Z-CH3), 20.0 (CH3), 18.0 (CH3), 16.3 (CH3). 
IR vmax 3400, 2970, 2940, 2870, 1740, 1660, 1460, 1380 cm-1.
EIMS (70eV) m/z 411 (M +\ 3), 396 [(M-H3C-)+, 6], 342 [(M-H9C5-)+, 81], 328 
(24), 274 (28).
HRMS Found M + \ 411.3858. C29H49NO requires M + \ 411.3865.
Optical Rotation [oc]D20 - 13.0 ° (c 1.0, CHC13).
Treatment of the mixture of carbamates 169 and 170 (46 mg, 0.08 mmol) in the 
same manner as described immediately above for isomers 171 and 172 gave a pale- 
yellow oil upon work-up. Subjection of this material to flash chromatography (5:5:1 
hexane/EtOAc/MeOH elution) afforded, after concentration of the appropriate fractions 
(Ry0.5) a ca. 2:1 mixture (as judged by 13C NMR analysis) of compounds 164 and 
173 (12 mg, 35%) as a clear, colourless oil.
1H NMR (300 MHz) Ö: 5.20-5.08 (5H, m), 2.17-1.99 (16H, m), 1.86 (1H, d, J  =
3.7 Hz), 1.68, 1.65, 1.61, 1.59, (21H, singlets, corresponding to 7 methyl group 
protons), 1.38-1.09 (2H, m), 1.13 (3H).
13C NMR (75.4 MHz) 6: 139.6 (C), 135.4 (C), 135.1 (C), 131.8 (C), 131.7 (C), 
130.2 (CH), 128.1 (CH), 125.6 (CH), 124.8 (CH), 124.7 (CH), 124.6 (CH), 43.4 
(CH), 39.5 (CH), 39.4 (CH2), 33.5 (CH), 33.4 (CH2), 32.3 (CH2), 29.4 (CH2),
29.5 (CH2), 28.4 (CH2), 28.3 (CH2), 27.1 (CH2), 26.8 (CH2), 26.5 (CH2), 26.0
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(CH3), 25.2 (C), 23.8 (Z-CH3), 19.2 (CH3), 18.0 (CH3), 17.5 (CH3), 16.4 (CH3), 
16.3 (CH3).
IR vmax 3400, 2970, 2940, 2870, 1740, 1660, 1460, 1380 c n r1.
EIMS (70eV) m/z 411 (M+\ 4), 396 [(M-H3C )+, 6 ], 342 [(M-H9C5-)+ 100], 328 
(32), 274 (36).
HRMS Found M+\ 411.3866. C29H49NO requires M+‘, 411.3865.
Optical Rotation [oc]d 20 + 14.0 0 (c 0.9, CHC13).
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6.5 Experimental Details Associated with Work Described in Chapter 
Five
Z?is-Acetonide (203).
2,2-dimethoxypropane 
p-toluenesulfonic acid
X
f-BuLi, ZnCl2 
Pd(PPh3)4
X (X=I) 202 203
/?-Toluenesulfonic acid monohydrate (210 mg, 1.6 mmol) was added, in one portion, 
to a magnetically stirred solution of (15,,2iS')-cfs'-3-iodo-3,5-cyclohexadiene-l,2-diol 
(14, X=I) (1.0 g, 4.2 mmol) in 2,2-dimethoxypropane (20 mL, 162 mmol) maintained 
at ca. -10 °C (salt-ice bath) under a nitrogen atmosphere. After 0.5 h the reaction 
mixture was diluted with triethylamine (0.5 mL) then concentrated under reduced 
pressure. The residue thus obtained was partitioned between Et20 (100 mL) and water 
(30 mL) and the separated aqueous phase extracted with Et2 Ü (2 x 50 mL). The 
combined organic phases were dried (MgSCLf), filtered and concentrated under reduced 
pressure to provide compound 202168 (950 mg, 82%) as a pale-yellow oil. This 
material was used, without purification, in the next step of the reaction sequence.
terr-Butylyllithium (2.2 mL of a 1.7 M solution in pentane, 3.64 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 202 (460 mg, 1.66 mmol) in 
dry THF (8 mL) maintained at -96 °C (acetone/liquid-nitrogen slush bath) under a 
nitrogen atmosphere. After 0.1 h a solution of flame-dried zinc chloride (252 mg, 1.66 
mmol) in dry THF (2 mL) was added, dropwise, to the reaction mixture. The resulting 
solution was warmed to -30 °C over 0.5 h then a solution of compound 202 (460 mg, 
1.66 mmol) and tetrakis(triphenylphosphine)palladium(0) (100 mg, 0.086 mmol) in dry 
THF (0.5 mL) was added dropwise. After stirring at 18 °C for 6 h, the reaction mixture 
was diluted with water (5 mL) and Et2 Ü (70 mL). The separated aqueous phase was 
extracted with Et20 (2 x 100 mL) and the combined organic phases were then dried
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(MgSC>4), filtered and concentrated under reduced pressure. The material obtained in 
this way was subjected to flash chromatography (25:25:1 hexane/Et20/triethylamine 
elution) which afforded, after concentration of the appropriate fractions (Ry0.8), 
compound 203 [254 mg, 40% from 14 (X=I)] as an unstable, clear, colourless oil.
XH NMR (300 MHz) 5: 6.38 (2H, d, J = 6.1 Hz), 6.07 (2H, dd, J = 6.1, 1.5 Hz), 
5.85 (2H, dd, J = 9.7 and 3.2 Hz), 4.82 (2H, dd, J = 8.3 and 3.2 Hz), 4.76 (2H, d, J 
= 8.3 Hz), 1.42 (6H, s), 1.37 (6H, s)
13C NMR (75.4 MHz) 5: 134.1 (2xC), 127.2 (2xCH), 123.8 (2xCH), 121.3 
(2xCH), 106.1 (2xC), 73.3 (2xCH), 71.1 (2xCH), 27.2 (2xCH3), 25.5 (2xCH3).
IR vmax 2985, 2933, 1380, 1369, 1210 cm'1.
EIMS (70eV) m/z 302 (M+\ 59), 244 {[M-(CH3)2CO]+-, 6}, 186 (100), 158 (69). 
HRMS Found M+‘, 302.1511. C18H22O4 requires M+', 302.1518.
Optical Rotation [a]D20 + 278.0 0 (c 10.0, CHC13).
Sodium hydroxide (4 mL of a 50% w/w aqueous solution, 52.1 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 203 (266 mg, 0.88 mmol) 
and benzyltriethylammonium chloride (20 mg, 0.086 mmol) in CHC13 (4 mL, 49.6 
mmol) maintained at 5 °C (ice-bath). The resulting dark-brown reaction mixture was 
stirred vigorously at 18 °C for 16 h then diluted with CHC13 (150 mL) and water (100 
mL). The separated aqueous phase was extracted with CH2CI2 (3 x 100 mL) and the
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combined organic phases were then dried (MgS04), filtered and concentrated under 
reduced pressure. The material obtained in this way was subjected to flash 
chromatography (3:1 hexane/Et20 elution) which afforded, after concentration of the 
appropriate fractions (R  ^0.5), a white solid. Recrystallization (CH3Cl3/Et20) of this 
material then gave compound 204 (117 mg, 29%) as colourless needles, m.p. 209-210 
°C.
NMR (300 MHz) 8: 6.05-6.02 (2H, m), 4.74 (2H, d, J  = 7.6 Hz), 4.66 (2H, d, J  
= 7.6 Hz), 2.35 (4H, s), 1.33 (6H, s), 1.25 (6H, s).
13C NMR (75.4 MHz) 8: 139.6 (2xC), 118.6 (2xCH), 109.7 (2xC), 72.0 (2xCH), 
69.4 (2xCH), 63.6 (2xC), 19.9 (2xCH or 2xCH3), 28.7 (2xCH or 2xCH3), 28.0 
(2xCH or 2xCH3), 26.9 (2xCH or 2xCH3).
IR vmax 2988, 2873, 23.9, 20.2, 1357, 1234, 1164, 1061 cm '1.
EIMS (70eV) m /z 453, 451 [(M-H3C )+, 5, 7], 409 (14), 351 (16), 314 (100), 286 
(32), 152 (58).
HRMS Found (M-H3C)+, 453.0015. C2oH2235C1337C104 requires (M-H3C)+, 
453.0004. Found (M-H3C)+, 451.0037. C2oH2235C140 4 requires (M-H3C-)+, 
451.0037.
Optical Rotation [a]D20 - 132.9 0 (c 1.4, CHC13).
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(3aR,5aR,6aR,6bS)-6,6-Dichloro-4-iodo-2,2-dimethyl-3a,5a,6a,6b- 
tetrahydro-5a//-cyclopropa[e]-l,3-benzodioxole (205).
Cl
202 205
Sodium hydroxide (9.2 mL of a 50% w/w aqueous solution, 0.12 mol) was added, 
dropwise, to a magnetically stirred solution of compound 202 (2.53 g, 9.13 mmol) 
and benzyltriethyiammonium chloride (50 mg, 0.22 mmol) in CHCI3 (10 mL, 124.0 
mmol) maintained at 5 °C (ice-bath). The resulting dark-brown reaction mixture was 
stirred vigorously at 18 °C for 16 h then diluted with CHCI3 (150 mL) and water (100 
mL). The separated aqueous phase was extracted with CH2CI2 (3 x 100 mL) and the 
combined organic phases were then dried (MgSC>4), filtered and concentrated under 
reduced pressure. The material obtained in this way was subjected to flash 
chromatography (1:1 hexane/Et20 elution) which afforded, after concentration of the 
appropriate fractions (R/0.8), a white solid. Recrystallization (hexane/Et20) of this 
material then gave compound 205 (2.55 g, 78%) as colourless needles, m.p. 128-129 
°C.
*H NMR (300 MHz) 5: 6.68 (1H, d, J = 4.9 Hz), 4.71 (1H, d, J = 5.5 Hz), 4.71 
(1H, d, J = 5.5 Hz), 2.43 (1H, dd, J = 9.6 and 1.6 Hz), 2.27 (1H, dd, J = 9.6 and 5.5 
Hz), 1.45 (3H, s), 1.40 (3H, s).
13C NMR (75.4 MHz) 8: 132.0 (CH), 110.2 (C), 103.5 (C), 76.1 (CH), 68.8 (CH), 
31.3 (CH or CH3), 29.2 (CH or CH3), 27.8 (CH or CH3), 26.6 (CH or CH3), (one 
signal due to a quaternary carbon not observed).
IR vmax 2987 ,2890, 1366, 1251, 1220, 1060, 874 cm-1.
EIMS (70eV) m/z 347, 345 [(M-H3C-)+, 52, 46], 302 {[M-(CH3)2CO]-1-, 80], 285 
(89), 267 (55), 175 (100).
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Elemental Analysis Found: C, 33.32; H, 2.81; Cl, 19.39; I, 35.11; C10H11CI2IO2 
requires: C, 33.27; H, 3.07; Cl, 19.64; I, 35.15%.
Optical Rotation [a ]D20 + 8.0 0 (c 2.7, CHCI3).
( l 1S,21S,35,6S)-7,7-Dichloro-4-iodobicyclo[4.1.0]hept-4-ene-2,3-diol
(206).
A magnetically stirred solution of compound 205 (450 mg, 1.37 mmol) in acetic acid 
(15 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled reaction 
mixture was then diluted with water (50 mL) and EtOAc (100 mL) and the separated 
aqueous phase was extracted with EtOAc (2 x 100 mL). The combined organic phases 
were dried (MgS0 4 ), filtered and concentrated under reduced pressure and the residue 
was subjected to flash chromatography (2:1 Et2 0 /hexane elution) which afforded, after 
concentration of the appropriate fractions (Ry0.4), a white solid. Recrystallization 
(CHCl3/Et2 0 ) of this material then gave compound 206 (355 mg, 81%) as colourless 
needles, m.p. 124-125 °C.
*H NMR (300 MHz) 5: 6.73 (1H, d, J = 4.5 Hz), 4.23 (2H, bs), 3.00-2.93 (1H, bd, 
J = 4.5 Hz), 2.31 (1H, dd, J  = 10.2, 4.5 Hz), 2.20 (1H, d, J  = 10.2 Hz), 1.73 (1H, 
bs).
13C NMR (75.4 MHz) 5: 135.1 (CH), 104.2 (C), 73.3 (CH), 66.3 (CH), 65.2 (C), 
33.3 (CH), 33.2 (CH).
IR vmax 3365,3295, 1345, 1255, 1070, 830, 795 cm '1.
EIMS (70eV) m /z 322, 320 (M+\ 0.2, 0.1), 267 (24), 249 (23), 175 (100), 147 (43), 
110 (77).
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Elemental Analysis Found: C, 25.90; H, 2.02; Cl, 21.75; I, 39.61.; C7H7CI2IO2 
requires: C, 26.20; H, 2.20; Cl, 22.09; I, 39.54%.
Optical Rotation [oc]d 20 - 93.7 0 (c 1.9, acetone).
(l/?,2/?,3R,6S)-7,7-Dichloro-4-(trim ethylstannyl)bicyclo[4.1.0]hept-4- 
ene-2,3-diol (207).
206 207
A solution of hexam ethylditin (3.0 mL, 10.1 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (350 mg, 0.30 mmol) in dry THF (5 mL) was 
added, dropwise, to a magnetically stirred solution of compound 206 (2.92 g, 9.12 
mmol) in dry THF (100 mL) maintained at 18 °C under a nitrogen atmosphere. The 
resulting dark-brown reaction mixture was heated at 50 °C for 16 h then cooled and 
diluted with water (10 mL) and Et2 0  (20 mL). The separated aqueous phase was 
extracted with EtOAc (2 x 100 mL) and the combined organic phases were then dried 
(MgSOzO, filtered and concentrated under reduced pressure. The material obtained in 
this way was subjected to flash chromatography (1:1 hexane/Et2 0  elution) which 
afforded, after concentration of the appropriate fractions (R/0.5), a white solid. 
Recrystallization (hexane/Et2 0 ) of this material then gave compound 207 (2.36 g, 
73%) as colourless needles, m.p. 72-73 °C.
!H NMR (300 MHz) 5: 6.17-6.15 (1H, m), 4.49-4.21 (2H, m), 2.59 (1H, d, J  = 9.4 
Hz), 2.35-2.28 (3H, m), 0.18 (9H, t, J  = 27.8 Hz).
SFORD 13C NMR (75.4 MHz) 5: 149.0 (C), 130.3 (t, J  =  15.6 Hz, CH), 69.5 
(CH), 64.2 (C), 63.2 (t, J  =  15.6 Hz, CH), 34.1 (CH), 29.3 (t, J  = 19.3 Hz, CH), 
-8.63 (t, J  =  177 Hz, CH3).
IRVmax 3350,1240, 1060, 1035, 770 cm'1.
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EIMS (70eV) m/z 345, 343, 341 [(M-H3C)+, 65, 73, 50], 325 (60), 185 (94), 165
( 100).
Elemental Analysis Found: C, 33.29; H, 4.28; Cl, 19.60.; C ioH iöC^C^Sn 
requires: C, 33.57; H, 4.51; Cl, 19.82%.
Optical Rotation [oc]d20 - 118.4 ° (c 1.0, acetone).
Tetra-Acetate (209).
Cl
206 207
1. Pd(PPh3 )4 , 1,4-dioxane
2. AC2 O, pyridine
Tetrakis(triphenylphosphine)palladium(0) (300 mg, 0.26 mmol) was added, in one 
portion, to a magnetically stirred solution of compound 206 (860 mg, 2.68 mmol) and 
compound 207 (1.15 g, 3.22 mmol) in 1,4-dioxane (50 mL) under a nitrogen 
atmosphere at 60 °C for 8 h. The resulting dark-brown reaction mixture was cooled, 
then diluted with water (100 mL) and EtOAc (200 mL). The separated aqueous phase 
was extracted with EtOAc (2 x 100 mL) and the combined organic phases were then 
dried (MgSÜ4), filtered and concentrated under reduced pressure to give a black solid. 
This material was treated with dry pyridine (20 mL) and acetic anhydride (5 mL, 53 
mmol) and the resulting reaction mixture stirred at 18 °C for 16 h, then concentrated 
under reduced pressure. The residue was subjected to high vacuum (10~3 Torr) for 1 h 
then to flash chromatography (1:1 hexane/Et20 elution). Concentration of the 
appropriate fractions (R/0.3) then gave a white solid. Recrystallization (hexane/Et20) 
of this material afforded compound 209 (1.10 g, 74% from 206) as colourless prisms, 
m.p. 204-206 °C.
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*H NMR (300 MHz) 5: 6.18 (2H, d, J = 3.0 Hz), 5.72 (2H, d, J = 3.0 Hz), 4.89 
(2H, dd, J = 4.7 and 3.0 Hz), 2.49 (2H, dd, J  = 12.5 and 3.0 Hz), 2.10 (2H, partially 
obscured dd), 2.09 (6H, s), 2.07 (6H, s).
!3C NMR (75.4 MHz) 8: 170.9 (2xC), 168.8 (2xC), 138.5 (2xC), 124.8 (2xCH), 
68.9 (2xCH), 65.9 (2xC), 64.3 (2xCH), 30.8 (2xCH or 2xCH3), 30.4 (2xCH or 
2xCH3), 21.2 (2xCH or 2xCH3), 21.0 (2xCH or 2xCH3).
IRVmax 1745 ,1 7 4 0 , 1370 , 1245 , 1220 , 7 7 0  c m -'.
EIMS (70eV) m/z 558, 556, 554 (M +\ 0.3, 0.5, 0.1), 454 (10), 412 (26), 394 (18), 
376 (30), 351 (28), 334(100).
Elemental Analysis Found: C, 47.46; H, 3.80; Cl, 25.50.; C22H22CI4O8 requires: 
C, 47.51; H, 3.99; Cl, 25.50%.
Optical Rotation [ a ]D20 - 235.0 0 (c 1.5, CHC13).
B is -Acetonide (204).
Cl
2. 2,2-dimethoxypropane 
p-toluenesulfonic acid
209
Potassium carbonate (835 mg, 6.04 mmol) was added, in one portion, to a 
magnetically stirred solution of compound 209 (50 mg, 0.091 mmol) in MeOH (5 mL) 
maintained at 18 °C under a nitrogen atmosphere. The reaction mixture was heated at 
reflux for 16 h then concentrated under reduced pressure and the residue partitioned 
between EtOAc (15 mL) and water (5 mL). The separated aqueous phase was extracted 
with EtOAc ( 2 x 1 0  mL) and the combined organic phases were dried (MgSOzO, filtered 
and concentrated under reduced pressure to give compound 208 (30 mg, 88%) as a
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clear, colourless oil. This intractable material was used, without purification, in the next 
step of the reaction sequence.
/?-Toluenesulfonic acid monohydrate (20 mg, 0.08 mmol) was added, in one portion, 
to a magnetically stirred solution of compound 208 (30 mg, 0.13 mmol) in 2,2- 
dimethoxypropane (1 mL, 8.1 mmol) maintained at ca. -10 °C (salt-ice bath) under a 
nitrogen atmosphere. After 0.5 h the reaction mixture was diluted with triethylamine 
(0.5 mL) and concentrated under reduced pressure. The residue was partitioned 
between Et2Ü (10 mL) and water (3 mL) and the separated aqueous phase was extracted 
with Et20 (2 x 10 mL). The combined organic phases were then dried (MgSC>4), 
filtered and concentrated under reduced pressure to give compound 204 (34 mg, 98%) 
as a white solid, m.p. 209-210 °C. The spectral data obtained on this material were 
identical, in all respects, with those derived from an authentic sample of compound 204 
produced under the conditions defined earlier (see page 171).
Tetra -Acetate (210).
ci
1. NaI04
2. NaBH4
3. AC2O, pyridine
Cl
A solution of sodium metaperiodate (83 mg, 0.39 mmol) in THF/water (2 mL of a 
1:1 v/v mixture) was added, dropwise, to a magnetically stirred mixture of compound 
208 (50 mg, 0.13 mmol) in THF/water (2 mL of a 1:1 v/v mixture) maintained at 5 °C 
(ice-bath). After 1 h the reaction mixture was diluted with water (2 mL) and Et2Ü (20 
mL) and the separated aqueous phase was extracted with EtOAc ( 2 x 1 0  mL). The 
combined organic phases were then dried (MgS(>4), filtered and concentrated under
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reduced pressure to give a clear, colourless oil (40 mg, 80%). This material was used, 
without purification, in the next step of the reaction sequence.
Sodium borohydride (88 mg, 2.28 mmol) was added, in small portions, to a 
magnetically stirred solution of the material obtained as described above (40 mg, 0.10 
mmol) in THF/MeOH (2 mL of a 10:1 v/v mixture) maintained at 5 °C (ice-bath) under 
a nitrogen atmosphere. After stirring at 18 °C for 8 h, the reaction mixture was 
quenched with water (10 mL) and EtOAc (20 mL). The separated aqueous phase was 
extracted with EtOAc ( 2 x 1 0  mL), and the combined organic phases were then dried 
(MgSÜ4), filtered and concentrated under reduced pressure to give a clear, colourless 
oil. The residue was treated with dry pyridine (8 mL) and acetic anhydride (4 mL, 16.8 
mmol) and the reaction mixture stirred at 18 °C. After 16 h the reaction mixture was 
concentrated under reduced pressure. The residue was subjected to high vacuum (10-3 
Torr) for 1 h then to flash chromatography (2:1 Et20/hexane elution). Concentration of 
the appropriate fractions (R/0.4) afforded compound 210 (35 mg, 50% from 208) as 
a clear, colourless oil.
*H NMR (300 MHz) 6: 6.15 (1H, d, J = 3.1 Hz), 5.73 (1H, d, J = 3.1 Hz), 5.60 
(1H, d, J  = 14.0 Hz), 4.98-4.92 (2H, m), 4.83 (1H, d, J  = 12.2 Hz), 4.20 (1H, dd, J 
= 7.8 and 7.2 Hz), 4.07 (1H, dd, J = 7.8 and 7.2 Hz), 2.72-2.67 (1H, m), 2.52 (1H, 
dd, J = 10.5 and 3.1 Hz), 2.26 (1H, ddd, J = 7.8, 7.2 and 7.2 Hz), 2.15-2.10 (1H, 
m), 2.08 (6H, s), 2.05 (6H, s).
13C NMR (75.4 MHz) 5: 171.1 (C), 170.8 (C), 170.6 (C), 169.9 (C), 140.1 (C), 
138.6 (C), 124.7 (CH), 124.4 (CH), 68.8 (CH), 66.1 (C), 64.5 (CH), 64.1 (C), 60.8 
(CH2), 60.2 (CH2), 33.9 (CH), 31.9 (CH), 30.8 (CH), 30.4 (CH), 21.2 (CH3), 21.1 
(CH3), 21.0 (CH3), 20.9 (CH3).
IR vmax 2980 ,1780, 1370, 1245, 1220, 770 cm*1.
EIMS (70eV) m/z 558, 556 (M +\ 0.2, 0.2), 523, 521 [(M-Cl-)+, 0.4, 0.4], 396 (9), 
359 (60), 299 (100), 281 (78), 263 (64).
HRMS Found M + \ 556.0248. C22H2435C140 8 requires M + \ 556.0225.
Optical Rotation [a ]D20 - 75.0 0 (c 1.0, CHC13).
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Tetra -Acetate (211).
Cl
"OAc 1. K2C 0 3
2. NaI04
3. NaBH4
4. Ac20 , pyridine
Cl
Potassium carbonate (200 mg, 1.50 mmol) was added to a magnetically stirred 
solution of compound 210 (16 mg, 0.085 mmol) in anhydrous MeOH (3 mL) 
maintained at 18 °C under a nitrogen atmosphere. The resulting mixture was heated at 
reflux for 16 h then cooled and concentrated under reduced pressure. The residue was 
partitioned between EtOAc (20 mL) and water (5 mL) and the separated aqueous phase 
was extracted with EtOAc (2 x 20 mL). The combined organic phases were then dried 
(M gSÜ 4), filtered and concentrated under reduced pressure to provide a clear, 
colourless oil (28 mg, 85%). This material was used, without purification, in the next 
step of the reaction sequence.
A solution of sodium metaperiodate (83 mg, 0.39 mmol) in THF/water (2 mL of a 
1:1 v/v mixture) was added to a magnetically stirred solution of the material obtained as 
described immediately above (14 mg, 0.04 mmol) in THF/water (2 mL, 1:1) maintained 
at 5 °C (ice-bath). After 1 h the reaction mixture was diluted with water (2 mL) and 
Et20 (20 mL) and the separated aqueous phase was extracted with EtOAc ( 2 x 1 0  mL). 
The combined organic phases were then dried (MgS0 4 ), filtered and concentrated under 
reduced pressure to give a clear, colourless oil (10 mg, 72%). This material was used, 
without purification, in the next step of the reaction sequence.
Sodium borohydride (10 mg, 0.25 mmol) was added, in small portions, to a 
magnetically stirred solution of the material obtained as described immediately above 
(10 mg, 0.03 mmol) in THF/MeOH (1 mL of a 10:1 v/v mixture) maintained at 5 °C 
(ice-bath) under a nitrogen atmosphere. After stirring at 18 °C for 8 h, the reaction
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mixture was quenched with water (10 mL) and EtOAc (20 mL) and the separated 
aqueous phase was extracted with EtOAc ( 2 x 1 0  mL). The combined organic phases 
were then dried (MgS0 4 ), filtered and concentrated under reduced pressure to give a 
clear, colourless oil. The residue thus obtained was treated with dry pyridine (10 mL) 
and acetic anhydride (5 mL, 21 mmol) and the resulting mixture stirred at 18 °C. After 
16 h the reaction mixture was concentrated under reduced pressure, and the residue was 
subjected to high vacuum (10‘3 Torr) for 1 h then to flash chromatography (2:1 
Et20/hexane elution). Concentration of the appropriate fractions (Rf 0.4) then gave 
compound 211 (10 mg, 60% from 210) as a clear, colourless oil.
*H NMR (300 MHz) 8: 5.59 (2H, d, J = 7.8 Hz), 4.86 (4H, s), 4.14 (4H, d, J  = 7.5 
Hz), 2.75 (2H, dd, J  = 7.8 and 1.6 Hz), 2.29 (2H, ddd, J  = 7.8, 7.5 and 7.3 Hz),
2.09 (6H, s), 2.06 (6H, s).
13C NMR (75.4 MHz) 5: 171.0 (2xC), 170.9 (2xC), 139.7 (2xC), 124.9 (2xCH), 
64.3 (2xC), 60.9 (2xCH2), 60.5 (2xCH2), 33.7 (2xCH), 31.8 (2xCH), 21.9 
(2xCH3), 21.8 (2xCH3).
IR vmax 2958 ,1741, 1442, 1228, 1036, 818 cm '1.
EIMS (70eV) m/z 524, 522 (4, 6), 499 [(M-C2H30 2 )+, 21, 33], 362 (62), 264 (80). 
CIMS (70eV) m/z 578 [(M+NH4)+, 100].
HRMS Found (M-C2H30 2 )+, 501.0235. C22H2635Cl337C10g requires (M- 
C2H30 2T ,  501.0219. Found (M-C2H30 2 )+, 499.0256. C22H2635C140 8 requires 
(M-C2H30 2 )+, 499.0248.
Optical Rotation [a ]D20 - 99.0 ° (c 1.2, CHC13).
General Procedure for the Extraction of (lS ,2R )-cis-3-Iodo-5-m ethyl- 
3,5-cyclohexadiene-l,2-diol (16) from the Fermentation Broth Supplied 
by Genencor International Inc.
Celite™ (ca. 200 g) and cellulose powder (ca. 200 g) were added to the fermentation 
broth containing compound 16 (ca. 5 litres). The resulting mixture was stirred at 18 °C 
for 0.5 h, then filtered. The filtrate was concentrated under reduced pressure (water
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bath temperature less than 40 °C) to ca. 750 mL then diluted with EtOAc (1.5 litres). 
The separated aqueous layer was extracted with EtOAc (4 x 500 mL), and the combined 
organic phases were washed with water (1 x 200 mL) before being dried (MgS0 4 ), 
filtered and concentrated under reduced pressure to afford a pale-yellow solid (64 g) 
which was comprised primarily of the title compound 16.
(3a/?,5a/?,6a5,6b5)-6,6-Dichloro-4-iodo-2,2,6a-trimethyI-3a,5a,6a,6b-  
tetrahydro-5a//-cycIopropa[e]-l,3-benzodioxole (216).
H O  O H
2,2 -d im ethoxypropane 
/7-toluenesulfonic acid
0  0
CH CI3, N aO H  
T E B A C
o X
~ C I  / O '
16 217
C l H 
216
p-Toluenesulfonic acid monohydrate (210 mg, 1.6 mmol) was added, in one portion, 
to a magnetically stirred solution of (15,2,S)-a'5-3-iodo-5-methyl-3,5-cyclohexadiene- 
1,2-diol (16) (2.0 g, 8.0 mmol) in 2,2-dimethoxypropane (5 mL, 41 mmol) maintained 
at ca. -10 °C (salt-ice bath) under a nitrogen atmosphere. After 0.5 h the reaction 
mixture was diluted with triethylamine (1.0 mL) then concentrated under reduced 
pressure. The residue was partitioned between Et2Ü (100 mL) and water (50 mL), and 
the separated aqueous phase extracted with Et2Ü (2 x 50 mL). The combined organic 
phases were then dried (MgS0 4 ), filtered and concentrated under reduced pressure to 
provide compound 217 (2.04 g, 97%) as a pale-orange oil. This material was used, 
without purification, in the next step of the reaction sequence.
Sodium hydroxide (13.7 mL of a 50% w/w aqueous solution, 0.17 mol) was added, 
dropwise, to a magnetically stirred solution of compound 217 (3.09 g, 10.5 mmol) 
and benzyltriethylammonium chloride (50 mg, 0.22 mmol) in CHCI3 (14.3 mL, 180 
mmol) maintained at 5 °C (ice-bath). The resulting dark-brown reaction mixture was 
stirred vigorously at 18 °C for 16 h then diluted with CHCI3 (200 mL) and water (100 
mL). The separated aqueous phase was extracted with CH2CI2 (3 x 100 mL) and the
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combined organic phases were then dried (MgSOzO, filtered and concentrated under 
reduced pressure. The material obtained in this way was subjected to flash 
chromatography (20:1 hexane/Et20 elution) which afforded, after concentration of the 
appropriate fractions (Rf 0.4) a white solid. Recrystallization (hexane) of this material 
then gave compound 216 (3.0 g, 77%) as colourless needles, m.p. 49-50 °C.
!H NMR (300 MHz) 8: 6.64 (1H, d, J  = 7.0 Hz), 4.44 (1H, d, J  = 7.2 Hz), 4.35 
(1H, d, J  = 7.2 Hz), 1.85 (1H, d, J  = 7.0 Hz), 1.54 (3H, s), 1.43 (s, 3H), 1.40 (3H, 
s).
13C NMR (75.4 MHz) 8: 132.6 (CH), 109.5 (C), 103.0 (C), 77.4 (CH), 73.7 (CH), 
69.2 (C), 37.0 (CH or CH3), 30.0 (C), 27.9 (CH or CH3), 26.4 (CH or CH3), 20.0 
(CH or CH3).
IR vmax 2985 ,2930, 2853, 2360, 1538, 1455, 1374, 1235, 1162, 1021, 918, 877 
cm-1.
EIMS (70eV) m /z 376, 374 (M+\ 52), 361, 359 [(M-H3G )+, 23, 15], 339 (8), 316 
(28), 281 (53), 189 (100), 125 (95).
Elemental Analysis Found: C, 35.32; H, 3.31; Cl, 18.69; I, 33.75.; C n H i3Cl2l02 
requires: C, 35.23; H, 3.49; Cl, 18.91; I, 33.84%.
Optical Rotation [a]D20 - 0.95 ° (c 1.0, CHC13).
Ester (218).
methyl acrylate, Et4NH4Cl 
PPh3, K2C03, Pd(OAc)2
Cl H
216 218
Methyl acrylate (73 jllI, 0.80 mmol) was added, dropwise, to a magnetically stirred 
mixture of compound 216 (250 mg, 0.67 mmol), palladium acetate (21 mg, 0.094 
mmol), triphenylphosphine (38 mg, 0.15 mmol), potassium carbonate (185 mg, 1.34
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mmol) and tetraethylammonium chloride (117 mg, 0.71 mmol) in dry DMF (4 mL) 
maintained at 18 °C under a nitrogen atmosphere. The reaction mixture was then heated 
at 75 °C for 16 h, cooled and diluted with water (20 mL) and Et2Ü (100 mL). The 
separated aqueous phase was extracted with EtOAc ( 2 x 1 0  mL) and the combined 
organic phases were then dried (MgSC>4), filtered and concentrated under reduced 
pressure to give a pale-yellow oil. This material was subjected to flash chromatography 
(2:1 hexane/Et20 elution) which afforded, after concentration of the appropriate 
fractions (Ry0.5) a white solid. Recrystallization (hexane) of this material then gave 
compound 218 (174 mg, 78%) as colourless needles, m.p. 69-70 °C.
*H NMR (300 MHz) 5: 7.22 (1H, d, J  = 16.0 Hz), 6.30 (1H, d, J = 16.0 Hz), 6.28 
(1H, d, J = 6.6 Hz), 4.64 (1H, d, J = 6.8 Hz), 4.48 (1H, d, J = 6.8 Hz), 3.76 (3H, 
s), 2.04 (1H, d, J = 6.6 Hz), 1.57 (3H, s), 1.39 (3H, s), 1.29 (3H, s).
13C NMR (75.4 MHz) 5: 168.0 (C), 143.7 (CH), 135.0 (C), 130.2 (CH), 120.5 
(CH), 109.4 (C), 73.3 (CH), 72.1 (CH), 51.9 (CH3), 44.8 (C), 34.9 (CH or CH3), 
31.4 (C), 27.7 (CH or CH3), 26.2 (CH or CH3), 19.6 (CH or CH3).
IR vmax 2995 , 1705, 1635, 1295, 1235, 1055 cm '1.
EIMS (70eV) m/z 334, 332 (M +\ 5, 3), 319, 317 [(M-H3C-)+, 10, 7], 300 (8), 274 
{[M-(CH3)2C O ]+\ 39}, 239 (84), 214 (82), 179 (100).
Elemental Analysis Found: C, 53.75; H, 5.40; Cl, 21.29.; C15H18CI2O4 requires: 
C, 54.07; H, 5.44; Cl, 21.28%.
Optical Rotation [oc]d20 + 32.3 0 (c 1.0, CHC13).
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ß/s-Cyclopropanes (219 and 220).
r
<
218
oX
/ /
T~ C02Me
H
219 (syn) 
+
O ^p
/ /
C1 H
V
C02Me
220 (anti)
A magnetically stirred solution of compound 218 (29 mg, 0.09 mmol) and palladium 
acetate (3 mg, 0.01 mmol) in dry CH2 CI2 (1 mL) maintained at 5 °C (ice-bath) was 
treated with an ethereal solution of diazomethane (excess). After 1 h the by now dark- 
brown reaction mixture was filtered through a short pad of TLC-grade silica gel. The 
filtrate was concentrated under reduced pressure to give a pale-yellow oil and this 
material was subjected to flash chromatography (2:1 hexane/Et20). Concentration of the 
appropriate fractions (R/0.5) gave a ca. 2.3:1 mixture (as determined by GC analysis) 
of compounds 219 and 220 (27 mg, 86%) as a clear, colourless oil.
*H NMR (300 MHz) 6: 5.61 (1H, d, J  = 6.1 Hz), 4.41 (1H, d, J  = 6.6 Hz), 4.36 
(1H, d, J  = 6.6 Hz), 3.68 (3H, s, minor), 3.69 (3H, s, major), 2.24-2.19 (1H, m), 
2.19-2.09 (1H, m), 1.86 (1H, d, J = 6.1 Hz), 1.60-1.53 (1H, m), 1.53 (3H, s), 1.37 
(6H, s), 1.28-1.21 (2H, m), 1.05-0.96 (1H, m, minor).
13C NMR (75.4 MHz) 5: 174.2 (C), 137.4 (C), 116.5 (CH), 116.2 (CH), 109.2 (C), 
74.6 (CH), 74.4 (CH), 73.2 (CH), 73.1 (CH), 52.2 (CH3), 33.7 (CH or CH3), 29.7 
(C), 29.6 (CH or CH3), 27.9 (CH or CH3), 27.9 (CH or CH3), 26.4 (CH or CH3), 
26.3 (CH or CH3), 24.5 (CH or CH3), 24.3 (CH or CH3), 22.2 (CH or CH3), 21.4 
(CH or CH3), 19.5 (CH or CH3), 19.4 (C), 15.5 (C), 15.4 (C).
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IRVmax 2987 ,2935, 1730, 1438, 1381, 1370, 1056 c n r 1.
EIMS (70eV) m/z 348, 346 (M + \ 0.5, 0.7), 333, 331 [(M -H3C-)+, 1.7, 2.5], 253 
(100), 193 (50), 165 (58), 129 (49).
HRMS Found M + \ 348.0694 C i6H 2o35Cl37C104 requires M +', 348.0709. Found 
M + \ 346.0736 C i6H 2035Cl2O4 requires M + \ 346.0738.
Optical Rotation [ a ]D20 - 42.4 ° (c 1.7, CHCI3).
Ester (215).
(£,E)-2,4-Pentadienoic acid173 (20 mg, 0.20 mmol), palladium acetate (5 mg, 0.024 
mmol), triphenylphosphine (9 mg, 0.033 mmol), potassium carbonate (44 mg, 0.31 
mmol) and tetraethylam m onium  chloride (28 mg, 0.17 mmol) were added, in that 
order, to a magnetically stirred solution of compound 216 (60 mg, 0.16 mmol) in dry 
DMF (1 mL) maintained at 18 °C under a nitrogen atmosphere. The resulting mixture 
was heated at 75 °C for 16 h then cooled and diluted with water (3 mL) and sufficient 
HC1 (3% of an aqueous solution) to attain pH of ca. 5-6. The mixture was then 
extracted with Et20  (2 x 30 mL) and the combined organic phases were washed with 
sodium diethyldithiocarbamate (1 x 10 mL of a 1% aqueous solution), dried (M gS04) 
and concentrated under reduced pressure to give a brown oil. The crude acid thus 
obtained was dissolved in CH2C12 (1 mL) and the resulting solution cooled to 0 °C (ice- 
salt bath) and treated with an ethereal solution of diazomethane (excess). After stirring 
for 1 h the dark-brown reaction mixture was filtered through a short pad of TLC-grade 
silica gel and the filtrate concentrated under reduced pressure to give a pale-yellow oil. 
This material was subjected to flash chromatography (2:1 Et20/hexane elution) which
216
2. CH2N2
215
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afforded, after concentration of the appropriate fractions (Ry 0.5), compound 215 (26 
mg, 45% from 216) as a clear, colourless oil.
*H NMR (300 MHz) 5: 7.30 (1H, dd, J = 15.0, 3.5 Hz), 6.68 (1H, dd, J = 15.0, 3.5 
Hz), 6.45 (1H, d, J = 15.0 Hz), 6.11 (1H, d, J = 6.3 Hz), 5.93 (1H, d, J = 15.0 Hz), 
4.66 (1H, d, J = 6.4 Hz), 4.49 (1H, d, J = 6.4 Hz), 3.74 (3H, s), 2.01 (1H, d, J =
6.3 Hz), 1.57 (3H, s), 1.40 (3H, s), 1.30 (3H, s).
13C NMR (75.4 MHz) 6: 167.8 (C), 145.6 (CH), 139.8 (CH), 136.0 (C), 129.0 
(CH), 126.4 (CH), 121.3 (CH), 109.3 (C), 73.4 (CH), 72.3 (CH), 70.8 (C), 51.8 
(CH3), 35.0 (CH or CH3), 31.1 (C), 27.7 (CH or CH3), 26.2 (CH or CH3), 19.6 
(CH or CH3).
IRVmax 2995 ,1715 ,1610, 1245, 1140, 1055 cm'1.
EIMS (70eV) m/z 360, 358 (M+\ 14, 12), 345, 343 [(M-H3C-)+, 7, 4], 299 [(M- 
C2H30 2 )+, 29], 284 (37), 265 [(M-C6H70 2-)+, 70], 239 (57), 205 (90), 177 (100). 
HRMS Found M+‘, 360.0708 C i7H2o33C137C104 requires M+', 360.0709. Found 
M+\ 358.0737 C i7H2035C12O4 requires M+\ 358.0738.
Optical Rotation [oc]d 20 + 49.6 ° (c 2.6, CHC13).
Alcohol (221).
A solution of (£)-tri-«-butyl-l-propen-3-ol stannane176 (6.56 g, 18.9 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (400 mg, 0.344 mmol) in dry THF (5 mL) 
was added, dropwise, to a magnetically stirred solution of compound 216 (1.26 g, 
3.37 mmol) in dry THF (10 mL) maintained at 18 °C under a nitrogen atmosphere. The 
reaction mixture was heated at 50 °C for 16 h then cooled and diluted with water (200
H H
216 221
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mL) and Et2Ü (400 mL). The separated organic phase was dried (MgS04), filtered and 
concentrated under reduced pressure to give a pale-yellow oil which was subjected to 
flash chromatography (2:1 Et20/hexane elution). Concentration of the appropriate 
fractions (R/0.4) then gave compound 221 (756 mg, 74%) as a clear, colourless oil. 
*H NMR (300 MHz) 8: 6.17 (2H, s), 5.93 (1H, d, J = 6.3 Hz), 4.61 (1H, d, J = 6.7 
Hz), 4.47 (1H, d, J = 6.7 Hz), 4.20 (2H, s), 1.96 (1H, d, J = 6.3 Hz), 1.75 (1H, bs), 
1.54 (3H, s), 1.39 (3H, s), 1.33 (3H, s).
13C NMR (75.4 MHz) 8: 135.5 (C), 131.0 (CH), 129.9 (CH), 122.2 (CH), 109.1 
(C), 73.3 (CH), 72.4 (CH), 70.8 (C), 64.0 (CH2), 34.6 (CH or CH3), 30.3 (C), 27.6 
(CH or CH3), 26.0 (CH or CH3), 19.5 (CH or CH3).
IR vmax 3458 (b), 2983, 2932, 2872, 1380, 1372, 1237, 1022 cm'1.
EIMS (70eV) mJz 291, 289 [(M-H3C-)+, 3, 2], 248, 246 [(M-C3H60)+ , 13], 215 
(100), 193 (22), 139 (56).
HRMS Found (M-H3C-)+, 289.0398 C i4H i835C120 3 requires (M-H3C)+,
289.0398.
Optical Rotation [oc] d 20 - 1.47 ° (c 1.7, CHC13).
Aldehyde (222).
TPAP, NMO
4Ä molecular sieves q
A solution of 4-methylmorpholine V-oxide (278 mg, 2.28 mmol) in dry CH2CI2 (2 
mL) was added, dropwise, to a magnetically stirred mixture of compound 221 (361 
mg, 1.19 mmol), 4Ä molecular sieves (760 mg) and terra-Zso-propylammonium 
perruthenate (VII) (27 mg, 0.07 mmol) in dry CH2 CI2 (4 mL) maintained at 18 °C. 
After 2 h the reaction mixture was diluted with CH2CI2 (5 mL) then filtered through a
189
Chapter Six
short pad of TLC-grade silica gel. The filtrate was concentrated under reduced pressure 
and the residue subjected to flash chromatography (2:1 hexane/Et20 elution). 
Concentration of the appropriate fractions (R/0.4) then gave compound 222 (263 mg, 
74%) as a clear, colourless oil.
*H NMR (300 MHz) 5: 9.54 (1H, d, J  = 7.7 Hz), 7.00 (1H, d, J  = 15.9 Hz), 6.54 
(1H, dd, J  = 15.9 and 7.7 Hz), 6.40 (1H, d, J  = 6.2 Hz), 4.65 (1H, d, J  = 6.8 Hz), 
4.50 (1H, d, J  =  6.8 Hz), 2.09 (1H, d, J  = 6.2 Hz), 1.58 (3H, s), 1.37 (3H, s), 1.28 
(3H, s).
13C NMR (75.4 MHz) 5: 194.6 (CH), 151.3 (CH), 135.2 (C), 131.7 (CH), 131.3 
(CH), 109.6 (C), 73.2 (CH), 72.0 (CH), 70.4 (C), 35.1 (CH or CH3), 31.6 (C), 27.7 
(CH or CH3), 26.0 (CH or CH3), 19.5 (CH or CH3).
IR vmax 2981, 2897, 1672, 1634, 1605, 1258 cm '1.
EIMS (70eV) m /z  289, 287 [(M-H3C-)+, 6, 9], 246, 244 [(M-C3H60 )+ , 21], 215 
(100), 181 (73), 145 (75), 115 (64).
HRMS Found (M-H3C)+, 289.0218 C ]4H i635C137C103 requires (M-H3C-)+, 
289.0212. Found (M-H3C )+, 287.0246 Ci4Hi635C l203 requires (M-H3C ) +, 
287.0241.
Optical Rotation [oc]d20 - 4.0 ° (c 3.0, CHC13).
Ester (215).
Trimethyl phosphonoacetate (213 |iL, 1.32 mmol) was added, dropwise, to a 
magnetically stirred suspension of sodium hydride (54 mg of a 60% dispersion in 
mineral oil, 1.34 mmol) (which was freed of oil by washing several times in anhydrous
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hexane) in dry THF (8 mL) maintained at 5 °C (ice-bath) under a nitrogen atmosphere. 
After stirring the resulting mixture for 0.3 h a solution of compound 222 (265 mg, 
0.88 mmol) in dry THF (2 mL) was added dropwise. The reaction mixture was then 
stirred at 18 °C for 2 h then diluted with water (20 mL) and Et20 (100 mL). The 
separated aqueous phase was extracted with Et2 Ü (1 x 100 mL) and the combined 
organic phases were then dried (MgSOzO, filtered and concentrated under reduced 
pressure. The material obtained in this way was subjected to flash chromatography (2:1 
Et20/hexane elution) which afforded, after concentration of the appropriate fractions (Ry 
0.5), compound 215 (261 mg, 83%) as a clear, colourless oil. The spectral data 
obtained on this material were identical, in all respects, with those derived from an 
authentic sample of compound 215 produced under the conditions defined earlier (see 
page 187).
Tri-C yclopropanes (223-224).
A magnetically stirred solution of compound 215 (26 mg, 0.07 mmol) and palladium 
acetate (3 mg, 0.01 mmol) in dry CH2 CI2 (1 mL) maintained at 5 °C (ice-bath) was 
treated with an ethereal solution of diazomethane (excess). After 1 h the dark-brown 
reaction mixture was filtered through a short pad of TLC-grade silica gel and the filtrate 
was then concentrated under reduced pressure to give a pale-yellow oil. This material 
was subjected to flash chromatography (2:1 hexane/Et20 elution) which afforded, after 
concentration of the appropriate fractions (Ry0.5), a ca. 4:3:1:1 mixture (as determined 
by GC analysis) of compounds 223-226 (27 mg, 86%) as a clear, colourless oil.
215 223 (A=syn, B =syn)
224 (A=syn, B =anti)
225 (A=anti, B=sy/i)
226 (A=anti, B=anti)
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Subjection of this material to semi-preparative HPLC (p-Porosil™ column, 10:1 
hexane:tert-buty\ methyl ether elution, flow rate = 2 mL/min) afforded two fractions, A 
and B.
Concentration of fraction A (Rt 13.5 min) yielded a mixture of three diastereomers 
of compounds 223-226 (14 mg, 54%), which was used in the next step of the reaction 
sequence without further purification.
Concentration of fraction B (Rt 15.3 min) yielded one of the single diastereomers 
223-226 (5 mg, 19%).
*H NMR (300 MHz) 5: 5.42 (1H, d, J = 6.3 Hz), 4.42 (1H, d, J = 6.6 Hz), 4.39 
(1H, d, J = 6.6 Hz), 3.66 (3H, s), 1.83 (1H, d, J = 6.3 Hz), 1.56 (3H, s), 1.55-1.32 
(3H, m), 1.39 (6H, s), 1.12-1.06 (2H, m), 0.77-0.71 (1H, m), 0.56-0.50 (2H, m). 
13C NMR (75.4 MHz) 5: 174.4 (C), 139.8 (C), 113.5 (CH), 109.0 (C), 75.0 (CH), 
73.2 (CH), 70.6 (C), 52.0 (CH3), 33.8 (CH or CH3), 29.4 (C), 28.0 (CH or CH3), 
26.4 (CH or CH3), 24.4 (CH or CH3), 21.7 (CH or CH3), 19.9 (CH or CH3), 19.5 
(CH or CH3), 19.4 (CH or CH3), 13.5 (CH2), 11.5 (CH2).
IRVmax 2996, 1729, 1437, 1401, 1208, 1170 cm '1.
EIMS (70eV) m/z 388, 386 (M+\ 1.0, 1.3), 373, 371 [(M-H3C-)+, 3.5, 5.6], 293 
(85), 215 (96), 167 (72), 139 (100).
HRMS Found M +\ 388.1028 C i9H2435ci37C104 requires M + \ 388.1022. Found 
(M )+\ 386.1057 C i9H2435C120 4 requires (M )+\ 386.1051.
Optical Rotation [oc]d 20 + 69.1 ° (c 0.5, CHC13).
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7/7-Cyclopropanes (213 and 234-236).
C 02Me 1. AcOH, H2Q
2. NaI04
3. NaBH4
4. Ac20 , pyridine
223 (A=syn, B=syn)
224 (A=syn, B=anti)
225 (A=anti, B=^yn)
226 (A=anti, B=anti)
213 (A=syn, B=syn)
234 (A=syn, B =anti)
235 (A=anti, B =syn)
236 (A=anti, B=anti)
A magnetically stirred solution (ca . 4:3:3:1 mixture) of compounds 223-226 (11 
mg, 0.028 mmol) in acetic acid (3 mL of a 60% aqueous solution) was heated at 80 °C 
for 16 h. The cooled reaction mixture was then diluted with water (5 mL) and EtOAc 
(10 mL) and the separated aqueous phase was extracted with EtOAc (2 x 10 mL). The 
combined organic phases were then dried (MgSÜ4), filtered and concentrated under 
reduced pressure to afford a pale-yellow oil (8 mg, 83%). This material was used, 
without purification, in the next step of the reaction sequence.
A solution of sodium metaperiodate (20 mg, 0.09 mmol) in THF/water (1 mL of a 
1:1 v/v mixture) was added, dropwise, to a magnetically stirred solution of the material 
obtained as described immediately above (8 mg, 0.023 mmol) in THF/water (1 mL of a 
1:1 v/v mixture) maintained at 5 °C (ice-bath). After 1 h the reaction mixture was diluted 
with water (2 mL) and Et2Ü (20 mL). The separated aqueous phase was extracted with 
EtOAc ( 2 x 1 0  mL), and the combined organic phases were then dried (MgSÜ4), 
filtered and concentrated under reduced pressure to provide a clear, colourless oil (7.5 
mg, 95%). This material was used, without purification, in the next step of the reaction 
sequence.
Sodium borohydride (10 mg, 0.25 mmol) was added, in small portions, to a 
magnetically stirred solution of the material obtained as described immediately above (5 
mg, 0.015 mmol) in THF/MeOH (1 mL of a 10:1 v/v mixture) maintained at 5 °C (ice- 
bath) under a nitrogen atmosphere. After stirring at 18 °C for 8 h, the reaction mixture 
was diluted with water (10 mL) and EtOAc (20 mL). The separated aqueous phase was
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extracted with EtOAc ( 2 x 1 0  mL), and the combined organic phases were then dried 
(M g S 0 4), filtered and concentrated under reduced pressure to provide a clear, 
colourless oil. The residue thus obtained was treated with dry pyridine (10 mL) and 
acetic anhydride (2.5 mL, 10 mmol) and the resulting mixture stirred at 18 °C for 16 h, 
then concentrated under reduced pressure. The residue so produced was subjected to 
high vacuum (10~3 Torr) for 1 h then to flash chromatography (2:1 Et20/hexane) which 
afforded, after concentration of the appropriate fractions (Ry 0.4) compounds 213 and 
234-236 (5 mg, 67% from 223-226) as a clear, colourless oil.
*H NMR (300 MHz) 5: 5.10 (1H, d, J = 7.6 Hz), 4.65-4.58 (2H, m), 4.03-4.01 
(4H, m), 3.67 (3H, s), 2.13 (1H, d, J = 7.6 Hz), 2.11 (3H, s), 2.09 (3H, s), 1.73- 
1.62 (2H, m), 1.47 (3H, s, major), 1.34 (3H, s, minor), 1.26 (3H, s, minor), 1.25- 
1.11 (2H, m), 0.76-0.53 (6H, m).
13C NMR (75.4 MHz) 5: 174.7 (C), 172.8 (C), 171.1 (C), 141.7 (C), 119.4 (CH), 
108.1 (C), 65.5 (CH2), 63.0 (CH2), 52.1 (CH3), 51.9 (CH3), 37.3 (CH or CH3),
33.8 (C), 28.6 (CH or CH3), 27.5 (CH or CH3), 25.7 (CH or CH3), 24.4 (CH or 
CH3), 24.3 (CH or CH3), 24.2 (CH or CH3), 22.7 (CH or CH3), 21.8 (CH or CH3), 
21.7 (CH2), 21.5 (CH or CH3), 21.3 (CH or CH3), 21.2 (CH or CH3), 21.1 (CH or 
CH3), 20.2 (CH or CH3), 19.6 (CH or CH3), 19.2 (CH or CH3), 18.4 (CH or CH3), 
16.3 (CH2), 15.3 (CH or CH3), 14.2 (CH2), 13.5 (CH2), 11.4 (CH2), 10.3 (CH2). 
IRVmax 2990, 1732, 1379, 1230, 1171, 1035 cm-1.
EIMS (70eV) m/z 240 [(M-C6H6C12 )+, 80)], 209 (41), 182 (59), 165 (65), 151 
(76).
HRMS Found (M-C6H6C12 )+ 240.1366 C i9H2635C120 4 requires (M-C6H6C12 )+ 
240.1366.
Optical Rotation [oc]d20 - 34.2 0 (c 1.1, CHC13).
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(3aS,5a,S ,6a/? ,6b/?)-6 ,6-D ichloro-2 ,2 ,6a-tr im ethyl-3a ,5a ,6a ,6b-tetra-  
hydro-5a//-cyclopropa[e]-l,3 -benzodioxole  (237) and 
(3a/? ,5a /? ,6a /? ,6bS)-6 ,6 -D ich loro-2 ,2 ,4 -trim ethyl-3a ,5a ,6a ,6b-tetra-  
h yd ro-5a //-cyclop rop a[e]-l ,3 -b en zod ioxo le  (238).
Sodium hydroxide (4.65 mL of a 50% w/w aqueous solution, 42.2 mmol) was 
added, dropwise, to a magnetically stirred solution of compound 27 (1.65 g, 9.91 
mmol) and benzyltriethylammonium chloride (25 mg, 0.10 mmol) in CHCI3 (5.3 mL, 
9.9 mmol) maintained at 5 °C (ice-bath). The resulting dark-brown reaction mixture was 
stirred vigorously at 18 °C for 16 h then diluted with CHCI3 (100 mL) and water (50 
mL). The separated aqueous phase was extracted with CH2CI2 (3 x 50 mL) and the 
combined organic phases were then dried (MgSCLO, filtered and concentrated under 
reduced pressure to afford a pale-yellow oil. The material obtained this way was 
subjected to flash chromatography (10:1 hexane/Et2 0  elution) which afforded, after 
concentration of the appropriate fractions (Ry0.8), a ca. 1.2:1 mixture (as determined 
by JH NMR analysis) of compounds 237 and 238 (2.0 g, 82%) as a clear, colourless 
oil. The spectral data obtained on this material were identical, in all respects, with those 
previously reported.75 This material was used, without purification, in the next step of 
the reaction sequence.
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( lS ,2 /? ,3 S ,6 S ) -7 ,7 -D ich lo ro - l -m eth y lb icy c lo [4 .1 .0 ]h ep t -4 -en e -2 ,3 -d io l  
(239) and ( lS ,25 ,3 i? ,6 /? ) -7 ,7 -D ich loro-4 -m eth y lb icyc lo [4 .1 .0 ] -h ep t-4 -  
ene-2,3-diol (240).
AcOH, H20
A magnetically stirred solution of compounds 237 and 238 (2.0 g, 8.0 mmol) in 
acetic acid (55 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled 
reaction mixture was then diluted with water (50 mL) and EtOAc (100 mL), and the 
separated aqueous phase was extracted with EtOAc (2 x 100 mL). The combined 
organic phases were then dried (MgSÜ4 ), filtered and concentrated under reduced 
pressure and the residue thus obtained was subjected to flash chromatography (2:1 
Et20/hexane elution) which afforded two fractions, A and B.
Concentration of fraction A afforded, after concentration of the appropriate fractions 
(Rf0.5) a white solid. Recrystallization (Et2 Ü) of this material then gave compound 
239 (610 mg, 36%) as colourless needles, m.p. 116-117 °C (lit.75 m.p. 116-117 °C).
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The spectral data obtained on this material were identical, in all respects, with those 
previously reported.75
Concentration of fraction B afforded, after concentration of the appropriate fractions 
(Rf 0.4) a white solid. Recrystallization (Et20) of this material then gave compound 
240 (462 mg, 27%) as colourless needles, m.p. 95-96 °C (lit.75 m.p. 94-95 °C). The 
spectral data obtained on this material were identical, in all respects, with those 
previously reported.75
(lS ,2/? ,6S)-7 ,7-D ichloro-2-hydroxy-l-m ethylbicyclo[4 .1 .0]hept-4-en-  
3-one (242) and 6-Chloro-2-hydroxy-7-methylcyclohepta-2,4,6-trien-l- 
one (241).
239
O
NMR tube, 12 h HO.Oxalyl chloride, DMSO
Dimethyl sulfoxide (164 pL, 2.3 mmol) was added, dropwise, to a magnetically 
stirred solution of oxalyl chloride (94 pL, 1.08 mmol) in dry CH2CI2 (2 mL) 
maintained at -78 °C (dry-ice/acetone slush bath) under a nitrogen atmosphere. After 0.5 
h, a solution of compound 239 (150 mg, 0.72 mmol) in dry CH2CI2 (2 mL) was 
added dropwise. After a further 1.5 h, triethylamine (319 pL, 2.3 mmol) in dry 
CH2CI2 (2 mL) was added, dropwise, and the reaction mixture was then stirred at -78 
°C for 0.25 h and then at -20 °C for 0.1 h before being quenched with water (8 mL). 
The resulting mixture was poured into Et20 (50 mL) and the separated organic phase 
was washed with KHSO4 (2 x 40 mL of a saturated aqueous solution). The combined 
aqueous layers were extracted with Et20 (1 x 200 m L) then the combined organic 
phases were washed with NaHCC>3 (2 x 20 mL of a saturated aqueous solution), water 
(2 x 20 mL) and NaCl (1 x 20 mL of a saturated aqueous solution) before being dried
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(MgSC>4), filtered and concentrated under reduced pressure. The pale-yellow oil 
obtained this way was subjected to flash chromatography (2:1 Et20/hexane elution) 
which afforded, after concentration of the appropriate fractions (Rj0.5), compound 
242 (156 mg, 65%) as a clear, colourless oil.
*H NMR (300 MHz) 6: 6.88 (1H, dd, J = 10.1, 5.4 Hz), 6.25 (1H, d, J = 10.1 Hz), 
4.40 (1H, s), 2.12 (1H, d, J = 5.4 Hz), 1.53 (3H, s).
IR vmax 3355, 2935, 1670, 1400, 1116 cm'1.
Optical Rotation [a]o20 + 290.0 ° (c 1.1, CHCI3).
Upon standing in an NMR tube for 12 h, compound 242 rearranged to give 
compound 241 as a white solid, m.p. 96-97 °C.
*H NMR (300 MHz) 6: 7.32-7.26 (2H, m), 7.08 (1H, t, J = 11.7 Hz), 6.73 (1H, 
bs), 2.63 (3H, s).
13C NMR (75.4 MHz) 8: 174.2 (C), 165.0 (C), 149.1 (C), 138.6 (C), 132.8 (CH), 
130.6 (CH), 117.4 (CH), 20.6 (CH3).
IR Vmax 3355, 2935, 1670, 1400, 1116 cm'1.
EIMS (70eV) m/z 172, 170 (M+\ 100, 45), 142 [(M-CO)+\ 37], 107 (94), 89 (26), 
77 (51).
HRMS Found M+\ 172.0104. C8H737C102 requires M+\ 172.0105. Found (M)+\ 
170.0133. C8H70 235C1 requires (M)+\ 170.0134.
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(l,S,2/?,6iS)-7 ,7 -DichIoro-4-iodO“2 -h y d r o x y - l -m eth y lb ic y c lo [4 .1 .0 ] -  
hept-4-en-3-one (243).
A solution of iodine (260 mg, 2.05 mmol) in CCU/pyridine (1:1,2 mL) was added, 
dropwise, to a magnetically stirred solution of compound 242 (100 mg, 0.485 mmol) 
in CCVpyridine (1:1,2 mL) maintained at 0 °C (ice-bath) under a nitrogen atmosphere. 
After stirring at 18 °C for 12 h the by now orange-coloured reaction mixture was diluted 
with EtOAc (20 mL) and washed with water ( 2 x 1 0  mL). The separated organic phase 
was washed with HC1 ( 1 x 1 0  mL of a 1M aqueous solution) and Na2S2Ü3 ( 1 x 1 0  mL 
of a saturated aqueous solution) before being dried (MgSÜ4), filtered and concentrated 
under reduced pressure. The material obtained this way was subjected to flash 
chromatography (2:1 Et20/hexane elution) which afforded, after concentration of the 
appropriate fractions (R^0.6), compound 243 (103 mg, 64%) as a clear, colourless 
oil.
NMR (300 MHz) 5: 7.62 (1H, d, J = 5.6 Hz), 4.53 (1H, s), 3.26 (1H, bs), 2.12 
(1H, d, J = 5.6 Hz), 1.54 (3H, s).
13C NMR (75.4 MHz) 5: 190.6 (C), 151.0 (CH), 101.1 (C), 71.7 (C), 70.4 (CH), 
38.8 (CH or CH3), 37.5 (C), 17.5 (CH or CH3).
IR vmax 3388, 1680, 1591, 1114, 1091, 1020 cm-1.
EIMS (70eV) m/z3 6, 334 (M+2H+, 3, 2), 298 (12), 281 (47), 189 (75), 125 
( 100).
HRMS Found (M+2H+), 337.8960 C8H70 2 37Cl2l requires (M+2H+), 337.8965. 
Found (M+2H+), 335.8985 C8H735C137C1I02 requires (M+2H+), 335.8994. Found 
(M+2H+), 333.9015 C8H735C12I 0 2 requires (M+2H+), 333.9024.
Optical Rotation [a ]D20 + 127.5 ° (c 3.2, CHC13).
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(15,2/?,3/?,65)-7 ,7-DichIoro-4-iodo-l-methylbicyclo[4.1 .0]hept-4-ene-  
2,3-diol (244) and ( lS ,2f l ,3S ,6S)-7 ,7-Dichloro-4- iodo- l-methyl-  
bicyclo[4.1.0]hept-4-ene-2,3-diol (245).
243
I
244
I
OH
OH
Reduction o f Compound 243 with Sodium Borohydride at 5 °C.
Sodium borohydride (19.5 mg, 0.52 mmol) was added, in small portions, to a 
magnetically stirred solution of compound 243 (39 mg, 0.12 mmol) and cerium 
trichloride heptahydrate (193 mg, 0.52 mmol) in MeOH/CH2 Cl2 (0.5 mL of a 1:1 v/v 
mixture) maintained at 5 °C (ice-bath) under a nitrogen atmosphere. After stirring at 18 
°C for 8 h, the reaction mixture was quenched with water (10 mL) and EtOAc (20 mL). 
The separated aqueous phase was extracted with EtOAc ( 2 x 1 0  mL), and the combined 
organic phases were then dried (MgSÜ4 ), filtered and concentrated under reduced 
pressure to give a pale-yellow oil. The material obtained this way was subjected to flash 
chromatography (2:1 Et20/hexane elution) which afforded, after concentration of the 
appropriate fractions (R^0.5), a 36:64 mixture (as determined by ]H NMR analysis) of 
compounds 244 and 245 (39 mg, 98%) as a clear, colourless oil. Subjection of this 
material to semi-preparative HPLC (|i-Porasil™ column, 95:5 hexane:isopropanol 
elution, flow rate = 2 mL/min) afforded two fractions, A and B.
Concentration of fraction A (Rr 12.8 min) yielded compound 245 (20 mg, 63%) as a 
clear, colourless oil.
!H NMR (300 MHz) 6: 6.43 (1H, m), 4.10 (1H, d, J  = 8.6 Hz), 4.06 (1H, d, J  =
8.6 Hz), 2.60 (1H, bs), 1.69 (1H, d, J  =  3.6 Hz), 1.61 (1H, bs), 1.44 (3H, s).
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13C NMR (75.4 MHz) 6: 132.3 (CH), 110.3 (C), 72.7 (CH), 71.4 (CH), 43.9 (C), 
39.1 (CH or CH3), 33.0 (C), 17.2 (CH or CH3).
IR Vmax 3385 ,2979, 2938, 1454, 1404, 1249, 1113 c n r 1.
EIMS (70eV) m/z 336, 334 (M+\ 34), 318, 316 [(M-H20 )+ \ 10, 16], 281 (64), 252 
(17), 189 (94), 125 (100).
HRMS Found M +\ 335.8989 C8H935C137C1I02 requires M +\ 335.8994. Found 
M+-, 333.9028 C8H935C12I 0 2 requires M+', 333.9024.
Optical Rotation [cx]d20 + 22.0 0 (c 1.0, CHC13).
Concentration of fraction B (Rt 18.0 min) yielded compound 244 (10 mg, 32%) as a 
clear, colourless oil.
*H NMR (300 MHz) 8: 6.65 (1H, d, J  = 3.6 Hz), 4.35 (1H, d, J = 3.8 Hz), 4.27 
(1H, d, J  = 3.8 Hz), 1.91 (1H, d, J = 3.6 Hz), 1.54 (3H, s), (signals due to two -OH 
protons not observed).
13C NMR (75.4 MHz) (d6 acetone) 8: 135.1 (CH), 103.6 (C), 77.6 (CH), 69.6 
(CH), 40.3 (C), 39.6 (CH or CH3), 31.9 (C), 18.8 (CH or CH3).
IR Vmax 3332 ,2936, 2871, 1455, 1404, 1249, 1113 cm -1.
EIMS (70eV) m/z 336, 334 (M+', 4, 3), 318, 316 [(M-H20 ) + \  16, 24], 281 (57),
252 (19), 189 (90), 125 (100).
HRMS Found M+', 335.8983 C8H935C137C1I0202 requires M +\ 335.8994. Found 
M+-, 333.9015 C8H935C12I02 requires M+', 333.9024.
Optical Rotation [(x]d20 + 54.0 ° (c 1.0, CHC13).
Reduction o f Compound 243 with Sodium Borohydride at - 78 °C.
Sodium borohydride (30 mg, 0.80 mmol) was added, in small portions, to a 
magnetically stirred solution of compound 243 (60 mg, 0.18 mmol) and cerium 
trichloride heptahydrate (297 mg, 0.80 mmol) in MeOH/CH2Cl2 (1.0 mL of a 1:1 v/v 
mixture) maintained at -78 °C (dry-ice/acetone slush bath) under a nitrogen atmosphere. 
After stirring at 18 °C for 8 h, the reaction mixture was quenched with water (10 mL)
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and EtOAc (20 mL) and the separated aqueous phase was extracted with EtOAc (2x10 
mL). The combined organic phases were then dried (MgSCL), filtered and concentrated 
under reduced pressure to give a pale-yellow oil. The material obtained this way was 
subjected to flash chromatography (2:1 Et2Ü/hexane elution) which afforded, after 
concentration of the appropriate fractions (Ry0.5), a 14:86 mixture (as determined by
NMR analysis) of compounds 244 and 245 (26 mg, 94%) as a clear, colourless 
oil.
Reduction of Compound 243 with Zinc Borohydride at -78 °C.
Zinc borohydride (860 pL of a 0.14 M solution in Et20, 0.12 mmol) was added, 
dropwise, to a magnetically stirred solution of compound 243 (40 mg, 0.12 mmol) in 
dry CH2CI2 (0.5 mL) maintained at -78 °C (dry-ice/acetone slush bath) under a nitrogen 
atmosphere. After stirring at -78 °C for 1 h the reaction mixture was quenched with 
water (10 mL) and EtOAc (20 mL), and the separated aqueous phase was extracted with 
EtOAc (2x10 mL). The combined organic phases were then dried (MgS04), filtered 
and concentrated under reduced pressure to give a pale-yellow oil. The material 
obtained this way was subjected to flash chromatography (2:1 Et20/hexane elution) 
which afforded, after concentration of the appropriate fractions (Rf 0.5), a 4:96 mixture 
(as determined by *H NMR analysis) of compounds 244 and 245 (37 mg, 93%) as a 
clear, colourless oil.
Reduction of Compound 243 with Lithium Aluminium Hydride at 0 °C.
A solution of compound 243 (18 mg, 0.053 mmol) in dry THF (0.5 mL) was 
added, dropwise, to a magnetically stirred solution of lithium aluminium hydride (66 
pL of a 1M solution in THF, 0.066 mmol) maintained at 0 °C (ice-bath) under a 
nitrogen atmosphere. The reaction mixture was stirred at 18 °C for 6 h then treated, 
sequentially, with water (1 mL) and sodium hydroxide (1 mL of a 15% aqueous 
solution). The resulting suspension was filtered and the solids thus retained were 
washed successively with Et20 (10 mL) and hot CHCI3 (10 mL). The combined
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filtrates were then dried (MgS0 4 ), filtered and concentrated under reduced pressure to 
give a pale-yellow oil. The material obtained this way was subjected to flash 
chromatography (2:1 Et20/hexane elution) which afforded, after concentration of the 
appropriate fractions (Ry0.5), a 3:97 mixture (as determined by *H NMR analysis) of 
compounds 244 and 245 (13 mg, 86%) as a clear, colourless oil.
Reduction o f Compound 244 with DIBAL-H at 0 °C.
DIBAL-H (130 |iL of a 1 M solution in THF, 0.13 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 243 (40 mg, 0.12 mmol) in dry THF (0.5 
mL) maintained at 0 °C (ice-bath) under a nitrogen atmosphere. After 2.5 h the reaction 
mixture was quenched with HC1 (5 mL of a 10% aqueous solution) and EtOAc (10 
mL). The combined organic phases were then dried (MgSO/O, filtered and concentrated 
under reduced pressure to give a pale-yellow oil. The material obtained this way was 
subjected to flash chromatography (2:1 Et20/hexane elution) which afforded, after 
concentration of the appropriate fractions (R/-0.5), a 37:63 mixture (as determined by 
*H NMR analysis) of compounds 244 and 245 (36 mg, 92%) as a clear, colourless 
oil.
Reduction o f Compound 243 with DIBAL-H at -78 °C.
DIBAL-H (130 (iL of a 1 M solution in THF, 0.13 mmol) was added, dropwise, to a 
magnetically stirred solution of compound 243 (40 mg, 0.12 mmol) in dry THF (0.5 
mL) maintained at -78 °C (dry-ice/acetone slush bath) under a nitrogen atmosphere. 
After 2.5 h the reaction mixture was quenched with HC1 (5 mL of a 10% aqueous 
solution) and EtOAc (10 mL), and the combined organic phases were then dried 
(MgSOzO, filtered and concentrated under reduced pressure to give a pale-yellow oil. 
The material obtained this way was subjected to flash chromatography (2:1 Et20/hexane 
elution) which afforded, after concentration of the appropriate fractions (R/0.5), a 
42:58 mixture (as determined by !H NMR analysis) of compounds 244 and 245 (34 
mg, 84%) as a clear, colourless oil.
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(l/?,25,35,6R )-7,7-D ichloro-4-iodo-l-m ethylbicyclo[4.1.0]hept-4-ene- 
2,3-diol (ent-244).
I I
216 ent- 244
A magnetically stirred solution of compound 216 (3.57 g, 9.54 mmol) in acetic acid 
(100 mL of a 60% aqueous solution) was heated at 80 °C for 16 h. The cooled reaction 
mixture was then diluted with water (200 mL) and EtOAc (300 mL). The separated 
aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic 
phases were then dried (MgSÜ4), filtered and concentrated under reduced pressure. The 
material obtained in this way was subjected to flash chromatography (2:1 Et2Ü/hexane 
elution) which afforded, after concentration of the appropriate fractions (R^0.5), a 
white solid. Recrystallization (CHCl3/Et2 0 ) of this material then gave compound ent- 
244 (2.42 g, 76%) as colourless needles, m.p. 112-113 °C.
*H NMR (300 MHz) 5: 6.65 (1H, d, J = 3.6 Hz), 4.35 (1H, d, J = 3.8 Hz), 4.27 
(1H, d, J=  3.8 Hz), 1.91 (1H, d, J = 3.6 Hz), 1.54 (3H, s), (signals due to two -OH 
protons not observed).
13C NMR (75.4 MHz) 5 (d6 acetone): 134.7 (CH), 103.6 (C), 77.6 (CH), 69.6 
(CH), 40.3 (C), 39.6 (CH or CH3), 31.9 (C), 18.8 (CH or CH3).
IR v max 3332 ,2936, 2871, 1455, 1404, 1249, 1113 cm-1.
EIMS (70eV) m/z 336, 334 (M+\ 4, 2.5), 318, 316 [(M-H20 )+ \ 18, 16], 281 (37), 
252 (32), 189 (65), 125 (100).
Elemental Analysis Found: C, 28.75; H, 2.68; Cl, 20.85; I, 37.64.; C8H9CI2IO2 
requires: C, 28.69; H, 2.71; Cl, 21.17; I, 37.89%.
Optical Rotation [a ]D20 - 57.2 0 (c 3.2, CHC13).
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1.1 X-Ray Structure Report for Compound 75*
Br5a
^  C5a
X-ray crystal data are presented as provided by Dr. David Hockless (Research School of Chemistry, 
ANU).
Appendices
Experimental
Data Collection
A colourless irregular crystal of CnHnB^NC^ having approximate dimensions of 0.20 x 
0.16 x 0.08 mm was mounted on a glass fiber. All measurements were made on a Rigaku 
AFC6R diffractometer with graphite monochromated Cu-Ka radiation and a 12kW rotating 
anode generator.
Cell constants and an orientation matrix for data collection , obtained from a least-squares 
refinement using the setting angles of 25 carefully centered reflections in the range 97.83 < 29 
< 99.86° corresponded to a primitive monoclinic cell with dimensions:
a = 6.322(1) Ä
b = 13.476(1) Ä ß = 106.54(1)° 
c = 9.115(2) Ä 
V = 744.5(2) Ä3
For Z = 2 and F.W. = 520.84, the calculated density is 2.32 g/cm3. Based on the systematic 
absences of:
OkO: k ^  2n
packing considerations, a statistical analysis of intensity distribution, and the successful solution 
and refinement of the structure, the space group was determined to be:
P2i (#4)
The data were collected at a temperature of -60 ±_ 1°C using the u-26 scan technique to 
a maximum 26 value of 120.1°. Omega scans of several intense reflections, made prior to data 
collection, had an average width at half-height of 0.31° with a take-off angle of 6.0°. Scans of 
(1.30 + 0.30 tan 0)° were made at a speed of 32.0°/min (in omega). The weak reflections (I < 
10.0cr(I)) were rescanned (maximum of 4 scans) and the counts were accumulated to ensure good 
counting statistics. Stationary background counts were recorded on each side of the reflection. 
The ratio of peak counting time to background counting time was 2:1. The diameter of the 
incident beam collimator was 0.5 mm, the crystal to detector distance was 400 mm, and the 
detector aperture was 7.0 x 7.0 mm (horizontal x vertical).
Data Reduction
Of the 1283 reflections which were collected, 1170 were unique (R,nt = 0.062). The in­
tensities of three representative reflection were measured after every 150 reflections. No decay 
correction was applied.
The linear absorption coefficient, p, for Cu-Ka radiation is 133.5 cm-1 . An empirical 
absorption correction based on azimuthal scans of several reflections was applied which resulted
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in transmission factors ranging from 0.61 to 1.00. The data were corrected for Lorentz and 
polarization effects. A correction for secondary extinction was applied (coefficient = 1.5(3)e-06).
Structure Solution and Refinement
The structure was solved by direct methods1 and expanded using Fourier techniques2. The 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were included but not refined. 
The final cycle of full-matrix least-squares refinement3 was based on 1134 observed reflections 
(I > 3.00cr(I)) and 171 variable parameters and converged (largest parameter shift was <0.01 
times its esd) with unweighted and weighted agreement factors of:
R = £ ||Fo | -  \Fc\\/Z\Fo\ = 0.027 
Rw = y/{i:w(\Fo\ -  \Fc\)7/YlvoFo2)) = 0.033
The standard deviation of an observation of unit weight4 was 2.80. The weighting scheme 
was based on counting statistics and included a factor (p = 0.010) to downweight the intense 
reflections. Plots of Eiu(|.Fo| — |/^cj)2 versus |.Fo|, reflection order in data collection, sin 9/ A and 
various classes of indices showed no unusual trends. The maximum and minimum peaks on the 
final difference Fourier map corresponded to 0.74 and -0.51 e“ /A3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber5 . Anomalous dis­
persion effects were included in Fcalc6; the values for Af’ and Af” were those of Creagh and 
McAuiey7. The values for the mass attenuation coefficients are those of Creagh and Hubbel8. All 
calculations were performed using the teXsan9 crystallographic software package of Molecular 
Structure Corporation.
References
(1) SIR92: Altomare, A., Burla, M.C., Camalli, M., Cascarano, M., Giacovazzo, C., Guagliardi, 
A., Polidori, G. (1994). J. Appl. Cryst., in preparation.
(2) DIRDIF94: Beurskens, P.T., Admiraal, G., Beurskens, G., Bosman, W.P., de Gelder, 
R., Israel, R. and Smits, J.M.M. (1994). The DIRDIF-94 program system, Technical Report of 
the Crystallography Laboratory, University of Nijmegen. The Netherlands.
(3) Least-Squares:
Function minimized: Etu(|.Fo| — |.Fc|)2
where w = a^ Fo^  — o?[fo2)
a 2 ( F o 2)  =  S \ C + R ' B ) + { p F o ' p
S = Scan rate
C = Total integrated peak count
R = Ratio of scan time to background counting time
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B = Total background count 
Lp = Lorentz-polarization factor 
p = p-factor
(4) Standard deviation of an observation of unit weight:
y/Zw(\Fo\ -  \Fc\Y/(No  -  Nv) 
where: No = number of observations 
Nv = number of variables
(5) Cromer, D. T. k  Waber, J. T.; ’’International Tables for X-ray Crystallography” , Vol. 
IV, The Kynoch Press, Birmingham, England, Table 2.2 A (1974).
(6) Ibers, J. A. k  Hamilton, W. C.; Acta Crystallogr., 17, 781 (1964).
(7) Creagh, D. C. k  McAuley, W.J ’’International Tables for Crystallography”, Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.6.8, pages 219-222 (1992).
(8) Creagh, D. C. k  Hubbell, J.H..; ’’International Tables for Crystallography”, Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.4.3, pages 200-206 (1992).
(9) teXsan: Crystal Structure Analysis Package, Molecular Structure Corporation (1985 k  
1992).
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EXPERIMENTAL DETAILS
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type
No. of Reflections Used for Unit 
Cell Determination (29 range)
Omega Scan Peak Width 
at Half-height 
Lattice Parameters
Space Group 
Z value 
D e a / c  
Fooo
/j(CuKa)
A. Crystal Data
Ci2HnBr4N02
520.84
colourless, irregular 
0.20 X 0.16 X 0.08 mm 
monoclinic 
Primitive
25 ( 97.8 - 99.9° )
0.31°
a = 6.322(1)A 
b = 13.476(1) A 
c = 9.115(2) A 
ß =  106.54(1)°
V = 744.5(2) A3 
P2i (#4)
2
2.323 g/cm3 
492.00 
133.48 cm-1
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B. In ten s ity  M easu rem en ts
D iffrac to m eter R igaku  A F C 6 R
R a d ia tio n C u K a  (A =  1.54178 A) 
g ra p h ite  m o n o ch ro m ated
T ake-o ff A ngle 6.0°
D e tec to r A p e rtu re 7.0 m m  h o rizo n ta l
7.0 m m  vertica l
C ry s ta l to  D e tec to r D istance 400 m m
T e m p e ra tu re -60 .0°C
Scan T y p e u>-2d
Scan R a te 3 2 .0 ° /m in  (in  u>) (up  to  4 scans)
Scan W id th (1.30 +  0.30 ta n  9 )°
2 @max 120.1°
No. o f R eflections M easured T o ta l: 1283
U nique: 1170 (R tnt =  0.062)
C orrec tio n s L o ren tz -p o la riza tio n
A b so rp tio n
( tra n s . facto rs: 0.6100 - 1.0000) 
S econdary  E x tin c tio n  
(coefficient: 1.5(3)e-06)
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C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized E in ( |F o |-  \ F c \ f
Least Squares Weights 1 _  4  F o ' 2
<t3 ( F o ) '
p-factor 0.0100
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I>3.00<t(I)) 1134
No. Variables 171
Reflection/Param eter Ratio 6.63
Residuals: R; Rw 0.027 ; 0.033
Goodness of Fit Indicator 2.80
Max Shift/Error in Final Cycle <0.01
M aximum peak in Final Diff. Map 0.74 e~ ) Ä Z
Minimum peak in Final Diff. Map -0.51 e ~ / Ä 3
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Table 1. Atomic Coordinates and Isotropic Displacement Parameters for C n H n B ^ N C ^
atom X y z Be$
Br(4a) 0.0868(2) -0.0250 -0.1721(1) 2.80(3)
Br(4b) -0.1009(2) -0.2429(1) -0.1830(1) 2.49(2)
Br(5a) -0.3639(2) -0.2804 -0.8642(1) 2.37(2)
Br(5b) 0.1380(2) -0.2185(1) -0.7381(1) 2.73(3)
0(1) 0.111(1) -0.4359(5) -0.3539(8) 2.3(2)
0(3) 0.357(1) -0.3295(6) -0.2106(7) 2.2(2)
N(3b’) 0.515(2) -0.0495(8) -0.361(1) 3.4(2)
0(2) 0.309(2) -0.4334(8) -0.226(1) 2.3(2)
0 (2 ’) 0.254(2) -0.4688(9) -0.085(1) 2.9(3)
C(2” ) 0.491(2) -0.4889(9) -0.265(1) 3.3(3)
C(3a) 0.296(2) -0.2871(9) -0.3606(10) 1.8(2)
C(3b) 0.218(2) -0.1796(8) -0.355(1) 1.7(2)
C(3b’) 0.388(2) -0.1060(8) -0.353(1) 2.0(2)
C(4a) -0.014(2) -0.1462(8) -0.448(1) 1.6(2)
0(4b) -0.165(1) -0.2210(8) -0.544(1) 1.7(2)
0(4) 0.041(2) -0.1498(8) -0.282(1) 2.0(2)
C(5a) -0.094(2) -0.3279(8) -0.552(1) 1.9(2)
C(5b) 0.135(2) -0.3640(8) -0.461(1) 2.1(2)
0(5) -0.124(1) -0.2606(8) -0.6862(10) 1.8(2)
H(2’a) 0.1659 -0.4204 -0.0542 3.4520
H(2’b) 0.1752 -0.5295 -0.1064 3.4520
H(2” a) 0.5160 -0.4612 -0.3544 3.9167
H(2”b) 0.4513 -0.5567 -0.2825 3.9167
H(2”c) 0.6226 -0.4839 -0.1823 3.9167
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Table 1. Atomic Coordinates and Isotropic Displacement Parameters for C i2H nB r4N02 (cont...)
atom X y z Beq
H(2’c) 0.3865 -0.4787 -0.0049 3.4520
H(3a) 0.4250 -0.2853 -0.3949 2.1586
H(4a) -0.0224 -0.0816 -0.4912 1.9564
H(4b) -0.3166 -0.2125 -0.5493 2.0230
H(5a) -0.2083 -0.3754 -0.5621 2.2500
H(5b) 0.2045 -0.3940 -0.5296 2.4932
B eq =  ^7r2(^ n (a a * )2+ t/2 2 (^ ’' ) 2+^33(cc*)2+2(/i2aa*66* cos74-2£/i3aa*cc* cosß+2U23bbmcc* cos a )
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Table 2. Anisotropic Displacement Parameters for Ci2H nB r4N 0 2
atom Uh u 22 u 33 Ui2 U13 u23
Br(4a) 0.0395(7) 0.0398(7) 0.0248(5) -0.0017(6) 0.0053(5) -0.0115(6)
Br(4b) 0.0295(6) 0.0458(7) 0.0212(5) -0.0034(5) 0.0101(4) 0.0053(5)
Br(5a) 0.0261(5) 0.0412(7) 0.0170(5) -0.0018(5) -0.0036(4) -0.0014(5)
Br(5b) 0.0258(6) 0.0595(9) 0.0187(5) -0.0063(6) 0.0069(4) 0.0029(6)
0(1) 0.027(4) 0.028(4) 0.024(4) -0.005(3) -0.008(3) 0.001(3)
0(3) 0.036(4) 0.026(4) 0.018(4) -0.003(3) 0.000(3) -0.001(3)
N(3b’) 0.026(5) 0.052(7) 0.048(6) -0.013(5) 0.007(4) 0.006(5)
0(2) 0.040(7) 0.027(6) 0.015(5) -0.004(5) -0.004(5) 0.003(5)
0 (2 ’) 0.040(6) 0.037(7) 0.027(6) -0.006(6) 0.001(5) 0.003(5)
C(2” ) 0.036(6) 0.038(7) 0.041(7) 0.008(6) -0.002(6) 0.003(6)
C(3a) 0.021(5) 0.038(6) 0.006(4) -0.008(5) -0.001(4) -0.005(5)
C(3b) 0.015(5) 0.034(6) 0.013(5) -0.001(5) 0.000(4) 0.003(4)
C(3b’) 0.027(6) 0.033(6) 0.016(5) 0.002(5) 0.002(4) -0.001(5)
0(4a) 0.019(5) 0.024(6) 0.020(5) -0.001(4) 0.009(4) 0.000(4)
C(4b) 0.016(5) 0.032(6) 0.016(5) -0.001(5) 0.005(4) 0.008(5)
0(4) 0.020(5) 0.037(6) 0.018(5) -0.007(5) 0.004(4) 0.000(5)
C(5a) 0.014(5) 0.032(6) 0.023(6) -0.003(5) 0.001(4) 0.004(5)
C(5b) 0.026(6) 0.030(6) 0.018(6) -0.004(5) -0.002(5) -0.001(5)
0(5) 0.016(5) 0.039(7) 0.011(4) -0.001(5) 0.000(4) -0.008(5)
The general tem perature factor expression:
exp(-27T2(a*2t/n /i2 +  6*2[/22fc2 + c*2C/33/2 +  2a 'b 'U i2hk +  2a 'c 'U x3hl +  2bmcmU23k l ))
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Table 3. Interatomic Distances (A) Involving Non-Hydrogen Atoms for Ci2HnBr4N02
atom atom distance
Br(4a) 0(4) 1.93(1)
Br(5a) 0(5) 1.900(9)
0(1) 0(2) 1.45(1)
0(3) 0(2) 1.43(1)
N(3b’) C(3b’) 1.13(1)
0(2) C(2”) 1.50(2)
C(3a) C(5b) 1.56(1)
C(3b) C(4a) 1.54(1)
C(4a) C(4b) 1.49(1)
C(4b) C(5a) 1.52(1)
C(5a) C(5b) 1.53(1)
atom atom distance
Br(4b) 0(4) 1.910(10)
Br(5b) 0(5) 1.930(9)
0(1) C(5b) 1.41(1)
0(3) C(3a) 1.43(1)
0(2) 0 (2 ’) 1.50(1)
C(3a) C(3b) 1.54(1)
C(3b) C(3b’) 1.46(1)
C(3b) 0(4) 1.51(1)
C(4a) 0(4) 1.46(1)
C(4b) 0(5) 1.50(1)
C(5a) 0(5) 1.49(1)
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Table 4. Interatomic Distances (A) Involving Hydrogen Atoms for C i2H nB r4N 02
atom atom distance
C(2>) H(2’a) 0.95
C(2’) H(2’c) 0.95
C(2” ) H(2”b) 0.95
C(3a) H(3a) 0.95
C(4b) H(4b) 0.95
C(5b) H(5b) 0.95
atom atom distance
C (2’) H (2’b) 0.95
C(2” ) H(2”a) 0.95
C(2” ) H(2”c) 0.95
C(4a) H(4a) 0.95
C(5a) H(5a) 0.95
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Table 5. Interatomic Angles(°) Involving Non-Hydrogen Atoms for Ci2H nBr4N02
atom atom atom angle atom atom atom angle
C(2) 0(1) C(5b) 107.7(7) 0(2) 0(3) C(3a) 107.9(8).
0(1) 0(2) 0(3) 102.1(8) 0(1) 0(2) 0 (2 ’) 109.0(9)
0(1) 0(2) C(2”) 110.0(9) 0(3) 0(2) 0 (2 ’) 108.8(9)
0(3) 0(2) C(2”) 110.8(9) 0 (2 ’) 0(2) C(2”) 115.3(10)
0(3) C(3a) C(3b) 110.2(8) 0(3) C(3a) C(5b) 104.4(8)
C(3b) C(3a) C(5b) 119.0(8) C(3a) C(3b) C(3b’) 113.4(8)
C(3a) C(3b) C(4a) 121.5(8) C(3a) C(3b) 0(4) 123.6(8)
C(3b’) C(3b) C(4a) 113.0(9) C(3b’) C(3b) 0(4) 116.8(9)
C(4a) C(3b) 0(4) 57.1(6) N(3b’) C(3b’) C(3b) 175(1)
C(3b) C(4a) C(4b) 118.6(9) C(3b) C(4a) 0(4) 60.4(6)
C(4b) C(4a) 0(4) 120.7(8) C(4a) C(4b) C(5a) 121.4(8)
C(4a) C(4b) 0(5) 120.5(8) C(5a) C(4b) 0(5) 59.3(7)
Br(4a) 0(4) Br(4b) 110.4(5) Br(4a) 0(4) C(3b) 116.0(7)
Br(4a) 0(4) C(4a) 117.7(8) Br(4b) 0(4) C(3b) 122.6(8)
Br(4b) 0(4) C(4a) 120.5(7) C(3b) 0(4) C(4a) 62.4(6)
C(4b) C(5a) C(5b) 121.6(9) C(4b) C(5a) 0(5) 59.6(6)
C(5b) C(5a) 0(5) 121.1(8) 0(1) C(5b) C(3a) 103.4(8)
0(1) C(5b) C(5a) 108.7(8) C(3a) C(5b) C(5a) 118.0(9)
Br(5a) 0(5) Br(5b) 111.4(4) Br(5a) 0(5) C(4b) 119.7(7)
Br(5a) 0(5) C(5a) 119.9(7) Br(5b) 0(5) C(4b) 118.9(7)
Br(5b) 0(5) C(5a) 117.6(6) C(4b) 0(5) C(5a) 61.1(6)
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Table 6. Interatomic Angles(°) Involving Hydrogen Atoms for C i 2H n B r4NOo
atom atom atom angle atom atom atom angle
C(2) 0 ( 2 ’) H(2’a) 109.5 0(2) 0 ( 2 ’) H(2’b) 109.5
C(2) 0 ( 2 ’) H(2’c) 109.5 H(2’a) 0 ( 2 ’) H(2’b) 109.5
H(2’a) 0 ( 2 ’) H(2’c) 109.5 H(2’b) 0 ( 2 ’) H(2’c) 109.5
C(2) C(2”) H(2” a) 109.5 0(2) C(2”) H(2” b) 109.5
C(2) C(2”) H(2”c) 109.5 H(2”a) C(2” ) H(2”b) 109.5
H(2” a) C(2”) H(2”c) 109.5 H(2”b) C(2” ) H(2”c) 109.5
0 (3 ) C(3a) H(3a) 107.6 C(3b) C(3a) H(3a) 107.6
C(5b) C(3a) H(3a) 107.6 C(3b) C(4a) H(4a) 115.4
C(4b) C(4a) H(4a) 115.4 0(4) C(4a) H(4a) 115.4
C(4a) C(4b) H(4b) 114.8 C(5a) C(4b) H(4b) 114.8
0 (5 ) C(4b) H(4b) 114.8 C(4b) C(5a) H(5a) 114.6
C(5b) C(5a) H(5a) 114.6 0(5) C(5a) H(5a) 114.6
0 (1 ) C(5b) H(5b) 108.8 C(3a) C(5b) H(5b) 108.8
C(5a) C(5b) H(5b) 108.8
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Table 7. Torsion Angles(°) Involving Non-Hydrogen Atoms for C i2H nB r4N02
atom atom atom atom angle atom atom atom atom angle
Br(4a) 0(4) C(3b) C(3a) 142.3(8) Br(4a) 0(4) C(3b) C (3b’) -7(1).
Br(4a) 0(4) C(3b) C(4a) -109.2(8) Br(4a) 0(4) C(4a) C(3b) 106.5(8)
Br(4a) 0(4) C(4a) C(4b) -145.9(8) Br(4b) 0(4) C(3b) C(3a) 1(1)
Br(4b) 0(4) C(3b) C(3b’) -148.5(8) Br(4b) 0(4) C(3b) C(4a) 110.2(9)
Br(4b) 0(4) C(4a) C(3b) -113.5(9) Br(4b) 0(4) C(4a) 0(4b) -5(1)
Br(5a) 0(5) 0(4b) C(4a) -139.4(8) Br(5a) 0(5) C(4b) C(5a) 109.9(8)
Br(5a) 0(5) C(5a) C(4b) -109.6(8) Br(5a) 0(5) C(5a) C(5b) 139.6(8)
Br(5b) 0(5) C(4b) C(4a) 3(1) Br(5b) 0(5) C(4b) C(5a) -107.5(8)
Br(5b) 0(5) C(5a) C(4b) 109.5(8) Br(5b) 0(5) C(5a) C(5b) -1(1)
0 (1 ) 0(2) 0(3) C(3a) -35.1(10) 0(1) C(5b) C(3a) 0 (3 ) 4.4(10)
0 (1 ) C(5b) C(3a) C(3b) -118.9(9) 0(1) C(5b) C(5a) C(4b) 116.3(10)
0(1) C(5b) C(5a) 0(5) -172.6(9) 0(3) 0(2) 0(1) C(5b) 38.4(10)
0(3) C(3a) C(3b) C(3b’) 98.5(9) 0(3) C(3a) C(3b) C(4a) -121.6(9)
0 (3 ) C(3a) C(3b) 0(4) -52(1) 0(3) C(3a) C(5b) C(5a) 124.4(9)
N(3b’) C(3b’) C(3b) C(3a) 86(15) N(3b’) C(3b’) C(3b) C(4a) -56(15)
N(3b’) C(3b’) C(3b) 0(4) -120(15) 0(2) 0(1) C(5b) C(3a) -26(1)
0(2) 0(1) C(5b) C(5a) -152.4(8) 0(2) 0(3) C(3a) C(3b) 148.1(8)
0(2) 0(3) C(3a) C(5b) 19(1) 0 (2 ’) 0(2) 0(1) C(5b) 153.5(9)
0 (2 ’) 0(2) 0(3) C(3a) -150.2(8) C(2” ) 0(2) 0(1) C(5b) -79(1)
C(2” ) 0(2) 0(3) C(3a) 82.1(10) C(3a) C(3b) C(4a) 0(4b) 1(1)
C(3a) C(3b) C(4a) 0(4) 112.1(10) C(3a) C(3b) 0(4) C(4a) -108(1)
C(3a) C(5b) C(5a) C(4b) 0(1) C(3a) C(5b) C(5a) 0(5) 70(1)
C(3b) C(3a) C(5b) C(5a) 1(1) C(3b) C(4a) C(4b) C(5a) 0(1)
C(3b) C(4a) C(4b) 0(5) -71(1) C(3b) 0(4) C(4a) C(4b) 107(1)
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Table 7. Torsion Angles(°) Involving Non-Hydrogen Atoms for C ^H nB r^N C ^ (cont...)
atom atom atom atom angle
C (3b’) C(3b) C(3a) C(5b) -141.1(9)
C (3b’) C(3b) C(4a) C(4) -107.9(10)
C(4a) C(3b) C(3a) C(5b) -1(1)
C(4a) C(4b) C(5a) C(5) -109.2(10)
C(4b) C(4a) C(3b) C(4) -111.0(10)
C(4) C(3b) C(3a) C(5b) 67(1)
C(4) C(4a) C(4b) C(5) -142.0(10)
atom atom atom atom angle
C(3b’) C(3b) C(4a) C(4b) 141.1(9)
C(3b’) C(3b) C(4) C(4a) 101.3(10)
C(4a) C(4b) C(5a) C(5b) 0(1)
C(4a) C(4b) C(5) C(5a) 110(1)
C(4b) C(5) C(5a) C(5b) -110(1)
C(4) C(4a) C(4b) C(5a) -71(1)
C(5b) C(5a) C(4b) C(5) 109(1)
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Table 8. Non-bonded Contacts out to 3.60 Ä for C n H n B ^ N C ^
atom atom distance ADC
Br(4a) N(3b’) 3.547(9) 45501
Br(5a) 0(3) 3.217(7) 45401
N(3b’) 0(4) 3.47(1) 65501
N(3b’) C(4a) 3.54(1) 65501
atom atom distance ADC
Br(4b) 0(3) 3.560(7) 45501
0(1) C(4a) 3.32(1) 54402
N(3b’) C(2”) 3.50(2) 65402
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit number: 
TA (first digit) + TB (second digit) + TC (third digit) +  SN (last two digits). TA, TB and 
TC are the crystal lattice translation digits along cell edges a, b and c. A translation digit of 5 
indicates the origin unit cell. If TA = 4, this indicates a translation of one unit cell length along 
the a-axis in the negative direction. Each translation digit can range in value from 1 to 9 and 
thus ±A  lattice translations from the origin (TA=5, TB=5, TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant to 
this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN = 1). Thus, the ADC for 
an origin atom is always 55501. The position of the second atom (target atom) can be generated 
using the ADC and the coordinates of the atom in the parameter table. For example, an ADC 
of 47502 refers to the target atom moved through symmetry operator two, then translated -1 
cell translations along the a axis, +2 cell translations along the b axis, and 0 cell translations 
along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) -X, 1/2+Y, -Z
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1.2 X-Ray Structure Report for Compound 66*
N6a’
* X-ray crystal data are presented as provided by Dr. David Hockless (Research School of Chemistry, 
ANU).
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Experimental
Data Collection
A colorless irregular crystal of C1 3 H1 7 NO2 having approximate dimensions of 0.34 x 0.14 
x 0.10 mm was mounted on a glass fiber. All measurements were made on a Rigaku AFC6R 
diffractometer with graphite monochromated Cu-Ka radiation and a rotating anode generator.
Cell constants and an orientation matrix for data collection , obtained from a least-squares 
refinement using the setting angles of 25 carefully centered reflections in the range 73.75 < 29 
< 88.94° corresponded to a primitive monoclinic cell with dimensions:
a =  8.942(1) A
b =  8.0016(9) A ß =  110.312(8)° 
c =  9.169(1) A 
V =  615.2(1) A3
For Z =  2 and F.W. =  219.28, the calculated density is 1.18 g/cm 3. Based on the systematic 
absences of:
OkO: k ^  2n
packing considerations, a statistical analysis of intensity distribution, and the successful solution 
and refinement of the structure, the space group was determined to be:
P2i (#4 )
The data were collected at a temperature of 23 ±_ 1°C using the u-29 scan technique to 
a maximum 29 value of 120.1°. Omega scans of several intense reflections, made prior to data 
collection, had an average width at half-height of 0.30° with a take-off angle of 6.0°. Scans of 
(1.30 +  0.30 tan 9)° were made at a speed of 8.0°/min (in omega). The weak reflections (I < 
10.0<x(I)) were rescanned (maximum of 4 scans) and the counts were accumulated to ensure good 
counting statistics. Stationary background counts were recorded on each side of the reflection. 
The ratio of peak counting time to background counting time was 2:1. The diameter of the 
incident beam collimator was 0.5 mm, the crystal to detector distance was 400 mm, and the 
detector aperture was 7.0 x 7.0 mm (horizontal x vertical).
Data Reduction
Of the 1061 reflections which were collected, 995 were unique (R,„t =  0.029). The intensities 
of three representative reflection were measured after every 150 reflections. Over the course of 
data collection, the standards decreased by 15.9%. A linear correction factor was applied to the 
data to account for this phenomenon.
The linear absorption coefficient, /i, for Cu-Ka radiation is 6.0 cm-1 . An empirical ab­
sorption correction based on azimuthal scans of several reflections was applied which resulted in
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transmission factors ranging from 0.98 to 1.00. The data were corrected for Lorentz and polar­
ization effects. A correction for secondary extinction was applied (coefficient =  1.26712e-05).
Structure Solution and Refinement
The structure was solved by direct methods1 and expanded using Fourier techniques2. The 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were refined isotropically. 
The final cycle of full-matrix least-squares refinement3 was based on 918 observed reflections (I 
> 3.00o-(I)) and 213 variable parameters and converged (largest parameter shift was 0.00 times 
its esd) with unweighted and weighted agreement factors of:
R = £ ||Fo | -  |F c ||/£ |Fo | = 0.026 
Rw = v^EwflFol -  \Fc\y/ZwFoi)\ = 0.031
The standard deviation of an observation of unit weight4 was 1.90. The weighting scheme 
was based on counting statistics and included a factor (p =  0.019) to downweight the intense 
reflections. Plots of HtndFol — |.Fc|)2 versus |Fo|, reflection order in data collection, sin 8/ A and 
various classes of indices showed no unusual trends. The maximum and minimum peaks on the 
final difference Fourier map corresponded to 0.07 and -0.09 e“ /A3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber5 . Anomalous dis­
persion effects were included in Fcalc6; the values for Af’ and Af” were those of Creagh and 
McAuley7. The values for the mass attenuation coefficients are those of Creagh and Hubbel8. All 
calculations were performed using the teXsan9 crystallographic software package of Molecular 
Structure Corporation.
References
(1) SIR92: Altomare, A., Cascarano, M., Giacovazzo, C., Guagliardi, A. (1993). J. Appl. 
Cryst., 26, 343.
(2) DIRDIF94: Beurskens, P.T., Admiraal, G., Beurskens, G., Bosman, W.P., de Gelder, 
R., Israel, R. and Smits, J.M.M. (1994). The DIRDIF-94 program system, Technical Report of 
the Crystallography Laboratory, University of Nijmegen, The Netherlands.
(3) Least-Squares:
Function minimized: £u;(|Fo| — |Fc|)2
where w = = [ac(F°) + ^ F o 2)-1
ac(Fo) = e.s.d. based on counting statistics 
p = p-factor
(4) Standard deviation of an observation of unit weight:
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yyilw(\Fo\ -  \Fc\y/{No -  N v ) 
where: No = number of observations 
Nv = number of variables
(5) Cromer, D. T. &; Waber, J. T.; ’’International Tables for X-ray Crystallography” , V qI. 
IV, The Kynoch Press, Birmingham, England, Table 2.2 A (1974).
(6) Ibers, J. A. k  Hamilton, W. C.; Acta Crystallogr., 17, 781 (1964).
(7) Creagh, D. C. & McAuley, W.J .; ’’International Tables for Crystallography” , Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.6.8, pages 219-222 (1992).
(8) Creagh, D. C. k  Hubbell, J.H..; ’’International Tables for Crystallography”, Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.4.3, pages 200-206 (1992).
(9) teXsan: Crystal Structure Analysis Package, Molecular Structure Corporation (1985 k  
1992).
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EXPERIMENTAL DETAILS
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type
No. of Reflections Used for Unit 
Cell Determination (20 range)
Omega Scan Peak Width 
at Half-height 
Lattice Parameters
Space Group 
Z value 
D calc
Fooo
/i(CuKa)
Diffractometer
A. Crystal Data
C 1 3 H 1 7 N O 2
219.28
colorless, irregular 
0.34 X 0.14 X 0.10 mm 
monoclinic 
Primitive
25 ( 73.8 - 88.9° )
0.30°
a = 8.942(1)A 
b = 8.0016(9) Ä 
c =  9.169(1) A  
ß = 110.312(8)°
V = 615.2(1) A 3 
P2i (#4)
2
1.184 g/cm3 
236.00 
6.04 cm-1
B. Intensity Measurements 
Rigaku AFC6R
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Radiation CuKa (A =  1.54178 A) 
graphite monochromated
Take-off Angle 6.0°
Detector Aperture 7.0 mm horizontal
7.0 mm vertical
Crystal to Detector Distance 400 mm
Temperature 23.0°C
Scan Type u j-2 6
Scan Rate 8.0°/min (in u )  (up to 4 scans)
Scan Width (1.30 + 0.30 tan 9 ) °
2-9m ax 120.1°
No. of Reflections Measured Total: 1061
Unique: 995 (Rtn* = 0.029)
Corrections Lorentz-polarization
Absorption
(trans. factors: 0.9792 - 1.0000) 
Decay (15.86% decline) 
Secondary Extinction 
(coefficient: 1.26712e-05)
C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized Z w ( \ F o \ - \ F c \ ) 2
Least Squares Weights W - - ^ ) - [ (rc{F °)  +  E4 ;F 02] 1
p-factor 0.0190
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I>3.00cr(I)) 918
No. Variables 213
Reflection/Parameter Ratio 4.31
Residuals: R; Rw 0.026 ; 0.031
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Goodness of Fit Indicator 
Max Shift/Error in Final Cycle 
Maximum peak in Final DifF. Map 
Minimum peak in Final DifF. Map
1.90
0.00
0.07 e-/A3 
-0.09 e~/ Ä3
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Table 1. Atomic coordinates and BiJ0/B e<?
atom X y z B e g
0(1) 0.8491(2) 0.2328 0.6896(2) 3.93(4)
0(3) 0.8683(2) 0.5116(3) 0.7484(2) 5.00(4)
N(6a’) 0.6718(3) -0.0960(4) 0.4472(3) 5.56(7)
0(2) 0.9191(3) 0.3492(4) 0.8114(3) 4.42(6)
C(3a) 0.7766(3) 0.4950(4) 0.5860(3) 3.88(5)
0(4) 0.8741(3) 0.5316(5) 0.4868(3) 4.30(6)
0(5) 0.8723(3) 0.4411(4) 0.3670(3) 4.36(7)
C(5a) 0.7715(3) 0.2912(4) 0.3141(3) 3.93(6)
0(6) 0.5914(3) 0.2988(4) 0.2639(3) 4.13(6)
C(6a) 0.6894(3) 0.2249(4) 0.4223(3) 3.44(5)
C(6b) 0.7174(3) 0.3152(4) 0.5747(3) 3.36(5)
C(6’a) 0.6813(3) 0.0447(5) 0.4372(3) 3.93(6)
0(21) 1.0991(4) 0.3344(6) 0.8557(6) 7.5(1)
C(22) 0.8593(8) 0.3223(7) 0.9438(5) 7.9(1)
0(61) 0.5053(4) 0.4628(5) 0.2537(4) 5.13(7)
C(62) 0.4986(4) 0.1754(6) 0.1408(4) 5.78(9)
H(3a) 0.690(3) 0.571(4) 0.567(3) 3.9(6)
H(4) 0.940(3) 0.632(4) 0.514(3) 5.2(7)
H(5) 0.939(3) 0.466(4) 0.305(3) 4.7(6)
H(5a) 0.819(3) 0.206(4) 0.261(3) 4.4(6)
H(6b) 0.622(2) 0.309(3) 0.600(2) 2.5(4)
H(21a) 1.135(7) 0.371(9) 0.761(7) 17(2)
H(21b) 1.150(5) 0.419(6) 0.939(5) 10(1)
H(21c) 1.131(5) 0.225(7) 0.902(5) 10(1)
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Table 1. Atomic coordinates and Biao/B eg (continued)
atom X y z
H(22a) 0.744(5) 0.338(6) 0.910(4) 9(1)
H(22b) 0.918(4) 0.222(5) 1.002(5) 8.2(9)
H(22c) 0.897(5) 0.420(6) 1.018(5) 10(1)
H(61a) 0.464(4) 0.502(6) 0.144(5) 9(1)
H(61b) 0.404(5) 0.446(6) 0.283(4) 10(1)
H(61c) 0.568(4) 0.555(5) 0.320(4) 6.1(8)
H(62a) 0.471(4) 0.225(5) 0.033(4) 8.0(9)
H(62b) 0.388(4) 0.153(5) 0.155(4) 6.9(8)
H(62c) 0.554(4) 0.077(5) 0.142(4) 6.1(8)
f le<J =  ?7r2(C/u (aa*)2-t-f/22(66*)2+C/33(cc*)2+2C/12aa*66* cos 7 + 2 f /13aa*cc* cos (3+2U ^bbmcc* cos a )
O
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Table 2. Anisotropic Displacement Parameters
atom U u Ü22 U33 U 12 U13 U23
0(1) 0.059(1) 0.034(1) 0.0454(9) 0.0060(8) 0.0042(8) 0.0023(8)
0(3) 0.090(1) 0.039(1) 0.046(1) 0.004(1) 0.0042(9) -0.0013(9)
N(6a’) 0.072(2) 0.042(2) 0.098(2) -0.008(1) 0.031(1) -0.004(1)
0(2) 0.073(2) 0.039(2) 0.044(1) 0.010(1) 0.006(1) 0.001(1)
C(3a) 0.057(1) 0.037(1) 0.046(1) 0.006(1) 0.009(1) 0.003(1)
0(4) 0.057(1) 0.042(2) 0.057(2) -0.010(1) 0.009(1) 0.010(1)
0(5) 0.054(1) 0.059(2) 0.055(2) -0.006(1) 0.021(1) 0.011(1)
C(5a) 0.051(1) 0.050(2) 0.048(1) 0.002(1) 0.018(1) 0.000(1)
0(6) 0.051(1) 0.058(2) 0.043(1) 0.001(1) 0.009(1) 0.000(1)
C(6a) 0.043(1) 0.039(1) 0.047(1) 0.002(1) 0.013(1) 0.002(1)
C(6b) 0.044(1) 0.038(1) 0.044(1) 0.006(1) 0.013(1) 0.006(1)
C(6’a) 0.046(1) 0.048(2) 0.057(2) -0.004(1) 0.020(1) -0.002(1)
0(21) 0.074(2) 0.067(3) 0.104(3) 0.009(2) -0.021(2) -0.017(3)
C(22) 0.178(5) 0.070(3) 0.065(2) 0.021(3) 0.057(3) 0.010(2)
0(61) 0.067(2) 0.067(2) 0.052(2) 0.016(2) 0.008(1) 0.013(2)
C(62) 0.071(2) 0.081(3) 0.055(2) -0.003(2) 0.006(2) -0.013(2)
The general tem perature factor expression:
exp(-27r2(a*2t/11/i2 +  b*2U22k 2 +  c*2U ^ l2 +  2 a*b*U12hk +  2 a*c*Ul3hl + 2 b 'c 'U n k l))
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Table 3. Bond Lengths(A )
atom atom distance
0 (1 ) 0 (2 ) 1.422(3)
0 (3 ) 0 (2 ) 1.431(3)
N (6a’) C (6’a) 1.135(4)
0 (2 ) C(22) 1.503(5)
C(3a) C(6b) 1.525(4)
0 (5 ) C(5a) 1.477(4)
C(5a) C(6a) 1.520(3)
0 (6 ) 0 (61) 1.508(4)
C(6a) C(6b) 1.515(3)
atom atom distance
0 (1 ) C(6b) 1.439(3)
0 (3 ) C(3a) 1.435(3)
0 (2 ) 0 (21 ) 1.522(5)
C(3a) 0 (4 ) 1.490(4)
C(4) 0 (5 ) 1.311(4)
C(5a) 0 (6 ) 1.515(4)
0 (6 ) C (6a) 1.531(3)
0 (6 ) C(62) 1.512(4)
C (6a) C (6 ’a) 1.452(5)
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Table 4. B on d  L en gth s(A )
atom a to m distance
C (3a) H (3a) 0 .9 5 (3 )
C (5) H(5) 0 .9 7 (3 )
C (6b) H (6b) 0 .9 6 (2 )
C (21) H (21b) 1 .00(5 )
C (22) H (22a) 0 .9 8 (4 )
C (22) H (22c) 1 .01(5)
C (61) H (61b) 1 .04(4)
C (62) H (62a) 1 .02(3)
C (62) H (62c) 0 .9 3 (4 )
a to m a to m distance
C (4) H (4 ) 0 .97(3)
C (5a) H (5 a ) 1.02(3)
C (21) H (2 1 a ) 1.07(6)
C (21) H (2 1 c) 0 .97(6 )
C (22) H (2 2 b ) 1.01(4)
C (61) H (6 1 a ) 0 .99(4 )
C (61) H (61c) 1.00(4)
C (62) II(62b) 1.05(3)
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Table 5. Bond Angle* (° )
atom atom atom angle
C(2) 0 (1 ) C(6b) 107.5(2)
0 (1 ) 0 (2 ) 0 (3 ) 106.6(2)
0 (1 ) 0 (2 ) C(22) 110.9(3)
0 (3 ) 0 (2 ) C(22) 107.7(3)
0 (3 ) C(3a) 0 (4 ) 111.8(2)
0 (4 ) C(3a) C(6b) 114.0(2)
0 (4 ) 0 (5 ) C(5a) 123.5(2)
0 (5 ) C(5a) C(6a) 116.5(2)
C(5a) 0 (6 ) C(6a) 59.9(2)
C(5a) 0 (6 ) C(62) 116.8(3)
C(6a) 0 (6 ) C(62) 116.1(3)
C(5a) C(6a) 0 (6 ) 59.5(2)
C(5a) C(6a) C (6 ’a) 117.4(2)
0 (6 ) C(6a) C (6 ’a) 116.2(2)
0 (1 ) C(6b) C(3a) 101.9(2)
C(3a) C(6b) C(6a) 117.0(2)
atom atom atom angle
0 (2 ) 0 (3 ) C(3a) 108.8(2)
0 (1 ) 0 (2 ) 0(21) 107.2(3)
0 (3 ) 0 (2 ) 0 (21) 109.7(3)
0 (21) 0 (2 ) C(22) 114.4(3)
0 (3 ) C(3a) C(6b) 102.6(2)
C(3a) 0 (4 ) 0 (5 ) 124.2(3)
0 (5 ) C(5a) 0 (6 ) 122.0(2)
0 (6 ) C (5a) C(6a) 60.6(2)
C(5a) 0 (6 ) 0(61) 121.3(3)
C(6a) 0 (6 ) 0(61) 120.4(2)
0(61) 0 (6 ) C(62) 112.7(3)
C(5a) C(6a) C(6b) 118.2(2)
0 (6 ) C(6a) C(6b) 123.2(2)
C(6b) C(6a) C (6’a) 112.6(2)
0 (1 ) C(6b) C(6a) 106.7(2)
N (6a’) C (6’a) C(6a) 178.7(3)
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Table 6. Bond Angles(°)
atom atom atom angle atom atom atom angle
0(3) C(3a) H(3a) 105(2) C(4) C(3a) H(3a) 112(2)
C(6b) C(3a) H(3a) 111(2) C(3a) C(4) H(4) 116(2)
C(5) C(4) H(4) 120(2) C(4) C(5) H(5) 123(2)
C(5a) C(5) H(5) 114(2) C(5) C(5a) H(5a) 113(2)
C(6) C(5a) H(5a) 117(2) C(6a) C(5a) H(5a) 117(2)
0(1) C(6b) H(6b) 112(1) C(3a) C(6b) H(6b) 110(1)
C(6a) C(6b) H(6b) 109(1) C(2) C(21) H(21a) 111(3)
C(2) C(21) H(21b) 108(2) C(2) C(21) H(21c) 108(3)
H(21a) C(21) H(21b) 105(4) H(21a) C(21) H(21c) 118(5)
H(21b) C(21) H(21c) 107(3) C(2) C(22) H(22a) 111(2)
C(2) C(22) H(22b) 106(2) C(2) C(22) H(22c) 107(3)
H(22a) C(22) II (22b) 124(4) H(22a) C(22) H(22c) 101(4)
H(22b) C(22) H(22c) 106(3) C(6) C(61) H(61a) 110(3)
C(6) C(61) H(61b) 110(3) C(6) C(61) H(61c) 116(2)
H(61a) C(61) H(61b) 105(3) H(61a) C(61) H(61c) 108(3)
H(61b) C(61) H(61c) 107(3) C(6) C(62) H(62a) H l(2)
C(6) C(62) H(62b) 108(2) C(6) C(62) H(62c) 113(2)
H(62a) C(62) H(62b) 105(3) H(62a) C(62) H(62c) 107(3)
H(62b) C(62) H(62c) 112(3)
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Table 7. Torsion Angles(°)
atom atom atom atom angle atom atom atom atom angle
0(1) 0(2) 0(3) C(3a) -3.9(3) 0(1) C(6b) C(3a) 0 (3 ) -34.3(2)
0(1) C(6b) C(3a) 0(4) 86.7(2) 0(1) C(6b) C(6a) C(5a) -92.9(2)
0(1) C(6b) C(6a) 0(6) -163.3(2) 0(1) C(6b) C(6a) C (6’a) 49.1(3)
0(3) 0(2) 0(1) C(6b) -19.4(3) 0(3) C(3a) 0(4) 0 (5 ) 135.6(3)
0(3) C(3a) C(6b) C(6a) -150.2(2) N(6a’) C(6’a) C(6a) C(5a) -105.5(1)
N(6a’) C(6’a) C(6a) 0(6) -37.9(1) N(6a’) C(6’a) C(6a) C(6b) 112.1(1)
0(2) 0(1) C(6b) C(3a) 33.2(2) 0(2) 0(1) C(6b) C(6a) 156.4(2)
0(2) 0(3) C(3a) 0(4) -98.8(3) 0(2) 0(3) C(3a) C(6b) 23.8(3)
C(3a) 0(3) 0(2) 0(21) 111.8(3) C(3a) 0(3) 0(2) C(22) -123.0(3)
C(3a) 0(4) 0(5) C(5a) 0.6(4) C(3a) C(6b) C(6a) C(5a) 20.3(3)
C(3a) C(6b) C(6a) 0(6) -50.1(3) C(3a) C(6b) C(6a) C (6’a) 162.3(2)
0(4) C(3a) C(6b) C(6a) -29.2(3) 0(4) 0(5) C(5a) 0(6) 59.5(4)
0(4) 0(5) C(5a) C(6a) -10.9(4) 0(5) 0(4) C(3a) C(6b) 19.8(3)
0(5) C(5a) 0(6) C(6a) -104.6(3) 0(5) C(5a) 0(6) 0(61) 4.8(4)
0(5) C(5a) 0(6) C(62) 149.3(3) 0(5) C(5a) C(6a) 0(6) 113.5(3)
0(5) C(5a) C(6a) C(6b) -0.4(3) 0(5) C(5a) C(6a) C (6’a) -140.6(2)
C(5a) 0(6) C(6a) C(6b) 105.7(3) C(5a) 0(6) C(6a) C (6’a) -107.7(3)
C(5a) C(6a) 0(6) 0(61) -110.8(3) C(5a) C(6a) C(6) C(62) 107.2(3)
0(6) C(5a) C(6a) C(6b) -113.9(3) 0(6) C(5a) C(6a) C (6’a) 105.8(3)
C(6a) C(5a) 0(6) 0(61) 109.4(3) C(6a) C(5a) 0(6) C(62) -106.1(3)
C(6b) 0(1) 0(2) 0(21) -136.8(3) C(6b) 0(1) 0(2) C(22) 97.6(3)
C(6b) C(6a) 0(6) 0(61) -5.1(4) C(6b) C(6a) 0(6) C(62) -147.1(3)
C(6’a) C(6a) 0(6) 0(61) 141.4(3) C(6’a) C(6a) 0(6) C(62) -0.6(3)
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Table 8. Non-bonded Contacts out to 3.60 Ä
atom atom distance ADC atom atom distance ADC
0(1) C(5) 3.581(3) 74602 N(6a’) 0(4) 3.439(4) 54501
N(6a’) C(6b) 3.488(4) 64602 N(6a’) C(3a) 3.518(4) 54501
2 5 2
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit number: 
TA (first digit) 4- TB (second digit) -f- TC (third digit) +  SN (last two digits). TA, TB and 
TC are the crystal lattice translation digits along cell edges a, b and c. A translation digit of 5 
indicates the origin unit cell. If TA = 4, this indicates a translation of one unit cell length along 
the a-axis in the negative direction. Each translation digit can range in value from 1 to 9 and 
thus ±4 lattice translations from the origin (TA=5, TB=5, TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant to 
this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN=1). Thus, the ADC for 
an origin atom is always 55501. The position of the second atom (target atom) can he generated 
using the ADC and the coordinates of the atom in the parameter table. For example, an ADC 
of 47502 refers to the target atom moved through symmetry operator two, then translated -1 
cell translations along the a axis, +2 cell translations along the b axis, and 0 cell translations 
along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) -X, 1/2+Y, -Z
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1.3 X-Ray Structure Report for Compound 65*
* X-ray crystal data are presented as provided by Dr. David Hockless (Research School of Chemistry, 
ANU).
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Experimental
Data Collection
A colorless plate crystal of C13H17O2N having approximate dimensions of 0.34 x 0.28 x 
0.08 mm was mounted on a glass fiber. All measurements were made on a Rigaku AFC6R 
diffractometer with graphite monochromated Cu-Ka radiation and a rotating anode generator.
Cell constants and an orientation matrix for data collection , obtained from a least-squares 
refinement using the setting angles of 22 carefully centered reflections in the range 50.07 < 29 
< 81.97° corresponded to a primitive orthorhombic cell with dimensions:
a = 11.745(1) Ä 
b = 11.918(1) Ä 
c = 8.879(2) Ä 
V = 1242.9(3) A 3
For Z = 4 and F.W. = 219.28, the calculated density is 1.17 g/cm3. The systematic absences of:
hOO: h #  2n 
OkO: k #  2n 
001: 1 #  2n
uniquely determine the space group to be:
P212121 (#19)
The data were collected at a temperature of -60 1°C using the uj-29 scan technique to
a maximum 29 value of 120.0°. Omega scans of several intense reflections, made prior to data 
collection, had an average width at half-height of 0.32° with a take-off angle of 6.0°. Scans of 
(1.10 -I- 0.30 tan 9)° were made at a speed of 8.0°/min (in omega). The weak reflections (I < 
10.0cr(I)) were rescanned (maximum of 4 scans) and the counts were accumulated to ensure good 
counting statistics. Stationary background counts were recorded on each side of the reflection. 
The ratio of peak counting time to background counting time was 2:1. The diameter of the 
incident beam collimator was 0.5 mm, the crystal to detector distance was 400 mm, and the 
detector aperture was 7.0 x 7.0 mm (horizontal x vertical).
Data Reduction
A total of 1104 reflections was collected. The intensities of three representative reflection 
were measured after every 150 reflections. No decay correction was applied.
The linear absorption coefficient, /i, for Cu-Ka radiation is 6.0 cm-1 . An empirical ab­
sorption correction based on azimuthal scans of several reflections was applied which resulted
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in transmission factors ranging from 0.90 to 1.00. The data were corrected for Lorentz and 
polarization effects. A correction for secondary extinction was applied (coefficient = 9.3(7)e-06).
Structure Solution and Refinement
The structure was solved by direct methods1 and expanded using Fourier techniques2. The 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were refined isotropically. 
The final cycle of full-matrix least-squares refinement3 was based on 934 observed reflections (I 
> 3.00cr(I)) and 214 variable parameters and converged (largest parameter shift was 0.00 times 
its esd) with unweighted and weighted agreement factors of:
R  = £ ||Fo | -  |F c ||/£ |F o | =  0.030
FU = ^(Xw(\Fo\ -  \Fc\)2/T.wFo'1)] = 0.032
The standard deviation of an observation of unit weight4 was 2.17. The weighting scheme 
was based on counting statistics and included a factor (p =  0.012) to downweight the intense 
reflections. Plots of £u;(|Fo| — \Fc\)2 versus |Fo|, reflection order in data collection, sin 9/ A and 
various classes of indices showed no unusual trends. The maximum and minimum peaks on the 
final difference Fourier map corresponded to 0.12 and -0.08 e“ / A 3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber5 . Anomalous dis­
persion effects were included in Fcalc6; the values for Af’ and A f’ were those of Creagh and 
McAuley7. The values for the mass attenuation coefficients are those of Creagh and Hubbel8. All 
calculations were performed using the teXsan9 crystallographic software package of Molecular 
Structure Corporation.
References
(1) SIR92: Altomare, A., Cascarano, M., Giacovazzo, C., Guagliardi, A. (1993). J. Appl. 
Cryst., 26, 343.
(2) DIRDIF94: Beurskens, P.T., Admiraal, G., Beurskens, G., Bosman, W.P., de Gelder, 
R., Israel, R. and Smits, J.M.M. (1994). The DIRDIF-94 program system, Technical Report of 
the Crystallography Laboratory, University of Nijmegen, The Netherlands.
(3) Least-Squares:
Function minimized: £tn(|Fo| — |Fc|)2
where w = = [a2(Fo) +  ^ F o 2]"1
ac(Fo) — e.s.d. based on counting statistics 
p = p-factor
(4) Standard deviation of an observation of unit weight:
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y/Xw{\Fo\ -  \Fc\y/ {No — Nv)  
where: No = number of observations 
Nv = number of variables
(5) Cromer, D. T. & Waber, J. T.; ’’International Tables for X-ray Crystallography”, Vol. 
IV, The Kynoch Press, Birmingham, England, Table 2.2 A (1974).
(6) Ibers, J. A. & Hamilton, W. C.; Acta Crystallogr., 17, 781 (1964).
(7) Creagh, D. C. &; McAuley, W.J .; ’’International Tables for Crystallography” , Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.6.8, pages 219-222 (1992).
(8) Creagh, D. C. Hubbell, J.H..; ’’International Tables for Crystallography”, Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.4.3, pages 200-206 (1992).
(9) teXsan: Crystal Structure Analysis Package, Molecular Structure Corporation (1985 &; 
1992).
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EXPERIMENTAL DETAILS
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type
No. of Reflections Used for Unit 
Cell Determination (29 range)
Omega Scan Peak Width 
at Half-height 
Lattice Parameters
Space Group 
Z value 
D c a /c 
Fooo
/i(CuKa)
Diffractometer
Radiation
A. Crystal Data
C 1 3 H 1 7 O 2 N
219.28
colorless, plate 
0.34 X 0.28 X 0.08 mm 
orthorhombic 
Primitive
22 ( 50.1 - 82.0° )
0.32°
a = 11.745(1)A 
b =  11.918(1) A 
c =  8.879(2) Ä
V = 1242.9(3) A3 
P212121 (#19)
4
1.172 g/cm3 
472.00 
5.98 cm-1
B. Intensity Measurements
Rigaku AFC6R 
CuKa (A =  1.54178 A)
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graphite monochromated
Take-off Angle 6.0°
Detector Aperture 7.0 mm horizontal
7.0 mm vertical
Crystal to Detector Distance 400 mm
Temperature -60.0°C
Scan Type w-2 e
Scan Rate 8.0°/m in (in a;) (up to 4 scans)
Scan W idth (1.10 +  0.30 tan 0)°
2 O m a x 120.0°
No. of Reflections Measured Total: 1104
Corrections Lorentz-polarization
Absorption
(trans. factors: 0.9044 - 1.0000) 
Secondary Extinction 
(coefficient: 9.3(7)e-06)
C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized Eu;(|Eo| -  |F c |)2
Least Squares Weights w  -  o )  +  it F o 2 ]  1
p-factor 0.0120
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I>3.00tr(I)) 934
No. Variables 214
Reflection/Parameter Ratio 4.36
Residuals: R; Rw 0.030 ; 0.032
Goodness of Fit Indicator 2.17
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Max Shift /Error in Final Cycle 0.00
Maximum peak in Final DifF. Map 0.12 e“/A3
Minimum peak in Final DifF. Map -0.08 e~/A3
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T able 1. A tom ic  coo rd ina tes and  B ,at>/B eq
a tom X y z B e?
0 (1 ) 0.0955(2) 0.1383(1) 0.9254(2) 4 .67(5)
0 (3 ) 0.2014(2) 0.0476(2) 1.0983(2) 5 .37(5)
N (6a’) -0.0284(3) 0.0131(2) 0.5270(3) 6 .93(9)
0 (2 ) 0.1732(3) 0.1577(2) 1.0461(4) 5.88(9)
C (3a) 0.2083(3) -0 .0220(2) 0.9660(3) 4 .60(7)
0 (4 ) 0.1827(3) -0 .1407(2) 1.0073(4) 5.16(8)
0 (5 ) 0.0957(3) -0 .1967(2) 0.9565(4) 5.30(8)
C (5a) 0.0074(3) -0 .1507(2) 0.8561(4) 4 .87(7)
0 (6 ) -0 .0749(2) -0 .0620(2) 0.9098(4) 5.14(8)
C (6a) 0.0225(2) -0 .0291(2) 0.8051(3) 3 .94(6)
C (6b) 0.1274(2) 0.0349(2) 0.8543(3) 3 .87(6)
C (6 a ’) -0 .0075(3) -0 .0060(2) 0.6501(4) 4 .79(7)
0 (2 1 ) 0.2792(5) 0.2179(4) 0.9923(7) 8.5(1)
C(22) 0 .1119(5) 0.2183(4) 1.1711(5) 8 .5(1)
0 (6 1 ) -0 .1940(3) -0 .0621(4) 0.8419(8) 7 .6(1)
C(62) -0 .0718(4) -0 .0247(4) 1.0744(5) 6 .6(1)
H (3a) 0.282(2) -0 .017(2) 0.922(3) 4 .9(7)
H(4) 0.242(3) -0 .175(3 ) 1.074(4) 6 .9(9)
H(5) 0 .082(3) -0 .272(3 ) 0.998(4) 8 .1(9)
H(5a) -0 .023(2) -0 .200(3) 0.782(3) 5 .4(7)
H (6b) 0.170(2) 0 .049(2) 0.766(3) 3 .4(6)
H(21a) 0.316(3) 0 .180(3) 0 .909(4) 7(1)
H (21b) 0.255(3) 0 .291(4) 0.948(5) 11(1)
H(21c) 0.334(4) 0 .230(4) 1.096(6) 15(1)
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Table 1. Atomic coordinates and Biao/B e9 (continued)
atom X y z B e ,
H(22a) 0.169(3) 0.234(3) 1.255(5) 10(1)
H(22b) 0.083(3) 0.281(3) 1.137(4) 9(1)
H(22c) 0.041(4) 0.171(4) 1.211(5) 13(2)
H(61a) -0.193(4) -0.091(4) 0.736(5) 11(1)
H(61b) -0.237(3) -0.103(4) 0.904(5) 10(1)
H(61c) -0.220(3) 0.016(3) 0.820(4) 7.4(9)
H(62a) -0.131(3) -0.068(3) 1.125(4) 8(1)
H(62b) -0.101(2) 0.048(3) 1.074(4) 5.8(7)
H(62c) 0.000(3) -0.027(3) 1.126(4) 5.7(9)
Beq — ^ 7r2(Lrii(a a * )2+ 6,22(6&*)2+ ^ 33(cc*)2+ 2£/i2aa*6&* cos 7+2{7i3aa*cc* cos ß + W ^ bb*cc* cos a)
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Table 2. Anisotropic Displacement Parameters
atom U n u22 u33 Ui2 Uw u23
0(1) 0.082(1) 0.0353(9) 0.060(1) 0.004(1) -0.016(1) -0.003(1)
0(3) 0.105(2) 0.041(1) 0.058(1) 0.014(1) -0.024(1) -0.005(1)
N(6a’) 0.114(2) 0.076(2) 0.073(2) 0.015(2) -0.029(2) -0.009(2)
0(2) 0.109(3) 0.043(2) 0.072(2) 0.007(2) -0.038(2) -0.005(2)
C(3a) 0.065(2) 0.048(2) 0.062(2) 0.007(2) -0.007(2) -0.008(2)
0(4) 0.086(3) 0.043(2) 0.067(2) 0.017(2) -0.014(2) -0.005(2)
0(5) 0.088(2) 0.035(1) 0.079(2) 0.010(2) -0.005(2) 0.001(2)
C(5a) 0.070(2) 0.036(1) 0.078(2) -0.001(2) -0.008(2) -0.005(2)
0(6) 0.059(2) 0.044(2) 0.092(2) 0.001(1) 0.012(2) 0.006(2)
C(6a) 0.058(2) 0.037(1) 0.055(2) 0.004(1) -0.004(1) -0.003(1)
C(6b) 0.057(2) 0.044(1) 0.046(2) 0.000(1) 0.003(1) -0.001(1)
C(6a’) 0.074(2) 0.044(2) 0.064(2) 0.006(2) -0.012(2) -0.007(2)
0(21) 0.119(4) 0.070(3) 0.132(4) -0.029(3) -0.054(4) 0.014(3)
C(22) 0.175(5) 0.063(2) 0.083(3) 0.044(3) -0.044(4) -0.029(2)
0(61) 0.059(2) 0.069(3) 0.161(5) -0.009(2) -0.003(3) 0.011(3)
C(62) 0.092(3) 0.059(2) 0.099(3) 0.022(2) 0.044(3) 0.018(2)
The general tem perature factor expression:
exp(-27r2(a*2*7n /i2 +  6*2[/22Jb2 +  c*2£/33/2 +  2a*b*U12hk + 2a*c*U13hl +  2b*cmU2akl))
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Table 3. Bond Lengths(A)
atom atom distance
0 (1 ) 0 (2 ) 1.426(3)
0 (3 ) 0 (2 ) 1.430(3)
N (6a’) C (6a’) 1.143(4)
0 (2 ) C(22) 1.508(5)
C(3a) C(6b) 1.531(4)
0(5) C(5a) 1.474(4)
C(5a) C(6a) 1.528(4)
0 (6 ) 0 (61) 1.524(5)
C(6a) C(6b) 1.514(4)
atom atom distance
0 (1 ) C(6b) 1.434(3)
0 (3 ) C(3a) 1.441(3)
0 (2 ) 0 (21) 1.515(6)
C(3a) C(4) 1.492(4)
0 (4 ) 0 (5 ) 1.302(4)
C(5a) 0 (6 ) 1.510(4)
0 (6 ) C(6a) 1.525(4)
0 (6 ) C(62) 1.528(6)
C(6a) C (6 a’) 1.447(4)
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Table 4. B o n d  L en gth s(A )
atom a to m distance
C (3a) H (3a) 0 .95(3 )
C(5) H (5) 0 .99(3 )
C (6b ) H (6b) 0 .94(2 )
C (21) H (21b) 1.00(5)
C (22) H (22a) 1.02(4)
C (22) H (22c) 1.06(4)
C (61) H (61b) 0 .89(4 )
C (62) R (6 2 a ) 0 .97(4 )
C (62) H (62c) 0 .95(3 )
a to m a to m distance
C (4) H (4) 1.00(3)
C (5 a ) H (5a) 0 .95(3 )
C (2 1 ) H (21a) 0 .97(3)
C (2 1 ) H (21c) 1.13(6)
C (22) H (22b) 0 .87(4 )
C (61) H (61a) 1.00(4)
C (61) H (61c) 1.00(4)
C (6 2 ) H (62b) 0 .93(3 )
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Table 5. Bond Angles(°)
atom atom atom angle atom atom atom angle
C(2) 0(1) C(6b) 107.6(2) 0(2) 0(3) C(3a) 106.1(2)
0(1) 0(2) 0(3) 104.1(2) 0(1) 0(2) 0(21) 111.5(3)
0(1) 0(2) C(22) 109.0(3) 0(3) 0(2) 0(21) 110.3(3)
0(3) 0(2) C(22) 108.1(3) 0(21) 0(2) C(22) 113.4(4)
0(3) C(3a) 0(4) 109.5(3) 0(3) C(3a) C(6b) 103.8(2)
0(4) C(3a) C(6b) 117.0(3) C(3a) 0(4) 0(5) 124.0(3)
0(4) 0(5) C(5a) 124.8(3) 0(5) C(5a) 0(6) 121.3(3)
0(5) C(5a) C(6a) 116.8(3) 0(6) C(5a) C(6a) 60.3(2)
C(5a) 0(6) C(6a) 60.5(2) C(5a) 0(6) 0(61) 117.6(3)
C(5a) 0(6) C(62) 119.4(3) C(6a) 0(6) 0(61) 116.6(3)
C(6a) 0(6) C(62) 119.4(3) 0(61) 0(6) C(62) 113.6(4)
C(5a) C(6a) 0(6) 59.3(2) C(5a) C(6a) C(6b) 119.1(2)
C(5a) C(6a) C(6a’) 115.7(3) 0(6) C(6a) C(6b) 124.3(3)
0(6) C(6a) C(6a’) 116.5(3) C(6b) C(6a) C(6a’) 112.1(2)
0(1) C(6b) C(3a) 105.0(2) 0(1) C(6b) C(6a) 110.3(2)
C(3a) C(6b) C(6a) 117.9(2) N(6a’) C(6a’) C(6a) 178.3(4)
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T a b le  6. B o n d  Angl<* ( ° )
a to m a to m a to m an g le
0 ( 3 ) C (3 a ) H (3 a) 110(2)
C (6 b ) C (3 a ) H (3 a ) 106(2)
0 ( 5 ) 0 ( 4 ) H (4 ) 123(2)
C (5 a ) 0 ( 5 ) H (5 ) 117(2)
0 ( 6 ) C (5 a ) H (5 a ) 114(2)
0 ( 1 ) C (6 b ) H (6 b ) 111(2)
C (6 a ) C (6 b ) H (6 b ) 107(1)
0 ( 2 ) 0 (2 1 ) H (2 1 b ) 108(3)
H (2 1 a ) 0 (2 1 ) H (2 1 b ) 103(4)
H (2 1 b ) 0 (2 1 ) H (21c) 112(3)
0 ( 2 ) C (2 2 ) H (2 2 b ) 110(3)
H (2 2 a ) C (2 2 ) H (2 2 b ) 110(3 )
H (2 2 b ) C (2 2 ) H (22c) 106(4)
0 ( 6 ) 0 (6 1 ) H (6 1 b ) 106(3)
H (6 1 a ) 0 ( 6 1 ) H (6 1 b ) 114(4)
H (6 1 b ) 0 (6 1 ) H (61c) 117(4)
0 ( 6 ) C (6 2 ) H (6 2 b ) 105(2)
H (6 2 a ) C (6 2 ) H (6 2 b ) 103(3)
H (6 2 b ) C (6 2 ) H (62c) 111(3)
a to m a to m a to m ang le
0 ( 4 ) C (3 a ) H (3 a ) 110(2)
C (3 a ) 0 ( 4 ) H (4 ) 113(2)
0 ( 4 ) 0 ( 5 ) H (5 ) 118(2)
C (5 ) C (5 a ) H (5 a ) 117(2)
C (6 a ) C (5 a ) H (5 a ) 115(2)
C (3 a ) C (6 b ) H (6 b ) 106(1)
0 ( 2 ) 0 ( 2 1 ) H (2 1 a ) 113(2)
0 ( 2 ) 0 ( 2 1 ) H (2 1 c) 106(3)
H (2 1 a ) 0 (2 1 ) H (2 1 c) 115(3)
0 ( 2 ) C (2 2 ) H (2 2 a ) 108(2)
0 ( 2 ) C (2 2 ) H (2 2 c) 111(3)
H (2 2 a ) C (2 2 ) H (2 2 c ) H l ( 3 )
0 ( 6 ) 0 (6 1 ) H (6 1 a ) 111(3)
0 ( 6 ) 0 ( 6 1 ) H (6 1 c) 111(2)
H (6 1 a ) 0 ( 6 1 ) H (6 1 c) 98(3 )
0 ( 6 ) C (6 2 ) H (6 2 a ) 106(2)
0 ( 6 ) C (6 2 ) H (6 2 c) 118(2)
H (6 2 a ) C (6 2 ) H (6 2 c) 113(3)
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Table 7. Torsion Angles(°)
atom atom atom atom angle atom atom atom atom angle
0(1) 0(2) 0(3) C(3a) 37.7(3) 0(1) C(6b) C(3a) 0(3) 7.8(3)
0(1) C(6b) C(3a) 0(4) 128.6(3) 0(1) C(6b) C(6a) C(5a) -126.3(3)
0(1) C(6b) C(6a) 0(6) -55.4(3) 0(1) C(6b) C(6a) C (6a’) 94.0(3)
0(3) 0(2) 0(1) C(6b) -32.5(3) 0(3) C(3a) 0(4) 0(5) 116.4(4)
0(3) C(3a) C(6b) C(6a) -115.5(3) N(6a’) C(6a’) C(6a) C(5a) -120.1(1)
N(6a’) C (6a’) C(6a) 0(6) 173.1(1) N(6a’) C(6a’) C(6a) C(6b) 21.1(1)
0(2) 0(1) C(6b) C(3a) 15.0(3) 0(2) 0(1) C(6b) C(6a) 143.0(2)
0(2) 0(3) C(3a) 0(4) -153.5(3) 0(2) 0(3) C(3a) C(6b) -27.8(3)
C(3a) 0(3) 0(2) 0(21) -82.0(4) C(3a) 0(3) 0(2) C(22) 153.5(3)
C(3a) 0(4) 0(5) C(5a) -2.5(6) C(3a) C(6b) C(6a) C(5a) -5.8(4)
C(3a) C(6b) C(6a) 0(6) 65.1(4) C(3a) C(6b) C(6a) C (6a’) -145.5(3)
0(4) C(3a) C(6b) C(6a) 5.3(4) 0(4) 0(5) C(5a) C(6) -68.0(5)
0(4) 0(5) C(5a) C(6a) 2.0(5) 0(5) 0(4) C(3a) C(6b) -1.3(5)
0(5) C(5a) 0(6) C(6a) 105.1(3) 0(5) C(5a) 0(6) 0(61) -148.4(4)
0(5) C(5a) 0(6) C(62) -4.1(4) 0(5) C(5a) C(6a) 0(6) -112.5(3)
0(5) C(5a) C(6a) C(6b) 2.3(4) 0(5) C(5a) C(6a) C (6a’) 140.7(3)
C(5a) 0(6) C(6a) C(6b) -106.3(3) C(5a) 0(6) C(6a) C (6a’) 105.5(3)
C(5a) C(6a) 0(6) 0(61) -108.1(3) C(5a) C(6a) 0(6) C(62) 109.2(3)
0(6) C(5a) C(6a) C(6b) 114.8(3) 0(6) C(5a) C(6a) C (6a’) -106.8(3)
C(6a) C(5a) 0(6) 0(61) 106.6(4) C(6a) C(5a) 0(6) C(62) -109.1(3)
C(6b) 0(1) 0(2) 0(21) 86.3(3) C(6b) 0(1) 0(2) C(22) -147.7(3)
C(6b) C(6a) 0(6) 0(61) 145.6(3) C(6b) C(6a) 0(6) C(62) 2.9(4)
C(6a’) C(6a) 0(6) 0(61) -2.6(4) C(6a’) C(6a) 0(6) C(62) -145.3(3)
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Table 8. Non-bonded Contacts out to 3.60 Ä
atom atom distance ADC atom atom distance
0(3) C(6b) 3.190(3) 2 0(3) C(3a) 3.446(4)
N(6a’) C(5) 3.550(4) 55604
ADC
2
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit number: 
TA (first digit) -f- TB (second digit) + TC (third digit) + SN (last two digits). TA, TB and 
TC are the crystal lattice translation digits along cell edges a, b and c. A translation digit of‘5 
indicates the origin unit cell. If TA = 4, this indicates a translation of one unit cell length along 
the a-axis in the negative direction. Each translation digit can range in value from 1 to 9 and 
thus ±A lattice translations from the origin (TA=5, TB=5, TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant to 
this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN=1). Thus, the ADC for 
an origin atom is always 55501. The position of the second atom (target atom) can be generated 
using the ADC and the coordinates of the atom in the parameter table. For example, an ADC 
of 47502 refers to the target atom moved through symmetry operator two, then translated -1 
cell translations along the a axis, +2 cell translations along the b axis, and 0 cell translations 
along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
( 1 ) X, Y, Z (2) 1/2-X, -Y, 1/2+Z
( 3 ) 1/2+X, 1/2-Y, -Z ( 4 ) -x, 1/2+Y, 1/2-Z
270
Appendices
1.4 X-Ray Structure Report for Compound 142*
n  C4A
C7’A
* X-ray crystal data are presented as provided by Dr. David Hockless (Research School of Chemistry, 
ANU).
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Experimental
Data Collection
A colorless prism crystal of C10H17O4.50 having approximate dimensions of 0.24 x 0.22 x 
0.16 mm was mounted on a glass fiber. All measurements were made on a Rigaku AFC6R 
diffractometer with graphite monochromated Cu-Ka radiation and a rotating anode generator.
Cell constants and an orientation matrix for data collection , obtained from a least-squares 
refinement using the setting angles of 25 carefully centered reflections in the range 25.10 < 29 
< 99.43° corresponded to a C-centered monoclinic cell with dimensions:
a = 23.651(1) Ä
b = 6.458(2) Ä ß =  114.089(5)° 
c = 15.444(1) Ä 
V = 2153.3(7) Ä3
For Z = 8 and F.W. = 209.24, the calculated density is 1.29 g/cm3. Based on the systematic 
absences of:
hkl: h+k ^  2n
packing considerations, a statistical analysis of intensity distribution, and the successful solution 
and refinement of the structure, the space group was determined to be:
C2 (#5)
The data were collected at a temperature of -80 ±  1°C using the u-29 scan technique to 
a maximum 29 value of 120.1°. Omega scans of several intense reflections, made prior to data 
collection, had an average width at half-height of 0.34° with a take-off angle of 6.0°. Scans of 
(1.20 + 0.30 tan 9)° were made at a speed of 16.0°/min (in omega). The weak reflections (I < 
lO.Oo-(I)) were rescanned (maximum of 4 scans) and the counts were accumulated to ensure good 
counting statistics. Stationary background counts were recorded on each side of the reflection. 
The ratio of peak counting time to background counting time was 2:1. The diameter of the 
incident beam collimator was 0.5 mm, the crystal to detector distance weis 400 mm, and the 
detector aperture was 7.0 x 7.0 mm (horizontal x vertical).
Data Reduction
Of the 1839 reflections which were collected, 1765 were unique (R,nt = 0.072). The in­
tensities of three representative reflection were measured after every 150 reflections. No decay 
correction was applied.
The linear absorption coefficient, p, for Cu-Ka radiation is 8.5 cm-1 . An empirical ab­
sorption correction based on azimuthal scans of several reflections was applied which resulted 
in transmission factors ranging from 0.80 to 1.00. The data were corrected for Lorentz and
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polarization effects.
Structure Solution and Refinement
The structure was solved by direct methods1 and expanded using Fourier techniques2. The 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were included but not refined. 
The final cycle of full-matrix least-squares refinement3 was based on 1631 observed reflections (I 
> 3.00<x(I)) and 260 variable parameters and converged (largest parameter shift was 0.00 times 
its esd) with unweighted and weighted agreement factors of:
R =  Z\\Fo\ -  |Fc||/E |Fo| = 0.036 
Rw =  y/(Ew(\Fo\ -  \Fc\y/ZwFo2)\ = 0.056
The standard deviation of an observation of unit weight4 was 2.34. The weighting scheme 
was based on counting statistics and included a factor (p = 0.033) to downweight the intense 
reflections. Plots of Eu>(|Fo| — |Fc|)2 versus |Fo|, reflection order in data collection, sin 6/ A and 
various classes of indices showed no unusual trends. The maximum and minimum peaks on the 
final difference Fourier map corresponded to 0.21 and -0.15 e~/ Ä3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber5 . Anomalous dis­
persion effects were included in Fcalc6; the values for Af’ and Af” were those of Creagh and 
McAuley7. The values for the mass attenuation coefficients are those of Creagh and Hubbel8. All 
calculations were performed using the teXsan9 crystallographic software package of Molecular 
Structure Corporation.
References
(1) SIR92: Altomare, A., Cascarano, M., Giacovazzo, C., Guagliardi, A. (1993). J. Appl. 
Cryst., 26, 343.
(2) DIRDIF94: Beurskens, P.T., Admiraal, G., Beurskens, G., Bosman, W.P., de Gelder, 
R., Israel, R. and Smits, J.M.M. (1994). The DIRDIF-94 program system, Technical Report of 
the Crystallography Laboratory, University of Nijmegen, The Netherlands.
(3) Least-Squares:
Function minimized: Eiu(|Fo| — |Fc|)2
where w = = [a2(Fo) +  ^ F o 2]"1
ac(Fo) = e.s.d. based on counting statistics 
p = p-factor
(4) Standard deviation of an observation of unit weight:
y/Xw{\Fo\ -  \Fc\)2/(No  -  Nv)
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where: No = number of observations 
Nv = number of variables
(5) Cromer, D. T. k  Waber, J. T.; ’’International Tables for X-ray Crystallography”, Vol. 
IV, The Kynoch Press, Birmingham, England, Table 2.2 A (1974).
(6) Ibers, J. A. k  Hamilton, W. C.; Acta Crystallogr., 17, 781 (1964).
(7) Creagh, D. C. k  McAuley, W.J .; ’’International Tables for Crystallography” , Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.6.8, pages 219-222 (1992).
(8) Creagh, D. C. k  Hubbell, J.H..; ’’International Tables for Crystallography”, Vol C, 
(A.J.C. Wilson, ed.), Kluwer Academic Publishers, Boston, Table 4.2.4.3, pages 200-206 (1992).
(9) teXsan: Crystal Structure Analysis Package, Molecular Structure Corporation (1985 k  
1992).
274
Appendices
EXPERIMENTAL DETAILS
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type
No. of Reflections Used for Unit 
Cell Determination (29 range)
Omega Scan Peak Width 
at Half-height 
Lattice Parameters
Space Group 
Z value 
D c a / c  
Fooo
p( CuKa)
A. Crystal Data
C 1 0 H 1 7 O 4 .5 0
209.24
colorless, prism 
0.24 X 0.22 X 0.16 mm 
monoclinic 
C-centered
25 ( 25.1 - 99.4° )
0.34°
a = 23.651(1)A 
b = 6.458(2) Ä
c = 15.444(1) A 
ß -  114.089(5)°
V = 2153.3(7) A3 
C2 (#5)
8
1.291 g/cm3 
904.00 
8.49 cm-1
B. Intensity Measurements
Diffractometer Rigaku AFC6R
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Radiation CuKa (A =  1.54178 Ä)  
graphite monochromated
Take-off Angle 6.0°
Detector Aperture 7.0 mm horizontal
7.0 mm vertical
Crystal to Detector Distance 400 mm
Temperature -80.0°C
Scan Type u -2 6
Scan Rate 16.0°/min (in cj) (up to 4 scans)
Scan Width (1.20 +  0.30 tan 9)°
2 9max 120.1°
No. of Reflections Measured Total: 1839
Unique: 1765 ( R =  0.072)
Corrections Lorentz-polarization
Absorption
(trans. factors: 0.8006 - 1.0000)
C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized X w ( \F o \  -  \F c \)2
Least Squares Weights » = ^k7  = k2(^) + ^ M - 1
p-factor 0.0330
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I>3.00cr(I)) 1631
No. Variables 260
Reflection/Parameter Ratio 6.27
Residuals: R; Rw 0.036 ; 0.056
Goodness of Fit Indicator 2.34
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M ax S h if t /E r ro r  in F in a l Cycle 0.00
M ax im u m  peak  in  F in a l Diff. M ap 0.21 e ~ / A 3
M in im u m  peak in  F in a l Diff. M ap -0.15 e ~ / Ä 3
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Table 1. Atomic coordinates and Biso/B eq
atom X y z Be?
0(01) -0.2965(1) 0.1869 -0.4972(2) 3.21(6)
0(2A ) -0.4080(1) -0.3896(5) -0.4182(2) 3.06(6)
0(3A ) -0.3078(1) -0.2292 -0.4551(2) 2.58(5)
0 (7 ’A) -0.2775(1) -0.3058(7) -0.1278(2) 4.72(8)
0(8A ) -0.3268(1) -0.1004(6) -0.0660(2) 3.84(7)
C(1A) -0.3588(2) -0.0850(7) -0.3213(2) 2.54(7)
C ( l ’A) -0.4155(2) 0.0285(8) -0.3904(3) 3.91(9)
C(2A) -0.3532(1) -0.3138(7) -0.3431(2) 2.45(7)
C(3A) -0.2995(2) -0.3478(7) -0.3720(2) 2.51(8)
C(4A) -0.2391(2) -0.2839(8) -0.2915(3) 3.34(9)
C(5A) -0.2382(2) -0.0545(9) -0.2648(3) 3.69(9)
C(6A) -0.2999(2) 0.0350(7) -0.2777(3) 3.22(8)
C(7’A) -0.3098(2) -0.1583(7) -0.1349(2) 2.89(8)
C(7A) -0.3358(2) -0.0147(7) -0.2161(3) 3.09(8)
C(8A) -0.3016(2) -0.2252(9) 0.0199(3) 4.5(1)
C(1B) -0.5742(1) -0.3395(7) -0.2541(2) 2.39(7)
C ( l ’B) -0.6135(2) -0.1516(7) -0.2970(3) 3.56(9)
C(2B) -0.5833(1) -0.5278(6) -0.3182(2) 2.30(7)
0(2B ) -0.6371(1) -0.4929(5) -0.4046(2) 2.73(5)
C(3B) -0.5273(2) -0.5661(8) -0.3408(3) 3.20(8)
0(3B ) -0.5156(1) -0.3914(7) -0.3884(2) 3.73(6)
C(4B) -0.4710(2) -0.6048(9) -0.2491(3) 3.9(1)
C(5B) -0.4551(2) -0.4214(9) -0.1812(3) 4.1(1)
C(6B) -0.5102(2) -0.3036(8) -0.1804(2) 3.12(8)
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Table 1. Atomic coordinates and Bia0/B eg (continued)
atom X y z Be?
C(7B) -0.5591(2) -0.3792(7) -0.1476(3) 2.98(8)
C (7’B) -0.5616(2) -0.5889(8) -0.1129(2) 2.83(8)
0 (7 ’B) -0.5380(1) -0.7452(6) -0.1266(2) 3.65(7)
C(8B) -0.6072(2) -0.7900(9) -0.0298(3) 4.6(1)
0(8B ) -0.5959(1) -0.5893(6) -0.0611(2) 3.70(6)
H(01a) -0.2618 0.1926 -0.5216 5.4194
H(01b) -0.2964 0.0310 -0.4579 5.4194
H (l’Aa) -0.4551 -0.0441 -0.3920 5.4194
H (l’Ab) -0.4147 -0.0255 -0.4555 5.4194
H (l’Ac) -0.4150 0.1839 -0.3789 5.4194
H ( l’Ba) -0.6018 -0.0423 -0.2519 4.2754
H (l’Bb) -0.6558 -0.1847 -0.3146 4.2754
H (l’Bc) -0.6075 -0.1094 -0.3516 4.2754
H(02B) -0.6533 -0.6479 -0.4177 5.4194
H(02A) -0.4455 -0.3884 -0.3957 5.4194
H(2A) -0.3481 -0.4177 -0.2799 5.4194
H(2B) -0.5983 -0.6761 -0.2881 5.4194
H(3B) -0.5359 -0.7175 -0.3832 5.4194
H(03A) -0.3370 -0.2959 -0.5030 5.4194
H(3A) -0.2935 -0.5279 -0.3754 5.4194
H(03B) -0.5494 -0.4071 -0.4509 5.4194
H(4Bb) -0.4789 -0.7217 -0.2185 4.6338
H(4Aa) -0.2016 -0.2957 -0.3100 5.4194
H(4Ab) -0.2315 -0.3512 -0.2342 5.4194
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Table 1. Atomic coordinates and Bt-,0/B e9 (continued)
atom X y z Be?
H(4Ba) -0.4366 -0.6327 -0.2640 4.6338
H(5Bb) -0.4300 -0.4697 -0.1214 5.4194
H(5Ab) -0.2081 -0.0335 -0.2092 5.4194
H(5Aa) -0.2076 -0.0190 -0.2950 5.4194
H(5Ba) -0.4341 -0.3451 -0.2235 5.4194
H(6B) -0.4959 -0.1329 -0.1656 5.4194
H(6A) -0.3052 0.2076 -0.2924 5.4194
H(7B) -0.5798 -0.2769 -0.1055 5.4194
H(7A) -0.3642 0.1225 -0.2047 5.4194
H(8Bc) -0.5691 -0.8473 0.0134 5.5225
H(8Ba) -0.6346 -0.7753 0.0008 5.5225
H(8Bb) -0.6252 -0.8791 -0.0830 5.5225
H(8Ab) -0.3259 -0.2056 0.0553 5.4032
H(8Ac) -0.2601 -0.1843 0.0570 5.4032
H(8Aa) -0.3024 -0.3672 0.0033 5.4032
B eq = ^ -^ (U u ia a * )2+U2 2 (bb*)2+U 3 3 (cc*)2 +2U\2aa*bb* cos 7+2f/i3aa*cc* cos ß+2U2sbb* cc* cos a )
«J
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Table 2. Anisotropic Displacement Parameters
atom Uii u 22 Ü 3 3 U12 U13 u 23
0(01) 0.035(1) 0.040(1) 0.047(2) 0.006(1) 0.017(1) 0.008(1)
0(2A) 0.027(1) 0.052(2) 0.036(1) -0.010(1) 0.012(1) -0.007(1)
0(3A) 0.028(1) 0.038(1) 0.027(1) -0.004(1) 0.007(1) 0.001(1)
0 (7 ’A) 0.070(2) 0.070(2) 0.041(2) 0.035(2) 0.024(2) 0.013(2)
0(8A) 0.061(2) 0.050(2) 0.036(1) 0.011(2) 0.021(1) -0.001(1)
C(1A) 0.027(2) 0.038(2) 0.025(2) 0.006(2) 0.005(1) -0.001(2)
C ( l’A) 0.043(2) 0.049(3) 0.042(2) 0.017(2) 0.004(2) 0.000(2)
C(2A) 0.024(2) 0.036(2) 0.029(2) -0.001(2) 0.007(1) -0.004(2)
C(3A) 0.029(2) 0.034(2) 0.032(2) 0.006(2) 0.012(1) 0.004(2)
C(4A) 0.023(2) 0.063(3) 0.034(2) 0.007(2) 0.004(2) 0.001(2)
C(5A) 0.026(2) 0.067(3) 0.036(2) -0.010(2) 0.001(2) -0.005(2)
C(6A) 0.046(2) 0.035(2) 0.032(2) -0.001(2) 0.006(2) 0.000(2)
C(7’A) 0.035(2) 0.043(2) 0.027(2) 0.002(2) 0.009(2) -0.006(2)
C(7A) 0.038(2) 0.041(2) 0.031(2) 0.009(2) 0.007(2) -0.001(2)
C(8A) 0.082(3) 0.059(3) 0.032(2) 0.006(3) 0.025(2) 0.003(2)
C(1B) 0.027(2) 0.032(2) 0.030(2) -0.002(2) 0.010(1) -0.006(2)
C ( l’B) 0.054(2) 0.034(2) 0.039(2) 0.003(2) 0.010(2) 0.004(2)
C(2B) 0.023(2) 0.033(2) 0.026(2) 0.002(2) 0.004(1) -0.001(2)
0(2B) 0.028(1) 0.036(1) 0.030(1) -0.003(1) 0.002(1) 0.005(1)
C(3B) 0.032(2) 0.054(2) 0.036(2) 0.005(2) 0.014(2) -0.002(2)
0(3B) 0.028(1) 0.078(2) 0.033(1) -0.007(1) 0.010(1) 0.006(2)
C(4B) 0.031(2) 0.074(3) 0.044(2) 0.014(2) 0.017(2) 0.006(2)
C(5B) 0.029(2) 0.084(4) 0.035(2) -0.007(2) 0.004(2) 0.007(2)
C(6B) 0.033(2) 0.048(2) 0.031(2) -0.010(2) 0.008(2) 0.001(2)
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Table 2. Anisotropic Displacement Parameters (continued)
a tom U n u 22 U33 U12 U13 u 23
C(7B) 0.044(2) 0.039(2) 0.030(2) -0.007(2) 0.016(2) -0.001(2)
C(7’B) 0.028(2) 0.053(3) 0.020(2) -0.004(2) 0.003(1) -0.002(2)
0 (7 ’B) 0.056(2) 0.040(2) 0.039(2) 0.008(1) 0.015(1) 0.005(1)
C(8B) 0.052(3) 0.068(3) 0.047(2) -0.020(3) 0.011(2) 0.012(3)
0(8B ) 0.041(1) 0.061(2) 0.039(1) -0.007(2) 0.016(1) 0.004(2)
The general tem perature factor expression:
exp(-27T2(a*2[ /n / i2 +  6*2[/22)fc2 +  c*2U33l2 +  2a*b*Ui2h k  +  2 a*c*U13hl +  2 b*c*U23kl))
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Table 3. Bond Lengths(A)
atom atom distance atom atom distance
0(2A ) C(2A) 1.427(4) 0(3A) C(3A) 1.438(4)
0 (7 ’A) C(7’A) 1.197(5) 0(8A) C (7’A) 1.335(5)
0(8A ) C(8A) 1.456(5) C(1A) C ( l ’A) 1.519(5)
C(1A) C(2A) 1.533(6) C(1A) C(6A) 1.493(5)
C(1A) C(7A) 1.557(5) C(2A) C(3A) 1.524(5)
C(3A) C(4A) 1.519(5) C(4A) C(5A) 1.536(7)
C(5A) C(6A) 1.505(6) C(6A) C(7A) 1.546(6)
C(7’A) C(7A) 1.476(6) C(1B) C ( l ’B) 1.507(5)
C(1B) C(2B) 1.527(5) C(1B) C(6B) 1.496(5)
C(1B) C(7B) 1.555(5) C(2B) 0(2B ) 1.437(4)
C(2B) C(3B) 1.519(5) C(3B) 0(3B ) 1.435(6)
C(3B) C(4B) 1.517(5) C(4B) C(5B) 1.523(7)
C(5B) C(6B) 1.513(6) C(6B) C(7B) 1.521(5)
C(7B) C(7’B) 1.466(6) C(7’B) 0 (7 ’B) 1.212(5)
C(7’B) 0(8B ) 1.354(4) C(8B) 0(8B ) 1.445(6)
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Table 4. Bond Lengths(A)
atom atom distance atom atom distance
0(01) H(01a) 1.03 0(01) H(01b) 1.18
0(2A ) H(02A) 1.08 0(3A ) H(03A) 0.89
C ( l ’A) H (l’Aa 1.04 C ( l ’A) H (l’Ab 1.07
C ( l ’A) H (l’Ac 1.02 C(2A) H(2A) 1.15
C(3A) H(3A) 1.17 C(4A) H(4Aa) 1.04
C(4A) H(4Ab) 0.94 C(5A) H(5Ab) 0.87
C(5A) H(5Aa) 1.03 C(6A) H(6A) 1.13
C(7A) H(7A) 1.17 C(8A) H(8Ab) 0.95
C(8A) H(8Ac) 0.95 C(8A) H(8Aa) 0.95
C ( l ’B) H (l’Ba 0.95 C ( l ’B) H (l’Bb 0.95
C ( l ’B) H (l’Bc 0.95 C(2B) H(2B) 1.18
0(2B ) H(02B) 1.06 C(3B) H(3B) 1.15
0(3B ) H(03B) 0.98 C(4B) H(4Bb) 0.95
C(4B) H(4Ba) 0.95 C(5B) H(5Bb) 0.92
C(5B) H(5Ba) 1.09 C(6B) H(6B) 1.15
C(7B) H(7B) 1.17 C(8B) H(8Bc) 0.95
C(8B) H(8Ba) 0.95 C(8B) H(8Bb) 0.95
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Table 5. Bond Angles(°)
atom atom atom angle atom atom atom angle
C(7’A) 0(8A ) C(8A) 115.3(3) C ( l ’A) C(1A) C(2A) 116.2(3)
C ( l’A) C(1A) C(6A) 117.4(4) C ( l ’A) C(1A) C(7A) 115.1(3)
C(2A) C(1A) C(6A) 116.9(3) C(2A) C(1A) C(7A) 119.0(3)
C(6A) C(1A) C(7A) 60.9(2) 0(2A ) C(2A) C(1A) 112.2(3)
0(2A ) C(2A) C(3A) 107.5(3) C(1A) C(2A) C(3A) 111.0(3)
0(3A ) C(3A) C(2A) 111.0(3) 0(3A ) C(3A) C(4A) 109.0(3)
C(2A) C(3A) C(4A) 109.9(3) C(3A) C(4A) C(5A) 112.7(3)
C(4A) C(5A) C(6A) 115.4(4) C(1A) C(6A) C(5A) 122.4(4)
C(1A) C(6A) C(7A) 61.6(3) C(5A) C(6A) C(7A) 125.8(4)
0 (7 ’A) C(7’A) 0(8A ) 122.5(4) 0 (7 ’A) C(7’A) C(7A) 127.4(4)
0(8A ) C(7’A) C(7A) 110.1(3) C(1A) C(7A) C(6A) 57.5(2)
C(1A) C(7A) C(7’A) 123.4(4) C(6A) C(7A) C(7’A) 120.7(3)
C ( l’B) C(1B) C(2B) 117.2(3) C ( l’B) C(1B) C(6B) 117.4(3)
C ( l’B) C(1B) C(7B) 115.6(3) C(2B) C(1B) C(6B) 116.6(3)
C(2B) C(1B) C(7B) 117.7(3) C(6B) C(1B) C(7B) 59.8(2)
C(1B) C(2B) 0(2B ) 108.3(3) C(1B) C(2B) C(3B) 111.9(3)
0(2B ) C(2B) C(3B) 109.8(3) C(2B) C(3B) 0(3B ) 111.0(3)
C(2B) C(3B) C(4B) 109.2(3) 0(3B ) C(3B) C(4B) 109.1(3)
C(3B) C(4B) C(5B) 113.0(4) C(4B) C(5B) C(6B) 115.1(3)
C(1B) C(6B) C(5B) 121.6(4) C(1B) C(6B) C(7B) 62.1(2)
C(5B) C(6B) C(7B) 128.1(4) C(1B) C(7B) C(6B) 58.2(2)
C(1B) C(7B) C (7’B) 120.8(3) C(6B) C(7B) C (7’B) 124.6(4)
C(7B) C(7’B) 0 (7 ’B) 128.0(3) C(7B) C(7’B) 0(8B ) 109.9(4)
0 (7 ’B) C(7’B) 0(8B ) 122.0(4) C(7’B) 0(8B ) C(8B) 115.9(4)
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Table 5. Bond Angles(°) (continued)
atom atom atom angle atom atom atom angle
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Table 6. Bond Angles(°)
atom atom atom angle atom atom atom angle
H(01a) 0(01) H(01b) 112.5 C(2A) 0(2A) H(02A) 109.3
C(3A) 0(3A) H(03A) 105.2 C(1A) C (l’A) H (l’Aa 109.2
C(1A) C ( l’A) H (l’Ab 98.8 C(1A) C (l’A) H (l’Ac 114.2
H (l’Aa C (l’A) H (l’Ab 101.0 H (l’Aa C (l’A) H (l’Ac 113.3
H (l’Ab C (l’A) H (l’Ac 118.7 0(2A) C(2A) H(2A) 103.7
C(1A) C(2A) H(2A) 111.5 C(3A) C(2A) H(2A) 110.6
0(3A) C(3A) H(3A) 117.5 C(2A) C(3A) H(3A) 106.6
C(4A) C(3A) H(3A) 102.4 C(3A) C(4A) H(4Aa) 112.3
C(3A) C(4A) H(4Ab) 113.6 C(5A) C(4A) H(4Aa) 103.0
C(5A) C(4A) H(4Ab) 102.6 H(4Aa) C(4A) H(4Ab) 111.8
C(4A) C(5A) H(5Ab) 109.2 C(4A) C(5A) H(5Aa) 91.6
C(6A) C(5A) H(5Ab) 115.3 C(6A) C(5A) H(5Aa) 132.4
H(5Ab) C(5A) H(5Aa) 88.2 C(1A) C(6A) H(6A) 114.4
C(5A) C(6A) H(6A) 115.2 C(7A) C(6A) H(6A) 106.5
C(1A) C(7A) H(7A) 113.6 C(6A) C(7A) H(7A) 115.4
C(7’A) C(7A) H(7A) 114.5 0(8A) C(8A) H(8Ab) 109.5
0(8A) C(8A) H(8Ac) 109.5 0(8A) C(8A) H(8Aa) 109.5
H(8Ab) C(8A) H(8Ac) 109.5 H(8Ab) C(8A) H(8Aa) 109.5
H(8Ac) C(8A) H(8Aa) 109.5 C(1B) C (l’B) H (l’Ba 109.5
C(1B) C ( l’B) H (l’Bb 109.5 C(1B) C (l’B) H (l’Bc 109.5
H (l’Ba C (l’B) H (l’Bb 109.5 H (l’Ba C (l’B) H (l’Bc 109.5
H (l’Bb C (l’B) H (l’Bc 109.5 C(1B) C(2B) H(2B) 112.0
0(2B) C(2B) H(2B) 101.4 C(3B) C(2B) H(2B) 112.9
C(2B) 0(2B) H(02B) 98.2 C(2B) C(3B) H(3B) 107.6
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Table 6. Bond Angles(°) (continued)
atom atom atom angle atom atom atom angle
0(3B) C(3B) H(3B) 113.7 C(4B) C(3B) H(3B) 106.0
C(3B) 0(3B) H(03B) 100.0 C(3B) C(4B) H(4Bb) 108.6
C(3B) C(4B) H(4Ba) 108.6 C(5B) C(4B) H(4Bb) 108.6
C(5B) C(4B) H(4Ba) 108.6 H(4Bb) C(4B) H(4Ba) 109.5
C(4B) C(5B) H(5Bb) 107.6 C(4B) C(5B) H(5Ba) 89.1
C(6B) C(5B) H(5Bb) 111.4 C(6B) C(5B) H(5Ba) 112.5
H(5Bb) C(5B) H(5Ba) 119.3 C(1B) C(6B) H(6B) 115.1
C(5B) C(6B) H(6B) 107.4 C(7B) C(6B) H(6B) 116.4
C(1B) C(7B) H(7B) 121.9 C(6B) C(7B) H(7B) 123.6
C(7’B) C(7B) H(7B) 103.4 0(8B) C(8B) H(8Bc) 109.5
0(8B) C(8B) H(8Ba) 109.5 0(8B) C(8B) H(8Bb) 109.5
H(8Bc) C(8B) H(8Ba) 109.5 H(8Bc) C(8B) H(8Bb) 109.5
H(8Ba) C(8B) H(8Bb) 109.5
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Table 7. Torsion Angles(°)
atom atom atom atom angle atom atom atom atom angle
0(2A) C(2A) C(1A) C ( l ’A) -8.7(5) 0(2A ) C(2A) C(1A) C(6A) -154.3(3)
0(2A) C(2A) C(1A) C(7A) 135.7(3) 0(2A ) C(2A) C(3A) 0(3A ) 63.4(4)
0(2A) C(2A) C(3A) C(4A) -176.0(3) 0(3A ) C(3A) C(2A) C(1A) -59.7(4)
0(3A) C(3A) C(4A) C(5A) 61.4(4) 0 (7 ’A) C(7’A) 0(8A ) C(8A) 2.0(6)
0 (7 ’A) C(7’A) C(7A) C(1A) 36.6(6) 0 (7 ’A) C(7’A) C(7A) C(6A) -32.5(6)
0(8A) C(7’A) C(7A) C(1A) -144.0(3) 0(8A ) C(7’A) C(7A) C(6A) 146.9(4)
C(1A) C(2A) C(3A) C(4A) 60.9(4) C(1A) C(6A) C(5A) C(4A) -5.1(5)
C(1A) C(6A) C(7A) C(7’A) 112.4(4) C(1A) C(7A) C(6A) C(5A) -111.2(5)
C ( l’A) C(1A) C(2A) C(3A) 111.6(4) C ( l ’A) C(1A) C(6A) C(5A) -138.6(4)
C ( l’A) C(1A) C(6A) C(7A) 105.0(4) C ( l ’A) C(1A) C(7A) C(6A) -108.7(4)
C ( l’A) C(1A) C(7A) C(7’A) 143.6(4) C(2A) C(1A) C(6A) C(5A) 6.5(5)
C(2A) C(1A) C(6A) C(7A) -109.9(4) C(2A) C(1A) C(7A) C(6A) 106.4(4)
C(2A) C(1A) C(7A) C(7’A) -1.3(5) C(2A) C(3A) C(4A) C(5A) -60.4(4)
C(3A) C(2A) C(1A) C(6A) -33.9(4) C(3A) C(2A) C(1A) C(7A) -103.9(3)
C(3A) C(4A) C(5A) C(6A) 31.8(5) C(4A) C(5A) C(6A) C(7A) 71.2(5)
C(5A) C(6A) C(1A) C(7A) 116.4(4) C(5A) C(6A) C(7A) C(7’A) 1.3(6)
C(6A) C(1A) C(7A) C(7’A) -107.7(4) C(7A) C(7’A) 0(8A ) C(8A) -177.4(3)
C(1B) C(2B) C(3B) 0(3B ) -60.0(4) C(1B) C(2B) C(3B) C(4B) 60.3(5)
C(1B) C(6B) C(5B) C(4B) -11.5(6) C(1B) C(6B) C(7B) C(7’B) 107.8(4)
C(1B) C(7B) C(6B) C(5B) -109.8(4) C(1B) C(7B) C(7’B) 0 (7 ’B) 49.6(6)
C(1B) C(7B) C (7’B) 0(8B) -129.8(3) C ( l ’B) C(1B) C(2B) 0(2B) -10.0(4)
C ( l’B) C(1B) C(2B) C(3B) 111.1(4) C ( l ’B) C(1B) C(6B) C(5B) -135.3(4)
C ( l’B) C(1B) C(6B) C(7B) 105.1(4) C ( l ’B) C(1B) C(7B) C(6B) -108.2(4)
C ( l ’B) C(1B) C(7B) C(7’B) 137.8(4) C(2B) C(1B) C(6B) C(5B) 11.4(5)
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Table 7. Torsion Angles(°) (continued)
atom atom atom atom angle atom atom atom atom angle
C(2B) C (1B) C(6B) C(7B) -108.1(4) C(2B) C(1B) C(7B) C(6B) 106.2(4)
C(2B) C (1B) C(7B) C (7 ’B) -7.8(5) C(2B) C(3B) C(4B) C(5B) -61.2(5)
0 (2B ) C(2B) C(1B) C(6B) -156.8(3) 0 (2 B ) C(2B) C(1B) C(7B) 135.1(3)
0 (2B ) C(2B) C(3B) 0 (3 B ) 60.2(4) 0 (2 B ) C(2B) C(3B) C(4B) -179.5(4)
C(3B) C(2B) C(1B) C(6B) -35.7(4) C(3B) C(2B) C(1B) C(7B) -103.8(4)
C(3B) C(4B) C(5B) C(6B) 36.3(5) 0 (3 B ) C(3B) C(4B) C(5B) 60.3(4)
C(4B) C(5B) C(6B) C(7B) 66.0(5) C(5B) C(6B) C(1B) C(7B) 119.5(5)
C(5B) C(6B) C(7B) C (7 ’B) -2.0(6) C(6B) C(1B) C(7B) C (7 ’B) -114.0(4)
C(6B) C (7B) C (7 ’B) 0 (7 ’B) -20.8(6) C(6B) C(7B) C (7 ’B) 0 (8 B ) 159.8(3)
C(7B) C (7 ’B)
PQooo C(8B) 174.4(3) 0 (7 ’B) C (7 ’B) 0 (8 B ) C(8B) -5.1(5)
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Table 8. Non-bonded Contacts out to 3.60 Ä
atom atom distance ADC
0(01) 0(2B ) 2.664(3) 46402
0(01) 0(3A ) 2.901(3) 45404
0(01) C(3A) 3.589(4) 56501
0(2A) 0(3B ) 2.790(4) 45402
0(2A) C(3B) 3.585(5) 45402
0(3A) C ( l ’B) 3.543(5) 45402
0 (7 ’A) 0(8A ) 3.555(4) 44504
0(8A) C(5B) 3.502(5) 1
C(5A) 0(8B ) 3.554(4) 3
C(5B) 0(8B ) 3.599(5) 45502
C(7’B) 0(8B ) 3.595(4) 45502
0 (7 ’B) Q(8B) 3.457(4) 45502
atom atom distance ADC
0(01) 0(3A ) 2.8032(9) 1
0(01) C(6A) 3.560(5) 1
0(2A) 0(3B ) 2.763(3) 1
0(2A) 0(2B ) 3.386(4) 45402
0(3A) 0(2B ) 2.643(3) 45402
0 (7 ’A) C(8A) 3.328(6) 44504
0(8A) C(8B) 3.246(5) 46502
C(3A) 0(2B ) 3.288(4) 45402
C(8A) C(8B) 3.584(7) 46502
C(7’B) C (7’B) 3.515(6) 45502
0 (7 ’B) C(8B) 3.307(5) 45502
0 (7 ’B) 0 (7 ’B) 3.574(5) 45502
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit number: 
TA (first digit) -f TB (second digit) + TC (third digit) + SN (last two digits). TA, TB and 
TC are the crystal lattice translation digits along cell edges a, b and c. A translation digit of 5 
indicates the origin unit cell. If TA = 4, this indicates a translation of one unit cell length along 
the a-axis in the negative direction. Each translation digit can range in value from 1 to 9 and 
thus ±A lattice translations from the origin (TA=5, TB=5, TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant to 
this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN=1). Thus, the ADC for 
an origin atom is always 55501. The position of the second atom (target atom) can be generated 
using the ADC and the coordinates of the atom in the parameter table. For example, an ADC 
of 47502 refers to the target atom moved through symmetry operator two, then translated -1 
cell translations along the a axis, -(-2 cell translations along the b axis, and 0 cell translations 
along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) -X, Y, -Z
292
Appendices
1.5 X-Ray Structure Report for Compound 209*
* X-ray crystal data are presented as provided by Dr. David Hockless (Research School of Chemistry, 
ANU).
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Experimental
Data Collection
A colorless prism crystal of C2 2 H2 2 CI4 O8  having approximate dimensions of 0.34 x 0.28 
x 0.18 mm was mounted on a glass fiber. All measurements were made on a Rigaku AFC6R 
diffractometer with graphite monochromated Mo-Ka radiation and a rotating anode generator.
Cell constants and an orientation matrix for data collection , obtained from a least-squares 
refinement using the setting angles of 25 carefully centered reflections in the range 9.19 < 20 < 
26.33° corresponded to a primitive monoclinic cell with dimensions:
a =  7.854(3) A
b =  13.794(1) A ß  =  92.95(2)° 
c =  12.147(2) A 
V =  1314.3(5) A3
For Z =  2 and F.W. =  556.22, the calculated density is 1.41 g /cm 3. Based on the systematic 
absences of:
OkO: k ^  2n
packing considerations, a statistical analysis of intensity distribution, and the successful solution 
and refinement of the structure, the space group was determined to be:
P2i (# 4 )
The data were collected at a temperature of -60 ±  14C using the u-29 scan technique to 
a maximum 26 value of 60.0°. Omega scans of several intense reflections, made prior to data 
collection, had an average width at half-height of 0.32° with a take-off angle of 6.0°. Scans of 
(0.89 +  0.30 tan 0)° were made at a speed of 4.0°/m in (in omega). The weak reflections (I < 
lO.Oo’(I)) were rescanned (maximum of 4 scans) and the counts were accumulated to ensure good 
counting statistics. Stationary background counts were recorded on each side of the reflection. 
The ratio of peak counting time to background counting time was 2:1. The diameter of the 
incident beam collimator was 0.5 mm, the crystal to detector distance was 400 mm, and the 
detector aperture was 7.0 x 7.0 mm (horizontal x vertical).
Data Reduction
Of the 4260 reflections which were collected, 4001 were unique (R,„i =  0.038). The in­
tensities of three representative reflection were measured after every 150 reflections. No decay 
correction was applied.
The linear absorption coefficient, /i, for Mo-Ka radiation is 4.9 cm- 1 . An empirical ab­
sorption correction based on azimuthal scans of several reflections was applied which resulted 
in transmission factors ranging from 0.94 to 1.00. The data were corrected for Lorentz and
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polarization effects.
Structure Solution and Refinement
The structure was solved by direct methods1 and expanded using Fourier techniques2. The' 
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were included but not refined. 
The final cycle of full-matrix least-squares refinement3 was based on 1803 observed reflections (I 
> 3.00<j (I)) and 305 variable parameters and converged (largest parameter shift was 0.00 times 
its esd) with unweighted and weighted agreement factors of:
R  = £ ||Fo | -  |F c ||/£ |F o | =  0.041 
Rw = y/(Lw(\Fo\ -  \Fc\)2/HwFo2)] = 0.035
The standard deviation of an observation of unit weight4 was 1.60. The weighting scheme 
was based on counting statistics and included a factor (p =  0.010) to downweight the intense 
reflections. Plots of Ein(|i:r'o| — |.Fc|)2 versus |.Fo|, reflection order in data collection, sin 6/ A and 
various classes of indices showed no unusual trends. The maximum and minimum peaks on the 
final difference Fourier map corresponded to 0.24 and -0.20 e“ /A3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber5 . Anomalous dis­
persion effects were included in Fcalc6; the values for Af’ and Af” were those of Creagh and 
McAuley7. The values for the mass attenuation coefficients are those of Creagh and Hubbel8. All 
calculations were performed using the teXsan9 crystallographic software package of Molecular 
Structute Corporation.
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Nv = number of variables
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EXPERIMENTAL DETAILS
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type
No. of Reflections Used for Unit 
Cell Determination (26 range)
Omega Scan Peak Width 
at Half-height 
Lattice Parameters
Space Group 
Z value 
D c a / c
Fooo
/i(MoKa)
A. Crystal Data
C 2 2 H 2 2 O 4 O 8
556.22
colorless, prism 
0.34 X 0.28 X 0.18 mm 
monoclinic 
Primitive
25 ( 9.2 - 26.3° )
0.32°
a = 7.854(3)A 
b = 13.794(1) Ä 
c =  12.147(2) A 
/?=  92.95(2)°
V = 1314.3(5) A3 
P2i (#4)
2
1.405 g/cm3 
572.00 
4.92 cm-1
B. Intensity Measurements
Diffractometer Rigaku AFC6R
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Radiation MoKa (A =  0.71069 Ä)  
graphite monochromated
Take-off Angle 6.0°
Detector Aperture 7.0 mm horizontal
7.0 mm vertical
Crystal to Detector Distance 400 mm
Temperature -60.0°C
Scan Type ui-26
Scan Rate 4.0°/min (in u;) (up to 4 scans)
Scan Width (0.89 + 0.30 tan 0)°
2 @max 60.0°
No. of Reflections Measured Total: 4260
Unique: 4001 (Rjnt =  0.038)
Corrections Lorentz-polarization
Absorption
(trans. factors: 0.9397 - 1.0000)
C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized S uj( |F  o| — |Fc |)2
Least Squares Weights w -  -  M(Fo) + \ F o ~] 1
p-factor 0.0100
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I>3.00<r(I)) 1803
No. Variables 305
Reflection/Parameter Ratio 5.91
Residuals: R; Rw 0.041 ; 0.035
Goodness of Fit Indicator 1.60
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M ax S h i f t /E r r o r  in  F in a l C yc le 0 .00
M a x im u m  p ea k  in  F in a l D iff. M ap 0.24  e ~ / A 3
M in im u m  p ea k  in  F in a l D iff. M ap -0 .2 0  e ~ / Ä 3
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Table 1. Atomic coordinates and B ^0/B e9
atom X y z B e<7
0(71) -0.9519(2) 0.2464 -0.3050(2) 5.77(5)
0 (7 1 ’) -0.1135(2) -0.2797(2) -0.3683(1) 4.38(4)
0(72) -0.6970(2) 0.1969(2) -0.1316(1) 5.25(5)
0 (7 2 ’) -0.1694(3) -0.4234 -0.1973(2) 5.21(5)
0(2) -0.3498(5) 0.2629(3) -0.3900(3) 3.2(1)
0 (2 ’) 0.0693(5) -0.1106(3) -0.0835(3) 3.0(1)
0(3) -0.3491(5) 0.0779(3) -0.4562(3) 3.0(1)
0 (3 ’) -0.2441(5) -0.0415(3) -0.0508(3) 2.8(1)
0 (8 ’) 0.2385(6) -0.2177(3) -0.1634(4) 3.7(1)
0(8) -0.4460(8) 0.3833(4) -0.2858(5) 5.5(2)
0(10) -0.0950(6) 0.0040(4) -0.4299(4) 5.0(1)
0(10’) -0.2463(9) 0.1205(4) -0.0654(4) 6.3(2)
C(l) -0.6260(7) 0.1933(4) -0.3567(5) 2.6(1)
C (l’) -0.1451(8) -0.2291(4) -0.1431(5) 2.8(1)
0(2) -0.4376(8) 0.1937(5) -0.3236(5) 2.6(1)
0 (2 ’) -0.0627(7) -0.1308(5) -0.1671(5) 2.5(1)
0(3) -0.3505(7) 0.0965(4) -0.3388(5) 2.4(1)
0(3’) -0.1910(7) -0.0491(4) -0.1633(5) 2.3(1)
0(4) -0.4451(8) 0.0150(4) -0.2843(5) 2.3(1)
0 (4 ’) -0.3482(7) -0.0679(5) -0.2375(5) 2.6(1)
0(5) -0.6149(8) 0.0185(4) -0.2842(5) 2.8(1)
0 (5 ’) -0.4039(8) -0.1601(5) -0.2527(5) 3.0(2)
0(6) -0.7186(7) 0.0969(5) -0.3360(5) 2.9(1)
0(6’) -0.3271(8) -0.2432(4) -0.1911(5) 3.3(1)
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Table 1. Atomic coordinates and Bjao/B e9 (continued)
atom X y z Be?
C(7) -0.7558(7) 0.1903(5) -0.2723(5) 3.6(2)
C(7’) -0.1809(8) -0.2996(5) -0.2353(5) 3.6(2)
C(8) -0.370(1) 0.3577(5) -0.3624(6) 3.9(2)
C(8’) 0.2148(8) -0.1620(5) -0.0898(6) 3.0(2)
C(9) -0.283(1) 0.4222(6) -0.4432(6) 5.0(2)
C (9’) 0.3384(9) -0.1396(6) 0.0043(6) 4.5(2)
C(10) -0.210(1) 0.0305(5) -0.4906(6) 4.0(2)
C(IO’) -02652(9) 0.0497(5) -0.0108(6) 3.4(2)
C ( ll) -0.222(1) 0.0216(6) -0.6142(6) 5.1(2)
C ( l l ’) -0.314(1) 0.0458(5) 0.1063(6) 5.1(2)
H ( l ) -0.6494 0.2115 -0.4504 6.0847
H(V) -0.0873 -0.2505 -0.0645 6.0847
H(2) -0.4233 0.2122 -0.2484 3.0931
H(2’) -0.0152 -0.1325 -0.2374 3.0194
H(3) -0.2368 0.0995 -0.3084 2.8358
H(3’) -0.1392 0.0100 -0.1841 2.8021
H(5) -0.6723 -0.0324 -0.2487 3.3746
H(5’) -0.4957 -0.1720 -0.3050 3.6002
H(6) -0.8424 0.0924 -0.3813 6.0847
H(6’) -0.3999 -0.3039 -0.1428 6.0847
H(9c) -0.2110 0.3841 -0.4864 6.0206
H(9a) -0.3668 0.4534 -0.4900 6.0206
H(9b) -0.2166 0.4697 -0.4039 6.0206
H(9’a) 0.2876 -0.0959 0.0533 5.4132
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Table 1. Atomic coordinates and B ,,0 /B e, (continued)
atom X y z Be,
H(9’b) 0.4379 -0 . 1 1 1 0 -0.0229 5.4132
H(9’c) 0.3685 -0.1978 0.0424 5.4132
H (llc ) -0.1875 -0.0416 -0.6348 6.1706
H (lla ) -0.3365 0.0324 -0.6407 6.1706
H (llb ) -0.1498 0.0684 -0.6453 6.1706
H ( l l ’a) -0.4185 0.0797 0.1133 6.1480
H ( l l ’b) -0.2275 0.0751 0.1524 6.1480
H ( l l ’c) -0.3281 -0.0199 0.1277 6.1480
B eq =  ^Tr2(U u(aa*)2+U‘22{bbm)2+U33(cc*)2+2U].2aa*bb* cos7 -f2U\zaa*ccm cosß +2U2 3 6 6 *cc* cos a)
O
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Table 2. Anisotropic Displacement Parameters
atom Un U22 u 33 U12 U13 U23
C l(71) 0.0332(9) 0.050(1) 0.136(2) 0 .0100(9) 0 .007(1) 0.003(1)
C l(7 1 ’) 0 .068(1) 0.052(1) 0.047(1) 0 .004(1) 0.0058(9) -0.0131(9)
C l(72) 0 .064(1) 0.086(2) 0.051(1) -0 .006(1 ) 0 .019(1) -0 .020(1)
C l(72 ’) 0 .075(1) 0.0264(8) 0.098(2) 0 .003(1) 0 .014(1) 0.001(1)
0 (2 ) 0 .038(3) 0.035(2) 0.047(3) 0 .000(2) 0 .008(2) 0.011(2)
0 ( 2 ’) 0 .036(3) 0.037(2) 0.040(3) 0 .002(2) -0 .004(2) 0.000(2)
0 (3 ) 0 .043(3) 0.044(2) 0.028(2) 0 .000(2) 0 .002(2) 0.000(2)
0 ( 3 ’) 0 .045(3) 0.031(2) 0.032(2) 0 .001(2) 0 .006(2) -0 .001(2)
0 ( 8 ’) 0 .045(3) 0.041(3) 0.054(3) 0 .010(2) 0 .005(2) -0.002(3)
0 (8 ) 0 .103(5) 0.039(3) 0.069(4) -0 .004(3 ) 0 .021(4) 0.001(3)
0 (1 0 ) 0 .044(3) 0.081(4) 0.063(4) 0 .020(3) 0 .007(3) -0.021(3)
0 ( 1 0 ’) 0 .157(6) 0.031(3) 0.053(4) 0 .005(3) 0 .020(4) -0 .001(3)
0 (1 ) 0 .025(3) 0.033(3) 0.039(4) 0 .003(3) -0 .001(3) 0.004(3)
C ( l ’) 0 .039(4) 0.025(3) 0.043(4) -0 .001(3) 0 .002(3) 0.003(3)
0(2) 0.038(4) 0.032(3) 0.028(3) 0 .001(3) 0 .001(3) 0.003(3)
0 ( 2 ’) 0 .031(3) 0.035(3) 0.029(3) -0 .004(3 ) -0 .004(3) 0.002(3)
0 (3 ) 0 .022(3) 0.038(4) 0.029(4) 0 .001(3) -0 .004(3) 0.003(3)
0 ( 3 ’) 0 .032(4) 0.026(3) 0.031(3) -0 .003(3) 0 .005(3) 0.002(3)
0 (4 ) 0 .032(4) 0.025(3) 0.031(4) 0 .000(3) -0 .004(3) -0 .003(3)
0 ( 4 ’) 0 .029(3) 0.036(3) 0.032(4) -0 .002(3 ) 0 .000(3) 0.000(3)
0 (5 ) 0 .035(4) 0.032(4) 0.039(4) -0 .002(3 ) -0 .001(3) 0.004(3)
0 ( 5 ’) 0 .038(4) 0.035(4) 0.041(4) 0 .003(3) 0 .000(3) -0 .002(3)
0 (6 ) 0 .020(3) 0 .047(4) 0.043(4) 0 .006(3) -0 .008(3) -0.001(3)
0 ( 6 ’) 0 .044(4) 0.027(3) 0.053(4) 0 .002(3) 0 .012(3) 0.004(3)
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Table 2. Anisotropic Displacement Parameters (continued)
atom U n u 22 u 33 U l 2 U l 3 u 23
C(7) 0.029(3) 0.043(4) 0.064(4) 0.006(3) -0.001(3) -0.004(4)
C(7’) 0.045(4) 0.032(3) 0.061(4) 0.005(3) 0.009(3) 0.001(4)
C(8) 0.051(5) 0.038(4) 0.057(5) -0.005(4) -0.012(4) 0.013(4)
C(B’) 0.031(4) 0.038(4) 0.045(4) -0.002(3) 0.000(3) 0.017(3)
C(9) 0.072(6) 0.046(4) 0.071(6) -0.009(4) -0.009(5) 0.023(4)
C(9’) 0.051(5) 0.069(5) 0.050(5) 0.007(4) -0.013(4) 0.002(4)
C(10) 0.056(5) 0.049(4) 0.048(5) -0.014(4) 0.018(4) -0.011(4)
C(IO’) 0.050(4) 0.043(4) 0.036(4) 0.002(4) -0.005(3) -0.010(4)
C (ll) 0.062(5) 0.088(6) 0.047(5) -0.012(5) 0.020(4) -0.022(5)
C ( l l ’) 0.092(7) 0.057(5) 0.047(5) -0.011(5) 0.019(4) -0.020(4)
The general tem perature factor expression:
exp(-27r2(a*2f /n / t2 +  6*2{722fc2 +  c*2[/33/2 +  2a'b 'U l2hk + 2a*c*Ul3hl +  26*c*t/23H))
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Table 3. Bond Lengths(A)
atom atom distance atom atom distance
Cl(71) 0(7) 1.752(6) 0 ( 7 1 ’ 0 (7 ’) 1.748(6)
Cl(72) 0(7) 1.749(7) 0 ( 7 2 ’ 0 (7 ’) 1.770(7)
0(2) 0(2) 1.447(7) 0(2) 0(8) 1.361(8)
0 (2 ’) 0 (2 ’) 1.440(7) 0 (2 ’) 0 (8 ’) 1.350(7)
0(3) 0(3) 1.450(7) 0(3) 0(10) 1.356(8)
0 (3 ’) 0 (3 ’) 1.453(6) 0 (3 ’) C(IO’) 1.362(7)
0 (8 ’) 0 (8 ’) 1.200(7) 0(8) 0(8) 1.187(9)
0(10) 0(10) 1.195(8) 0 (1 0 ’) C(IO’) 1.194(8)
C (l) 0(2) 1.513(7) 0(1) 0(6) 1.541(8)
C (l) 0(7) 1.483(8) C ( l ’) 0 (2 ’) 1.537(8)
C ( l ’) 0 (6 ’) 1.528(8) O (l’) 0 (7 ’) 1.499(8)
C(2) 0(3) 1.520(8) C(2’) 0 (3 ’) 1.515(8)
0(3) 0(4) 1.518(8) 0 (3 ’) 0 (4 ’) 1.514(8)
0(4) 0 (4 ’) 1.472(8) 0(4) 0(5) 1.334(8)
0 (4 ’) 0 (5 ’) 1.355(8) 0(5) 0(6) 1.476(8)
0 (5 ’) 0 (6 ’) 1.479(8) 0(6) 0(7) 1.538(9)
0 (6 ’) 0 (7 ’) 1.509(8) 0(8) 0(9) 1.51(1)
0 (8 ’) 0 (9 ’) 1.494(9) 0(10) 0(11) 1.505(9)
C(IO’) C ( l l ’) 1.493(9)
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Table 4. Bond Lengths(A)
atom atom distance
C (l) H (l) 1.17
C(2) H(2) 0.95
C(3) H(3) 0.95
C(5) H(5) 0.95
C(6) H(6) 1.09
C(9) H(9c) 0.95
C(9) H(9b) 0.95
C(9’) H(9’b) 0.95
C (ll) H (llc ) 0.95
C ( ll) H (llb ) 0.95
C ( l l ’) H ( l l ’b 0.95
atom atom distance
C ( l ’) H ( l’) 1.08
C(2’) H(2’) 0.95
C(3’) H(3’) 0.95
C(5’) H(5’) 0.95
C(6’) H(6’) 1.19
C(9) H(9a) 0.95
C(9’) H(9’a) 0.95
C(9’) H(9’c) 0.95
C ( ll) H (lla ) 0.95
C ( l l ’) H ( l l ’a 0.95
C ( l l ’) H ( l l ’c 0.95
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Table 5. Bond Angles(°)
atom atom atom angle atom atom atom angle
C(2) 0(2) 0(8) 115.6(5) 0 (2 ’) 0 (2 ’) 0 (8’) 116.0(5)
C(3) 0(3) 0(10) 115.8(5) 0 (3 ’) 0 (3 ’) C(IO’) 116.6(5)
C(2) 0(1) 0(6) 115.1(5) 0(2) 0(1) 0(7) 120.9(5)
C(6) 0(1) 0(7) 61.1(4) 0 (2 ’) 0 (1 ’) 0 (6 ’) 115.8(5)
C(2’) C ( l’) 0 (7’) 119.7(5) 0 (6 ’) C ( l’) 0 (7 ’) 59.8(4)
0(2) 0(2) 0(1) 110.0(5) 0(2) 0(2) 0(3) 106.5(4)
C(l) 0(2) 0(3) 113.8(5) 0 (2 ’) 0 (2 ’) C (l’) 109.4(5)
0 (2 ’) 0 (2 ’) 0 (3 ’) 106.9(5) C (l’) 0 (2 ’) 0 (3 ’) 111.3(5)
0(3) 0(3) 0(2) 107.5(5) 0(3) 0(3) 0(4) 109.0(5)
0(2) 0(3) 0(4) 111.5(5) 0 (3 ’) 0 (3 ’) 0 (2 ’) 107.8(5)
0 (3 ’) 0 (3 ’) 0 (4 ’) 107.9(4) 0 (2 ’) 0 (3 ’) 0 (4 ’) 112.2(5)
0(3) 0(4) 0(4’) 119.3(5) 0(3) C(4) 0(5) 119.0(5)
0(4’) 0(4) 0(5) 121.6(6) 0 (3 ’) 0 (4 ’) 0(4) 119.1(5)
0 (3 ’) 0 (4 ’) 0 (5 ’) 119.3(6) 0(4) C(4’) 0 (5 ’) 121.4(6)
0(4) 0(5) 0(6) 123.8(6) 0 (4 ’) 0 (5 ’) 0 (6 ’) 122.5(6)
0(1) 0(6) 0(5) 116.5(5) 0(1) 0(6) 0(7) 57.6(4)
0(5) 0(6) 0(7) 120.9(5) 0 (1 ’) 0 (6 ’) 0 (5 ’) 116.3(5)
C (l’) 0 (6 ’) 0 (7 ’) 59.1(4) 0 (5 ’) 0 (6 ’) 0 (7’) 121.2(6)
Cl(71) 0(7) Cl(72) 112.5(4) Cl(71) 0(7) 0(1) 117.3(5)
Cl(71) 0(7) 0(6) 116.3(4) Cl(72) 0(7) 0(1) 121.2(4)
Cl(72) 0(7) 0(6) 119.2(5) 0(1) 0(7) 0(6) 61.3(4)
Cl(71 ’ 0 (7 ’) Cl(72’ 112.3(4) Cl(71’ 0 (7 ’) C ( l’) 122.3(5)
Cl(71’ 0 (7 ’) 0 (6 ’) 121.3(5) Cl(72’ 0 (7 ’) C ( l’) 115.3(4)
Cl(72’ 0 (7 ’) 0 (6 ’) 115.8(4) C (l’) 0 (7 ’) 0 (6 ’) 61.1(4)
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Table 5. Bond Angles(°) (continued)
atom atom atom angle atom atom atom angle
0(2) 0(8) 0(8) 123.3(7) 0(2) 0(8) 0(9) 110.1(7)
0(8) 0(8) 0(9) 126.6(7) 0 (2 ’) 0 (8 ’) 0 (8 ’) 122.9(6)
0 (2 ’) 0 (8 ’) 0 (9 ’) 111.5(6) 0 (8 ’) 0 (8 ’) 0 (9 ’) 125.6(6)
0(3) 0(10) 0(10) 123.5(6) 0(3) 0(10) C(H) 109.7(7)
0(10) 0(10) 0(11) 126.7(7) 0 (3 ’) C(IO’) 0(10’) 122.4(6)
0 (3 ’) C(IO’) C ( l l ’) 110.4(6) 0(10’) C(IO’) C ( l l ’) 127.2(6)
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Table 6. Bond Angles(°)
atom atom atom angle atom atom atom angle
C(2) 0(1) H (l) 111.1 C(6) 0(1) H (l) 107.0
C(7) 0(1) H (l) 126.8 C(2’) C ( l ’) H (l’) 104.3
C(6’) C ( l’) H ( l’) 130.3 C(7’) O ( l’) H (l’) 122.6
0(2) 0(2) H(2) 108.8 0(1) 0(2) H(2) 108.8
C(3) 0(2) H(2) 108.8 0 (2 ’) 0 (2 ’) H(2’) 109.7
C ( l’) 0 (2 ’) H(2’) 109.7 0 (3 ’) 0 (2 ’) H(2’) 109.7
0(3) 0(3) H(3) 109.6 C(2) 0(3) H(3) 109.6
0(4) 0(3) H(3) 109.6 0 (3 ’) 0 (3 ’) H(3’) 109.6
0 (2 ’) 0 (3 ’) H(3’) 109.6 0 (4 ’) 0 (3 ’) H(3’) 109.6
0(4) 0(5) H(5) 118.1 C(6) 0(5) H(5) 118.1
0 (4 ’) 0 (5 ’) H(5’) 118.7 C(6’) 0 (5 ’) H(5’) 118.7
0(1) 0(6) H(6) 112.4 0(5) 0(6) H(6) 129.0
0(7) 0(6) H(6) 96.5 O (l’) 0 (6 ’) H(6’) 111.5
0 (5 ’) 0 (6 ’) H(6’) 127.1 C(7’) 0 (6 ’) H(6’) 101.9
0(8) 0(9) H(9c) 109.5 0(8) 0(9) H(9a) 109.5
0(8) 0(9) H(9b) 109.5 H(9c) 0(9) H(9a) 109.5
H(9c) 0(9) H(9b) 109.5 H(9a) 0(9) H(9b) 109.5
0 (8 ’) 0 (9 ’) H(9’a) 109.5 0 (8 ’) 0 (9 ’) H(9’b) 109.5
0 (8 ’) 0 (9 ’) H(9’c) 109.5 H(9’a) 0 (9 ’) H(9’b) 109.5
H(9’a) 0 (9 ’) H(9’c) 109.5 H(9’b) 0 (9 ’) H(9’c) 109.5
0(10) 0(11) H (llc ) 109.5 0(10) c(ii) H (lla ) 109.5
0(10) 0 (H ) H (llb ) 109.5 H (llc ) 0(11) H (lla ) 109.5
H (llc) 0(11) H (llb ) 109.5 H (lla ) 0(11) H (llb ) 109.5
C(IO’) c(ii’) H ( l l ’a 109.5 C(IO’) C ( l l ’) H ( l l ’b 109.5
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Table 6. Bond Angles(°) (continued)
atom atom atom angle atom atom atom angle
C(IO’) C ( l l ’) H ( l l ’c 109.5 H ( l l ’a C ( l l ’) H ( l l ’b 109.5
H ( l l ’a C ( l l ’) H ( ir c 109.5 H ( l l ’b C ( l l ’) H ( l l ’c 109.5
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Table 7. Torsion Angles(°)
atom atom atom atom angle atom atom atom atom angle
Cl(71) 0(7) 0(1) 0(2) 149.9(5) 0(71) 0(7) 0(1) 0(6) -106.7(5)
0(71) 0(7) 0(6) 0(1) 108.2(5) 0(71) 0(7) 0(6) 0(5) -148.1(5)
0 (7 1 ’ 0 (7 ’) C (l’) 0 (2 ’) 6.4(8) 0 (7 1 ’ 0(7’) C ( l’) 0 (6 ’) 110.7(6)
0 (7 1 ’ 0 (7 ’) 0 (6 ’) 0 (1 ’) -112.2(6) 0 (7 1 ’ 0(7’) 0 (6 ’) 0 (5 ’) -8.2(9)
0(72) 0(7) 0(1) 0(2) 5.2(9) 0(72) 0(7) 0(1) 0(6) 108.6(6)
0(72) 0(7) 0(6) 0(1) -111.7(5) 0(72) 0(7) 0(6) 0(5) -8.0(8)
0 (7 2 ’ 0 (7 ’) C ( l’) 0 (2 ’) 148.9(5) 0 (7 2 ’ 0(7’) C ( l’) 0 (6 ’) -106.8(5)
0 (7 2 ’ 0 (7 ’) 0 (6 ’) C ( l’) 105.9(5) 0 (7 2 ’ 0(7’) 0 (6 ’) 0 (5 ’) -150.0(5)
0(2) 0(2) 0(1) 0(6) 152.7(5) 0(2) 0(2) 0(1) 0(7) -137.2(6)
0(2) 0(2) 0(3) 0(3) -53.4(6) 0(2) 0(2) 0(3) 0(4) -172.9(5)
0 (2 ’) 0 (2 ’) C ( l’) 0 (6 ’) 155.7(5) 0 (2 ’) 0(2’) C ( l’) 0 (7 ’) -135.9(6)
0(2’) 0 (2’) 0 (3’) 0 (3 ’) -54.1(6) 0(2’) 0(2’) 0 (3 ’) 0 (4 ’) -172.7(4)
0(3) 0(3) 0(2) 0(1) 68.0(6) 0(3) 0(3) 0(4) 0 (4 ’) 93.7(6)
0(3) 0(3) 0(4) 0(5) -83.6(7) 0 (3 ’) 0 (3’) 0 (2 ’) C ( l’) 65.4(6)
0 (3 ’) 0 (3 ’) 0 (4 ’) 0(4) 89.3(6) 0 (3 ’) 0 (3’) 0 (4 ’) 0 (5 ’) -85.8(7)
0 (8 ’) 0 (8 ’) 0 (2 ’) 0 (2 ’) 3.9(8) 0(8) 0(8) 0(2) 0(2) 4(1)
0(10) 0(10) 0(3) 0(3) 1(1) 0(10’) C(IO’) 0 (3 ’) 0 (3 ’) 2(1)
C(l) 0(2) 0(2) 0(8) 76.2(6) 0(1) 0(2) 0(3) 0(4) -51.5(7)
C(l) 0(6) 0(5) 0(4) -20.4(9) 0(1) 0(7) 0(6) 0(5) 103.7(6)
C (l’) 0 (2 ’) 0 (2 ’) 0 (8 ’) 74.1(6) C (l’) 0 (2 ’) 0 (3 ’) 0 (4 ’) -53.3(6)
C (l’) 0 (6 ’) 0 (5 ’) 0 (4 ’) -22.4(9) C (l’) 0 (7’) 0 (6 ’) 0 (5 ’) 104.0(6)
0(2) 0(2) 0(8) 0(9) -175.7(5) 0(2) 0(1) 0(6) 0(5) 1.7(8)
0(2) 0(1) 0(6) 0(7) 113.0(6) 0(2) 0(1) 0(7) 0(6) -103.5(6)
0(2) 0(3) 0(3) 0(10) 145.2(5) 0(2) 0(3) 0(4) 0 (4 ’) -147.7(5)
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Table 7. Torsion Angles(°) (continued)
atom atom atom atom angle atom atom atom atom angle
C(2) C(3) C(4) 0(5) 35.0(8) 0 (2 ’) 0 (2 ’) 0 (8 ’) 0 (9 ’) -176.6(5)
C(2’) C (l’) C(6’) 0 (5 ’) -1.3(8) 0 (2 ’) C ( l’) 0 (6 ’) 0 (7 ’) 110.9(6)
C(2’) C (l’) C(7’) 0 (6 ’) -104.3(6) 0 (2 ’) 0 (3 ’) 0 (3 ’) C(IO’) 140.3(6)
C(2’) C(3’) C(4’) 0(4) -152.1(5) 0 (2 ’) 0 (3 ’) 0 (4 ’) 0 (5 ’) 32.8(8)
C(3) 0(3) C(10) 0(11) -176.8(5) 0(3) 0(2) 0(2) 0(8) -159.9(5)
C(3) C(2) C(l) 0(6) 33.3(7) 0(3) 0(2) 0(1) 0(7) 103.3(7)
C(3) C(4) C(4’) 0 (3 ’) 48.1(8) C(3) 0(4) 0 (4 ’) 0 (5 ’) -136.8(6)
C(3) C(4) C(5) 0(6) 1(1) 0 (3 ’) 0 (3 ’) C(IO’) C ( l l ’) -178.2(5)
C(3’) C(2’) 0 (2 ’) 0 (8 ’) -165.3(5) 0 (3 ’) 0 (2 ’) C (l’) 0 (6 ’) 37.8(7)
C(3’) C(2’) C (l’) 0 (7 ’) 106.2(6) C(3’) 0 (4 ’) 0(4) 0(5) -134.7(6)
C(3’) C(4’) 0 (5 ’) 0 (6 ’) 6(1) 0(4) 0(3) 0(3) 0(10) -93.7(6)
C(4) 0(4’) C(5’) 0 (6’) -168.8(6) 0(4) 0(5) 0(6) 0(7) -86.9(8)
C(4’) C(3’) 0 (3 ’) C(IO’) -98.3(6) 0 (4 ’) 0(4) 0(5) 0(6) -176.1(6)
C(4’) 0 (5’) 0 (6 ’) 0 (7 ’) -90.7(8) 0(5) 0(4) 0 (4 ’) 0 (5 ’) 40.3(9)
C(5) C(6) 0(1) 0(7) -111.3(6) 0 (5 ’) 0 (6 ’) C (l’) 0 (7 ’) -112.1(6)
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Table 8. Non-bonded Contacts out to 3.60 Ä
atom atom distance ADC
0 (7 1 ) 0(2) 3.248(4) 45501
0 (8 ’) 0 (5 ’) 3.164(8) 65501
0 (8 ’) 0 (6 ’) 3.463(7) 65501
0(8) 0(11) 3.40(1) 45402
0(10) 0(6) 3.366(8) 65501
0 (1 0 ’) 0 (9 ’) 3.475(9) 2
C (ll) C ( l l ’) 3.45(1) 55401
atom atom distance ADC
0 ( 7 2 ’ 0 (8 ) 3.569(6) 54501
0 (8 ’) C ( l l ’) 3.382(9) 54502
0 (8 ’) 0 (1 0 ’) 3.563(6) 54502
0(8) 0 (9 ’) 3.493(9) 2
0(10) 0(9) 3.596(9) 54402
0 (1 0 ’) C (8’) 3.545(8) 2
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The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit number: 
TA (first digit) 4- TB (second digit) + TC (third digit) + SN (last two digits). TA, TB and 
TC are the crystal lattice translation digits along cell edges a, b and c. A translation digit of 5‘ 
indicates the origin unit cell. If TA = 4, this indicates a translation of one unit cell length along 
the a-axis in the negative direction. Each translation digit can range in value from 1 to 9 and 
thus ±4  lattice translations from the origin (TA=5, TB=5, TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant to 
this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN=1). Thus, the ADC for 
an origin atom is always 55501. The position of the second atom (target atom) can be generated 
using the ADC and the coordinates of the atom in the parameter table. For example, an ADC 
of 47502 refers to the target atom moved through symmetry operator two, then translated -1 
cell translations along the a axis, +2 cell translations along the b axis, and 0 cell translations 
along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) -X, 1/2+Y, -Z
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